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 “Well my soul checked out missing as I sat listening  
To the hours and minutes tickin' away  
Yeah just sittin' around waitin' for my life to begin  
While it was all just slippin' away  
I'm tired of waitin' for tomorrow to come  
Or that train to come roarin' 'round the bend  
I got a new suit of clothes a pretty red rose  
And a woman I can call my friend  
 
These are better days baby  
Yeah there's better days shining through  
These are better days baby  
Better days with a girl like you  
 
Well I took a piss at fortune's sweet kiss  
It's like eatin' caviar and dirt  
It's sad funny ending to find yourself pretending  
A rich man in a poor man's shirt  
Now my ass was draggin' when from a passin' gypsy wagon  
Your heart like a diamond shone  
Tonight I'm layin' in your arms carvin' lucky charms  
Out of these hard luck bones  
 
These are better days baby  
These are better days it's true  
These are better days  
There's better days shining through  
 
Now a life of leisure and a pirate's treasure  
Don't make much for tragedy  
But it's a sad man my friend who's livin' in his own skin  
And can't stand the company  
Every fool's got a reason for feelin' sorry for himself  
And turning his heart to stone  
Tonight this fool's halfway to heaven and just a mile outta hell  
And I feel like I'm comin' home  
 
These are better days baby  
There's better days shining through  
These are better days  
Better days with a girl like you  
 
These are better days baby  
These are better days it's true  
These are better days  
Better days are shining through” 
(B. Springsteen, Better Days) 
  
  
  
 
To my endless nights… 
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Abstract 
 
 
Aluminum is the third most abundant element on Earth’s crust, and the first metal. Nevertheless, its 
complex chemical features, mainly its low solubility, have prevented its utilization within the 
biological cycles of living organisms, leading to a not fully understood paradox from an evolutionary 
point of view1. 
In the last Century, the acidification of the environment due to the human intervention, has allowed 
Al(III) to become one of the main components of our daily lives. It has become so highly 
(bio)available that some authors state that we are currently living “The Aluminum Age”2.  
As a consequence of such massive human exposure to this non-essential metal ion, detrimental 
neurological effects have been reported, raising concerns about the potential toxic role of aluminum 
in the biological environment3. In particular, the link between the presence of Al(III) in neuronal 
tissues and the development of Alzheimer’s Disease is a matter of debate and controversy, despite all 
the many efforts made in order to unveil the pathogenic effects of Al(III)4,5. 
In this rather controversial context, the quest for reliable chelating agents that can efficiently remove 
Al(III) from the biological environment has attracted much interest in the last years6. The goal of 
chelation therapy is the development of chelating agents with a high affinity and specificity for a 
given metal ion, lack of toxicity and strong competitiveness with respect to endogenous metal ions 
and chelators. However, due to the complex chemistry of aluminum, a suitable and specific Al(III) 
chelating agent has not yet been found6. 
Accordingly, we believe that a computational approach to aluminum biochemistry, by using state-of-
the-art computational tools and in collaboration with experimental partners, would allow for a strong 
help towards a clearer understanding of the role and the behavior of Al(III) in the human organism. 
In this sense, the present PhD project has covered three main areas: i) chelation therapy and 
development of new chelation strategies. ii) Understanding of the potential toxic role of aluminum in 
the biological environment, considering different bioligands. iii) Validation and calibration of the 
accuracy of theoretical methods (mainly DFT) with respect to available experimental data and other 
high level benchmarks, in order to improve the reliability of our computational approach. Moreover, 
the work was carried out in close collaboration with experimental partners from the University of 
Cagliari (Italy).  
Abstract 
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A wide range of methods have been used for that purpose, such as cluster-continuum approaches at 
the DFT level of theory, thermodynamics of metal-ligand complexes in solution, chemical bond 
analysis, QM/MM simulations. The availability and fine understanding of experimental data has 
allowed the setup of a reliable computational protocol suitable for the investigation of Low-
Molecular-Mass (LMM) aluminum chelators. Additionally, other methodologies were used during 
the secondment at SmartLigs®, such as classic MD simulations, docking and MonteCarlo-based 
conformational sampling techniques. 
All results achieved so far are contained in the publications list along with the scientific production 
(e.g. conferences, meetings etc.), and will be presented and discussed in this Thesis dissertation. 
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INTRODUCTION 
 
 
 
 
“My name is Joe Roberts I work for the state  
I'm a sergeant out of Perrineville barracks number 8  
I always done an honest job as honest as I could  
I got a brother named Franky and Franky ain't no good” 
(B. Springsteen, Highway Patrolman) 
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1.1 Living the “Aluminum Age” 
 
1.1.1 What’s wrong with aluminum ? 
Aluminum is the third most abundant element on Earth’s crust (8%) , after oxygen and silicon, and it 
is the most abundant metal7. Al(III) is locked into minerals, and in Nature it occurs only in combined 
forms: as an oxide in bauxite, the primary one, and in complex with aluminosilicates such as micas 
and feldspars7-9. Interestingly, the reaction of silicic acid [Si(OH)4]  with aluminum hydroxide 
[Al(OH)3] to form hydroxyaluminosilicates (HAS) has been proposed to be critical for the non-
selection of aluminum in biochemical evolution and, therefore, as a natural mechanism to combat the 
eco-toxicity of Al(III) including human exposure to this metal8. In other words, it is thought that the 
formation of HAS is a process, created by Nature, to reduce the biological availability of Al(III) and, 
therefore, to reduce its potential toxic effects in living organisms. 
In contrast to its abundance in the crust, the ocean concentration of aluminum is below 1μg of Al/L; 
this low level may be the result of the accumulation of aluminum and silicon by diatoms7. 
However, with the advent of acid rain, metals like aluminum are able to escape from mineral deposits 
and dissolve in fresh waters. Accordingly, acid rain is the key responsible for metal ions release, 
leading to their accumulation in fresh water and, in turn, to their availability to living organisms7. 
Such an acidification of the environment, mainly due to the human intervention in the last Century 
that dramatically changed the environment, is therefore the main factor that lead aluminum to become 
highly available and, most importantly, for the first time bioavailable.  
Indeed, it has been proposed that the non-availability of biologically reactive aluminum species 
throughout the biochemical evolution is what today explains its lack of essentiality in all extant biota2. 
In addition, due to the improvements in the ability to separate aluminum metal from its ores on an 
industrial scale, Al(III) changed from being a largely decorative metal to the most widely used metal 
of the 21st Century2. It has been so widely used that Prof. Christopher Exley (Keele University, UK), 
probably the leading researcher on Al(III) biochemistry, states that we are currently living “The 
Aluminum Age” 2,10,11. 
Accordingly, the ordinary exposure to this metal is the reason that transformed the geochemical cycle 
of aluminum into a biogeochemical cycle, raising concerns about the potential toxic effects that such 
an exogenous and non-essential metal ion can have in the human organism.  
It is indeed true that aluminum finds its way into virtually every aspect of our everyday lives (Fig. 
1.1): it is used in cans and cookware, aluminum foil, housing materials, components of electrical 
devices, airplanes, boats, cars and numerous hardware items10. 
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In terms of bioavailability, nowadays aluminum is found in drinking water due to its action as a 
flocculant, is a common additive in various processed foods, is added to cosmetics of many types, 
and, increasingly, is used in pharmaceutical products. In particular, regarding the latter aspect, it is 
worth to emphasize that various aluminum salts are used as vaccine adjuvants10. This is particularly 
important at present, since such metal-based adjuvants raised concerns about the involvement of 
Al(III) towards the insurgence of autism12-14.  
 
 
 
Fig.1.1. Sources of aluminum in our everyday lives. Taken from ref.10. 
 
In light of the discussion above, is therefore surprising how such an abundant metal, from an 
evolutionary point of view, has not been employed in the biological cycles of living organisms. It is 
reasonable to argue that the complex chemistry and properties of the aluminum ion, mainly its low 
solubility at physiological (biological) conditions, have prevented its utilization within the 
biochemical pathways and molecular life of humans. 
This “big” paradox has been unveiled and discussed in an elegant way by C. Exley in its opinion 
article “Darwin, natural selection and the biological essentiality of aluminum and silicon” 1. 
According to Prof. Exley, “the abundance of an element in the lithosphere only becomes a major 
driving force for its selection for biochemical purpose when abundance is commensurate with the 
availability of biologically reactive forms of the element. Selection acts upon the biological reactivity 
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of an element through pressures such as reaction thermodynamics and reaction kinetics. The former 
are exemplified by equilibrium constants which define properties of reaction products such as 
solubility and complex stability whereas kinetic constraints influence how (bio)chemical equilibrium 
is approached and ultimately which biochemical pathways predominate” 1. 
These arguments clearly explain why Aluminum has not been evolved as an essential and widely 
employed element in the (bio)chemical environment: it is indeed mainly the low solubility of Al(III) 
that provokes its unfavorable thermodynamics in aqueous solution, as it will be largely investigated 
and discussed throughout the results of this thesis dissertation. As previously mentioned, the role of 
silicates, another non-essential element, could be a protective one against Al(III). 
According to what it has been discussed up to this point, an automatic question would be:  
“So, what’s wrong with aluminum?”.  
In fact, this exogenous metal has been related to many toxic effects10,15, and ultimately to an 
involvement towards the development of neurodegenerative diseases, in particular the Alzheimer’s 
Disease5, among others. 
Before deepening this rather controversial topic, in the next section a survey on the physico-chemical 
properties of this metal ion, as well as its binding features, is presented. 
 
1.1.2 The complex and unique (bio)chemistry of the aluminum ion and coordination principles 
1.1.2.1 Hard and Soft Acids and Bases (HSAB) principle 
Aluminum exists only as a trivalent ion in the biological environment of living organisms, and it is 
too reactive to be found in its elemental state in nature16, as discussed in the previous section. 
All metals and metal ions are Lewis acids (electron pair acceptors, i.e. electrophiles) that have 
incomplete valence electron shells. They complex with Lewis bases (electron pair donors, i.e. 
nucleophiles), which are small molecules or ions that have at least one electron pair that can be 
donated16. 
In coordination chemistry, a very useful concept to classify the properties of these metal-donor 
complexes is the Pearson’s Hard and Soft Acids and Bases (HSAB) principle17. According to the 
HSAB classification, small metal atoms with high charge density, that are not easily polarizable, are 
defined as “hard” (Table 1.1). These metals have the tendency to form almost purely ionic bonds with 
hard bases, while bigger and more polarizable atoms, that therefore belong to the “soft” category, 
form mostly covalent bonds with complementary “soft” bases (Table 1.1). 
Considering these main rules, it has been possible to make useful predictions, in terms of Lewis acids 
and bases, of metal complexes with various ligands18. However, it should be taken into account that 
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the HSAB principle is not universal and, moreover, it has been the subject of criticisms in recent 
years19. 
 
Acids 
HARD SOFT 
H+, Li+, Na+, K+, Be2+, Mg2+, Ca2+, 
Sr2+, Ba2+, Al3+, Sc3+, Ga3+, In3+, 
La3+, Gd3+, Lu3+, Cr3+, Co3+, Fe3+, 
As3+, Si4+, Ti4+, Zr4+, Hf4+, Th4+, U4+, 
Pu4+, Ce4+ 
Cu+, Ag+, Au+, Ti+, Hg+, Pd2+, Cd2+, 
Pt2+, Hg2+, Pt4+, Te4+, Br+, I+ 
Borderline 
Fe2+, Co2+, Ni2+, Cu2+, Zn2+, Pb2+, Sn2+, Sb3+, Bi3+, Rh3+, Ir3+  
Bases 
HARD SOFT 
H2O, OH-, F-, PO43-, SO42-, Cl-, 
CO32-, CH3COO-, ClO4-, NO3-, NH3, 
ROH, RO-, R2O, NH3, RNH2, 
R2S, RSH, RS-, I-, SCN-, S2O32-, R3P, 
R3As, CO, (RO)3P, CN-, RNC, C2H4, 
H-, R- 
Borderline 
N3-, Br-, NO2-, N2, SO32- 
 
Table 1.1. Hard and soft acids and bass according to the HSAB principle. Borderline cases are molecules that 
show ambiguous behavior17. 
  
Al(III) is therefore a hard acid (and the hardest trivalent metal ion) because of its small ionic radius 
and high oxidation state. It possesses an effective ionic radius of 0.50 Å, which is smaller than other 
trivalent metals ions like Fe(III), which is a key feature in the field of chelation therapy6. 
Following the HSAB principle, aluminum has high affinity for hard anions (Table 1.1); among the 
hardest donors is the oxide (OH-) anion20. Although OH- and F- are isoelectronic, the OH- ion has 
much more affinity for Al(III) because of the partially covalent nature of the Al-O bond, while the 
Al-F bond is almost purely ionic20. The partial (and small) covalency of the Al-ligand coordinate 
bond is important since it plays an important role in the modulation of the aluminum-ligand binding 
affinity21. Considering the nature of the coordinate (dative) Al-O bond, such covalent character has 
been confirmed to be due to the high electron donation from the donor’s lone pair to the formally 
empty 3s and 3p valence shell of aluminum21. However, in agreement with the HSAB principle, the 
Al-O bond is mainly electrostatic in nature (chapter 3). 
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The high affinity for OH- molecules leads to the fact that, in solution, [Al(OH)4]
− is the most stable 
complex7,22, as it will be discussed in the next section. Such a situation is coherent with the fact that, 
being hydrogen less electronegative than, for instance, carbon, an OH- oxygen is more basic (i.e. 
bears higher electron density) than a phenoxide (C-O) or a superoxide (O-O) oxygen23. This higher 
basicity is, in turn, reflected by the higher covalent character of the Al-O bond23. 
However, it should be always taken into account that, despite the presence of this small but yet 
important covalent character, the Al-ligand bond is mainly ionic/electrostatic driven, a factor that 
shifts the preferential binding of Al(III) to negatively charged donors such as the carboxylate donors 
of protein siechains24. It is important to emphasize that the above discussion is mainly the fruit of 
some of the results achieved in this thesis dissertation, it will be presented and more deeply discussed 
in the results chapters. 
As a result, negatively charged oxygen atoms are the main donors to aluminum, with phenolates, 
carbonyls, carboxylates, catecholates and (bio)phosphates being the main donor groups that can be 
found in the biological environment, and that are used in the design of therapeutic Al(III) chelating 
drugs6,22,25.  
The preferential binding of aluminum to different types of O-donors is, as discussed before, is dictated 
by their basicity; the more basic the donor, the stronger the binding affinity with this hard metal ion20. 
An important consideration must be made at this point: indeed, the increase in basicity of oxygen 
donors is not only responsible for the enhancement of their affinity towards the aluminum ion, but 
also towards the proton. This is due to the fact that H+ is also a hard acid according to the HSAB 
principle20 (Table 1.1). Such a situation is reflected by the increase of the protonation constants of the 
O-donors, a situation that makes energetically more expensive for Al(III) to displace the protons and 
bind to the coordination site of a given ligand21. Accordingly, the aluminum ion/proton competition 
is an aspect that must be seriously taken into account when evaluating the performance of Al(III) 
chelating agents. This aspect will be discussed in chapter 3. 
On the other hand, amines and thiolates are not competitive aluminum binders, as they can barely 
compete with Al(III) hydrolytic species under physiological conditions. Similarly, the nitrogen bases 
of nucleic acids or nucleotides are not strong aluminum binders22. However, it is important to note 
that, if nitrogen donors are placed in a coordination site close to O-donors, then their binding ability 
may change considerably22. 
Clearly, the stronger binding affinity of oxygen atoms over amines and thiolates is due to the mainly 
electrostatic nature of the aluminum-ligand interactions, as discussed before, and aluminum shows 
preference towards negatively charged donors. This is highlighted by the fact that carbonyl groups, 
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such as those that can be found in the backbone of proteins, are not competitive Al(III) binders when 
compared to carboxylates that are found in the sidechains of peptides24 (see chapter 5). 
 
1.1.2.2 Aluminum chelation principles and binding features 
Al(III) preferred coordination number is six, with a preference to form stable octahedral complexes 
with its ligands, although very stable tetrahedral [Al(OH)4]
− complexes can also be formed in 
solution depending on the pH (Fig. 1.2), as it will be discussed in the next section. At low pH values 
(lower than 5.0, Fig. 1.3), the octahedral [Al(H2O)6]
3+complex has been proposed to be higly 
symmetric with a Th point group symmetry, on the basis of both experimental and computational 
studies26. The average Al-O equilibrium bond length was found to be 1.90 Å in ref.26, although this 
value can vary slightly considering different reference works. Interestingly, Hay and coworkers 
suggested that both Al 3p—O 2s and Al 3p—O 2p orbital contributions contribute to the stability of 
the octahedral [Al(H2O)6]
3+ complex26. 
Different ligands (ions, biomolecules, organic compounds) can interact with aluminum through 
different binding modes, i.e. different denticities, which is another important factor that modulates 
the strengths of the Al-ligand(s) affinity. 
The term “chelator” comes from the Greek and refers to the claw of the crab; a chelator is a molecule 
that is able to form at least two or more coordinate bonds with a metal ion, where each functional 
group donates a pair of electrons. The term “denticity”, that comes from the Latin and stays for tooth, 
is used to classify a chelator by the number of donor groups that coordinate a given metal. 
In the case of Al(III) we can have bidentate, tridentate, tetradentate and hexadentate chelators 
(Fig.1.2). Pentadentate chelators are not common since they require the distortion of the octahedral 
or tretrahedral geometries, that are the most common point group symmetries of metals. However, in 
some special cases that involve chelators with many degrees of freedom such as Desferroxamine, 
intra-molecular forces (steric repulsions, H-bonds, etc.) may lead to pentadentate binding modes 
(Fig.1.2). 
The denticity of a given chelator is important since it defines its binding strength towards the metal: 
therefore, considering the thermodynamic equilibria of the aquo aluminum ion in solution (in its 
octahedral state) with a given bidentate chelator (LIGbid), we will have: 
 
 Al(H2O)6 + LIGbid ⇌ [LIGbid − Al(H2O)4] + 2H2O  (1.1) 
 
 Al(H2O)6 + 2 ∗ LIGbid ⇌ [2LIGbid − Al(H2O)2] + 4H2O  (1.2) 
 
 Al(H2O)6 + 3 ∗ LIGbid ⇌ [3LIGbid − Al] + 6H2O  (1.3) 
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For bidentate ligands, three stoichiometric aluminum-chelator complexes are possible; it is important 
to take into account, however, that the formation of these complexes is pH dependent, and it is 
affected mainly be the number of tritratable groups present in the ligand. As discussed before, the 
protonation constants of the ligand’s donor groups to aluminum (e.g. the competition between the 
metal ion and the proton for the ligand binding site) is a pivotal factor that determines the chelation 
performance of a given chelating agents. Such an aspect will be discussed in more detail in chapter 
3. 
Following the equilibria outlined previously for bidentate chelators,  in the case of tridentate ligands 
(Fig. 1.2) we get: 
   
 Al(H2O)6 + LIGtri ⇌ [LIGtri − Al(H2O)3] + 3H2O  (1.4) 
 
 Al(H2O)6 + 2 ∗ LIGtri ⇌ [2LIGtri − Al] + 6H2O  (1.5) 
 
And, for hexadentate chelators: 
 
 Al(H2O)6 + LIGhexa ⇌ [LIGbid − Al] + 6H2O  (1.6) 
 
 
 
 
Fig 1.2. Main species of aluminum in solution and binding modes (denticities) of some common endogenous 
and exogenous Al(III) chelators. Geometries optimized at the B3LYP-D3(BJ)/6-31++(d,p) level of theory. 
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It is clear, from a thermodynamic point of view, that the binding affinity provided by hexadentate 
chelators is much stronger than bi- or tri-dentate chelating agents. Indeed, if we consider the metal 
fully coordinated by the ligand(s), bidentate chelators require three separate reaction steps to 
completely bind to aluminum, tridentate chelators two and hexadentate one. Accordingly, the total 
entropy required in the latter case to form the complex is smaller than those of the previous ones27,28. 
Such an aspect will be further discussed in section 1.2.2.1. 
 
1.1.2.3 Aluminum speciation in solution 
The solubility and speciation of the aluminum ion in aqueous solution are a central point to understand 
the behavior of this metal in the biological environment and, therefore, to investigate its interactions 
with endogenous and exogenous ligands. 
Due to its complex chemical properties, Al(III) forms different hydrolytic species in solution 
according to the pH (Fig. 1.3)7,22. At acidic conditions (pH < 5), aluminum exists as an octahedral 
hexahydrated complex, [Al(H2O)6]
3+. As the solution becomes less acidic, the hexahydrated 
aluminum complex undergoes successive deprotonations leading to [Al(OH)]2+, [Al(OH)2]
+ and a 
soluble [Al(OH)3] complex, with a decreasing and variable number of water molecules
7. This latter 
implies that other different geometries than the octahedral one are possible in solution. 
Neutral solutions give an [Al(OH)3] precipitate that re-dissolves, due to the formation of the 
tetrahedral [Al(OH)4]
− complex, the primary and most stable Al(III) species at pH > 6.2, which is 
the prevalent one at basic pH ranges (Fig. 1.3)7,22. 
 
 
Fig 1.3. Speciation diagram of Al(III) in solution. Taken from ref.29. 
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The four successive deprotonations from [Al(H2O)6]
3+ to give rise to [Al(OH)4]
− are confined 
within an unusually restrained pH range of less than 1 log unit, with pKa values of 5.5, 5.8, 6.0 and 
6.27. This narrow span for Al(III) is explained by the cooperative nature of the successive 
deprotonations due to a concomitant decrease in the coordination number from 6 to 4 (Fig. 1.3). 
Interestingly, while Al(III) is 3 log units less acidic than Fe(III), [Al(OH)4]
− becomes the dominant 
species at almost 3 units lower pH than [Fe(OH)4]
− 7. In the case of, Al(III) only two species 
dominate over the entire pH range, the octahedral hexahydrate [Al(H2O)6]
3+ at acidic pH values and 
the tetrahedral [Al(OH)4]
− at basic pH values, while there is a mixture of different hydrolytic species 
and coordination numbers near physiological pH values (Fig. 1.3)7. 
In light of the above discussion, it is clear that the investigation of aluminum in solution is a very 
challenging task from an experimental point of view, but also for modelling the behavior of such 
metal in solution by means of theoretical approaches. In this latter case, it is important to emphasize 
that, although a reference complex (e.g. an aluminum hydrolytic species) has to be chosen, one should 
always also consider the other different Al(III) species present at a given pH. Different aluminum 
species may lead to different pattern of interactions and binding modes with ligands, providing 
different pictures and scenarios that can provoke the misinterpretation of results. Another challenging 
task and big source of errors concerns the proper evaluation of solvation effects in solution, especially 
when dealing with implicit solvation models30. A paradigmatic case in this sense is a work published 
in Angew. Chem. Int. Ed. where authors limited their investigations and speculations to a single 
[Al(OH)(H2O)5]
2+complex, also without considering solvation effects31. As we demonstrated, the 
account for other aluminum species and for solvation models in the calculations changes considerably 
the nature of the results24. The speciation of Al(III), along with its hybrid bonding nature with ligands, 
is a big limiting factor for the parameterization of specific Force Fields and semiempirical 
methods32,33. More details about the solutions and strategies that we adopted in our computational 
approach to aluminum biochemistry is discussed in the results section. 
 
1.1.3 Is aluminum a (neuro)toxic element ? A (still) controversial topic 
The potential toxic effects of Al(III) are a highly debated matter that still nowadays is not fully 
accepted. The first evidence of the influence of aluminum on the biochemical reactions that govern 
the homeostasis of our body dates back to the 70’s. 
In 1970, it was believed that the phosphorylation of glucose by the hexokinase enzyme in the presence 
of ATP required some kind of “activator” such as citrate at physiological pH. Later, in 1979, the so-
called allosteric activity of citrate (and other activators) was found to be the consequence of 
contamination of laboratory supplies of ATP by aluminum11. Considering the strong affinity that ATP 
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has with respect to Al(III) compared to its usual co-factor Mg(II), it follows that when the Al-ATP 
complex replaces Mg-ATP as a source of phosphate, then the activity of hexokinase is significantly 
lowered11. Under the same conditions, but additionally in the presence of citrate (an extremely 
competitive Al(III) chelator in the biological environment34-36), the Al-ATP complex dissociates and 
the formation of Al-citrate complexes protects the enzyme-substrate complex from the inhibitory 
effect of Al-ATP2. 
In order to argument whether aluminum is toxic or not, first of all it is important to fully understand 
the human’s exposure to this exogenous metal as well as the its potential interference with 
biochemical pathways and molecular processes in the biological environment. 
As mentioned in the beginning, we are all exposed to aluminum because of the human intervention 
in the last Century, that allowed Al(III) to become a major component of our daily lives. An 
interesting concept that provides a mean of the ways by which Al(III) is accumulated in our body is 
the “body burden” of aluminum introduced by Prof. Exley2. 
“The body burden of aluminum is defined as the sum of aluminum atoms associated with the body at 
any one moment in time. It includes aluminum on the surface of the skin, aluminum in hair and nails, 
aluminum associated with external secretions/excretions in the mouth, nose, ear, lung, stomach, small 
intestine, urinary and reproductive tracts and aluminum in the large intestine. It also includes Al(III) 
associated with all of the systemic compartments including endo/epithelia, blood, lymph, sweat, tears, 
humours, tissues, organs and bone”2. 
According to the picture outlined above and shown in Fig. 1.4, it is clear the aluminum ion has the 
potential to interact with many tissues and, therefore, different cellular types and cell components. 
However, in order for that to happen, obviously we must be in close contact with Al(III). Accordingly, 
how are humans exposed to aluminum ? 
It has been show that in order to meet the annual global demand for this metal, approximately 11kg 
of aluminum has to be accumulated for every person from Earth. This aluminum is extracted by 
industry and finds its way in many aspects of our everyday life, as discussed in section 1.1.1; if we 
assume that, for instance, we are exposed to the 0.1% of this potential (e.g. 11kg/year), then it has 
been calculated that our everyday intake of aluminum is 30mg. On the same basis, our intake was 
1mg in 1950 and would be 100mg per day in 20502. 
The first significant contribution to the body burden of aluminum is the air that we breath (Fig. 1.4). 
Aluminum-based particulates of myriad sizes, shapes and compositions are components of aerosols, 
especially in industrialized centers of rapidly growing economies such as China. Exposure to 
aluminum by breathing can be increased in many ways, like industrial workplaces, smoking of 
cigarettes and cannabis2. 
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Fig. 1.4. The body burden of aluminum. Taken from ref.2. 
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Diet is another significant contributor to the body burden of Al(III). Intake of aluminum from the diet 
has been measured to be between 1 to 20mg per day2.  
Topically applied cosmetics, hair, skin and hygiene products are often significant contributors of the 
daily intake of aluminum. This is especially true for antiperspirants, as their use involves the 
application of about 2g of aluminum every day2. 
Finally, it is important to mention that sources of aluminum intake come from intentional and 
unintentional component of many medicines. Intentional ones include antacid and buffered aspirin, 
as well as adjuvants that are added to vaccines and allergy treatments2. 
A more detailed picture (Fig. 1.5) about the systemic pathways and cellular components that are 
affected by the body burden of aluminum can be found in ref.2 and is beyond the scope of this thesis 
dissertation. 
However, it is important to take into account that upon absorption, in an open biological environment 
Al(III) can interact with a wide range of High Molecular Mass (HMM, e.g. transferrin) and Low 
Molecular Mass (LMM, e.g. citrate) endogenous ligands, as well as to easily cross cellular 
membranes and the blood-brain-barrier (Fig. 1.5). Obviously, this makes the understating of the 
possible mechanism of toxicity of Al(III) a very challenging task. 
 
 
Fig.1.5. Schematic representation of sources of aluminum intake and its speciation in the biological 
environment. 
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In conclusion, in this section a general picture about the human’s exposure to Al(III) and, moreover, 
its potential interferences with the biochemical environment of the human organism has been 
provided. In light of what discussed above, can we state that aluminum is a potential health problem? 
Unfortunately, there is not a clear answer to this question. It depends on many factors, the most 
important of which is the concentration of aluminum that we are exposed to. It is undoubted that, as 
discussed in this section, in places where for environmental, workplace-based or atmospheric reasons 
there is a high exposure to this exogenous metal, then it is reasonable to argue that (long-term) toxic 
effects mediated by Al(III) may occur due to its accumulative power in the organism. 
In this sense, I think that it is worth to mention the McIntyre Powder Project 
(http://www.mcintyrepowderproject.com/) by Janice Martell. The goal of this non-profit project is to 
gather information about the health issues (mainly neurological) caused by aluminum dusts to miners 
and other steelworkers of several regions of Canada. This project was started after Janice’s father, 
one of these steelworkers, was diagnosed with Parkinson’s Disease. 
However, a central point to understand aluminum’s toxicity is the concept of tolerance. It is well 
assessed that plants, in order to protect from the detrimental effects of Al(III), have evolved some 
mechanisms that induce tolerance to this non-essential metal37. In humans, it has measured that the 
tolerable weekly intake of Al(III) is 1mg aluminum/kg body weight38. Nevertheless, mechanisms and 
genes that may be involved in the biological tolerance of aluminum in humans are not known yet. 
This is clearly pivotal in order to address the effective toxicity of this metal in “standard” daily lives, 
and, in that sense, to develop different and more specific therapeutic strategies than chelation therapy. 
A general view of the proposed molecular basis of aluminum toxicity, with special focus on tis role 
with respect to Alzheimer’s Disease, will be provided in the next section. 
 
1.1.4 The (neuro)toxicity of aluminum and its link to Alzheimer’s Disease: an overview of the 
current status  
 
1.1.4.1 Aluminum’s interaction with the biological environment 
Several potential detrimental effects have been attributed to the aluminum ion in the biological 
environment; these include interaction with Low Molecular Mass (LMM) molecules such as 
citrate36,39, 2,3-diphosphoglycerate22,40, Glucose-6-phosphate41, nicotinamide adenine dinucleotide 
(NADH)42,43, catecholamines44, biophosphates (DNA, RNAs and in particular Adenosine-5-
phosphates like ATP)22,45 among others. Likewise, Al(III) can interact with High Molecular Mass 
(HMM) ligands such as transferrin22,46,47, albumin22 and Aβ-amyloid48-50. 
Moreover, the interference of aluminum with the biochemical processes of the cell has been related 
to the production of dangerous free radicals51-53; in particular, although Al(III) is a non-redox metal, 
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it has been proposed that its pro-oxidant activity is mediated through its interference with the Fenton 
reaction54-56. 
The harmfulness of aluminum has been also related to patients with chronic renal failure and 
dialysis14,36,57, dialysis encephalopathy5,14,58, autism12,13 and neurodegenerative diseases such as 
amyotrophic lateral sclerosis (ALS)5,6, Gulf War Syndrome5,6, and, above all, Alzheimer’s Disease 
(AD)4,5,48,49,59-61 and Parkinson’s Disease (PD)49,62-64.  
Due to the enormous size of the topic, this section will focus in detail on the role of Al(III) in the 
brain and on its link with neurodegenerative diseases, in particular AD.  
 
1.1.4.2 Aluminum and neurodegenerative diseases: towards a link with Alzheimer’s Disease 
Although the potential toxic role of Al(III) has been presented and largely discussed in the previous 
setions, the mechanisms and the molecular basis by which this metal influences the physiological 
activities of the cell are still obscure. This is particularly true when we consider the effects of 
aluminum in the brain, where its competition with myriad of biomolecules and other endogenous 
metals, as well as its low concentration, make the speculation of its detrimental effects a hard matter, 
as outlined by Exley: 
“The neurotoxicity of aluminum is well documented and widely accepted while the mechanisms 
through toxicity is brought about are much less completely understood”49. 
In Table 1.2 and Fig. 1.6, sites of the central nervous system (CNS) that are affected by the presence 
of aluminum according to the most recent literature are summarized. These adverse effects include 
crucial reactions for brain development such as the axonal transport, neurotransmitter synthesis 
(specially the catecholamines pathway), synaptic transmission, phosphorylation or dephosphorylation 
of proteins (such as Tau), protein degradation, gene expression and infiammatory responses (Table 
1.2). An excellent review that discusses these aspects in detail can be found in Ref.5.  
 
Effects of aluminum in the central nervous system (CNS) 
Nucleus and gene expression 
Binding to DNA 
 Binds to Histone-DNA complex and 
induces conformational changes of 
chromating. 
 Induces topological changes of DNA. 
Altered gene expression 
 Induces decreased expression of 
neurofilaments and tubulin. 
 Induces altered expression of genes of 
neurofilament, APP, and neuron specific 
enolase. 
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 Induces decreased expression of transferrin 
receptor. 
 Induces altered expression of RNA 
polymerase I. 
 Induces downregulation of mitochondrial 
cytochrome c oxidase. 
 Induces altered expression of calbindin-
D28k. 
 Induces decrease in the expression of nerve 
growth factor (NGF) and brain derived 
neurotrophic factor (BDNF). 
 Induces expression of pro-inflammatory 
genes and pro-apoptotic genes. 
 Induces elevated expression of APP. 
 Induces altered expression of oxidative 
stress marker genes (SOD1, glutathione 
reductase, etc.). 
 Induces decreased expression of neprilysin. 
 Induces altered expression of β-APP 
secretase (BACE1 and BACE2). 
Cellular functions 
Energy metabolism 
 Inhibits the activity of hexokinase. 
 Inhibits the activity of phosphofructokinase. 
 Inhibits the activity of glucose-6-phosphate 
dehydrogenase. 
 Causes mitochondrial dysfunction and 
depletion of ATP. 
 Decreases in activity and expression of 
TCA-cycle related enzymes (succinate 
dehydrogenase (SDH), alpha-ketoglutarate 
dehydrogenase (KGDH), isocitrate 
dehydrogenase-NAD+ (IDH), fumarase 
(FUM), aconitase (ACN), and cytochrome c 
oxidase (Cyt C Ox)). 
Phosphorylation and dephosphorylation 
 Inhibits the activity of protein 
phosphatase. 
 Increases the activity of protein kinase C 
and cytoskeleton proteins. 
 Accelerates phosphorylation and 
accumulation of neurofilament. 
 Enhances Ca2+/Calmodulin dependent 
protein kinase activity. 
 Accelerates phosphorylation of MAP 2 
and neurofilament. 
 Inhibits dephosphorylation of tau. 
 Induces nonenzymatic phosphorylation 
of tau. 
Abnormal accumulation of proteins 
 Causes the conformational change and 
the accumulation of neurofilament and 
MAP1A, MAP1B. 
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 Accelerates the phosphorylation of tau 
and its accumulation. 
 Causes the accumulation of tau protein 
in neuroblastoma cells or in primary 
cultured neurons. 
 Causes the accumulation of tau protein 
in experimental animals. 
 Causes neurofibrillary degeneration in 
vivo. 
 Causes the accumulation of Aβ-amyloid 
in cultured neurons or in neuroblastoma 
cells. 
 Causes the accumulation of Aβ-amyloid 
in vivo. 
Neurotransmitter release 
 Inhibits glutamate release. 
 Impairs synaptic transmission. 
 Inactivates glutamate dehydrogenase. 
 Inhibits NMDA-type glutamate 
receptor. 
 Inhibits choline acetyl transferase and 
tyrosine hydroxyl11ase, glutamate 
decarboxylase. 
 Influences acetyl-CoA and inhibits 
acetylcholine release. 
 Activates monoamine oxidase. 
 Inhibits dopamine beta-hydroxylase. 
 Inhibits uptake of serotonin and 
noradrenalin in synaptosomes. 
Channel inhibition 
 Influences the activities of Na+ channels 
and K+ channels. 
 Enhances the voltage-activated Na+ 
channels. 
 Inhibits the voltage-gated calcium 
channel. 
 Inhibits the IP3-mediated Ca2+ release. 
Others 
 Influences GTP binding proteins as 
aluminum fluoride. 
 Inhibits GAP junction. 
 Inhibits axonal transports. 
 Binds to calmodulin and inhibition of 
calmodulin-binding enzymes. 
 Induces inflammatory responses. 
Membrane lipids 
Peroxidation 
 Accelerates iron-induced membrane 
lipid peroxidation. 
 Enhances lipid peroxidation in 
liposomes. 
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 Induces peroxidation of myelin lipids in 
vivo. 
 Increases peroxidation products 
(malondialdehyde). 
Membrane properties 
 Causes the change the 
lipid/phospholipids profiles of myelin in 
vivo. 
 Induces the change in membrane 
physical properties (surface potential, 
lipid fluidity, and lipid arrangement). 
 Induces the change of membrane fluidity. 
Higher properties 
Cell death 
 Causes the apoptotic neuronal death. 
 Causes the apoptosis of astrocytes. 
 Causes the death of motor neuron. 
Behavior, learning and memory, others 
 Inhibits long term potentiation (LTP). 
[99, 100] 
 Causes learning disorder or memory 
deficit in experimental animals. 
 Influences electrical activity in 
hippocampus and inhibits spatial 
learning memory deficit in aging rats. 
 Causes memory deficit in AD model 
mice. 
 Causes encephalopathy in dialysis 
patients. 
 Causes encephalopathy in patients with 
renal failure. 
 
Table 1.2. Effects of aluminum in the central nervous system (CNS). Edited from ref.5 and references herein. 
 
It is clear that Al(III) has the potential to affect the normal biochemistry of neuronal cells at many 
different levels; accordingly, what is the controversial role of aluminum in the pathogenesis of 
Alzheimer’s Disease (AD) ? What are the evidences in this sense and (if any) the molecular basis that 
lead to the neurodegenerative phenotype ? 
AD is a severe type of senile dementia first reported in 19065. The pathological hallmarks are the 
deposition of extracellular senile plagues, intracellular neurofibrillary tangles (NFTs) and the 
selective loss of synapses and neurons in the hippocampal and cerebral cortical regions5. 
Intracellular NFTs are mainly composed of the phosphorylated tau protein. In a pioneering study, 
Hollender et al., investigated the structural features of an octapeptide NFT analogue (GEGEGSGG) 
and its phosphorylated serin (ser(P)) derivative, both in presence/absence of Al(III)65. 
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Fig. 1.6. Major biological effects of Al(III) in the central nervous system (CNS). Taken from ref.5. 
 
Their results revealed that both phosphorylated and dephosphorylated octapeptide is able to bind 
aluminum; however, NMR chemical shifts pointed to a significant change in the Al-binding pattern 
upon phosphorylation65. 
Further computational studies, were able to unveil the effect of phosphorylation to this NFTs 
analogue: the addition of phosphates has been proposed to (i) change the binding pattern to AlII 
shifting the preferential site from C-terminus to ser6(P). (ii) Increase its binding affinity by 15 
kcal/mol, a fact mainly due to the increase in the overall negative charge upon phosphorylation. And 
(iii) cause important changes in the secondary structure of the polypeptide chain, which may be a 
contributing factor to the aggregation process of NFTs in Alzheimer’s Disease66. 
Extracellular senile plagues contain a large amount of Aβ-amyloid protein67. The hypothesis that 
Al(III) is an environmental contributor of the pathogenesis of AD, the “aluminum hypothesis”, was 
proposed in 1960s based on various neurotoxicological, analytical and epidemiological evidences5. 
In a seminal study, Exley et al. demonstrated the affinity of aluminum for Aβ-amyloid(1-40), and 
highlighted the partial loss of α-helical conformation of the oligopeptide upon aluminum binding, 
leading to a β–sheets rich structure, typical of the amyloid aggregates68. Moreover, very recent studies 
with state-of-the-art experimental techniques demonstrated the presence of high levels of aluminum 
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in brain tissues of patients diagnosed with familial AD69,70, and that this non-essential metal might be 
a strong contributor to the development of AD4. 
However, in spite of these findings, the aluminum hypothesis has been the subject of much debate 
and criticism for several decades, and still it is. 
In order to try to explain and clarify the link between Al(III) and AD at the molecular level, many 
hypothesis have been made: 
 
I. A fist hypothesis proposes that aluminum may lead to conformational changes in the Aβ 
peptide from an α-helices based structure to a β-sheets rich one, as mentioned before68, also 
promoting their incorporation into cell membranes as calcium-permeable channels and 
provoking the increase of intracellular calcium levels and cell death6,68. 
 
II. In the second hypothesis, the idea is that Al(III) may interact with the acidic groups of Aβ-
amyloid promoting its aggregates and accelerating the formation of amyloid fibrils6,71. 
 
III. A third possibility states that aluminum facilitates iron-mediated oxidative damage in neurons, 
caused by co-deposition of Aβ peptides with Al(III) and Fe(III) 6,72. 
 
IV. The fourth hypothesis, that has been called the “amyloid cascade hypothesis” 5, shares 
characters from the previous hypothesis and tries to outline a multistep complex picture. It  
relies on the fact that the metal-induced conformational changes of Aβ-amyloid, and its 
consequent neurotoxicity, play a central role in the development of AD. Al(III) as well as 
other endogenous metals such as Fe(III), Zn(II) and Cu(II), influence, in different manners 
and at different stages, the oligomerization and conformational changes of Aβ-amyloid  thus 
acting as bridging factors with respect of negatively charged oligopeptides side chains5. A 
more detailed discussion on this aspect is provided in the next section. 
 
1.1.4.3 The amyloid cascade hypothesis 
Aβ-amyloid (AβP) is a small peptide consisting in 39-42 aminoacids, secreted by cleavage of the 
amyloid precursor protein (APP), a membrane protein whose primary function is still unknown. The 
N-terminus of APP is cleaved by the β-site APP cleaving enzyme 1 (BACE 1) while its 
intramembrane C-terminus is cleaved by γ-secretase5. 
The resulting AβP is a hydrophobic peptide with an intrinsic tendency to self-assemble and form 
stable oligomers in aqueous solution. In its monomeric form, AβP has a random coil structure, while 
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the oligomeric form is mainly composed of by β-sheet structures and form insoluble aggregates, 
known as amyloid fibrils5. 
As previously mentioned, it has been proposed that aluminum can bind to the negatively charged side 
chains of AβP. Other metals share the binding site, although their stability constants (i.e. binding 
affinities) are different. Al(III) is known to bind and affect several metal binding proteins, as well as 
to influence the homeostasis of other biologically important metals; therefore, the interplay of 
aluminum with other endogenous metals should be considered a possible explanation for the 
implications of various trace elements in the pathogenesis of AD5. 
Figure 1.7 summarizes the hypothesized synergic interactions between aluminum and other metals 
towards the formation and stabilization of detrimental amyloid aggregates. 
Aluminum, as an hard Lewis acid, shares some similar characteristic to the trivalent Fe(III) ion, and 
therefore is prone to ligate to iron regulatory proteins such as transferrin or the iron regulating protein 
(IRP). The iron responsive element/iron regulatory protein network (IRE/IRP) regulates the 
production of iron binding proteins (transferring, ferritin) which prevent the formation of free Fe(II) 
ions that are involved in dangerous free radicals production5 (Fig. 1.7). 
In iron-deficient conditions, IRP binds to IRE and regulates the expression of genes that contain iron 
responsive elements in their mRNA such as transferrin or ferritin. As the concentration of Fe(II) 
increases, iron binds to IRP and the expression of transferrin is downregulated while that of ferritin 
is upregulated leading to a decrease in the amount of free Fe(II) 5. 
Al(III) can also bind to IRP and therefore influences the expression of iron binding proteins that 
contain IREs in their mRNA, causing high concentrations of iron in the cell (Fig. 1.7)5. 
In this way aluminum affects iron homeostasis and the expression of genes regulated by its 
homeostasis. The crucial point is that APP-associated mRNA contains an IRE as well as ferritin, and 
its expression is regulated by iron. The consequence is that aluminum causes elevated expression of 
APP5. 
On the other hand, it has been found that Zn(II) inhibits the ferroxidase activity of APP; moreover, 
APP contains copper/zinc binding sites in its N-terminal and in the AβP domain and therefore it may 
be involved in the homeostasis of these metals5. 
An abnormal expression of APP could lead to an increased production of AβP and enhance its 
accumulation. AβP is usually degraded by proteases like neprilysin after a shor period. Al(III) has 
been shown to downregulate neprilysin, which in turn implies increased accumulation of AβP5. Other 
evidences point to a promotion of the oligomerization of AβP in presence of trace metals like Al(III), 
Zn(II) and Fe(III), to its resistance to proteases and its accumulation in brain. 
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Fig. 1.7. Schematic representation of the amyloid cascade hypothesis. Taken from ref.5. 
 
The newly formed AβP oligomers could be incorporated into cell membranes, resulting in the 
formation of ion channels. A subsequent influx of calcium through these amyloid-based channels 
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would lead to the phosphorylation of tau proteins, depletion of neurotrophic factors and the formation 
of free radicals, whose final outcome would be neuronal death (Fig. 1.7)5. 
It is worth to mention that, in light of the above discussion, the use of chelation therapy as a potential 
cure for the attenuation of the severe phenotypes caused by AD has shown very promising results73, 
which is another evidence towards the involvement of trace metals, and aluminum among them, in 
the pathogenesis of neurodegenerative diseases. 
As previously mentioned, the exact molecular basis of the binding of Al(III) to Aβ-amyloid are not 
well understood. However, a recent computational study carried out in our group by means of a multi-
level approach ranging from Quantum Mechanical cluster models to full size QM/MM hybrid 
simulations helped in elucidating, for the first time, a possible 3D structure of Al(III)-AβP(1-42) (Fig. 
1.8)74. 
 
 
 
Fig. 1.8. Proposed structure for the most stable 1:1 Al(III)- β-amyloid complex. Created with data from ref.74. 
 
By translating the pre-organization concept of host-guest interaction for the binding of metals to 
peptides, this study proposes that the most stable structures are formed by the interaction of aluminum 
with  the negatively charged carboxylate groups of Glu3, Asp7 and Glu11; some peptide bond 
carbonyl oxigens may fill the coordination sphere of Al(III) through dative bonding (Fig. 1.8)74. 
The calculated interaction energy (ΔE) of the most stable Al-AβP complex was found to be -172.9 
kcal/mol at the PBE/def2-SV(P) - COSMO level of theory. Comparing the relative binding affinity 
with those of other bioligands previously calculated in other works, it has been found that the stability 
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of the complex is comparable to those of citrate (the strongest endogenous Al(III) chelator)39.  These 
findings are coherent with hypothesis that monomeric β-amyloid has high affinity for this metal and, 
accordingly, it might be a primary aluminum chelator in the brain.   
Such a study aimed to help to unveil a possible structure for the aluminum-amyloid complex in 
absence of an experimental X-ray template; such results may be a starting point towards the 
understanding of the molecular basis of the role of aluminum in the aggregation process of amyloid 
fibrils. 
 
1.2 Chelation therapy 
 
1.2.1 The goal of chelation therapy 
Chelation therapy can be defined as the use of a chelating agent in order to remove an undesired metal 
ion and/or the attenuation of its toxicity by transforming it into less toxic compounds.  
Metal-induced toxicity can be classified according to the source and the effect: 
 
1. Acute ingestion of a toxic metal, that can be accidental (children) or voluntary or self-induced 
(suicidal/homicidal purposes). 
 
2. Chronic intoxication, that may have environmental, occupational or iatrogenic causes. 
 
 
3. Metal overload due to genetic diseases (e.g. Wilson’s Disease75). 
 
It is clear that, as thoroughly discussed in the previous sections, Al(III) mainly relates to point 2, as 
the environmental and occupational features of the “Aluminum Age” are supposed to lead to chronic 
accumulation of this metal with long-term effects that may be related to the insurgence of 
neurodegenerative diseases. 
One of the main challenges of chelation therapy, that will be discussed in section 1.2.4, is the small 
degree (or, in some cases, lack) of specificity, i.e. the distinction between different essential and toxic 
metal ions. 
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1.2.1.1 Essential and non-essential metal ions 
Essential elements are chemical compounds that are fundamental for the biochemical processes of 
living cells; mammalians require 30 essential elements, that can be classified as essential, inert and 
toxic18. Among these elements, eukaryote cells require 17 metals. Much of these metals paly a dual 
role in the organisms, according to their concentration: toxic compounds can be tolerated in low 
doses, while essential elements can be toxic at thigh concentrations, as showed in the Bertrand 
diagram of Fig. 1.9. 
Essential metals include copper, which is a cofactor of many oxidative enzymes such as the 
Dopamine-β-hydroxylase involved in the catecholamine biosynthesis pathway64,76,77. Iron is involved 
in hundreds of enzymatic reactions (such as the Fenton reaction54) and is the most important 
component of hemoglobin, the oxygen carrier in red blood cells. Zinc is a component of more than 
three hundred of proteins18. Zinc deficiency, which is often encountered in third world countries, can 
lead to dwarfism, and adolescent nutritional-associated disorder18. 
 
 
 
Fig. 1.9. Bertrand diagram showing essential and non-essential (toxic) metal ions. 
INTRODUCTION 
 
42 
 
Cobalt is an essential cofactor of vitamin B12, which is involved in DNA redulation; manganese is a 
cofactor of many enzymatic reactions involving phosphorylation, cholesterol and fatty acids 
synthesis. Selenium is essential for several anti-oxidant enzymes; it is interesting to note that, contrary 
to animals, plants do not require selenium to survive, however they can adsorb it and this is the reason 
of selenium poisoning that may occur upon eating plants growing in selenium rich soils18. 
Molybdenum is an essential cofactor for xanthine oxidase and aldehyde oxidase; it is also essential 
to plant as it is involved in the regulation of nitrogen metabolism through bacteria18. 
Fundamental and clear knowledge of the essential metal ions is mandatory since aluminum, a non-
essential element, can influence and interfere with the concentrations and biochemical pathways of 
many of these essential metals in several different ways that are still not properly understood. 
From n experimental point of view, the behavior of a metal at physiological conditions mainly 
depends on its speciation, as discussed in section 1.1.2.3. In this sense, different species that are 
formed, as well as the thermodynamic equilibria in solution and their stability constants, allow to 
determine their soluble/insoluble species, complexes with endogenous/exogenous chelators and their 
concentrations. In this sense, the thermodynamic approach is a very reliable choice in analytical 
chemistry for the study of ligands that interact with metal ions like aluminum78-80. 
In particular, such an approach has been found to be very reliable for the study of ligands that may 
be used as chelating agents for metal intoxication6,25,28. In the next section an overview on the 
properties of these chelators is provided. 
The concepts of “chelator” and “denticity” were introduced in section 1.1.2.3, explaining the possible 
binding modes with respect to aluminum (Fig. 1.2).  
 
1.2.2 Al(III)-based chelating agents 
Chelating agents (chelators) are organic or inorganic compounds able to bind metal ions and form 
complex ring-like structures called “chelates”. As introduced in section 1.1.2.3, they can have 
different binding modes (denticity, Fig. 1.2) which influences the strength and the stoichiometries of 
the formed complex according to the pH considered.  
In light of what it was discussed in section 1.1.2 for the case of aluminum, the main determinants that 
influence the Al-chelator binding affinity can be summarized as follows, ordered by their relative 
effect on the stability: 
  
i) Aluminum/proton competition for the ligand’s binding site: since both Al(III) and H+ 
are hard Lewis acids, the higher the pKa of the donor atoms of the chelator, the higher the 
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affinity for the proton and, therefore, the higher the energy required for Al(III) to displace 
the proton and bind the ligand. 
 
ii) Competition with aluminum hydroxide: [Al(OH)4]
− is the most stable aluminum species 
in solution at physiological and basic pH range; therefore, in order to bind Al(III), a given 
chelator must form complexes that are thermodynamically more stable than aluminum 
hydroxide formation. 
 
iii) Steric effects (geometrical distortions): Al(III) first coordination shell can accept up to 
six donor atoms,  with octahedral and tetrahedral geometries being the preferred ones. 
When steric hindrances take place within the Al-chelator complex due to intramolecular 
H-bonds (Desferroxamine in Fig. 1.2) or substituents close one another (6-methylsalicylic 
acid in Ref.81) then the final complex may contain distorted geometries that lower the 
overall complex stability. 
 
iv) Denticity and stoichiometry: different pH values lead to different stoichiometric Al-
ligand complexes depending on the denticity of the chelator; due to the chelate effect 
(explained in the next section), ligand’s denticity usually follows the trend monodentate 
< bidentate < tridentate < tetradentate < pentadentate < hexadentate. 
 
v) Charge of the donor atoms: as previously discussed, Al(III) prefers to bind to negatively 
charged donors, although it can also bind to neutral ligands (H2O, amines) via their lone 
pairs because of the dative nature of most of the Al-ligand interactions. The charge of the 
donors is so important that may overcome the denticity of the chelator. 
 
vi) Basicity of the donor atoms: when donor atoms bear the same charge, then the 
determinant for the stability of the Al-ligand complex shifts to their basicity; the higher 
their Lewis basicity, the higher their affinity for Al(III). 
 
vii) Kinetic factors and relative concentrations: finally, other important factors to be 
considered in an open biological environment are the competition with endogenous 
aluminum chaltors (e.g. citrate), the relative Al(III)/ligand concentrations in a given site 
and the kinetics or their reaction1,82,83 . These later factors are far beyond the scope of this 
dissertation (and an extremely challenging task in computational modelling based on 
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cluster-continuum approaches); this thesis work will mainly focus on the thermodynamics 
of the Al-ligand interactions. 
 
Therefore, an effective and potentially therapeutic aluminum chelating agent must meet the 
requirements summarized above in order to be able to form competitive complexes. 
In addition, an “ideal” and clinically relevant chelating agent should possess the following 
features6,28:  
 
 Low toxicity of both the chelating agent and the formed complex. 
 Fast elimination of the metal-chealtor complex. 
 High selectivity toward the aluminum ion (extremely challenging). 
 Biochemical metabolism of the chelating agent once entered in the body. 
 Fast kinetic and exchange with endogenous ligands. 
 Favorable intestinal adsorption. 
 
Most of these biomedical factors belong to medicinal chemistry and are not the subject of this thesis 
dissertation. 
 
1.2.2.1 The chelate effect 
The “chelate effect” relies on entropic parameters. Considering the thermodynamic relationship 
between Gibbs free energy and stability constants79,80 (logβ, discussed in section 1.2.3.1): 
 
 𝛥𝐺 = 𝑅𝑇𝑙𝑛𝛽                                                  (1.7) 
 
 𝛥𝐺 = 𝛥𝐻 − 𝑇𝛥𝑆                                                  (1.8) 
 
Where ΔG is the Gibbs free energy, R is the gas constant (1.987 cal mol-1 K-1) and T is the 
temperature. Accordingly, β increases as ΔG becomes more negative (due to more negative ΔH or 
more positive ΔS ). 
As a very simple case, consider the reaction equilibria of eq. 1.9 and 1.10 as well as their 
thermodynamic data reported in table 1.3 (taken from Ref.18): 
 
 Cdaq
2+ + 4 ∗ CH3NH2 ⇌ [Cd(CH3NH2)4]aq
2+                                     logβ=6.5     (1.9) 
 
 Cdaq
2+ + 2 ∗ NH2CH2NH2 (aq) ⇌ [Cd(NH2CH2NH2 )2]aq
2+             logβ=10.6     (1.10) 
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Ligand ΔH (kJ mol-1) ΔS (J mol-1 deg-1) -TΔS (kJ mol-1) ΔG (kJ mol-1) 
4(CH3NH2) -57.3 -67.3 20.1 -37.2 
2(NH2CH2NH2) -56.5 14.1 -4.2 -60.7 
 
Table 1.3. Thermodynamic data of a purely entropic chelate effect.  
 
In this example, CdII, whose coordination shell has a tetrahedral geometry, coordinates four 
methylamines (eq1.9) and two ethylenediamines (eq 1.10). 
As shown in Table 1.3, the enthalpies of the two reactions are similar, therefore the differences in 
stability constants can be attributed solely to the difference in entropy. The main cause for the large 
increase in entropy is probably the net increase in the number of unbound water molecules. 
Thus, although four CH3NH2 displace four H2O from cadmium with no net change in the number of 
indipendent molecules, it takes only two ethylenediamines to displace four waters. 
In summary, the chelate effect, that is, the increase in the metal-chelator complex stability through 
different denticities is (usually) an entropic-driven process.  
However, it is worth to emphasize one more time that other determinants (discussed in the previous 
section) concur in the modulation of the stability of a given complex. All these components lead to 
an overall complex picture whose clear understanding is of paramount importance towards the 
development of new and powerful Al(III) chelating agents. 
 
1.2.2.2 Al(III) chelating agents: the current status 
Since the trivalent aluminum ion shares many properties with the trivalent iron ion, in particular they 
are both hard Lewis acids, the Al(III)-based chelation therapy is irreversibly coupled with Fe(III)-
based chelation therapy. Indeed, all chelating agents developed so far for the treatment of iron 
overload disorders are also employed in aluminum-related toxicity such as dialysis dementia 84,85. 
The reason is that all chelators that show high affinity for Al(III) also retain high (and in almost all 
cases higher) affinity for the trivalent iron ion, due to the main ionic nature of the metal-chelator 
interaction. This lack of specificity is an important problem that has not been solved yet and will be 
discussed more in detail in section 1.2.4. 
Currently, there are two main commercial chelating agents that have been approved by the U.S. Food 
and Drug Administration (FDA) for the treatment of iron- and aluminum-related pathologies: 
deferiprone (Ferriprox®) and deferoxamine (Desferal®), presented in Fig. 1.10. 
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Deferiprone (1,2-dimethyl-3-hydroxy-4-pyridinone, Fig. 1.11) has been approved and introduced into 
clinical practice since 200027,86. It is a bidentate chelating agents, and. Most importantly, it is orally 
active, in contrast to other chelators such as deferoxamine that need to be administred by 
subcutaneous injection87. It binds the metal through the negatively charged phenoxide, after 
deprotonation, and the carbonyl oxygen (Fig. 1.11). The phenoxide group bears a relatively small pKa 
value of 9.886, which allows the metal to have a good competition with respect to the proton; on the 
other hand, the metal binds through dative bonding to the lone pairs of the carbonyl. The presence of 
both a single proton competition (opposed to a dual proton competition as in the case of catechols, 
explained later on in this section) and the methyl in position 3 (electron donating group, see section 
3.1) result in a good chelating performance for this chelator expressed by the value of pAl (see section 
1.2.3.2) of 15.886. 
The main drawbacks of this widely studied Al(III) chelating agents are its poorer performance when 
compared with other hexadentate cheators such as deferoxamine, due to the chelate effect explained 
before, its lack of specificity for aluminum6 and the presence of some undesired side effects during 
the therapy87. 
 
 
 
Fig. 1.10. Commercially available aluminum chelating agents: deferiprone (bidentate chelator) and 
deferoxamine (hexadentate chelator). Geometries optimized at the B3LYP-D3(BJ)/6-31++G(d,p) – IEFPCM 
level of theory. 
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Deferoxamine (DFO, DFB, Fig. 1.10 and 1.11) is a naturally occurring hidroxamate-based 
siderophore, used as a metal sequestering agent88. The linear tri-hidroxamic acid is composed by 
alternating 1,5-diaminopentane and succinic acid residues (Fig. 1.11); DFO is used by 
microorganisms for the solubilization and transport of iron, properties that make this compound to be 
an excellent chelating agent88. Although all three hydroxamate coordinating groups are protonated at 
physiological pH, the proton/metal competition is highly favoured by the chelate effect, which leads 
to extremely stable Al-DFO complexes, with a pAl value of 19.489. 
However, there are some limitations in the use of this chelating agent in aluminum therapy; the first 
shortcoming is that DFO is not orally active, which means that it must be administrated by invasive 
intravenous injections. Moreover, like in the case of deferiprone, long-term treatments with 
deforaximine have been related to the production of  undesired and potentially dangerous toxic 
effects16. Again, the high affinity of DFO for iron is clearly another big limitation in the use of this 
compound for the treatment of chronic Al(III) intoxications. 
In light of the reasons discussed above, the quest for efficient, non-toxic and specific aluminum 
chelating agents has been the subject of several and important efforts in recent years6,16,25,90-93. A 
summary of the main and more promising building blocks that are commonly employed in the design 
of chelators with this aim is provided below and in Fig. 1.11. 
Catechol and salicylic acid are the two building blocks that, potentially, show the highest affinity for 
aluminum20,94. The reason relies on the fact that two phenoxide groups of catechol are among the 
hardest Lewis bases20, therefore are able to form strong dative bonds thanks to their high electron 
density. The big shortcoming for their use, as single compounds in chelation therapy, comes from the 
high pKa values of the two phenoxide that make the metal/proton competition at physiological pH 
highly unfavorable (Fig. 1.11). Such an aspect is thoroughly explained in chapter 3 of the results. On 
the other hand, catechol-based moieties have been extensively used to design several hexadentate 
chelating agents whose chelate effect, in principle, would overcome the negative competition related 
to the deprotonation of the oxygen donors by aluminum89. This strategy is successfully employed in 
Nature in the case of the tris-catechol based siderophore Enterobactin.95 
Salicylic acid (Fig. 1.11) allows for a better performance regarding the metal/proton competition 
because of the low pKa of the carboxylate group
94. However, the latter is a weaker Lewis base than 
phenoxide due to its intrinsic resonance and, therefore, leads to lower affinity towards Al(III) than 
catechol20. This compound is also widely analyzed in chapter 3. 
Hydroxy-pyridin-Carboxylic acids (HPCs, Fig. 1.11) are among the most promising aluminum 
chelating agents25,92,96. They retain the advantage of the small pKa value of the carboxylic group at  
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physiological pH; moreover, the electronegativity of the nitrogen placed in the ring lowers the pKa of 
the phenolate by decreasing its electron density, allowing for an improved metal/proton competition.  
 
 
 
Fig. 1.11. Main bidentate and hexadentate Al(III) chelating agents commonly used as building blocks in 
chelation therapy. In red, donor atoms that form the coordination site for aluminum. 
HPC=Hhydroxypyridincarboxylic acid. EDTA=ethylenediaminetetraacetic acid. 
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On the other hand, the reduction of electron density in the two oxygen donors makes them poorer 
Lewis bases, leading to less competitive metal-ligand complex stabilities than those of salicylic acid 
and catechol. A promising strategy to improve their stability may be the tuning of the pyridinic ring 
by the addition of electron donating groups such as the methyl, as experimentally assessed by Di 
Marco’s group25. Hydroxypyrones (HPOs) is a highly related family that contain the commercial drug 
deferiprone previously described; they differ from HPCs by the fact that they contain a carbonyl 
instead of the carboxylate, and they share very similar properties to HPCs . Due to their promising 
features, both HPCs- and HPOs-based building block have been extensively used to design a wide 
range of polydentate chelating agents90,91,96-99. 
Hydroxypyrones are kojic acid derivatives (Fig. 1.11) that differ from HPOs by an oxygen in the ring 
in place of the nitrogen. The stronger electronegativity of the oxygen has the positive effect of further 
lowering the pKa value of the phenolic oxygen but, at the same time, the negative one of further 
decreasing the electron density from the oxygen donors, thus leading to even less stable aluminum-
chelator complexes. Despite these shortcomings, the polyfunctional heterocyclic ring allows for an 
extensive tuning of the properties of these compounds as well as the synthesis of many improved 
derivatives with higher denticities100-102. The main developments in this sense have been made by 
Crisponi’s group25. 
The current status of the cutting edge research on aluminum’s chelating agents is based on the 
building blocks discussed above and depicted in figure 1.11. They conjugate the affinity towards 
Al(III) in terms of Lewis basicity with metal/proton competition for the binding site in different 
extents, with the aim of identifying the “ideal” and most suitable solution. It is important highlight 
that, experimentally, metal-ligand binding affinity and metal/proton competition for a given ligand 
are measured by two important parameters, stability constants and pM, respectively. They will be 
discussed in the next section. 
Finally, it is also worth to mention that, for hexadentate chelators, a pre-organization hypothesis has 
shown to be very promising towards the design of new and efficient sequestering agents80. This 
hypothesis was firstly demonstrated for the conformational properties of the natural and powerful 
siderophore Enterobactin95 (Fig. 1.12). It has been shown that, in this highly flexible ligand that 
contains many degrees of freedom, multiple intra-molecular H-bonds networks are responsible for 
the stabilization of a pre-organized structure where the ligand’s chelation groups are placed in such a 
way that are ready to bind the metal95,103,104. In other words, the entropy needed to deform the ligand 
in order for it to adopt a conformation suitable to chelate the metal ion is minimal due to the presence 
of a pre-organized structure stabilized by intra-molecular H-bonds and other interactions (Fig. 1.12).  
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Figure 1.12. (A) Pre-organized structure of free Enterobactin in solution. Intramolecular interactions and 
significant hydrogen atoms are highlighted. (B) Aluminum-bound Enterobactin. Geometries obtained by 
means of conformational analyses followed by DFT optimization with implicit solvation models. 
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Figure 1.13. (A) Pre-organized structure of free O-TRENSOX in solution. Intramolecular interactions and 
significant hydrogen atoms are highlighted. (B) Aluminum-bound O-TRENSOX. Geometries obtained by 
means of conformational analyses followed by DFT optimization with implicit solvation models. 
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The same hypothesis has been invoked to explain the high affinity for Al(III) (pAl=20.0) showed by 
the synthetic chelator O-Trensox (Fig. 1.13)89,105,106. 
 
1.2.3 Experimental criteria to evaluate the performance of a given chelator in solution 
1.2.3.1 Stability (formation) constants 
From an experimental pont of view, the thermodynamics of aluminum-ligand affinity is measured by 
means of stability constants. These experimental parameters are a measure of the strength of the 
interaction between a metal and a ligand that form a given complex. In fact, the formation of a 
complex between a metal M and a ligand L in aqueous solution is usually a substitution reaction107:  
 
 [M(H2O)n] + L ⇌ [M(H2O)n−1L] + H2O     (1.11) 
 
where n is the number of water molecules that surround the ligand. Notice that, for convenience, eq. 
1.11 considers an hypothetical monodentate ligand. 
Although equilibrium constants can be very useful in predicting the direction of a given reaction and 
the thermodynamic stability, it is important to bear in mind that they don’t provide any information 
concerning the rate of the reaction. Indeed, we can find that a given metal-chelator formation 
equilibrium is very favorable, but the rate of the reaction is slow, so the ligand is not useful in practical 
terms107. This latter information rely on kinetics; however, since this thesis dissertation is focused on 
the thermodynamics of metal-ligand complexes in solution, as previously emphasized, the evaluation 
of kinetic effects either from a theoretical or experimental point of view is beyond the scope of the 
present work. 
There are three main formation constants that are commonly used in literature: stepwise, cumulative 
and conditional stability constants.  
Considering the reaction equilibrium outlined in  eq. 1.11,  the equilibrium constant K is given by: 
 
 K =
[M(H2O)n−1L][H2O]
[M(H2O)n][L]
 
    
(1.12) 
 
We can greatly simplify this expression considering that the number of water molecules surrounding 
the metal ion are constant, since in excess of water (e.g. in solution), the concentration of water is 
constant. Accordingly, we get:  
 
 K =
[ML]
[M][L]
 
    
(1.13) 
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Stepwise stability constants refer to the formation of metal-ligand complexes one step at a time. 
Considering the formation equilibria of a complex ML2 formed by one metal M and two ligands L, 
we get: 
 
 M + L ⇌ ML                                             K1 =
[ML]
[M][L]
 
    
(1.14) 
 
 ML + L ⇌ ML2                                             K2 =
[ML2]
[ML][L]
 
    
(1.15) 
 
Cumulative stability constants are designed by the symbol β and are the product of all stepwise 
constants of a given reaction: 
 
 β = K1K2     (1.16) 
 
 M + 2L ⇌ ML2                                             β =
[ML2]
[M][L]2
 
    
(1.17) 
 
In literature, cumulative stability constants are usually reported as a logarithmic function (logβ), and 
this is the usual parameter employed to report and compare the strength of the interaction between a 
metal and a ligand78. 
It is important to highlight that the calculation of logβ considers the ligand’s coordination site in its 
unprotonated form; in this way, the metal/proton competition for a given coordination site is not taken 
into account. This can lead to a misinterpretation of results when, for instance, the energetic penalty 
to deprotonate a coordinating group is high (e.g. the functional group bears high pKa(s)). 
In order to try to overcome this issue and provide more realistic formation equilibria, conditional 
stability constants have been introduced; these latter parameters weight the overall formation constant 
of a given reaction according to the pKa(s) of the coordination site of the chelator. 
Considering the ML2 complex of the previous example, the conditional stability constant β’ derived 
from stability constant β of eq. 1.17 is expressed as94: 
 
β′ = β × [1 + KHL × [H] × (1 + KH2L × [H])]
2     (1.18) 
 
Where KHL and KH2L are the protonation constants of the ligand. It follows that, when the protonation 
and the stability constants decrease by the same order of magnitude, the conditional stability constant 
increases, since the protonation constants are raised to the second power in eq. 1.1894. 
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Although the use of conditional stability constants provide a more reliable picture when comparing 
the chelation properties of different ligands towards a given metal ion,  they still retain a big 
shortcoming: they cannot be used to compare ligands bearing different denticities78. 
As mentioned before, stability constants rely on the thermodynamics of formation of metal-ligand 
complexes. Therefore, the formation of the 1:3 Aluminum-deferiprone complex (Fig. 1.10) requires 
three reaction steps to fill the coordination sphere of Al(III) , being deferiprone is a bidentante chelator 
(Fig. 1.10). On the hand, the formation of the 1:1 aluminum-deferoxamine complex (Fig. 1.10) 
requires only one reaction step to fill the six coordination sites of the metal; indeed, deferoxamine is 
a hexadentate chelator. Accordingly, the cumulative stability constant of a given 1:3 complex is 
thermodynamically different from that of a given 1:1 complex; this is mainly due to the different 
entropic contributions needed for the ligands to bind to aluminum, as explained in section 1.2.2.1 
regarding the chelate effect. This becomes a big issue when one needs to evaluate the performance of 
different chelators displaying different binding modes (Fig.1.2).  
In order to overcome this problem, the pM parameter has been introduced, and will be explained in 
the next section. 
Finally, and important remark should be reported. In principle, experimental stability constants can 
be derived by using first principle methods such as DFT, as it can be calculated as a Gibbs free energy 
change associated to the metal-ligand complexation108. The thermodynamic relationship between the 
stability constant β and the Gibbs free energy is:  
 
𝛥𝐺 = −𝑅𝑇𝑙𝑛𝛽     (1.19) 
 
However, in practice, the error associated to the absolute values of ΔG calculated at the DFT level 
(or other first principle methods) is usually huge108. This is mainly due to the fact that experimental 
values are taken in solution, and the use of approximate continuum solvation models severely 
under/overestimate theoretical solvation energies, especially when dealing with charged 
compounds108. 
For this reason, when comparing experimental data with theoretical results, it is much more 
convenient to rely on relative trends between the theoretically calculated Gibbs free energies (ΔGTheo) 
and experimental stability constants, usually reported in a logarithmic scale (logβexp). In this way, 
when the thermodynamics of complexation energies of given metal-ligand complexes are properly 
calculated at the DFT level, relative stability trends between  ΔGTheo and logβexp can be very similar. 
This is the strategy that has been adopted in this thesis work and that will be explained and discussed 
in the results section. 
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1.2.3.2 The pM parameter 
In order to try to overcome the limitations intrinsic of the use of formation constants as a measure of 
the chelation performance towards a given metal, the pM has been introduced109. This parameter is 
defined as -log[MF] usually taken at [MT] = 1x10
6 M and [LT] = 1x10
5 M at pH 7.4, where [MF] is 
the concentration of free metal in solution (in this case Al(III)), and [MT] and [LT] are the total 
concentration of the metal and the ligand, respectively78. 
In other words, pAl measures the concentration of free Al(III) in solution upon addition of a given 
chelating agent. The higher the pAl value, the lower the concentration of free aluminum and, 
therefore, the better the chelation performance of the ligand. Conversely, the lower the value of pAl, 
the lower the affinity of Al(III) for a given chelator. A list of pAl values for some common aluminum 
chealtors is provided in table 1.4. 
 
Ligand pAl 
Hydroxide (Fig. 1.2)           12.17 
Catechol (Fig. 1.11)           10.194 
Salicylic acid (Fig. 1.11)           8.294 
Kojic Acid (Fig. 1.11)           9.1110 
Deferiprone (Fig. 1.11)           15.4111 
Deferoxamine (Fig. 1.11)           20.87 
EDTA (Fig. 1.11)           16.47 
Citric acid (Fig. 7.1)           14.47 
Dopamine (Fig. 7.1)           10.8 
 
Table 1.4. pAl values for some common Al(III) endogenous and exogenous ligands. 
 
The advantages in the use of this metal affinity criterion are that pAl does not depend on the 
stoichiometry of ligand-metal complexes, since it directly considers all species that are formed in 
solution at physiological pH. This is extremely useful as it allows for an immediate and direct 
comparison of the chelation performance of chemically different chelating agents towards aluminum. 
Moreover, pAl clearly takes into account the aluminum ion/ proton competition for the binding of a 
given ligand, providing in this way a very reliable information concerning chelation affinity78.  
In this sense, the pM parameter is the most widely used criterion in literature to compare newly 
developed  chelating agents for a given metal ion. 
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However, since it provides only a general information about the performance of a ligand (e.g. it 
includes contributions from different chemical properties), then more specific and detailed 
information about the chelation properties of the ligand must be evaluated, such as stability constants, 
protonation constants, number and types of complexes that can be formed, influence of the pH etc. 
An overview about the predominant parameters employed in coordination chemistry can be find in 
ref.78. 
A question that comes to mind is: “What is the relationship between pM and logβ ?”. 
In principle, they are in linear correlation, since the higher the stability constant (e.g. the strength of 
a given metal-ligand complex), the lower the amount of free metal in solution and, therefore, the 
higher the pM value. 
However, this is not always true. The reason relies on the fact that, as previously discussed, logβ does 
not take into account the effect of protonation constants at the ligand’s binding site. Accordingly, 
when there is a significant modulation of their pKa values like, for instance, upon addition of electron 
donating/withdrawing groups (EDGs and EWGs, respectively), then a small effect towards stability 
constants might be overcame by a higher effect towards pM. As a result, an inverted trend between 
the two metal affinity parameters is found21. A paradigmatic case in this sense is presented in chapter 
3 of the results section, where we investigated the effects of different substituents (EDGs, CH3 and 
OCH3, EWGs, NO2 and CF3) towards the modulation of the molecular properties of two families of 
Al(III) chelating agents (catechol and salicylic acid)21. 
It follows that, for a proper characterization of a new ligand, different sources of information need to 
be investigated, and there not exists a single and universal parameter that can be unequivocally used 
to evaluate the reliability of a given chelator.  
Finally, it is important to mention that, again, it is very challenging to predict (at least the trend) of 
the pM parameter from a theoretical point of view. The efforts and strategies that we adopted in order 
to compare theoretical results with respect to experimental pAl values are presented and discussed 
throughout the results section.  
The development of a suitable theoretical protocol that would be able to unequivocally predict 
experimental pAl trends is currently work in progress and will not be included in the current thesis 
dissertation. 
 
1.2.4 The dark side of Al(III) chelation therapy: challenges and perspectives 
So far, an overview on the properties that the ideal Al(III) chelating agent should possess have been 
provided, along with the current status on the most promising chelating agents and a focus on the 
main experimental criteria used to measure their chelation performance. 
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Nevertheless, despite many efforts have been made in order to identify a suitable aluminum chelator 
to be used in Al(III) chelation therapy, one major shortcoming is still present: the lack of specificity. 
Indeed, as mentioned in the previous sections, Al(III) chelation therapy is indissolubly coupled to 
Fe(III) chelation therapy, since all chelators that show affinity for aluminum, show affinity for iron 
as well. 
This is due to the fact that, as discussed before, the Al-ligand interactions are mainly of electrostatic 
nature. Therefore, a negatively charged ligand’s binding site will not show particular specificity 
towards trivalent metal ions bearing the same charge. This is witnessed by the clinical use of 
deferiprone and deferoxamine (Fig. 1.10 and Fig. 1.11) in both aluminum- and iron-based overload 
diseases6,28. However, considering that the amount of the exogenous aluminum ion in the body is 
much smaller than the amount of the endogenous ferric ion, short time therapies with deferiprone will 
be able to sequester all Al(III) and will non severely affect the homeostasis of iron6,112. 
An interesting point concerns the higher affinity shown by all ligands tested so far with respect to 
Fe(III) compared with Al(III). Crisponi et al. compared the stability constants of a wide range of 1:1 
aluminum- and iron-chelator complexes reported in literature, finding a remarkably good correlation 
(R= 0.988) with a loKFe/logKAl ratio of 1.21
6. Interestingly, this ratio resembles the electronegativity 
ratio of Fe(III) and Al(III), 1.96/1.61=1.226. 
A possible explanation for the higher iron affinity over aluminum is given by Albrecht-Gary and 
Crumbliss113, who state: “… a consequence of the different charge/radius ratios for Fe(III) and Al(III) 
is the fact that the free energy of formation of the hydrated metal ion (ΔG◦f [M3+aq]) is less negative 
for Fe3+aq (−10.6 kJ mol−1) than for Al3+aq (−486 kJ mol−1). Since a stability constant for complex 
formation between the aquated metal ion and the metal complex, the more strongly aquated Al3+ ion 
will not be as likely to have as great a ΔG◦ between the hexaaquo ion and the complex as will Fe3+”. 
In other words, according to this hypothesis, the hydrated aluminum ion in solution is more stable 
than the hydrated iron ion, and, therefore, is less prone to leave water molecules and bind to a new 
ligand than iron does. Notice, however, that the presence of hydroxide species is not taken into 
account. 
Accordingly, it seems that, in principle, it is not possible to target ligands selectivity towards 
aluminum due to its intrinsic physico-chemical properties in solution. 
Crisponi et al., in a different paper, proposed two possible strategies to shift ligands selectivity 
towards aluminum79: 
 
i) Insertion of proper substituents such as EDGs and EWGs in the ligand’s scaffold; this can 
be of paramount importance in altering the chelation properties of the coordination site. 
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The fine modulation of the physico-chemical properties of the ligand might result in a 
change of its selectivity between Al(III) and Fe(III). 
 
ii) Pre-organization of the ligand; due to the smaller ionic radius of Al(III) compared to 
Fe(III), the design of proper ligands forming four- five- or six-membered rings may lead 
to a significant change in metal selectivity. Additionally, the design of ligands able to 
discriminate metal ions by the ionic radius might be a potentially reliable strategy. 
 
The lack of aluminum selectivity of most chelators is not only a problem with respect to trivalent 
metal ions. There are many essential metal ions needed by the human metabolism, as discussed in 
section 1.2.1.1. Some chelators can have such a strong chelation performance that retain significant 
affinity not only for trivalent metal ions, but for divalent ones as well. 
This is specifically the case of ethylenediaminetetraacetic acid (EDTA, Fig. 1.2 and 1.11). Although 
this chelator has been proposed as a potential therapeutic cure against aluminum-induced 
neurodegeneration114, its use in Al(III) chelation therapy is still very controversial. Indeed, it has been 
shown that EDTA can alter and imbalance the homeostasis of essential metal ions112. In particular, 
EDTA was found to form stable complexes with Mg(II), Zn(II) and, most importantly, Ca(II). This 
chelating agent can severely perturb the homeostasis of calcium leading to detrimental effects when 
assumed at high concentrations, and ultimately to death112. 
The potentially undesired toxicity related to the chelation properties of a given chelator towards 
essential metal ions is a subject that must be carefully taken into account, and that is not always easy 
to be overcame. 
In this sense, the understanding of the determinants behind metal selectivity is a topic that needs to 
be improved with the aim of finding new and efficient aluminum chelating agents, and computational 
approaches might provide a fundamental help in that sense. 
 
1.3 A computational approach to aluminum biochemistry 
 
1.3.1 Thermodynamics of Al-ligand complexes in aqueous solution 
Challenges in the investigation of the potential toxic role of Al(III) in the biological environment, as 
well as in the design of efficient aluminum chelating agents, have been highlighted through the 
previous sections. In light of that, modern molecular modelling approaches, when properly applied, 
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might be a valuable source of insights helping to elucidate binding mechanisms and/or rationalizing 
experimental procedures. 
In particular, the computational approach towards the characterization and evaluation of the 
thermodynamics of Al-ligand complexes in solution was introduced, for the first time, some years 
ago by Prof.Xabier Lopez’s group at the University of the Basque country. The purpose is the 
understating of the properties of the aluminum ion in the biological environment with respect to 
different low- and high-molecular mass bioligands (Fig. 1.14 and 1.15).  
A wide range of computational tools have been used for that purpose, ranging from classical MD 
simulations, hybrid QM/MM simulations, chemical bond analysis using the Bader’s Quantum Theory 
of Atoms in Molecules (QTAIM) and Natural Bond Orbital (NBO) theory, high level CASSCF and 
 
 
 
Fig. 1.14. Main topics covered in Xabier Lopez’s group. 
 
CASSPT  approaches, and others (Fig. 1.15). The main sources of information rely on the evaluation 
of the thermodynamics of binding energies in aqueous solution, obtained by means of a cluster-
continuum approach115. 
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Such an approach, has allowed to unveil several properties and binding features of the interaction of 
Al(III) with several different bioligands, providing a clear understanding and rationalization of the 
available experimental data and, moreover, providing an answer to some unknown issues such as the 
role of neurofibrillary tangles (NFTs)66, hydroxyaluminosilicates (HAS)8 and a possible structure for 
the 1:1 Al-Aβ1-42 complex74. 
 
1.3.2 Aim of the thesis 
In light of what discussed above, the goal of the present thesis project is to carry on with the 
computational approach to aluminum biochemistry, with the aim of increasing the knowledge in this 
rather controversial field. For such a purpose, different theoretical methods have been used, which 
will be presented and discussed throughout the results sections, where the main computational 
protocol (Fig. 1.16) was adapted and fixed according to the specific systems and investigations of the 
different works. 
 
 
 
Fig. 1.15. Detailed schematic representation of the research lines and methodologies developed in Xabier 
Lopez’s group.  
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More into details, the Ph.D. project has covered three main areas: 
 
1. Chelation therapy and development of new chelation strategies.  
In this rather new research topic, not covered before in Xabier Lopez’s group, the aim is to 
develop a computational protocol that would be able to fully characterize Al(III)-based 
chelating agents, and therefore help towards the design of new and efficient compounds that 
might be used in aluminum chelation therapy. The fine understanding of experimental data 
(e.g. stability constants and pAl), as well as the modulation of their trends upon addition of 
chemically different substituents, is a central part of the work, that allowed for a strong 
validation of the computational protocol. Moreover, in collaboration with experimentalists 
from the University of Cagliari, we have designed and characterized a novel family of peptide-
based Al(III) chelating agents. 
Results obtained in this topic lead to two publications (chapter 3 and chapter 4of the results 
section). 
 
2. Understanding the potential toxic role of Al(III) in the biological environment.  
This is the main research area of Xabier Lopez’s group, that has been active since early 2000. 
Departing from the knowledge obtained from previous works published in the group, as well 
as using knowledge gained from the previous research topic (chelation therapy), the molecular 
basis of the potential mechanisms of toxicity of aluminum with respect to different 
endogenous ligands in aqueous solution (model peptides, citric acid, neurotransmitters) were 
investigated. Biological implications of the results in light of an open biological environment 
are discussed using previous reports in literature; additionally, new hypotheses and 
speculations have been made, that will be the substrate for future works in this area. 
Results are presented in chapters 5, 6 and 7 of the results section. 
 
3. Calibration of the computational protocol and benchmarking of approximate theoretical 
methods.  
The third and very important research area concerns the thorough evaluation of the accuracy 
of the theoretical methodologies utilized in the present thesis work. Investigations in this sense  
include the validation of the computational protocol with respect to experimental stability 
constants and experimental pAl values, as well as the modification of the computational 
protocol according to the different systems under investigation (chapters 3-7). Moreover, an 
independent work has been made in order to benchmark approximate exchange-correlation 
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functionals and semiempirical methods with respect to high level CCSD(T)/CBS reference 
energies. The purpose is to benchmark binding energies of seven different 1:1 metal-chelator 
complexes in aqueous solution so that to highlight what are the functionals and corrections 
(e.g. dispersion, range-separation) that may improve the accuracy of the thermodynamics and 
geometries of our metal-ligand complexes. We took advantage of the extensive experience of 
Prof. Maria João Ramos’s group in that field116-118. 
This latter work is currently work in progress, and some preliminary results will be discussed 
in the concluding remarks of this thesis dissertation. 
 
 
 
 
 
Fig. 1.16. Schematic representation of the topic covered in the present thesis dissertation. 
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“Every day here you come walking 
I hold my tongue, I don't do much talking 
You say you're happy and you're doin' fine well go ahead, baby, I got plenty of time 
Sad eyes never lie 
Sad eyes never lie” 
(B. Springsteen, Sad Eyes) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODS 
 
66 
 
2.1 Potential energy surfaces 
 
The Potential Energy Surface (PES) associated to a given reacting system is a hypersurface defined 
by the potential energy of all the atoms over all possible atomic arrangements119. 
A useful way to describe the PES of a system is to consider its internal or geometric coordinates (e.g. 
bond distances, angles and torsions); in this way, the PES has 3𝑁 − 6 degrees of freedom, where N 
is the number of atoms of the system (𝑁 ≥ 3). 
Let us imagine to have a three atoms system. The choice of the first atom involves no degrees of 
geometric freedom as the first atom defines the origin. The position of the second atom is specified 
by its distance from the first atom; therefore, a two atoms system contains a single degree of freedom. 
The third atom can be specified by either its distances to each the two preceding atoms or by a distance 
from one and an angle between the two bonds formed by the three atoms. It follows that a three atoms 
system contains a total of 3 degrees of freedom; each additional atom requires the specification of 
three geometric coordinates to describe its position. 
Usually, the PES is investigated within the Born-Oppenheimer approximation120, which enables to 
separate the motion of electrons and nuclei so that to consider electrons at fixed nuclear positions, 
because of their much smaller mass and much higher velocity compared to nuclei (107cm/s and 105 
cm/s respectively, at 300 K). 
It is important to bear in mind that the shape PES depends, to a certain extent, on the method utilized 
to calculate its potential energy. Accordingly, the PES of a system calculated by means of molecular 
mechanics (force fields) methods can be very different from those calculated by means of ab initio 
methods, due to the lack of electrons in the former. The choice of the most suitable method for the 
study of a given a given system is a critical step in each Molecular Modelling investigation; ideally, 
the “calculated” PES should be parallel to the “real” PES, which means that the chosen method is 
able to describe the shape and features of the real system. 
Usually, one is not interested in the calculation of the whole PES, but rather in the identification of 
the most interesting and most informative points of the PES. These include local minima, which 
correspond to optimal molecular structures (e.g. points where all second derivatives are zero), the 
global minimum, which is the lowest energy (most stable) structure and saddle points, characterized 
by having no slope in any direction, downward curvature for a single coordinate and upward direction 
for all the other coordinates. Saddle points are the lowest energetic barriers on paths connecting 
minima, so they have been related to the chemical concept of transition state119. 
When a given system contains many degrees of freedom, it can be very challenging to identify all the 
local minima and/or the global minimum of its PES, because of the huge number of possible 
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conformations. For such a purpose, a wide range of conformational sampling techniques suitable for 
different problems/systems have been developed so far, including molecular dynamics-based ones. 
Some interesting review in that sense can be found in ref.119,121-124. 
In the present PhD dissertation, we mainly focus on ground state local minima of the systems under 
investigation by using Densify Functional Theory-based methods. However, as discussed above, 
when the system under investigation is very flexible, we have used QM/MM approaches in order to 
properly sample the conformational space of the ligand and identify the most relevant conformations. 
 
2.2 Density Functional Theory (DFT) 
 
Density Functional Theory (DFT) is one of the most popular approaches that provides, in principle, 
an exact approach to the problem of electronic structure theory125. 
As demonstrated by Hohenber and Kohn, within the Born-Oppenheimer approximation the electronic 
energy 𝐸𝑒[𝜌(𝑟)] can be written as a functional of the electron density (𝜌) 
125: 
 
 𝜌(𝑟) = ∑ |Ψ(𝑟)|2      (2.1) 
 
 𝐸𝑒[𝜌(𝑟)] = 𝑇[𝜌(𝑟)] + 𝑉𝑒𝑛[𝜌(𝑟)] + 𝐽[𝜌(𝑟)] + 𝑄[𝜌(𝑟)]     (2.2) 
 
where 𝑇[𝜌(𝑟)] is the kinetic energy of the electrons, 𝑉𝑒𝑛[𝜌(𝑟)] is the nuclear-electron attraction, 
energy, 𝐽[𝜌(𝑟)] is the Coulomb electron-electron repulsion energy and 𝑄[𝜌(𝑟)] is the electron-
electron interaction energy126. 
The second and third terms of equation (2.1) are known and can be computed according to equations 
(2.3) and (2.4), respectively: 
 
 
𝑉𝑒𝑛[𝜌(𝑟)] = − ∑ ∫
𝑍𝐴
|𝑟 − 𝑅𝐴|
𝜌(𝑟)𝑑𝑟
𝑀
𝐴=1
 
    
(2.3) 
 
 
𝐽[𝜌(𝑟)] =
1
2
∬
𝜌(𝑟1)𝜌(𝑟2)
𝑟12
𝑑𝑟1𝑑𝑟2 
    
(2.4) 
 
The goal of DFT is to develop accurate approximation for 𝑇[𝜌(𝑟)] and 𝑄[𝜌(𝑟)]. Since the kinetic 
energy contribution is the largest unknown term, the corresponding kinetic energy functional must be 
approximated or, ideally, its exact nature must be identified. 
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The simplest approximation to  𝑇[𝜌(𝑟)] is the Thomas-Fermi model, which is exact for an infinite 
uniform electron gas (UEG)127: 
 
 
𝑇[𝜌(𝑟)] =
3
10
(3𝜋2)2/3 ∫ 𝜌(𝑟)5/3𝑑𝑟 
    
(2.5) 
 
However, such an approximation is only applicable to systems with nearly uniform densities like 
some alloys and semiconductors and cannot properly describe chemical bonds126. 
Accordingly, designing accurate kinetic energy functionals for molecular applications is a difficult 
task that has yet to be satisfactorily accomplished. 
In this sense, the kinetic energy problem has been greatly improved by Kohn and Sham equations 
(KS)128. They demonstrated that the kinetic energy could be accurately approximated by a single 
Slater determinant (of orbitals {𝜙𝑖}) describing a fictious system of non-interacting electrons that has 
the same density as the exact electronic wave function. 
The KS non-interacting kinetic energy 𝑇𝑠[{𝜙𝑖}] can be written as: 
 
 
𝑇𝑠[{𝜙𝑖}] = −
1
2
∑ ∫ 𝜙𝑖
∗(𝑟)
𝑛
𝑖=1
∇2𝜙𝑖(𝑟)𝑑𝑟 
    
(2.6) 
 
Considering that the non-interacting kinetic energy is not equal to 𝑇[𝜌(𝑟)], the difference between 
these two terms is combined with 𝑄[𝜌(𝑟)] tp define the exchange-correlation energy, 𝐸𝑥𝑐[𝜌(𝑟)] 
126: 
 
 𝐸𝑥𝑐[𝜌(𝑟)] = 𝑇[𝜌(𝑟)] − 𝑇𝑠[{𝜙𝑖}] + 𝑄[𝜌(𝑟)]     (2.7) 
 
The only unknown term in KS-DFT is the exchange-correlation functional (eq. 2.6), which is often 
represented as a sum of an exchange functional, 𝐸𝑥[𝜌(𝑟)], and a correlation functional, 𝐸𝑐[𝜌(𝑟)]. 
Like DFT, KS-DFT is in principle exact; however, the quest for the exact exchange-correlation term, 
and therefore for the “universal” DFT functional that can be applied for any molecular system, is still 
far from being accomplished129. 
In the past thirty years hundreds of non-empirical and semi-empirical DFT functionals have been 
developed, mixing in many different flavors as the main ingredients of KS-DFT, as well as ab initio 
ones such as Hartree-Fock (HF) and Möller-Plesset second order perturbation theory (MP2), in order 
to try to reach the chemical accuracy126,129. As a result, many different types of functionals containing 
different functional forms are nowadays available. In this sense, a useful concept to provide a 
classification and a hierarchy is represented by Perdew’s Jacob’s Ladder130 (Fig. 2.1). 
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In this metaphorical representation, the Jacob’s Ladder is composed of five rungs corresponding to 
increasingly sophisticated models for the unknown exchange-correlation functional. The ladder has 
its foundation on the “Hartree World”, where the exchange-correlation energy (eq. 2.7) is zero and 
electron-electron interaction is provided solely by classical electrostatic, 𝐽[𝜌(𝑟)]. Moving up the 
ladder introduces additional ingredients into the functional form, culminating in the “Heaven” of 
chemical accuracy (e.g. ≤ 1 kcal/mol).  Since each rung contains new physical content that is missing 
in lower rungs, improved accuracy should be attainable at each higher level126. 
The majority of the most popular DFT functionals fall within rung 4 of the Jacob’s Ladder (Fig. 2.1), 
which belongs to the hybrid and meta-hybrid General Gradient Approximation (GGA). The reason 
relies on the fact that such approximations were found to provide reasonable accurate results for many 
systems, compared to the previous rungs, at a very affordable computational cost compared to rung 
5126. 
Nevertheless, in rung 5 there still remain some important inaccuracies in the functionals developed 
so far; the most important ones, that were the subject of intensive work in the past fifteen years to try 
to solve the issue are126: 
 
1. Self-interaction error (SIE), that led to the development of range-separation corrections 
briefly presented in section 2.2.2. 
 
2. Long range dynamic correlation (London dispersion forces), that are pivotal especially for 
biological systems, which is discussed in section 2.2.3. 
 
3. Strong correlation; this issue has not yet been properly investigated or solved. 
 
Several correction scheme have been proposed and implemented over the past years to solve, or at 
least to attenuate, point I and II, which allowed for a great improvement in the performance of hybrid-
GGA functionals. However, one has bear in mind that there not exist (yet) the “universal” DFT 
functional; therefore, one should always consider the question “which functional should I use ?”. To 
find the answer, insights from the literature about the properties of specific system under 
investigation, the comparison/validation with respect to available experimental data and/or 
benchmarking of different functionals with respect to high level reference calculations (such as the 
CCSD(T)/CBS level of theory, considered the “golden standard”) are the most straightforward 
strategies that one should always pursue prior to any molecular modelling job. 
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A survey on all the DFT exchange-correlation approximations (Fig. 2.1) is far beyond the scope of 
this thesis dissertation (two excellent reviews can be found in refs.126,129).  
 
 
 
 
Fig. 2.1. Perdew’s metaphorical Jacob’s Ladder of DFT hierarchy. Taken from ref.131.  
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The majority of the work has been carried out employing the hybrid-GGA B3LYP functional in 
conjunction with Grimme’s D3(BJ) dispersion scheme (see next sections) and will be presented in 
the next section. 
The reason of that choice relies on the very good performance of the B3LYP-D3(BJ) corrected 
functional for metal-containing systems and non-covalent interactions, which will be discussed in 
more detail in each chapter of the results section, along with comparison with experimental data. 
Moreover, it is worth to mention that these speculations were confirmed by our benchmark of 
different correlation-exchange functionals in the calculation of metal-ligand binding energies, 
compared to CCSD(T)/CBS reference data. The B3LYP-D3(BJ) functional was found to be one of 
the best performers (briefly discussed in the concluding remarks of this thesis dissertation). 
 
2.2.1 B3LYP 
The popular, and yet mystical, B3LYP functional is a hybrid (or global-hybrid) GGAs family (rung 
4, Fig. 2.1). The idea behind the creation of hybrid-GGAs was an attempt to attenuate the self-
interaction error (electrons interacting with themselves) of most exchange-correlation functionals. 
The simplest way to demonstrate SIE is to consider the Hartree-Fock (HF) description of the hydrogen 
atom. Since the hydrogen atom contains only one electron, the electron-electron interaction energy 
should be exactly zero. At the complete basis set limit (CBS), the HF energy for the hydrogen atom 
is -0.5 Hartrees, which comes from summing the kinetic (0.5 Hartrees), nuclear-electron attraction (-
1.0 Hartrees), Coulomb (0.3125 Hartrees) and exchange (-0.3125 Hartrees) energy contributions. 
Accordingly, the classical and non-classical electron-electron contributions cancel each other exactly, 
making HF one-electron SIE free126. 
In KS-DFT, since the exact exchange term is replaced by approximate exchange correlation terms, 
most of functionals are not one-electron SIE free (e.g. 𝐽[𝜌(𝑟)] + 𝐸𝑥𝑐[𝜌(𝑟)] ≠ 0) for the hydrogen 
atom126. 
A strategy to overcome, or at least to attenuate such issue came from the idea of replacing the local 
exchange functional with the exact exchange functional (Hartree-Fock), while employing a local 
correlation functional that gives exactly zero correlation energy for any one-electron system. Despite 
the many efforts done to combine exact and different DFT functionals, the overall performance did 
not show significant improvements until early 1990 when Becke introduced the idea of mixing only 
a global fraction of exact exchange with the exchange-correlation functional132,133. 
Such an approach gave rise to rung 4 of the Ladder, the family of hybrid-GGas exchange correlation 
functionals. Becke’s B3LYP functional has been one of the most popular ones with broad 
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applicability; taking advantage of the adiabatic connection theory134-137, the B3LYP functional can be 
written in the form: 
 
 𝐸𝑥𝑐
𝐵3𝐿𝑌𝑃 = (1 − 𝑎)𝐸𝑥
𝐿𝐷𝐴 + 𝑎𝐸𝑥
𝐻𝐹 + 𝑏𝐸𝑥
𝐵88 + (1 − 𝑐)𝐸𝑐
𝐿𝐷𝐴 + 𝑐𝐸𝑐
𝐿𝑌𝑃     (2.8) 
 
Where 𝐸𝑥
𝐿𝐷𝐴 and 𝐸𝑐
𝐿𝐷𝐴 are the Local Density Approximation (LDA, rung 1 of Fig. 2.1) exchange and 
correlation VWN functionals138, respectively. 𝐸𝑥
𝐵88 is Becke’s B88 exchange functional139, 𝐸𝑐
𝐿𝑌𝑃 is 
the Lee-Yang-Parr correlation functional140. Finally, a, b and c are three empirical parameters (0.20, 
0.72 and 0.81, respectively).   
Therefore, considering eq. (2.8), B3LYP contains 20% of exact (HF) exchange energy. This 
percentage differs in other hybrid-GGAs, as it is optimized according to the functional form and 
eventual empirical parameters. 
This venerable functional has been found to be rather versatile, as its broad use in the calculation of 
different properties such as barrier heights, kinetics, heats of formation, non-covalent interactions 
showed acceptable performances, although it does not excel in any of these properties126,129. However, 
the addition of some correcting terms such as dispersion and range separation corrections greatly 
improved the performance of the B3LYP functional compared to other popular functionals, as 
emphasized by Stefan Grimme141: 
 
“Of particular note is that the B3LYP-D3 method provided the best geometries, suggesting that this 
much (and justly) maligned functional can be significantly improved with just the simple D3 fix”. 
 
As introduced in the previous section, these two corrections represent a huge improvement in the 
accuracy of approximate exchange/correlation functionals, and will be briefly presented in the next 
sections. 
 
2.2.2 Range-separated DFT 
In order to try to alleviate the problem of self-interaction errors in global hybrid functionals, the range 
separation approach has been proposed. The basic idea is that the interelectronic Coulomb operator 
can be split in a short range (SR) part and long range (LR) part. 
This effort is usually achieved by using an operator such as129: 
 
 1
𝑟12
=
𝑒𝑟𝑓𝑐(𝜔𝑟12)
𝑟12(𝑆𝑅)
+
𝑒𝑟𝑓(𝜔𝑟12)
𝑟12(𝐿𝑅)
 
    
(2.9) 
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Where r12 is the interelectronic distance. The Coulomb operator of the short-range component (SR) 
is attenuated by the complementary error function erfc(ωr12), while the long-range component is 
attenuated by the error function erf(ωr12). The error function is used since it allows a simple 
calculation of integrals129. 
The most popular kind of range-separated hybrid functionals is called long-range corrected (LC) 
functionals, using the popular LC scheme developed by Hirao and co-workers142. They use 100% of 
HF exchange in the LR limit and a smaller value, usually between 0% and 50%, in the SR limit. 
Notice that the Hartree-Fock theory is SIE-free, therefore the use of 100% HF exchange in the LR 
limit ensures a strong attenuation of the self-interaction error. 
Another closely related range-separation strategy is those employed in the CAM-B3LYP functional, 
which has 19% non-local exchange in the SR limit and 65% in the LR limit143. 
An alternative (and opposite) approach to LC is represented by the so-called screened-exchange 
hybrid functionals, such as the HSE-based family of functionals144,145 and Truhlar’s N12-SX146 and 
MN12-SX146. This approach uses a finite amount of HF exchange at SR, but none in the LR limit, in 
order to cut the computational cost of non-local exchange integrals for extended systems, while, at 
the same time, (in principle) retaining the good performance features of global hybrid functionals for 
most chemical properties129. 
 
2.2.3 London dispersion corrections 
London dispersion forces (interactions) are the attractive part of a van der Walls (vdW)-type 
interaction potential between atoms or molecules that are not directly (covalent or ionic) bonded each 
other147. According to a more precise definition, London dispersion interactions result from relatively 
long-ranged electron correlation effects in any many-electron system that neither requires “polarity” 
nor wave function (WF) overlap147. 
In 1930, from the simplest perturbation theory, Eisenschitz and London have derived the famous 
asymptotic formula for the dispersion energy between two atoms A and B at large distance R148: 
 
 
𝐸𝑑𝑖𝑠𝑝
𝐴𝐵 ≈
3
2
𝐼𝐴𝐼𝐵
𝐼𝐴 + 𝐼𝐵
𝛼𝐴
0𝛼𝐵
0𝑅−6 = 𝐶6,𝑎𝑝𝑝𝑟𝑜𝑥
𝐴𝐵 𝑅−6 
    
(2.10) 
 
Where α0 is the static dipole polarizability and I is the atomic ionization potential. The atomic 
constants can be condensed to the pair-specific C6 dispersion coefficient, which determines the 
strength of the interaction. Note that 𝐸𝑑𝑖𝑠𝑝 is attractive for any distance and hence stabilizes molecules 
with respect to their constituting atoms, condensed phases over the (diluted) gas phase147. 
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Since London dispersion forces are a component of vdW interactions, of course they are most 
important when aiming to describe noncovalent interactions; in particular, they are fundamental when 
characterizing biological systems. 
Mean-field electronic structure methods such as Hartree-Fock, Kohn-Sham DFT and semiempirical 
ones are not able to describe long-range electronic effects and, therefore, are not able to account for 
London dispersion forces147. 
For this reason, different DFT and semiempirical correction schemes have been proposed during the 
last years, with the aim of improving the description of dispersion energies. Among the DFT schemes, 
the most popular ones were mainly (but not only) developed by three different groups: 
 
1. G. DiLabio’s group; they designed dispersion-correcting potentials for global nd range-
separated hybrid functionals. They are known in literature as “DCP” corrections149-151. 
 
2. Vydrov and Van Voorhis’s group; they developed some nonlocal vdW-based functionals that 
model the contribution of the dispersion energy arising from the fluctuations of electron 
density fluctuations in distant regions of a system by explicitly accounting for the interaction 
of those distant parts. Such kind of correction is termed in literature “DFT-NL” and the latest 
development in such regard is known as “VV10”152. 
 
3. S. Grimme’s group; S. Grimme developed a so-called atom-pairwise approach which consists 
in the addition of the semiclassical treatment of dispersion energy evaluated between atom 
pairs to the electronic energy of the DFT functional. This is achieved by simple empirical 
fitting of such semiclassical dispersion energy (parameterized for many different systems). 
The latest improvement in that sense is known in literature as “D3”147,153,154. 
 
Interestingly, it has been found that, in general, all of these different approaches improve the 
performance of DFT methods towards non-covalent interactions155, as well as towards many other 
properties156,157. Moreover, they have been also found to improve geometries141. 
It is important to mention that, however, these different approaches to account for London dispersion 
forces improve the accuracy of KS-DFT functionals by very similar degrees158. Accordingly, there is 
not a given correction approach that prevails over the others. 
Nevertheless, the Grimme’s approach has become the most widely used and widely implemented one 
in most computational chemistry packages. The reason, very simple, relies on the fact that, being the 
METHODS 
 
\75 
 
D3 method an empirical fitting, it does not lead to any significant increase in the computational cost 
of a given calculation when applied. This is, clearly, a huge advantage in routine calculations. 
For such a reason, it is often discussed that, nowadays, dispersion corrections such as the D3 one 
should be used by default in Quantum chemistry independently from the real need of using it. 
The popular atom-pairwise D3 method developed by S. Grimme to correct the lack of dispersion 
energy in most density functionals is given by147,159: 
 
 
𝐸𝑑𝑖𝑠𝑝
𝐷𝐹𝑇−𝐷3 = − ∑
AB
∑
𝑛=6,8,10,…
= 𝑠𝑛
𝐶𝑛
AB
𝑅AB
𝑛 𝑓𝑑𝑎𝑚𝑝(𝑅AB) 
    
(2.11) 
 
Where, the sum is over all atom pairs of the system, 𝐶𝑛
AB denotes the averaged (isotropic) nth-order 
dispersion coefficient, (orders n=6,8,10,…) for atom pair AB, and RAB is their internuclear distance. 
Global (functional-dependent) scaling factors sn are typically used to adjust the correction to the 
repulsive behavior of the chosen density functional159. 
However, it has been found that 𝐶𝑛
AB alone is not able to describe medium- and short-range dispersion, 
but only long-range effects (Fig. 2.2)159. 
Accordingly, in order to overcome that limitation and provide the asymptotically correct behavior of 
dispersion energy (depicted in Fig. 2.2), several damping functions (fdamp) have been provided; the 
most widely used one (along with the D3 methods) is based on the scheme proposed by Becke and 
Johnson160: 
 
 
𝑓𝑑𝑎𝑚𝑝
(𝑛) (𝑅) =
𝑅𝑛
𝑅𝑛 + (𝑎1𝑅0 + 𝑎2)𝑛
 
    
(2.12) 
 
Where the density functional specific parameters a1 and a2 and the radii 𝑅0 = √𝐶8
𝐴𝐵/𝐶6
𝐴𝐵 are 
introduced147.The overall dispersion correction (eq. 2.11 and 2.12) are known in literature with the 
suffix “D3(BJ)”, and specific parameters were developed for several density functionals153,154. 
It is important to highlight that the introduction of the D3(BJ) scheme has allowed for a huge 
improvement of the accuracy of most DFT functionals specially in the case of non-covalent 
interactions155,156 and metal-containing systems141. Therefore, in this sense, the D3(BJ) scheme 
outperforms the D3 one and it is the recommended one when dealing with interactiong systems. 
Finally, it should be mentioned that dispersion corrections, as well as hydrogen bond corrections, 
were developed for semiempirical methods, mainly thanks to the work of Hobza and co-workers161-
164. Like in the case of DFT-based corrections, methods that ensure the proper treatment of dispersion 
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energy in PM6 and PM7 semiempirical methods significantly increased their accuracy in many 
systems161. 
 
 
 
Fig. 2.2. Qualitative behavior of dispersion energy at short-, medium- and long-range distances (R). k1, k2 and 
C6 are system specific constants. Taken from ref.147. 
 
Most of the calculations presented in the results section were performed using the D3(BJ) dispersion 
correction applied to the B3LYP functional, as mentioned before. Comparison with other dispersion-
corrected functionals (also including different dispersion schemes) is also provided. 
 
2.3 Basis sets 
 
The Schrödinger equation165 can only be analytically solved for hydrogen-like atoms, that is, for 
mononuclear systems. In other cases, the Schrödinger equation needs to be solved in an approximated 
way; in this sense, a useful strategy is to use a set of basis functions to  construct the corresponding 
wave function (ψ). Indeed, the wave function is formed by a set of molecular orbitals, that result from 
the combination of these basis functions. This is usually achieved by using the convenient Linear 
Combination of Atomic Orbitals (LCAO) approach, firstly reported by Lennard-Jones in 1929166: 
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 𝜙𝑖 = 𝑐1𝑖𝜒1 + 𝑐2𝑖𝜒2 + 𝑐3𝑖𝜒3 + ⋯ + 𝑐𝑛𝑖𝜒𝑛 = ∑ 𝑐𝑟𝑖𝜒𝑟
𝑟
      (2.13) 
 
Where 𝜙𝑖 is a molecular orbital represented as a sum of n atomic orbitals 𝜒𝑟, each multiplied by 
a corresponding coefficient 𝑐𝑟𝑖, and r (numbered 1 to n) indicates which atom orbital is combined 
in the term. 
Basis functions are typically hydrogen-like orbitals that consists of a radial 𝑅𝑛,𝑙 and spherical 
harmonic angular part 𝑌𝑙,𝑚: 
 
 𝜙(𝒓; 𝛼, 𝑅) =  𝑅𝑛,𝑙𝑌𝑙,𝑚     (2.14) 
 
Where the radial part, 𝑅𝑛,𝑙, is of Slater type. 
Slater Type Orbitals (STO)167 are defined as: 
 
 𝜙𝑆𝑇𝑂(𝒓; 𝛼, 𝑅) = 𝐴𝑟𝑙𝑒−𝛼(𝑟−𝑅)      (2.15) 
 
Where r is the electron position, R refers to the position of the nucleus, α is a charge dependent 
constant, l an integer number accounting for the angular momentum and A is the normalization 
constant so that ∫ | 𝜙𝑆𝑇𝑂|2𝑑𝑟 = 1. 
Slater type orbitals are functions that describe well the exponential behavior of electrons’ orbitals. 
However, three and four-center two electron orbitals involving STO cannot be easily solved 
analytically. For this reason, a more convenient approximation is given by Gaussian Type Orbitals 
(GTO)168. GTO are easier to integrate, and, accordingly, are less computationally demanding: 
 
 𝜙𝐺𝑇𝑂(𝒓; 𝛼, 𝑅) = 𝐴𝑟𝑙𝑒−𝛼(𝑟−𝑅)
2
      (2.16) 
 
The main problem with GTO is represented by the fact that they are not able to represent the cusp of 
STO near the nucleus, and decay too rapidly far from the nucleus. In order to try to alleviate these 
significant shortcomings, the solution is to represent STO as a linear combination of many GTO: 
 
 
𝜙𝑆𝑇𝑂 ≈ ∑ 𝑐𝑖𝜇𝜙
𝐺𝑇𝑂
𝐿
𝑖=1
 
    
(2.17) 
 
In the present thesis work, both STO and GTO have been used. 
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2.3.1 Basis Sets Superimposition Errors (BSSE) 
The BSSE is a significant problem that arises in dimers. Such an issue is a consequence of a sharing 
of basis sets coming from each monomer that form a complex. Originally introduced by Liu and 
McLean in 1973169, it was firstly reported by Kestner in 1969170. 
From a conceptual point of view, BSSE can be explained as having a dimer AB, formed by monomer 
A and monomer B. When forming the complex AB, each monomer is further stabilized because A 
donates extra basis functions to B, and B donates extra basis functions to A. Such a phenomenon 
cannot occur in separate monomers and, therefore, the dimer is overstabilized. In other words, it is an 
artificial shortening of intermolecular  distances with a concomitant artificial strengthening of 
intermolecular interactions171. 
A popular strategy to overcome that issue is represented by the counterpoise corrections to the 
BSSE172,173. This is achieved by including the neighbor monomer’s orbitals in order to have the same 
basis set as in the dimer. However, such an approach has serious issues when dealing with open shell 
systems and solvation treatments. 
Several cases have been critically discussed by Alvarez-Idaboy and Galano174; it was concluded that 
the best solution is to not take into account counterpoise corrections and to try to use as much as large 
basis sets as possible, so that to attenuate the BSSE problem. 
Extensive triple-ζ Pople’s basis sets175 (6-311++G(3df,2p) were mostly used in the result section of 
this thesis work, when dealing with GTO functions. When STO are needed, we have employed very 
large quadruple-ζ even-tempered basis sets176. 
 
2.4 Solvation 
  
Biochemical processes arising in an open biological environment take place mainly in water, unless 
some special cases such as the catalytic pockets of enzymes that can be solvent-free. Therefore, in 
order to properly investigate the behavior of aluminum with respect to common bioligands, it is 
important to mimic the behavior of the solvent. Implicit solvation models are often used in Quantum 
chemistry as they allow computationally affordable treatments of solvation effects, rather than 
explicitly consider solvent molecules177. 
From a conceptual point of view, solvated molecules can be viewed as a process in which first a 
cavity has to be created in the solvent in order to place the solute (molecule). Then, the cavity becomes 
polarized because of the electric field created by the solvent. The polarization of the cavity generates 
an electric field at the solvent molecules. It is this last effect that can be modelled as a perturbation 
operator which is added to the Hamiltonian of the solute in gas phase. 
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The solute is embedded in a polarizable continuum of dielectric ε. The first step is to create a cavity 
in order to accommodate the solute; the free energy variation in this step is called the “cavitation 
energy”. When the molecule with the gas phase geometry and electronic structure is placed within 
the cavity, the electric field created by the molecule polarizes the continuum and an electrostatic 
potential arises in the cavity. Such electrostatic potential is called “reaction potential” and interacts 
with the molecule generating a total free energy change. 
This latter change in free energy arises from the solute-solvent, solvent-solvent and internal solute 
electrostatic interactions; such energy is called “electrostatic” contribution. Finally, the solute-solvent 
dispersion energy gives rise to the “dispersion” term. 
Accordingly, the solvation free  energy Δ𝐺𝑠𝑜𝑙𝑣 , that is, the change in free energy needed to transfer 
a molecule from the gas phase to the solvation, is given by: 
 
 Δ𝐺𝑠𝑜𝑙𝑣 = Δ𝐺𝑐𝑎𝑣 + Δ𝐺𝑒𝑙𝑒𝑐 + Δ𝐺𝑑𝑖𝑠𝑝     (2.18) 
 
When the solvent is treated as a continuum, as discussed above, the Laplacian of the reaction 
potential, 𝜙(𝑟), is related to the free charge density, 𝜌(𝑟), by the Poisson’s equation: 
 
 ∇𝜀(𝑟)[∇𝜙(𝑟)] = −4𝜋𝜌(𝑟)     (2.19) 
 
Where 𝜀 is the homogenous dielectric constant. 
The polarizable continuum model (PCM)177 solves the electrostatic problem by introducing a charge 
distribution spread over the cavity surface178,179. The volume of the cavity is obtained by adding up 
van der Waals spheres of solute’s atoms. The surfaces of these resulting volumes are rather irregular 
and, in general, no analytic function can fit them. 
For that reason, Δ𝐺𝑒𝑙𝑒𝑐 is calculated numerically. The cavity surface is divided into a large number 
of small surface elements, and a point  charge is associated to each surface element. 
The reaction potential is added to the solute Hamiltonian and solved iteratively by means of the SCF 
procedure: 
 
 Ĥ = Ĥ0 + 𝜙(𝑟)     (2.20) 
 
After each SFC cycle new values of the surface changes are calculated from the current wave function 
to update the reaction potential; this is then used in the next iteration until the solute wave function 
and the surface changes are self-consistent. 
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The dispersion and cavitation components are usually considered proportional to the surface defined 
by the van der Waals spheres and the solvent accessible surface is used to calculate dispersion 
contribution.  
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PART I 
Chelation therapy and development 
of new chelation strategies 
 
 
 
 
“Some girls they want a handsome Dan  
Or some good-lookin' Joe, on their arm  
Some girls like a sweet-talkin' Romeo  
Well 'round here baby  
I learned you get what you can get  
So if you're rough enough for love  
Honey I'm tougher than the rest” 
(B. Springsteen, Tougher than the Rest) 
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Tuning the affinity of catechols and salicylic acids towards Al(III): 
characterization of Al-chelator interactions. 
 
 
3.1 Introduction 
 
Aluminum is the third most abundant element in the Earth’s crust, following oxygen and silicon. 
However, complex but effective geochemistry has prevented its solubilization8,180, allowing 
biological systems to evolve in the absence of this abundant metal. Nonetheless, in the last century, 
human intervention has made aluminum bioavailable in a myriad different ways, and as a 
consequence, important trace amounts of this element are found in the human body. The introduction 
of a nonessential element into biological cycles has raised justified concerns about its biological 
effects and potential toxicity7,10,181, and the scientific literature on the adverse health effects of 
aluminum is extensive182. Although the exact mechanisms of aluminum toxicity are not well 
understood at the atomic level, there is increasing evidence that aluminum promotes oxidative 
stress52,56,183, inhibits the normal function of several enzymes (such as hexokinase184, glutamate 
dehydrogenase185-187, etc.), interferes with several key cell metabolism cycles188-190, and alters the 
structure and chemistry of important metabolites186 and cofactors42. Aluminum is also considered a 
neurotoxic element191. Early studies supported this hypothesis, linking aluminum and the formation 
of neurofibrillary tangles (NFT)192. In fact, both experimental and theoretical studies have underlined 
the ability of aluminum to bind to phosphorylated peptides66,193 and to promote hyperphosphorylation 
of normal neurofilaments194. In addition, the ability of aluminum to contribute to Aβ-amyloid 
aggregation has been recently demonstrated49,50, and growing evidence is linking aluminum to be a 
decisive contributing factor in Alzheimer’s disease3,59,61. 
In this controversial context, the quest for chelating agents that could make an effective treatment for 
aluminum-related disorders has attracted considerable interest6,16,22,25,112. In particular, catechols and 
salicylic acids have emerged as very promising building blocks for the design of effective alumninum 
chelators, because they constitute two of the strongest bidentate aluminum binding species20. The 
reason for that relies on the fact that Al(III) is a hard Lewis acid (and the hardest trivalent metal), and 
therefore it prefers to coordinate to hard Lewis bases such as phenoxide and carboxylate20. Moreover, 
the interaction of aluminum with such functional groups is supposed to be mainly of electrostatic 
nature16. Due to this inherent affinity, it is not surprising that the biochemistry of important 
neurotransmitters like catecholamines is highly affected by the presence of aluminum195-197. It has 
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been shown that aluminum affects the signaling process mediated by these neurotransmitters198, it 
alters their content in animal models195, and it interferes with enzymatic activities that involve these 
neurotransmitters64,76. Because of their strong binding affinity, both catechols and salicylic acids have 
been extensively studied6,16,94,199 in the framework of aluminum chelation therapy with the aim of 
finding improved and aluminum-specific chelators by tuning their chemical environment with 
different substituents. The efficiency of low molecular mass aluminum-chelator complexes has been 
studied by means of several experimental techniques, such as potentiometric titrations, UV/Vis. 
spectra, 1H NMR and ESI-MS94,102,199-201. Nevertheless, the effects mediated by the inclusion of 
different substituents in the molecule and how they may modulate the binding affinity toward 
aluminum are still not well understood199,201. In this sense, the understanding of the effect of electron 
withdrawing (EWGs) and electron donating groups (EDGs), the role played by aromaticity in these 
chelators, the rationalization of complex stability, and the specific nature of the Al-O bonds is of 
paramount importance to guide the quest for improved aluminum chelating agents. However, often 
this relevant information can not be deduced directly from experimental procedures alone. 
The use of state-of-the-art theoretical methods can provide valuable insights on the properties of these 
systems, as demonstrated elsewhere108,202,203. In the present work, we present a comprehensive 
computational protocol to investigate the behavior of different chelating agents interacting with 
Al(III). Validation with respect to available experimental data is also performed. Then, the validated 
protocol is applied to the characterization of the substituent effects and the bonding nature of various 
aluminum-chelator complexes, as well as their aromatic-related properties, in order to provide a 
thorough rationalization of the behavior of these chelators. We have considered two main families of 
chelating agents, salicylic acids and catechols, bearing electron donating groups (EDGs, methyl and 
methoxy) and electron withdrawing groups (EWGs, nitro and trifluoromethyl) placed at different 
positions along the aromatic ring and in different quantities (see Fig. 3.1  and Table 3.2). These 
substituents were chosen since they exert opposite effects through different mechanisms of actions 
(resonance and/or induction). Our results demonstrate that although the Al-O bond is mainly of ionic 
nature, as it corresponds to a hard metal ion, the trend in the stability for these complexes is mainly 
determined by covalent dative interactions. We also analyze how Al(III)/proton competition modulate 
the properties of these chelators. 
 
3.2 Methodology 
 
The computational protocol that we developed for the investigation of different Al(III)-chelator 
complexes is outlined in Fig. 3.2 and presented in the following sections. For the sake of simplicity,  
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Fig. 3.1. Summary of the two families of chelators with the four differents substituents considered in this work: 
methyl and methoxy (EDGs), nitro and trifluoromethyl (EWGs). The different mechanisms of action of the 
substituents are also summarized. 
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Fig. 3.2. Schematic representation of the computational protocol developed in this work. 
 
we provide only a schematic overview of the whole protocol; therefore, for the full theory and 
technical details of each methodology we redirect the reader to the specific computational details 
section of Appendix A. 
 
3.2.1 Definition of binding affinities: cluster-continuum approach 
In order to investigate the thermodynamics of all Al(III)-chelator complexes in aqueous solution, we 
utilized the so-called cluster-continuum approach115,204,205, with the first-coordination shell of 
aluminum surrounded by explicit water molecules in a octahedral fashion and a second solvation shell 
treated with a continuum dieletric model (see Fig. 3.4). Optimization and single point calculations 
were performed at the B3LYP-D3(BJ)/6-311++G(3df,2p)//B3LYP-D3(BJ)/6-31++G(d,p) using the 
integral equation formalism variant (IEFPCM) solvation model177. Such a choice was made since it 
has been shown that the introduction of dispersion corrections on both geometry and single point 
energy calculations improve the overall results206. In general, the addition of methods that properly 
take into account dispersion energies in DFT has been proven to improve the precision of computed 
non-covalent interactions141,155. 
For results with different Density Functionals and the MP2 methods and their evaluation versus 
experimental stability constants see Appendix A. 
We characterized bidentate Al-Lig complexes with 1:1, 1:2 and the 1:3 stechiometry following the 
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ligand substitution reaction shown in eq. 3.1: 
 
 Al(H2O)6](aq.,1M)
3+ + Lr(aq.1M)
−q
⇄ Al(H2O)6−mLr](aq,1M)
3−q
+ mH2O(aq,1M)     (3.1) 
 
where q is the net charge of the ligand L, r the number of ligands and m depends on the stoichiometry 
of the complex, such as m=2, m=4 and m=6 for 1:1, 1:2 and 1:3 complexes, respectively. Notice that 
we consider the ligand in its unprotonated form, which is the state considered when evaluating 
experimental log(β) (see section 3.3). 
The enthalpy in solution corresponding to the binding of the ligand to Al(III) is therefore calculated 
as: 
 
 Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝 = 𝐻𝑎𝑞𝐴𝑙(𝐻2𝑂)6−𝑚𝐿𝑟 + 𝑚𝐻𝑎𝑞(𝐻2𝑂) − 𝐻𝑎𝑞[𝐴𝑙(𝐻2𝑂)6] − 𝐻𝑎𝑞(𝐿)𝑟
+ Δ𝑛𝑅𝑇𝑙𝑛(24.46) 
    
(3.2) 
 
Since the enthalpies are determined using an ideal gas at 1 atm as the standard state, the last term in 
eq. 3.2 corresponds to the volume change due to the transformation from 1 atm to 1 M in solution, 
where Δn refers to the change in the number of species in the reaction207. In a similar way, the free 
energy of the complexes is determined as: 
 
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝 = 𝐺𝑎𝑞𝐴𝑙(𝐻2𝑂)6−𝑚𝐿𝑟 + 𝑚𝐺𝑎𝑞(𝐻2𝑂) − 𝐺𝑎𝑞[𝐴𝑙(𝐻2𝑂)6] − 𝐺𝑎𝑞(𝐿)𝑟
+ Δ𝑛𝑅𝑇𝑙𝑛(24.46) + 𝑚𝑅𝑇𝑙𝑛(55.34) 
    
(3.3) 
 
where the last term is the entropic factor that accounts for the concentration of 55.34 M of water in 
liquid water207. 
The validation of binding energies with respect to experimental stability constants (i.e. logβ) is 
thoroughly discussed in section 3.3. 
 
3.2.2 Chemical bond analysis and evaluation of molecular properties 
At the second stage, to provide a quantitative and qualitative characterization of the interactions 
arising in these Al(III)-chelator complexes, as well as to unveil the effect of different substituents 
(EDGs and EWGs) toward complex stability, we have employed several state-of-the-art 
computational techniques summarized as follows: 
 
 Quantum Theory Of Atoms In Molecules (QTAIM): the Bader’s theory208 allows to 
classify the nature of a given bond according to the carachteristics of its Bond Critical Point 
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(BCP), such as the electron density at the BCP 𝜌(𝑟𝐵𝐶𝑃), the Laplacian of the electron density 
∇2(𝑟𝐵𝐶𝑃)  and the total energy density 𝐻(𝑟𝐵𝐶𝑃). Delocalization Indices (𝐷. 𝐼.𝐴𝐵 )  provide a 
mean of the average number of electron pairs shared between two atoms A and B. 
 
 Energy Decomposition Analysis (EDA): the EDA scheme by Morokuma209 and Ziegler and 
Rauk210 decomposes the total interaction energy (Δ𝐸𝑖𝑛𝑡) between two molecules into three 
main components, that is, an electrostatic interaction term (Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡), an orbital interaction 
term (Δ𝐸𝑜𝑖) and a Pauli repulsion term (Δ𝐸𝑃𝑎𝑢𝑙𝑖). Therefore, the EDA scheme allows to 
measure and quantify the electrostatic and covalent effects that may arise in a given complex. 
 
 Aromaticity analysis: the analysis of the aromaticity of a molecule according to the Iring211 
and MCI212 aromatic descriptors is useful to compare the overall aromatic character of a given 
ligand with respect to a refence (i.e. benenze for an aromatic compound, ciclohexane for a non 
aromatic one); moreover, it is possible to analyze the effects that the addition of substituents 
of different nature may have on the aromatic-based properties (like resonance) of the ligand, 
so that to provide a rationale for their mechanism of action. 
 
 Evaluation of possible steric effects: steric hindrances may take place between two or more 
functional groups placed close one another; accordingly, it is important to evaluate the change 
in stability due to repulsive phenomena upon addition of bulky functional groups. 
 
3.2.3 Aluminum ion and proton competition 
Finally, we developed a strategy to account for the influence of the protonation constants of a given 
ligand toward the stability of the complex with Al(III), and, therefore, for the competition between 
Al(III) and the proton for the ligand. The latter aspect is particularly important upon addition of 
substituents because different functional groups lead to different effects against ligand’s pKa, 
modulating the overall basicity/acidity of the chelator94,199,213. The whole strategy is presented and 
discussed in the aluminum ion/proton competition section; its evaluation and validation with respect 
to the experimental pAl criteria is also provided. 
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3.3 Results and discussion 
 
3.3.1 Validation of binding affinities 
Experimentally, chelation affinity is usually measured by using two different criteria: pM and logβ 
(cumulative stability constant)27. pM is defined as the negative logarithm of the concentration of the 
free metal in solution, calculated for total [ligand] = 10-5 M and total [metal] = 10-6 M at pH 7.4, 
usually calculated from data at 25°C and 0.1 M ionic strength28. This criteria is usually useful when 
comparing different chelators, as pM takes into account the effects of ligand protonation and 
denticity, so that it can provide a general and qualitative insight about the chelation properties of the 
molecule in solution27,28,78. On the other hand, stability constants logβabc can be expressed as 𝑎𝑀 +
𝑏𝐿 + 𝑐𝐻 ⇄ 𝑀𝑎 + 𝐿𝑏 + 𝐻𝑐, where M is the metal, L is the ligand (in its unprotonated form) and H 
stands for a given protonation state. In other words, this is a measure of the strength of the interaction 
between the metal and the ligand that form the complex. 
In order to validate our approach, theoretical binding energies of 1:1, 1:2 and 1:3 complexes were 
evaluated with respect to the available experimental logβ and pAl values taken from ref.94. At this 
stage, those complexes with available experimental data were included, namely: catechol, 4-
nitrocatechol, salicylic acid, 3-nitrosalycilic acid, 5-nitrosalycilic acid and 3,5-dinitrosalycilic acid. 
Optimized geometries are shown in Fig. 3.4, and the Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 and Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 values reported in Table 
3.1 along with experimental data. 
As we can see in Fig. 3.3, our theoretical protocol is able to describe the relative affinity for this set 
of molecules. Indeed, theoretical Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 shows the same trends as the experimental logβ for all 
stechiometries, with a total correlation coefficient of 0.9692. On the other hand, If we analyze the 
trends observed for pAl (Table 3.1), we can see that these trends are not the same order as for logβ 
and Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
. Notice that pAl does not depend on the stochiometry (Table 3.1), so it is often used as 
an indirect ligand affinity indicator78. However, the observed discrepancies between pAl and logβ are 
due to the fact that, as previously mentioned, pAl depends not only on the stability of the complexes, 
but also on other factors like metal/proton competition, the number of different Al(III)-chelator 
species present at pH 7.4 and the denticity of the chelator27,78. This remarks the limits of using pM 
alone, as a unique measure of complex stability. A more detailed discussion about pAl is provided in 
the aluminum ion/proton competition section. 
Optimized geometries for 1:1, 1:2 and 1:3 complexes can be found in Fig. 3.4. In all complexes the 
ligands interact bidentately with aluminum. Since Al(III) is always hexacoordinated, the remaining 
coordination sites are filled with water molecules. In 1:1 and 1:2 complexes, aluminum is always 
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placed coplanar to the aromatic rings. 
In 1:2 complexes, the two ligands are not fully coplanar as they are slightly tilted one another 
(deviation dihedrals in the 8.0-11.0 degrees range, (Fig. 3.4). In the case of 1:3 complexes, whereas 
catechol family still retain the coplanarity (Fig. 3.4) of aluminum with respect to the aromatic rings, 
salicylic acid complexes show slight distortions, due to π − π stacking interactions that arise between 
the adjacent aromatic rings. 
 
  Theoretical Experimental 
Stoichiometry  Ligand Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ pAl 
1:1 Complexes 
Catecholates 
Cathecolate -88.4 -91.4 16.3 10.1 
4-nitrocatecholate -71.6 -75.8 13.3 14.2 
Salicylates 
Salicylicate -76.9 -78.7 13.3 8.2 
3-nitrosalicylicate -64.2 -66.7 9.5 8.7 
5-nitrosalicylicate -63.3 -65.4 9.3 8.4 
3,5-dinitrosalicylicate -55.0 57.1 6.9 9.1 
       
1:2 Complexes 
Catecholates 
Cathecolate -151.8 -157.7 31.7 10.1 
4-nitrocatecholate -124.0 -130.8 24.8 14.2 
Salicylates 
Salicylicate -130.8 -136.9 24.2 8.2 
3-nitrosalicylicate -110.6 -114.6 17.7 8.7 
5-nitrosalicylicate -109.2 -114.2 17.7 8.4 
3,5-dinitrosalicylicate -95.4 -101.0 13.3 9.1 
       
1:3 Complexes 
Catecholates 
Cathecolate -183.1 -191.7 41.1 10.1 
4-nitrocatecholate -154.8 -164.6 33.7 14.2 
Salicylates 
Salicylicate -160.6 -167.5 32.1 8.2 
3-nitrosalicylicate -139.8 -145.8 23.7 8.7 
5-nitrosalicylicate -137.8 -141.7 23.7 8.4 
3,5-dinitrosalicylicate -125.8 -127.9 18.5 9.1 
       
Total correlation coefficients   0.9692 0.1235 
     
 
Table 3.1. Binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol calculated for 1:1, 1:2 and 
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1:3 Al-ligand complexes with available experimental logβ and pAl data, taken from ref.94. 
 
Finally, we would like to point out that we repeated our calculations with other dispersion corrected 
DFT functionals, as well as at the MP2 level of theory (Appendix A), finding a good agreement 
between all different methods and B3LYP-D3(BJ) binding energies, which further validates our 
approach. 
  
 
 
Fig. 3.3. B3LYP-D3(BJ) binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) versus experimental stability constants (logβ)94. 
 
3.3.2 Modulation of the binding affinities by electron donating and withdrawing groups 
Once validated our theoretical binding energies with respect to available stability constants, and 
taking into account that the relative affinities are not affected by the different stoichiometries, we 
focus in 1:1 complexes and enlarge our dataset of possible chelators by considering the four types of 
substituents presented in Fig. 3.1 (bottom table): methyl and methoxy (EDGs), and nitro and 
trifluoromethyl (EWGs). These substituents were placed at different positions of the 
catecholate/salicylate rings, and in different quantities. In this way, a total of 27 complexes were 
considered (1:1 complexes of Fig. 3.4 and  3.5). Results can be found in Table 3.2. 
Our results show that the inclusion of methyl and methoxy groups leads to larger binding energies 
when compared with the unsubstituted compounds of both families, whereas the inclusion of nitro 
and trifluoromethyl groups leads to lower affinities. The destabilizing effect of the inclusion of a nitro  
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Fig. 3.4. Optimized geometries of 1:1, 1:2 and 1:3 Al(III)-chelator complexes used to validate the theoretical 
protocol: catechol, 4-nitrocatechol, salicylic acid, 3-nitrosalicylic acid, 5-nitrosalicylic acid, 3,5-
dinitrosalicylic acid. 
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Ligand Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 
Catecholates 
Catecholate -88.4 -91.4 
Electron Withdrawing Groups 
4-nitrocatecholate -71.6 -75.8 
4,6-dinitrocatecholate -62.0 -65.9 
4,5,6-trinitrocatecholate -52.8 -56.4 
4-trifluoromethylcatecholate -81.4 -87.1 
4,6-trifluoromethilcatecholate -75.5 -78.6 
4,5,6-trifluoromethylcatecholate -70.1 -74.0 
Electron Donating Groups 
4-methylcatecholate -89.5 -93.3 
4,6-dimethylcatecholate -91.6 -95.4 
3,4,5,6-tetramethylcatecholate -97.2 -101.2 
4-methoxycatecholate -89.6 -92.8 
Salicytates 
Salicylicate -76.9 -78.7 
Electron Withdrawing Groups 
3-nitrosalicylicate -64.2 -66.7 
5-nitrosalicylicate -63.3 -65.4 
3,5-dinitrosalicylicate -57.1 -55.0 
3,4,5-trinitrosalicylicate -50.5 -52.4 
5-trifluoromethylsalicylicate -70.3 -75.3 
3,5-trifluoromethylsalicylicate -65.5 -67.6 
3,4,5-trifluoromethylsalicylicate -61.8 -64.2 
Electron Donating Groups 
3-methylsalicylicate -79.2 -82.5 
4-methylsalicylicate -79.3 -82.3 
5-methylsalicylicate -79.3 -82.9 
6-methylsalicylicate -74.9 -77.2 
3,5-dimethylsalicylicate -80.7 -83.6 
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4,6-dimethylsalicylicate -76.4 -79.4 
3,4,5-trimethylsalicilicate -82.0 -85.3 
3,5-dimethoxysalicylicate -79.5 -82.3 
 
Table 3.2. Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed for 1:1 complexes 
(compounds are shown in Fig.  3.1) considering the whole dataset of compounds bearing different substituents. 
 
group is larger than the destabilizing effect of a trifluoromethyl group and, moreover, larger than the 
stabilizing effect of the inclusion of both methyl/methoxy groups. 
This can be qualitatively explained in terms of inductive and resonance effects (see Fig. 3.1): nitro is 
an EWG by both inductive and resonance effects, whereas trifluoromethyl is an EWG only by 
induction. Moreover, methoxy shows contrary effects that partially compensate, i.e. an electron 
withdrawing effect by induction and a donating one by resonance. Finally, methyl is electron donating 
only by inductive effect. As we will see in the aromaticity section, resonance effects dominate over 
inductive effects and methoxy has an overall electron donating behavior. Our results are consistent 
with the hypothesis by Nurchi et al.94 in that the decrease in the stability constants caused by the nitro 
substituent was due to a mixture of inductive/resonance effects. On the other hand, in a more recent 
paper, Nurchi et al.199 also pointed to the increase in stability of complexes formed by 
methoxysalicylic acids and aluminum, although the origin of the enhancement of ligand affinity by 
methoxy substituents was not deeply analyzed. Another interesting feature that can be observed from 
our calculated binding affinities, is the additive character of the substituents effects: the higher the 
number of the substituents, the stronger their modulation of binding affinities. On the other hand, the 
specific position of the substituent in the aromatic ring does not lead to significant differences in the 
stability of both families of chelators (Table 3.2). These latter findings are in agreement with those 
reported in the literature, considering stability constants of differently substituted (EWGs or EDGs) 
salicylic acids94,199. 
In order to rationalize the opposite behavior of the two different classes of substituents and to obtain 
a more detailed picture about the change in the electronic structure of these complexes, we proceeded 
to characterize the nature of the Al-O interactions by means of the QTAIM theory and Energy 
Decomposition Analysis (EDA). 
 
3.3.3 Chemical bond analysis of Al-chelator interactions 
3.3.3.1 QTAIM analysis suggests a mainly ionic interaction but with a sizeable covalent degree 
Results of QTAIM topological analyses of the Al-O bond critical points (BCPs) for all 1:1 complexes 
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are shown in Appendix A. The values of the electron density at all Al-O bond critical points,  𝜌(𝑟𝐵𝐶𝑃), 
are rather small; such a situation has been reported in literature as a typical feature for metal-
containing systems214-216. Interestingly, there is very good correlation between 𝜌(𝑟𝐵𝐶𝑃) and binding 
affinities (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
): the higher the value of  𝜌(𝑟𝐵𝐶𝑃), the stronger the affinity (see Appendix A). 
 
 
 
Fig. 3.5. Optimized geometries of 1:1 complexes between aluminum and catecholates or salicylates bearing 
the four different substituents: a) 4-methylcatecholate, b) 4-methoxycatecholate, c) 4,6-dimethylcatecholate, 
d) 3,4,5,6-tetramethylcatecholate, e) 4,6-dinitrocatecholate, f) 4,5,6-trinitrocatecholate, g) 4-
trifluoromethylcatecholate, h) 4,6-trifluoromethylcatecholate, i) 4,5,6-trifluoromethylcatecholate, j) 3-
methylsalicylate, k) 4-methylsalicylate, l) 5-methylsalicylate, m) 6-methylsalicylate, n) 3,5-dimethylsalicylate, 
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o) 3.5-dimethoxysalicylate, p) 4,6-dimethylsalicylate, q) 3,4,5-trimethylsalicylate, r) 3,4,5-trinitrosalicylate, s) 
5-trifluoromethylsalicylate, t) 3,5-trifluoromethylsalicylate, u) 3,4,5-trifluoromethylsalicyate. 
 
In addition, we find positive values of  ∇2(𝑟𝐵𝐶𝑃), and small but negative values of the energy densities 
at the bond critical points 𝐻(𝑟𝐵𝐶𝑃), consistently for all Al-O BCPs. Positive values of ∇
2𝜌(𝑟𝐵𝐶𝑃) and 
𝐻(𝑟𝐵𝐶𝑃) are indicative of closed-shell interactions (i.e. ionic or electrostatic bonds), while negative 
values for both quantities indicate the presence of shared (covalent) interactions. The mixed situation 
present in our results, previously reported for bonds involving metals214, suggests that, although the 
Al-O bonds are mainly of ionic nature, there is also a small degree of covalency that could play a 
significant role. It is worth to emphasize that also both the Laplacians and the energy densities at all 
Al-O BCP show a strong correlation with binding energies (see Appendix A). To further investigate 
these findings, we decided to calculate the delocalization indices (D.I.) for all the Al-O bonds. These 
indices are quantities integrated in the whole volumes of the respective atom basins, and therefore 
they give a more global and reliable picture of a bond interaction than the analysis based on the 
properties of a single point in space like the bond critical point. 
 
3.3.3.2 Delocalization Indices show a strong correlation versus binding affinities 
D.I. for all Al-O bonds are shown in Appendix A, along with the Localization Indices of aluminum. 
In Fig. 3.6, we represent Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 versus the sum of the two Al-O delocalization indices for each 
complex (D.I.Al-O). The differences in Al-O bond delocalization indices among the various complexes 
are small. Nevertheless, there is a clear correlation between the values of these delocalization indices 
and the binding affinities (see Fig. 3.6), finding a remarkable linear correlation between Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 and 
D.I.Al-O, with a value of the correlation coefficient (r) of 0.9854 for salicylates (16 compounds), 
0.9926 for catecholates (11 compounds), and 0.9884 for the whole dataset of 27 compounds. Since 
D.I. are a measure of the number of electron pairs shared between two atoms, they have been related 
to the covalent character of a given bond217. Our results point to a clear modulation of the D.I.Al-O by 
the opposite effect of EDGs and EWGs, confirming our previous findings of a small but important 
degree of covalency in these mainly electrostatic interactions. 
The overall picture provides a clear rationalization of the effect of substituents: EDGs donate electron 
density to the aromatic ring, which in turn increase the covalency of the Al-O bonds, as it can be seen 
by larger values of D.I.Al-O, higher 𝜌(𝑟𝐵𝐶𝑃) and more negative 𝐻(𝑟𝐵𝐶𝑃) of the Al-O bonds (Fig. 3.6, 
Appendix A). On the other hand, EWGs take electron density away from the aromatic ring, leading 
to weaker Al-O interactions with lower D.I.Al-O values, lower 𝜌(𝑟𝐵𝐶𝑃) and less negative 𝐻(𝑟𝐵𝐶𝑃). In 
summary, QTAIM topological analysis and D.I. suggest that there is a degree of covalency in the Al-
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O interactions, modulated by the effect of substituents, which correlates with both theoretical 
(Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
, Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and experimental (logβ, when available) binding affinities. It is also important to 
note that values of aluminum Localization Indices (average number of electrons localized on a given 
atom) are stable among different compounds, suggesting that no charge transfer takes place in these 
aluminum-chelator complexes.  
 
 
 
Fig. 3.6. Binding enthalpies 𝚫𝑯𝒂𝒒
𝒄𝒐𝒎𝒑
 in kcal/mol versus the sum of the two Al-O delocalization indices (D.I.Al-
O) in a.u. for all complexes. 
 
Finally, we would also like to highlight the effect that substituents have in the modulation of atomic 
charges at the oxygen atoms coordinated to aluminum. In general, methyl and methoxy groups tend 
to increase the negative charges at those oxygen atoms, whereas the presence of nitro and 
trifluoromethyl groups lead to lower negative charges in both families (see Appendix A). Quite 
interestingly, high electron delocalizations from the lone pairs of the two oxygen atoms to the 3s and 
3p orbitals of aluminum was assessed by means of the Natural Bond Orbital approach. According to 
these latter findings, we can rationalize such small covalent character as a dative interaction between 
the two oxygen donors and the formally empty orbitals of the metal. 
To further investigate the relative contributions of the electrostatic and covalent components of these 
Al-O bonds, we performed the energy decomposition analysis (EDA) of all compounds. 
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3.3.3.3 Energy decomposition analysis confirms a mainly ionic bond with a significant covalent 
character that modulates the binding affinity 
 In Appendix A, we can find the values of the Energy Decomposition Analysis terms calculated at 
the B3LYPD3(BJ)/ET-QZ3P-1DIFFUSE level of theory in gas phase. In Fig. 3.7, we represent the 
values of binding enthalpies versus the total EDA interaction energies (Δ𝐸𝑖𝑛𝑡), and its electrostatic 
(Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡) and orbital interaction (Δ𝐸𝑜𝑖) components. First, we have to remark that there is a good 
linear correlation (r= 0.9727, salicylates and r= 0.9841, catecholates) between the total interaction 
energies calculated with EDA and  Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
, remarking the adequacy of using the EDA analysis to 
understand the origin of the different affinities of the chelators towards aluminum. The decomposition 
of interaction energies into electrostatic and orbital interaction (which accounts for the covalent 
character) terms points to mainly electrostatic interactions, and, in agreement with the previous 
QTAIM analysis, there is a sizable contribution from orbital interaction terms (between 27-37%). In 
general, the percentage of covalency is higher for catecholates than for salicylates (Fig. 3.7 and 
Appendix A), and EWGs tend to decrease the degree of covalency of these interactions, whereas 
EDGs increase it. However, it is important to take into account that such calculations were performed 
in gas phase, so environmental effects (i.e. implicit solvent) are expected to alter the degree of the 
covalent character. Interestingly, although Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 is significantly larger than Δ𝐸𝑜𝑖 in all compounds, 
it is only the latter that correlates with the binding enthalpies (See Fig. 3.7). The linear regression of 
Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 versus Δ𝐸𝑜𝑖 shows a correlation coefficient of 0.8964 for salycilates (16 compounds) and 
0.9366 for catecholates (11 compounds), and 0.9185 if we consider the whole dataset of 27 
compounds. Conversely, there is no correlation between Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 and Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡, and even though 
salicylates have on average larger electrostatic interaction energy than catecholates, they have lower 
affinity for aluminum. The other two terms of the EDA, Δ𝐸𝑃𝑎𝑢𝑙𝑖 and Δ𝐸𝑑𝑖𝑠𝑝  (Appendix A), don’t 
show significant variations and therefore don’t have a direct influence on the overall behavior of these 
compounds. 
In summary, in agreement with QTAIM analysis, the tuning of the covalency of the Al-O bonds by 
the different EWG/EDG substituents modulates the differential affinities towards aluminum shown 
by these chelators. In this sense, the introduction of nitro and trifluoromethyl groups in the catecholate 
and salicylate rings leads to smaller absolute values of Δ𝐸𝑜𝑖, and this decrease is significantly larger 
for the former than for the latter. On the other hand, methyl and methoxy substituents lead to larger 
orbital interactions. 
 
3.3.4 The role of aromaticity 
The aromatic character of the ligands could be important to transmit the substituent effects. As it can 
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be seen in Fig. 3.1, the four substituents provide different effects: nitro is EWG by both inductive and  
 
Fig. 3.7. Representation of the binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) versus three components of the Energy 
Decomposition Analysis: i) Total interaction energies (top diagram), ii) Orbital interaction term (middle 
diagram) and iii) Electrostatic energy term (bottom diagram) for all the 11 aluminum-catecholate and 16 
 
resonance effects, trifluoromethyl is EWG only by inductive effect, methoxy shows opposite effects  
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that partially compensate, (electron withdrawing by induction and electron donating by resonance), 
and finally methyl is EDG only by inductive effect. Therefore, we chose to investigate how the 
aromaticity of the ligands changes upon aluminum binding and introduction of substituents. We 
investigate the aromatic character of all complexes according to the Iring and MCI aromatic 
descriptors218 (Appendix A). Both give similar trends and we will focus our discussion on Iring indices. 
Benzene is used as reference for an aromatic compound, while cyclohexane for a non-aromatic one. 
As expected, both catechol and salicylic acid show lower aromatic characters than the pure benzene 
ring. Upon deprotonation, both catecholate and salicylate display a sizable reduction of the aromatic 
character to 0.0235 and 0.0306 a.u., respectively. Notice, however, that upon aluminum binding the 
values are restored to 0.0345 and 0.0351 a.u.. Thus, in terms of aromaticity, the interaction with 
aluminum recovers the values obtained for the original protonated catechol and salicylic acid. For the 
rest of the discussion, we will focus on Al-bound complexes, taking as reference the corresponding 
unsubstituted Al-catecholate/salicylate complex. 
In both families of chelators, the addition of substituents, independently from the electron 
donating/withdrawing nature, decreases the aromatic character of the complexes. Moreover, such 
decrease in aromaticity follows a clear trend depending on the number of substituents that are added, 
so that the higher the number of substituents, the lower the aromatic character of the corresponding 
complex. Interestingly, substituents with a mechanism of action mediated by resonance (nitro and 
methoxy), show a larger decrease of aromaticity than those that work through inductive effects 
(methyl and trifluoromethyl). The lowest aromatic character is observed for tri-nitro-substitued 
compounds (4,5,6-trinitrocatecholate and 3,4,5-trinitrosalicylate), with values of 0.0207 and 0.0249 
a.u. respectively. Regarding the electron-donating substituents, methoxy leads to lower aromaticity 
indices than methyl, because in aromatic molecules resonance effects dominate over inductive effects 
and methoxy has an overall electron donating behavior. 
One may ask, as partially hypothesized by Dean et al. for similar pyridine-based aluminum 
chelators200, whether the aromatic character of a chelating agent is one of the main factors contributing 
to the different stability of the Al-chelator complexes. Clearly, our calculations points to a negative 
answer. Both EWGs and EDGs decrease the aromatic character of the compounds, but in the latter 
case there is an increase in the affinity towards aluminum. Thus, aromaticity does not play a direct 
role in the stabilization of these aluminum-chelator complexes. 
Nevertheless, the role of aromaticity is critical to modulate the mechanism of action of the 
substituents through resonance. In order to analyze this aspect, we calculated the binding energies of 
a series of non-aromatic 4-R-1,2-dihydroxy-ciclohexanes (See Fig. 3.8), and evaluated the changes 
in the binding affinities towards aluminum caused by the introduction of the four substituents listed 
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in Fig. 3.1. Results are summarized in Fig. 3.8, where we depict the relative binding energies 
ΔΔ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 of each complex with respect to the unsubstituted chelator in each case. We can see 
important differences in ΔΔ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 between aromatic and non-aromatic compounds; whereas in the 
case of non-aromatic chelators the range of ΔΔ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 expands from -0.6 kcal/mol to 6.4 kcal/mol, in 
the case of the aromatic catecholates ΔΔ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 expands to a much larger range, from -1.9 kcal/mol 
to 15.7 kcal/mol. This is indicative of a larger sensitivity of aromatic chelators towards substituent 
effects. Notice for instance, the large increase in the relative binding energies when considering the 
nitro group, 6.4 kcal/mol (non-aromatic chelator) versus 15.7 kcal/mol (aromatic chelator); clearly, 
this difference demonstrates that when the resonance transmission mechanism of the substituent is 
absent, the nitro group loses some of its electron-withdrawing character, partially maintained by the 
inductive-based one. Methoxy is a very significant case: while in the case of the aromatic chelator 
OCH3 leads to stabilizing effects (-1.4 kcal/mol), in the case of the non-aromatic compound leads to 
a destabilizing effect (0.8 kcal/mol). This is due to the fact that OCH3 acts as a EDGs by resonance, 
but as a EWGs by inductive effect. Accordingly, when resonance is absent like in 4-methoxy-1,2-
dihydroxy-ciclohexane, the inductive-based electron withdrawing mechanism is the only one 
working. 
In summary, although the introduction of electron donating/withdrawing substituents in both 
catecholate and salicylate families of chelators reduce the aromaticity of the compounds, the 
complexes still retain enough aromatic character to permit the transmission of substituent effects by 
a combination of both resonance and inductive mechanisms. This is a key factor in tuning the covalent 
character of the Al-O interactions. 
 
3.3.5 Proton and aluminum ion competition 
So far, we have not considered the possible competition between Al(III) and proton(s) for ligand 
binding. In other words, the overall performance of a chelator at a given pH will be dictated not only 
by the stability of the corresponding aluminum-ligand complex, but also by the deprotonation 
capacity of a ligand at a certain pH. As a result, the experimental trends in logβ and pAl to characterize 
the performance of a given chelator can differ27,78 (see Table 3.1). For instance, catechol shows a pAl 
value of 10.1, and the introduction of a nitro electron-withdrawing group raises this value up to 14.2, 
indicating better chelation properties94. However, as we have seen, 4-nitro-catecholate shows a lower 
logβ value than the unsubstituted catecholate (see Table 3.1). Conversely, in the case of salicylic 
acids, Nurchi et al.199 reported that methoxy-substituted salicylic acids (an overall electron-donating 
group) show significant higher pAl values (9.6/10.2 for orto/para metoxy-salicylic acid) than the  
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Fig. 3.8. Relative binding energies (𝛥𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) of non-aromatic (4-R-1,2-dihydroxy-ciclohexane) and aromatic 
(4-R-chatecholate) chelators calculated with respect to their unsubstitued counterparts. R can be methyl, 
methoxy, nitro or trifluoromethyl. All energies are in kcal/mol. 
 
unsubstituted one (8.2), while the introduction of a nitro group provokes only a moderate variation of 
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pAl, (8.4/8.7 for orto/para nitro-salicylic acid). What is the reason of these differential trends between 
salicylic acids and catechols, and between logβ and pAl in catechols? We have to take into account 
that whereas logβ is a measure of the stability of the complex with respect to the dissociation of 
unprotonated ligands, pAl takes into account additional factors, like proton/metal ion competition. 
Another important difference is that logβ is specific for each stoichiometry, while different 
stoichiometries and denticities contribute to a given value of pAl28,78. 
In order to account for proton/metal ion competition in our calculations, we have evaluated the 
relative proton affinities of the different ligands, and combine them with the relative aluminum 
affinities. The procedure is as follows: we evaluate the relative proton affinities of the ligands with a 
given functional group with respect to the unsubstituted catechol and salicylic acid, by the estimation 
of the following ΔΔ𝐺𝑛ℎ(𝐿𝑠𝑢𝑏𝑠
−2 ) reaction energy: 
 
 𝐶𝑎𝑡2𝐻,0 + 𝐶𝑎𝑡𝑠𝑢𝑏𝑠
−2 →ΔΔ𝐺
2𝐻(𝐿𝑠𝑢𝑏𝑠
−2 )→ 𝐶𝑎𝑡𝑠𝑢𝑏𝑠
2𝐻,0 + 𝐶𝑎𝑡−2     (3.4) 
 
 𝑆𝑎𝑙1𝐻,−1 + 𝑆𝑎𝑙𝑠𝑢𝑏𝑠
−2 →ΔΔ𝐺
1𝐻(𝐿𝑠𝑢𝑏𝑠
−2 )→ 𝑆𝑎𝑙𝑠𝑢𝑏𝑠
1𝐻,−1 + 𝑆𝑎𝑙−2     (3.5) 
 
As one can see in these equations, there is an important difference between catechols and salicylic 
acids. The pKa values of catechols (see Table 3.3 and ref.
94) are such that at neutral pH both chelating 
positions are likely to be protonated and, therefore, Al(III) binding has to compete with the removal 
of two protons from the ligand. 
 However, the first pKa
1of salycilic acid is so low (see Table 3.3 and refs.94,199) that at neutral pH the 
carboxylic group is undoubtedly unprotonated; accordingly, the binding of the aluminum ion only 
involves the removal of the hydroxyl proton. Besides, we define a relative aluminum affinity of a 
given ligand in each family of compounds with respect to the unsubstituted ligand, using the 
Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
values of Table 3.2, namely: 
 
 𝐴𝑙 − 𝑙𝑖𝑔−2 + 𝐿𝑖𝑔𝑠𝑢𝑏𝑠
−2 →ΔΔ𝐺
𝐴𝑙(𝐿𝑠𝑢𝑏𝑠
−2 )→ 𝐴𝑙 − 𝑙𝑖𝑔𝑠𝑢𝑏𝑠
−2 + 𝐿𝑖𝑔−2     (3.6) 
 
 ΔΔ𝐺𝐴𝑙(𝐿𝑠𝑢𝑏𝑠
−2 ) = Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
−2 ) − Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝(𝐴𝑙 − 𝐿−2)     (3.7) 
 
with Lig = Catecholate,  Salicylate. Combining the relative proton/aluminum ion affinities, we can 
estimate a value for the relative Al(III) affinity of a ligand that takes into account proton/metal ion 
competition, namely, 
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Ligand 𝛥𝛥𝐻𝑠𝑢𝑏𝑠
𝑛𝐻  𝛥𝛥𝐻𝑠𝑢𝑏𝑠
𝑛𝐻  pKa1(exp.) pKa2(exp.) 
𝐶𝑎𝑡2𝐻,0 + 𝐶𝑎𝑡𝑠𝑢𝑏𝑠
−2 ⇄ 𝐶𝑎𝑡𝑠𝑢𝑏𝑠
2𝐻,0 + 𝐶𝑎𝑡−2 
Catechol 0.0 0.0 9.2 14.3 
Electron Withdrawing Groups 
4-nitrocatechol 21.3 20.8 6.6 10.7 
4,6-dinitrocatechol 36.0 36.0   
4,5,6-trinitrocatechol 47.6 46.9   
4-trifluoromethylcatechol 9.3  6.2   
4,6-trifluoromethilcatechol 18.7 19.0   
4,5,6-trifluoromethylcatechol 26.4 26.0   
Electron Donating Groups 
4-methylcatechol -1.6 -3.0   
4,6-dimethylcatechol -3.9 -4.8   
3,4,5,6-tetramethylcatechol -9.1 -10.1   
4-methoxycatechol -1.6 -1.6   
𝑆𝑎𝑙1𝐻,−1 + 𝑆𝑎𝑙𝑠𝑢𝑏𝑠
−2 ⇄ 𝑆𝑎𝑙𝑠𝑢𝑏𝑠
1𝐻,−1 + 𝑆𝑎𝑙−2 
Salicylic acid 0.0 0.0 3.1 13.6 
Electron Withdrawing Groups 
3-nitrosalicylic acid 10.8 10.5 1.5 9.9 
5-nitrosalicylic acid  11.4 11.8 1.7 10.0 
3,5-dinitrosalicylic acid 16.0 16.3 -0.1 7.0 
3,4,5-trinitrosalicylic acid  18.9 18.9   
5-trifluoromethylsalicylic acid 5.2 2.9   
3,5-trifluoromethylsalicylic acid 9.7 9.4   
3,4,5-trifluoromethylsalicylic acid 12.7 12.6   
Electron Donating Groups 
4-methylsalicylic acid -1.0 -1.3   
5-methylsalicylic acid -1.1 -0.7   
6-methylsalicylic acid 2.5 1.5   
3,5-dimethylsalicylic acid -2.4 -2.7   
4,6-dimethylsalicylic acid 1.5 1.4   
3,4,5-trimethylsalicilic acid -3.4 -3.7   
3,5-dimethoxysalicylic acid -2.1 -1.3   
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Table 3.3 (previous page). Relative proton affinities with respect to catechols and salicylic acids in kcal/mol. 
Experimental protonation constants are taken from Ref.94. 
 
 
 ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
𝑛𝐻 ) = ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
−2 ) − ΔΔ𝐺𝑛𝐻(𝐿𝑠𝑢𝑏𝑠
−2 )     (3.8) 
 
with n = 2 for catechols, and n = 1 for salicylic acids. The results for ΔΔ𝐺𝑛ℎ(𝐿𝑠𝑢𝑏𝑠
−2 )can be found in 
Table 3.3 and Fig. 3.9-A, and the results for ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
𝑛𝐻 ) are also plotted in Fig. 3.9-B. 
As one can see in Fig. 3.9-A, EDGs lie at the top-right side of the diagram, whereas EWGs at the 
bottom-left side, manifesting that those ligands that have the largest affinities for aluminum, also 
display the largest affinities for protons. This is the case for both catechols and salicylic acids, but 
with an important difference. Catechols span a wider range of relative proton affinities than salicylic 
acids, a fact mainly attributed to the fact that two protons are removed in catechol and only one in 
salicylic acids. In order to estimate the aluminum relative binding affinity in the presence of 
protonated ligands (Fig. 3.9-B), we have to combine these two relative proton/aluminum affinities 
according to eq. 3.8, to yield ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
2𝐻 ) (displayed in the y-axis of Fig. 3.9-B). Our data 
clearly shows an inverse trend between ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
2𝐻 ) and ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
−2 ) for catechols, 
but not for salicylic acids. Our results for catechols suggest that the introduction of EWGs leads to a 
better Al(III) chelation performance upon competition with the removal of two protons, and this 
corresponds to the previously described experimental increase of pAl with nitro-substitution (Tables 
3.1 and 3.3). In the case of salicylic acids, since we are only removing one proton upon aluminum 
binding, relative aluminum affinity is still the overall leading factor in chelator binding, and now it is 
the introduction of an EDG what clearly improves the performance of the chelator. This is again in 
agreement with the clear increase in the experimental pAl of salicylic acids upon the introduction of 
methoxy groups199. In summary, our results demonstrate that in the competition between aluminum 
binding and deprotonation, the latter factor dominates when the binding of Al(III) requires the 
removal of two protons from the ligand, whereas the former is dominant if only one proton has to be 
removed, in agreement with the experimental results for catechols and salicylic acids, 
respectively94,199. 
To complete our analysis, we provide a possible explanation of how the introduction of EWGs (i.e. 
nitro) in salicylic acids lead to similar albeit a bit higher pAl values. Our data for 1:1 complexes show 
a moderate decrease in ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
1𝐻 ) for both 3 and 5-nitro-substitution (namely 1.5 kcal/mol), 
which in principle should point to a lower value of pAl. One aspect should be remarked in this regard: 
the experimental values of pAl doesn’t take into account only 1:1 aluminum-ligand stoichiometry, 
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but different stoichiometrical complexes like 1:2 and 1:3. Therefore, we recalculated the differential 
binding free energies for 1:2 complexes, and 1:3 stoichiometries of the single nitro-substituted 
salicylic acids of Table Errore. L'origine riferimento non è stata trovata., namely, 
 
 ΔΔ𝐺𝐴𝑙(𝐴𝑙 − [𝐿𝑠𝑢𝑏𝑠
1𝐻 ]𝑛) = ΔΔ𝐺
𝐴𝑙(𝐴𝑙 − [𝐿𝑠𝑢𝑏𝑠
−2 ]𝑛) + n ΔΔ𝐺𝑠𝑢𝑏𝑠
1𝐻      (3.9) 
 
Where n is the number of ligands bound to aluminum. The results are as follows: for 1:1 complexes, 
we obtain values for ΔΔ𝐺𝐴𝑙(𝐴𝑙 − [𝐿𝑠𝑢𝑏𝑠
1𝐻 ]1) of 1.5 kcal/mol (3-nitro), 1.5 kcal/mol (5-nitro); for 1:2 
complexes: 1.3 kcal/mol (3-nitro), -0.9 kcal/mol (5 nitro); finally, for 1:3 complexes, we found -9.8 
kcal/mol (3-nitro), -9.6 kcal/mol (5-nitro). Thus, we can observe how the stoichiometry is an 
additional contributing factor in the modulation of the aluminum ion/proton competition for ligand 
binding, with higher stoichiometries favoring those substituents that lead to a more favorable 
deprotonation (i.e. EWGs), albeit lower interaction with aluminum itself. The overall result is that, 
for 1:3 complexes, the introduction of EWGs promotes their chelation to aluminum because of the 
lower protonation energies (i.e. lower protonation constants, Table 3.3), and would lead to higher pAl 
values; the case of 1:2 complexes lie in between 1:1 and 1:3-related behavior. The fact that the 
experimental data point only to a moderate increase in pAl upon nitro introduction in salicylic acids, 
suggests that different stoichimoetries with opposite effects are contributing to these values, and thus 
there is a partial cancelation and compensation of their effects. Finally, it is important to mention that 
both families of compounds, when protonated, form an intramolecular hydrogen bond between the 
two phenolates (catechol) and phenolate and carboxylate (salicylic acid), which is a further factor 
contributing to the modulation of the aluminum/proton competition. 
 
3.3.6 Tuning the molecule: the role of substituents 
The present paper provides the most complete and thorough theoretical study of the interaction of 
aluminum with catechols and salicylic acids chelating agents done so far. We have identified and 
rationalized important factors affecting ligand binding to aluminum, which are crucial to design new 
chelators of increased affinity. Namely, we have characterized the strength of the aluminum-ligand 
interactions, interpreted the binding strengths in terms of the electrostatic/covalent nature of the Al-
O bonds, unveiled the role played by the aromaticity of these chelators, rationalized the modulation 
of the stability through addition of substituents and, finally, determined how aluminum/proton 
competition affects the overall activity of a chelator. 
In this sense, our calculations demonstrate that although the bond is mainly electrostatic in nature, as 
it corresponds to a hard metal, the fine tuning of the stability in both families of chelators is mediated 
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through the modulation of the covalent character of the Al-O bonds. 
 
 
 
Fig. 3.9. Proton versus aluminum competition analysed as: (a) ΔΔ𝐺𝑛𝐻(𝐿𝑠𝑢𝑏𝑠
−2 ) vs ΔΔ𝐺 𝐴𝑙(𝐿𝑠𝑢𝑏𝑠
−2 ) (top diagram). 
(b) ΔΔ𝐺𝐴𝑙(𝐴𝑙 − 𝐿𝑠𝑢𝑏𝑠
𝑛𝐻 ) vs ΔΔ𝐺𝐴𝑙(𝐿𝑠𝑢𝑏𝑠
−2 ) (bottom diagram). Terms are defined in the body text. All energies 
are in kcal/mol. 
 
This covalent character can be classified as a dative bond from the lone pair of the oxygens to the 3s, 
Tuning the affinity of catechols and salicylic acids toward Al(III): characterization of Al-chelator interactions 
 
112 
 
3p valence shell of Al(III). The increase in the dative Al-O bond character through the introduction 
of EDGs leads to complexes of higher stability, whereas EWGs lead to complexes of lower stability, 
in agreement with the experimental trends of logβ (Table 3.1). Such a picture is also coherent with 
the Pearson’s Hard and Soft Acids and Bases (HSAB) principle17. Indeed, the two phenolate groups 
of catechol are harder Lewis bases than the carboxylate one of salicylic acid, because of the intrinsic 
resonance of the COO- moiety, and therefore the former are expected to show higher affinity for hard 
Lewis acids such as Al(III). This is quite interesting considering that salicylates family shows, overall, 
a higher electrostatic interaction (three negatively charged oxygens) than the catecholate family, as 
shown by EDA results (Appendix A). Nevertheless, the catecholate family has a higher affinity for 
the trivalent metal, a fact that can be related to the more covalent Al-O bond as revealed by both 
QTAIM and EDA results and summarized in the electrostatic potential plots shown in Appendix A. 
We have also determined the role that the aromatic nature of these two families of chelators plays in 
the metal-ligand complexes. Aromaticity is only slightly affected upon aluminum binding, being 
more sensible to the introduction of EDG/EWG substituents in the ring. In both salicylates and 
catecholates, the introduction of both electron donating/withdrawing substituents leads to a lower 
aromatic character. Nevertheless, a significant degree of aromaticity is maintained in all complexes, 
which is pivotal to modulate and transmit some of the resonance-based substituent effects. 
We should remark that, although the covalent character is the main driving factor in the modulation 
of the affinity toward aluminum for these two families of chelators, other factors can also affect the 
observed stability. For instance, in some of the complexes we found steric hindrances that put them 
out of the general trend in binding energy (see Table 3.2). Indeed, 6-methylsalicylate has a lower 
stability when compared with unsubstituted salicylic acid, despite the presence of an EDG, which 
should enhance its binding affinity. The optimized geometry for that compound shows that the six-
membered ring formed by aluminum, the carboxylate and the enolate groups is slightly distorted from 
full planarity (by 16.8° and 20.9°), suggesting a steric repulsion between methyl at the 6 position and 
the carboxylate group (m compound in Fig. 3.5). Such a situation leads to a decrease in binding 
affinity (Table 3.2). Moreover, If we consider 4,6-dimethylsalicylate (p compound in Fig. 3.5), we 
can see that the addition of a second methyl in position 4 partially recovers the stability and planarity 
of the complex (12.6° and 15.6°) when compared with salicylate (Table 3.2), because of the electron 
donating effect that counterbalances the steric repulsion of the methyl in position 6. However, the 
recovered stability is still not as stable as another di-substitued compound like 3,5-dimethylsalicylate 
(0.1° and 0.1°), where no steric effects are present (n compound in Fig. 3.5). This situation was also 
hypothesized by Dean et al.201 for similar compounds. It is clear that, when considering new strategies 
toward the improvement and design of new Al(III) chelating agents, one should carefully consider 
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possible repulsive phenomena. Regarding proton/aluminum ion competition, we have been able to 
reproduce the inverse trends in ligand affinity when comparing logβ and pAl values for catechols 
(Table 3.1), and to explain how the introduction of an electron withdrawing group in catechols, but 
electron donating group in salicylic acids, enhances the chelation properties of the ligands upon 
competition with protonation. Taking into account that the metal/proton competition for ligand 
binding is critical to determine the performance of a given ligand in chelation therapy, as established 
by Hider et al.27, complex stability is also important in order to compete with other endogenous 
ligands (like citrate) in an open biological environment36. Moreover, if the stablity of the Al(III)-
chelator complex is too weak, then the metal may prefer to form the very stable [Al(OH)4]
− hydroxo 
complex27,219. We have found that those substituents that favor aluminum binding (in terms of logβ), 
they also favor protonation27,94,199. The overall effect is a balance between the Al(III)-ligand complex 
stability and the competition with H+. In this sense, EWGs, by lowering the affinity toward aluminum, 
they also favor deprotonation (by lowering the protonation constants of the ligand), and this latter 
factor is the dominant one at a pH in which aluminum competes with two protons for ligand binding. 
Conversely, when only one proton has to be removed, like in salicylic acids at weakly acidic or neutral 
pH, the nature of the dominant factor shifts to aluminum complex stability. Other factors such as 
stoichiometry of the complex can also contribute to the proton/aluminum ion competition toward a 
given ligand. Our results suggest that higher stoichiometries favor deprotonation as a leading factor 
in the overall performance of a given chelator. 
 
3.4 Conclusions 
 
In the present work, we have developed, validated and applied a state-of-the-art theoretical protocol 
suitable for the investigation of two families of bidentate Al(III) chelating agents (catechols and 
salicylic acids). Trends in binding affinities show very good agreement with respect to available 
experimental data. We have rationalized our results analyzing the nature of the Al-O bonds, finding 
that the covalent part of a mainly ionic Al-O interaction is the driving force in the fine tuning of the 
stability of these complexes. Such covalent character is modulated by the opposite effect of the 
substituents: methyl and methoxy groups increase this covalency, leading to higher affinities, whereas 
the nitro and trifluoromethy groups decrease the covalent component leading to lower binding 
affinities. We have also determined how the overall performance of a chelator depends critically on 
the metal/proton competition toward ligand binding. In summary, the present work establishes a 
reliable and transferable theoretical protocol aimed to test the behavior of metal organic chelators, 
which would help in the future deign and tuning of novel chelating agents of increased efficacy. 
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 Design of new efficient chelators of aluminum based on Mimosine-
containing peptides 
 
 
4.1 Introduction 
 
Aluminum is the most abundant metal (about 8.3% by mass) in the Earth’s crust220, found in more 
than 270 different minerals in the insoluble form of hydroxy-aluminosilicates. It remained 
inaccessible for living matter for billions of years, until the acid rains started the massive export of 
aluminum from the crust of the earth to surface waters, putting vegetables, animals and humans in 
contact with absorbable cationic aluminium species, probably for the first time in their history221.  
In the 1970s, aluminum was recognized as a neurotoxin and since then, numerous scientific reports 
have linked aluminum to neurological disorders and bone and brain pathologies222. A role of 
aluminium in human pathology has been clearly established in at least three diseases: dialysis 
dementia223, osteomalacia224 and microcytic anaemia without iron deficiency57,225. The principal 
symptoms of aluminium toxicity are: diminished intellectual function, forgetfulness, inability to 
concentrate; speech and language impairment; personality changes, altered mood, depression; 
dementia; visual and/or auditory hallucinations; osteomalacia with fracturing; motor disturbances; 
weakness, fatigue, mainly related to microcytic anaemia; epileptic seizures.  
In the case of aluminum intoxication, Al(III) chelation is performed to reduce Al(III) organ levels 
(especially in bone) and reduce toxicity of Al(III). This may benefit patients with end-stage renal 
disease or with neurodegenerative disorders as well as patients suffering from neurobehavioral 
toxicity due to prolonged occupational Al(III) exposure226. In chronic hemodialysis patients chelation 
therapy is indicated at serum Al(III) concentration higher than 80 μg/L227. Previously, the only 
available chelator for treating Al(III) overloaded patients was deferoxamine (DFO) originally 
developed for decorporation of iron in transfusional iron overload in thalassemia and sickle cell 
anemia patients. The hydrophilic chelator DFO is poorly absorbed in the gastrointestinal tract and 
must be administered parenterally, either subcutaneously, intramuscularly, or intravenously. DFO is 
not an ideal chelating agent due to the high frequency of side effects, the need for parenteral 
administration restricting off-clinic self-administration, and high price. However, despite the advent 
of alternative chelators for aluminum chelation, DFO still has an important role in treatment of Al 
intoxication228. An extensive body of evidence from in vitro and experimental animal studies 
demonstrates the potential of hydroxypyridinone derivatives from both series to reduce Al(III) 
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toxicity and promote Al(III) decorporation. The most promising compound among the 
hydroxypyridinones for iron chelation after extensive animal experimentation, 1,2-dimethyl-3-
hydroxy-4-pyridone (deferiprone, DFP, see scheme 4.1) went into clinical trial initially for iron 
decorporation and is licenced in USA and Europe for treatment of iron overload in thalassemia major. 
Even if less efficient in aluminum coordination respect to DFO, DFP is orally administrated, 
somewhat less toxic, and much cheaper than DFO16. Nevertheless, there is an urgent need for other, 
more efficient, less toxic and cheaper aluminum chelator.  
Mimosine [β-[N-(3-hydroxy-4-oxypyridyl)]-α-aminopropionic acid] (see scheme 4.1) is a non-
protein amino acid found in the members of Mimosoideae family. It has been found to have various 
biological activities such as antibacteria, anti-cancer, antiinflammation, anti-fibrosis, anti-influenza, 
anti-virus, herbicidal and insecticidal activities229. In the 90’s Mimosine was studied as an inducer of 
G1/S phase arrest230 and over the past years of active research, Mimosine evolved as promising agent 
for the treatment of cancer disease. Mimosine dipeptides and tetrapeptides were synthesised as 
neuraminidase231, tyrosinase14,15 and cyclooxigenase232 inhibitors. 
The presence of the carbonyl and alcohol groups in the side chain of Mimosine makes this residue an 
effective ligand for binding metal ions, and thus Mimosine can bind divalent and tetravalent transition 
metal ions233-235. Due to its structural similarity to DFP it is expected a high affinity towards Al(III) 
as well. Moreover, joining three Mimosine residues in the same peptide could enhance significantly 
aluminum complex stability, and obtain new class of chelating agents based on non-proteinogenic 
amino acids. However, to the best of our knowledge this activity of Mimosine containing peptides 
has not been investigated yet.  
 
 
Scheme 4.1. Chemical structures of Deferiprone (DFP) and Mimosine residue in its neutral (MIH) and ionic 
(MIM) form. The labels of the two O atoms of Mimosine residue are also illustrated. 
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The present study aims to find the smallest Mimosine containing peptide that interacts tightly with 
Al(III), i.e., to find an efficient chelator of the cation. To do that, we employed state-of-the-art 
computational methods to characterize systematically the complexation of Al(III) to several peptides 
of different length that contain three Mimosine residues (shown in Fig. 4.1).  
The geometric and energetic stabilities of all the Al(III)-peptide complexes were analyzed, paying 
special attention on the interactions between the cation and the peptide. All this information allows 
us to propose for the first time the shortest Mimosine-based peptide with the highest coordination 
stability toward Al(III) ions.  This will certainly open the field to a new type of chelators, not only 
for aluminum, but for highly valent metals showing similar coordination features as Al(III).  
 
4.2 Methodology 
 
4.2.1 Systems set-up 
 
 
 
Scheme 4.2. Theoretical protocol used throughout this study (described in the Methodology section) for each 
of the structures shown in Fig. 4.1. 
 
The complexation of Al(III) to eight Mimosine containing peptides of different length has been 
investigated following the protocol shown in scheme 4.2. All peptides contain three Mimosine 
residues (sequences presented in Fig. 4.1) and they differ in the two linkers connecting the Mimosine 
residues: the two longest peptides contain nine amino acids so that their two linkers are made of three 
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amino acids: in Pept93G the linker includes three glycine residues, whereas in Pept
9
GPG a proline was 
inserted in the middle of the linkers. This is the only peptide containing a standard residue other than 
glycine, in order to check the effects that the insertion of a rigid amino acid such as proline may 
induce in the peptide's rigidity. Next, two eight residues-long peptides were built, what implies two 
different linkers: GG and GGG in Pept82G-3G and the reverse in Pept
8
3G-2G. Next, Pept
7 includes two 
symmetric linkers made of two glycine residue each. The six amino acid long peptides involve two 
asymmetric linkers, namely G and GG in Pept6G-2G and the opposite in Pept
6
2G-G. Finally, Pept
5 is the 
shortest peptide, with just a glycine residue at each of the two linkers. In all peptides, the N- and C- 
terminals were neutralized by adding methyl groups.  
The Al-Pept93G system was the first one to be built, for what the Fe(III)-N-derivatized 3-hydroxy-4-
pyridiones complex236 was used as initial template. Once the complex was set up and equilibrated by 
molecular dynamics simulation, its structure was used as template to build the initial structure for the 
complexes formed by Pept9GPG, Pept
8
2G-3G and Pept
8
3G-2G. In a similar manner, previously equilibrated 
Al(III)-peptide structures were used to build the initial structures for the complexes of the remaining 
shorter peptides. 
 
4.2.2 Molecular dynamics simulations 
Each of the eight systems listed about was sampled by QM/MM molecular dynamics simulation using 
the Amber14 suite of programs237. The choice of running QM/MM MD simulations was based on 
two main reasons: a) lack of reliable MM parameters for the non-standard Mimosine amino acid, and 
b) description of the metal binding site by a quantum methods allows polarization, what it is expected 
to be relevant with a highly charged cation such as Al(III). The PM6 semiempirical method238 was 
chosen to treat the Al(III) binding site, since it provides a good compromise between calculation 
speed and accuracy.  
The LEaP program was used to build the topology of each system, for which Amber ff14SB all-atom 
force field parameters239 were chosen for standard amino acids. The parameters for MIM needed to 
build the system (but not used during the QM/MM MD simulations) were obtained with 
Antechamber. Periodic boundary conditions were applied in all directions using an octahedron cell, 
with a minimal distance between the peptide and the wall of the cell set to 10 Å. The structures were 
solvated by a box of TIP3P-type water molecules240. 
First a MM minimization was carried out to relax the solvent, in which the Al(III)-Peptide complex 
was restrained. Then, in order to keep the initial rearrangement, a second minimization was performed 
restraining only the three Mimosine residues and Al(III). Next, the system was heated to 300 K by a 
1ns-long equilibration defining a canonical thermodynamic ensemble (NVT), and using the Langevin 
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thermostat to couple the temperature of the system (collision frequency of 1.0 ps−1). Again, the Al-
Peptide solute was restrained. All this calculations were carried out at the MM level. 
The QM part was treated with the PM6 semiempirical method and includes the side chains of the 
three unprotonated MIM residues (pink region depicted in scheme 4.1) and Al(III), so that the total 
charge of the QM part was always neutral. The Amber ff14SB force field was employed to describe 
the remaining part of the system.  
Once the system was heated, the QM/MM MD simulations were carried out without applying any 
restraint and keeping the condition at the heating stage, that is, NVT ensemble and the Langevin 
thermostat to couple the temperature of the system (collision frequency of 1.0 ps−1).  
 
 
Fig. 4.1 Molecular structures of the eight Mimosine-containing peptides studied in this work. 
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All bonds involving hydrogens were constrained with the SHAKE algorithm241, allowing for an 
integration time step of 2 fs. Long-range electrostatics were calculated using the smooth particle mesh 
Ewald (PME) method242,243, and a cutoff of 8 Å was defined for all nonbonded interactions.  
The first 1 ns of the QM/MM MD simulation were leave to equilibrate the system, whereas the 
remaining 20 ns of simulations were employed for the analysis. From each QM/MM MD simulation, 
representative structures were extracted by cluster analysis using the cpptraj utility in Amber14244. 
 
4.2.3 Relative Binding Energies 
In order to estimate the absolute binding energy of Al(III) to a given peptide, we should calculate the 
binding energy of the next reaction: 
 
 [Al(H2O)6]
3+ + Peptx(MIH)3 ⇄ [Al. Peptx(MIM)] + 6H2O + 3H
+  (4.1) 
 
where Peptx refers to any of the peptides considered herein and MIH and MIM refer to the protonated 
and deprotonated Mimosine residue, respectively (see scheme 4.1). However, this procedure includes 
many technical difficulties (how to deal with protons, difficulties defining the QM part, etc...). 
Alternatively, from a technical point of view the next reaction is easier to deal with: 
 
 [Al. Peptx(MIM)3] + Pepty(MIH)3 ⇄ [Al. Pepty(MIM)3] + Peptx(MIH)3  (4.2) 
 
where Peptx and Pepty refer to peptides of different sequence. This reaction therefore will estimate 
the difference in energy between the interaction of Al(III) with Peptx and Pepty. In other words, it will 
give us the relative stability between the two complexes. Based on reaction 4.2, the relative binding 
enthalpies between the complexes formed by Peptx and Pepty with Al(III) are calculated as: 
 
 
ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦 = (𝐸)[Al.Pepty(MIM)3] + (𝐸)Peptx(MIH)3 − (𝐸)[Al.Peptx(MIM)3]
− (𝐸)Pepty(MIH)3 
 (4.3) 
 
where (E) stands for the average potential energy calculated at the corresponding QM/MM MD 
simulation. A positive value of ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦  will mean that Al(III) has a larger affinity towards Peptx, 
whereas a negative value will suggest a larger affinity towards Pepty. The Pept
9
3G system was taken 
as reference.  
Nevertheless, the computation of the ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦  values is not straightforward since the number of 
explicit water molecules differs at each MD simulation (and therefore with unbalance number of 
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interactions), making unrealistic a direct comparison between them. In order to overcome this 
problem, the potential energies were determined replacing the explicit water molecules by a 
Generalized Born implicit solvent245 as implemented in Amber14. The structures saved every 5 ps of 
each simulation were used to calculate the (E) average potential energies with implicit solvent.  
The estimation of the relative binding energies (Equation 4.3) requires the energies of the apoform of 
the peptides as well. Thus, 20ns long QM/MM MD simulations were also performed for the eight 
apoform of the peptides using an implicit solvent. Note that unlike when the Mimosine residues 
interact with Al(III), we assume the Mimosine residues protonated in solution. This assumption relies 
on the pKa values estimated by cyclic voltammetry
246 for the two oxygen atoms of deferiprone: 3.5 
and 10.2. Based on these values, it is clear that the two oxygen atoms should be as a keto and 
hydroxide group, respectively, and therefore, the later protonated. However, when they interact with 
Al(III), it is expected a significant drop of their pKa values, as computed for some oxygen-containing 
standard amino acids interacting with Al(III)247. Consequently, it is reasonable to assume that the 
hydroxide group is deprotonated when complexed to Al(III), but protonated in the apoform.  
 
4.2.4 Electron delocalization indices 
Electron delocalization indices (D.I.) were calculated on the most representative structures extracted 
by cluster analysis from the QM/MM MD simulations of all Al(III)-peptide complexes. These indices 
are a measure of the covariance between the population of two atoms A and B and, consequently, a 
measure of the number of electrons simultaneously fluctuating between these atoms:  
 
 𝛿(𝐴, 𝐵) = ∫ ∫ 𝑑
𝐵𝐴
1𝑑2𝜌𝑥𝑐(1,2) = 𝑐𝑜𝑣(𝑁𝐴, 𝑁𝐵)  (4.4) 
 
Where ρxc(1,2) is the exchange-correlation density and it can be taken as the number of electron pairs 
shared between atoms A and B, i. e., the bond order248,249. The AIMAll v17.11.14 program250 was 
used to carry out the QTAIM analysis208 (what includes the characterization of D.I.) on the previously 
optimized structures. Wavefunctions for QTAIM analysis were obtained at the B3LYP/6-
311++g(3df,2p) level of theory using the IEFPCM solvation model. 
 
4.3 Results 
 
The sequences of the eight peptides studied herein are shown in Fig. 4.1. The name of each peptide 
is composed by a superscript indicating the length of the peptide, and a subscript referring to the 
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linker sequences (one for symmetric peptides, and two for the asymmetric ones). For instance, the 
Pept9GPG system is nine residues long and contains three Mimosine residues, which are spaced with 
GPG sequence linker. The two oxygen atoms of Mimosine residue are denoted as OC and OOH, and 
correspond to the carbonyl and hydroxyl oxygen atoms, respectively (scheme 4.1). Along the body 
text, the atom names include a subscript to specify the atom type and a superscript to refer to the 
residue number. 
The RMSD computed on the QM/MM molecular dynamic simulations for the eight Al(III)-peptide 
complexes (shown in Appendix B) demonstrate that all systems are equilibrated during the 20-ns run 
of production. Representative snapshots of each simulation are shown in Fig. 4.2. First, the structural 
data of each complex is analysed, with special attention on the metal coordination shell. Then, the 
electronic structures of the Al(III) first coordination shell are described, and next the binding energy 
values of each Al(III).peptide complex presented. Finally, the structures of the Al.Pept complexes are 
compared with Al.DFP3. 
 
 MIMA MIMB MIMC 
 Al-OC Al-OOH Al-OC Al-OOH Al-OC Al-OOH 
Pept93G 
1.961 
(0.075) 
1.922 
(0.066) 
1.969 
(0.079) 
1.935 
(0.068) 
1.957 
(0.075) 
1.931 
(0.068) 
Pept9GPG 
1.969 
(0.086) 
1.921 
(0.065) 
1.982 
(0.140) 
1.936 
(0.069) 
1.950 
(0.087) 
1.931 
(0.060) 
Pept82G-3G 
1.970 
(0.077) 
1.923 
(0.066) 
1.972 
(0.093) 
1.939 
(0.069) 
1.955 
(0.079) 
1.931 
(0.070) 
Pept83G-2G 
1.961 
(0.099) 
1.931 
(0.069) 
1.967 
(0.078) 
1.934 
(0.068) 
1.962 
(0.073) 
1.927 
(0.067) 
Pept7 
1.934 
(0.070) 
1.934 
(0.070) 
2.514 
(0.944) 
1.917 
(0.085) 
1.938 
(0.072) 
1.932 
(0.070) 
Pept6G-2G 
1.932 
(0.069) 
1.891 
(0.059) 
4.347 
(0.197) 
1.842 
(0.057) 
1.892 
(0.062) 
1.926 
(0.066) 
Pept62G-G 
1.903 
(0.065) 
1.913 
(0.064) 
4.252 
(0.235) 
1.836 
(0.057) 
1.935 
(0.070) 
1.896 
(0.062) 
Pept5 
1.917 
(0.068) 
1.911 
(0.065) 
4.112 
(0.634) 
1.839 
(0.063) 
2.090 
(0.586) 
1.889 
(0.062) 
 
Table 4.1. Average and standard deviation (in Å) of the six distances between the OC and OOH atoms of the 
three Mimosine residues and Al(III) computed along the QM/MM MD simulation trajectories of the Al-Pept 
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complexes. Since the indexes of the three Mimosine residues differ on the systems, they are referred to as A, 
B and C for the first, central and last Mimosine in the corresponding sequence shown in Fig. 4.1. 
 
 4.3.1 Structural stability of the first Al(III) coordination shell 
The optimum coordination shell of Al(III) is the one presented in Al-DFP3 (see Appendix B)251, with 
the cation octahedral and the three MIM residue bidentated through the OC and OOH atoms. In order 
to analyse the Mimosine layout, some geometrical parameters were analysed: i) distances between 
Al(III) and the six O atoms of the three MIM residues (Table 4.1 and Fig. 4.3), ii) all possible O-Al-
O angles formed by the six oxygen atoms (Fig. 4.4 and Appendix B). The complexes are presented 
from the longest to the shortest peptides. 
 
    
Pept93G Pept
9
GPG Pept
8
2G-3G Pept
8
3G-2G 
    
    
Pept7 Pept6G-2G Pept
6
2G-G Pept
5 
 
Fig. 4.2. Representative snapshot of the MD simulations of the eight Al(III)-peptide complexes determined by 
cluster analysis. 
 
Pept93G and Pept9GPG: the two longest peptides form octahedral complexes with Al(III), as the values 
of the six Al-O Mim distances, which are very stable throughout the entire simulations (Table 4.1). 
Interestingly, although both oxygen atoms are deprotonated, the Al-Oxygen distances are not 
equivalent and OC presents longest distances than OOH: the average values of the Al-OC and Al-OOH 
distances are ca. 1.97 Å and 1.93 Å, respectively, with both Pept9. Moreover, overall, the average 
distances are very similar with both Pept9 peptides, except the Al-OC
5 distance, which is about 0.02 
Å longer for Pept9GPG (1.982 Å). 
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Fig. 4.3. 3 Evolution of the distances between Al(III) and the two OC and OOH atoms of the Mimosine residues 
during the QM/MM MD simulations. From left to right, upper line: A) Pept93G, B) Pept9GPG, C) Pept82G-3G, D) 
Pept83G-2G; Bottom line: E) Pept7, F) Pept6G-2G, G) Pept62G-G, H) Pept5. The colour scheme is shown in the D) 
panel. Since the indexes of the three Mimosine residues differ on the systems, they are referred to as A, B and 
C for the first, central and last Mimosine in the corresponding sequence shown in Fig.4.1. 
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The OMim-Al-OMim angles computed for the two Al-Pept9 complexes confirm that Al complexes adopt 
a nearly octahedral arrangement. We can observe in Fig. 4.4 that OMim-Al-OMim angles are divided in 
two sets: a prevalent one centered on 90 degrees and a second one centered on 160 degrees, which  
correspond to equatorial and axial angles, respectively, in an octahedral arrangement. A deeper 
analysis of the angles (Appendix B) shows that during the simulation of the Al.Pept93G complex, 11 
out of the 15 angles are in the 86-92 degree range (the range is slightly wider for Al-Pept9GPG: 82-94 
degrees), very close to the ideal value of 90 degrees for equatorial angles. OOH
1-Al-OOH
9 is the only 
angle out of these ranges, with average values of 101 degrees on both complexes. On the other hand,  
 
Pept82G-3G and Pept83G-2G: the Al-O distances calculated for the complexes of these two peptides are 
similar to those of Pept9 peptides, i. e., ca. 1.97 Å for the three Al-OC distances and 1.93 Å for the 
Al-OOH distances. Also the average values of the angles computed for the Al-Pept
8
2G-3G complex are 
very similar to the ones calculated for Pept9 peptides: a maximum deviations of 7 degrees is observed 
with respect to the angles computed on the Al.Pept93G complex. The similarity is maintained with the 
three axial angles. However, some differences are found in the Al-Pept83G-2G complex, in which only 
seven angles lie between 86-95 degrees, and the remaining equatorial angles are in the 103-115 range, 
with larger standard deviations. Moreover, the values of the three axial angles are smaller, with larger 
standard deviation. The origin of these differences does not lie in the change of metal coordination 
mode, but rather in spatial rearrangement of the ligands, in the way that some equatorial angles 
become axial and the contrary. The metal complex structure remains octahedral and the distribution 
of the angles (Fig. 4.4) is invariable respect to Pept9 peptides. 
 
Pept7: the octahedral complexes of peptide Pept7 are less stable compare to longer peptides and only 
five out of six oxygen atoms (of the three MIM residues) are tightly bound to Al(III). Al-OOH
4 presents 
the shortest distance (1.917 Å), while the distances between Al(III) and the four oxygen atoms of 
MIM1 and MIM7 are 1.93 Å. Unlike with the two Pept9 peptides, no clear difference between OC and 
OOH is observed. The remaining distance, Al-OC
4, shows a significantly longer average value (2.514 
Å), with a larger deviation (0.944 Å). As it can be observed in Fig. 4.3, the values of Al-OC
4 distance 
fluctuates between 2 Å and 4.5 Å. As shown in the histogram of the distance (small panel in Fig. 
4.3E), two clear peaks are centered on 2 Å and 4.5 Å, the former being predominant, without any 
significant intermediate value. Hence, MIM4 does not bind Al(III) tightly and fluctuates between 
bidentate and monodentate (through OOH atom) coordination modes. These two conformations are 
superimposed in Fig. 4.5C.  
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The distribution of the O-Al-O angles reflects such multiple conformations. Even if two clear peaks 
are located at 90 and 160 degrees, the angles population between these two peaks has increased, and 
it is not any more nearly zero (as in the simulations with larger peptides). Moreover, the peak of the 
axial angles has shifted to smaller values. At this point, the simulation suggests that Pept7 presents 
less stable octahedral arrangement, even if this coordination mode is still the most prevalent one (see 
below). 
 
Pept6G-2G, Pept62G-G and Pept5: the three shortest peptides exhibit a similar pattern during the MD 
simulation: five out of six Mimosine oxygen atoms are tightly bound to Al(III), with average lengths 
of 1.8-1.9 Å. By contrast, the OC atom of the central Mimosine residue (MIM
4 in the two Pept6 
peptides and MIM3 in Pept5) is clearly out of the metal coordination shell, with an average length of 
ca. 4.2 Å. Even that OC
3 atom interacts with Al(III) for a short period of time during the Al-Pept5 
simulation, during this period of simulation OC
5 atom leaves the Al(III) first coordination shell. 
Therefore, Al(III) appears always pentacoordinated with these three peptide: the two terminal 
Mimosine residues coordinate metal ion bidentatedly, while the central one can bind Al(III) only 
monodentatedly.  
Interestingly, in longer peptides Al-Oc distance of a Mimosine residue is around 0.3 Å longer than 
with its OOH counterpairs. In the complexes of two Pept
6 asymmetric peptides this trend is maintained 
only by one of the two Mimosine residues bidentatedly bound to Al(III), whereas the Al-OC distance 
is slightly shorter in the other Mimosine (Mim3 in Pept6G-2G and Mim
4 in Pept62G-G). This fact may be 
due to the shortness of the peptide backbone, too short to allow the Mimosine side chain positioning 
in a more suitable orientation and optimize their interactions with Al(III) (see Figure 5D). 
The angles distribution computed on the MD simulations of the shortest three peptides are very 
similar and confirm that the octahedral arrangement of Al(III) is not possible due to the shortness of 
the peptides. The peak ascribed to the axial angles has lowered, and even if the peak located at around 
90 degrees is still predominant, the angle distribution is significantly broader than with longer 
peptides. 
 
4.3.2 Al(III) coordination mode 
The analysis of the geometries has shown that the peptide length clearly influences the interaction of 
the peptide with Al(III). In order to quantify this trend, we calculated the coordination number (C.N.) 
of Al(III) along each MD simulation, which can be either 5 or 6. In order to do that, two alternative 
geometrical criteria were defined to consider a frame from a trajectory octahedral: i) six Al-O 
distances shorter than 2.5 Å, and ii) if three O-Al-O angles are larger than 150 degrees.  
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Fig. 4.4. Distribution of all OMim -Al-OMim angles computed along the QM/MM MD simulations trajectories 
of the eight Al.Pept complexes (sequences shown in Fig. 4.1). 
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The results (presented in Table 4.2) show the same trend for both criteria, although the percentage of 
C.N.= 6 are slightly lower with the angles criteria. During the corresponding QM/MM MD 
simulations, Pept9 and Pept8 bind Al(III) in the octahedral complex. According to the distance 
criterion, during almost all their simulations the C.N. is six. 
The percentage is slightly lower according to the angle criterion, ca. 97% for the two Pept9 peptides 
and 94% for the two Pept8 peptides. The three shortest peptides, with five and six residues, do not 
form octahedral complexes with the Al(III) ion (the percentage of frames with C.N.= 6 is almost 
zero).  
By contrast, the Al-Pept7 complex is the borderline system, in which both C.N.= 5 and C.N.= 6 are 
significantly sampled. However, C.N.= 6 prevails during the MD simulation, with 72-75% of the 
structures with hexa coordination mode, while in the remaining 25-28% of snapshots the metal ion is 
pentacoordinated. 
 
 
% Oct 
(dist) 
% Oct 
(angle) 
ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 
Pept93G 100.0 98.0 0.0 
Pept9GPG 99.6 96.5 1.8 
Pept8 2G-3G 99.8 94.2 2.5 
Pept8 3G-2G 99.9 93.1 1.7 
Pept7 74.9 72.1 11.4 
9.4 (C.N.=6) 
17.3 (C.N.=5) 
Pept6G-2G 0.0 0.0 12.9 
Pept62G-G 0.0 0.1 13.9 
Pept5 0.1 2.2 20.0 
 
Table 4.2. On the left section of the table, percentages of snapshots extracted from the QM/MM MD 
simulations of the Al-Pept complexes with an octahedral Al(III), determined based on two criteria: a) Al-O 
distances shorter than 2.5 Å, and b) presence of three axial angles (>150 degrees). On the right section of the 
table, relative binding enthalpies (ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
, in kcal/mol) between the Mim-containing peptides of different 
sequence, taking the Al-Pept93G complex as reference. In the case of Pept7, the relative energies between the 
two coordination modes observed during its MD simulation (Al(III) octahedral or pentacoordinated) are also 
shown. 
 
4.3.3 Electronic structure of Al(III) coordination shell 
Delocalization indices (D.I.) are a measure of the electron sharing between two atoms (see 
Methodology section). Although Al-O bonds are mainly electrostatic in nature, there are also 
important dative interactions from the lone pair of the oxygen atoms to the formally vacant 3s and 3p 
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orbitals of Al(III)21. Therefore, the higher the D.I. value, the stronger the covalent character of the 
bond between the two atoms. The D.I. were computed at the bonds formed by Al(III) and the six 
oxygen atoms of the three Mimosine residues in all Al-Pept complexes (Table 4.3). 
Starting from the Al.Pept9 complex, it can be observed that the D.I. values are ca 0.02 a.u. higher at 
Al-OOH (ca 0.17 a.u.) than at Al-OC (ca 0.15 a.u.).This is in agreement with the shorter bond distances 
of the formers (Table 4.1): the shorter the distance, the higher the D.I value due to the higher electron 
density. However, a closer analysis of the values indicates that the values are about 0.005 a.u. smaller 
at the central Mimosine residues. Even if the difference is very small, it suggests that the interaction 
with the central Mimosine is the weakest one among the three Mimosine residues (note this residue 
weakens its interaction with Al(III) with the shortest peptides). The total electron delocalization 
computed for the six Al-O bonds is 0.9590 a.u. These trends and values are maintained by Pept9 and 
Pept8 peptides, in which Al(III) is hexacoordinated, and in all of them the accumulated D.I. value is 
maintained in a narrow range between 0.9579-0.9590 a.u. We also add in Table 4.3, the values for 
the Al-DFP3 complex, which demonstrates that the Al-Pept
9 complexes show a very similar binding 
patterns from the electronic point of view with respect to the aluminum-deferiprone complex. In this 
sense, the D.I. for Al-OOH bonds are larger than for Al-OC and the total D.I. is 0.9580. That is, the 
four Al-Pept9 and Al-Pept8 complexes have adopted the optimum interaction with respect to the three 
mimosine residues, and in this sense, an efficient chelation of the aluminum ion is expected for these 
polypeptides. 
For the Al-Pept7 complex two coordination modes were observed during the MD simulation of this 
complex and therefore two distinct structures were selected, with Al(III) hexa- or pentacoordinated. 
For Al(III) hexacoordinated structure,  the D.I. values of Mim4 and Mim7 are very similar to the ones 
observed for the Pept8 and Pept9 peptides (again, the D.I. values are slightly smaller in the central 
Mimosine), while the two D.I. values computed on the first Mimosine residue are now almost the 
same (0.16 a.u.), although the accumulated D.I. maintains in the range of 0.958 a.u. 
A different scenario emerges when Al(III) is pentacoordinated by Pept7. The D.I. value of Al-OC
4 is 
almost vanished (0.0005 a.u.), since the OC
4 atom is not present in the first coordination shell of the 
cation. Interestingly, the loss of OC
4 atom interaction has strengthened the other five Al-O 
interactions, when comparing with the Al-Pept7hexa structure. For instance, the D.I. value of the 
Al(III)-OOH
4 bond is increased up to 0.2228 a.u, 0.06 a.u. higher than the same bond in the 
hexacoordinated complex. The indices of the other Al-O bonds are also incremented, namely 0.04 a. 
u. at Al-OOH
1, 0.03 a.u. at Al-OC
7, ca 0.1 at Al-OC
1 and 0.1 a.u. at Al-OOH
7. As a consequence, the 
accumulated D.I. is equal to 0.9769 a.u., 0.02 a.u. higher than in its counterpair with a 
hexacoordinated Al(III). This pattern is maintained by the three shortest peptides, in which Al(III) is 
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pentacoordinated: the loss of one Al-O interaction has enlarged the indices of the other Al-O bond, 
and the accumulated D. I. value is ca. 0.98 in all of them. 
In summary, the computed delocalization indices show that the reduction in the Al(III) coordination 
mode (from six to five) leads to an increment on the total dative interactions between Al(III) and the 
ligands. Nevertheless, note that this increment corresponds to the covalent part of the Al(III)-O bonds, 
and as we show in the next section this slightly enhanced covalent interactions between aluminum 
and mimosine can not compensate the loss of one Al-O electrostatic interaction in the first 
coordination shell when shifting from coordination number six to five. 
 
 L.. I. D. I. 
Complex Al Al-OC Al-OOH Al-OC Al-OOH Al-OC Al-OOH Total 
Pept93G 9.9493 0.1520 0.1722 0.1472 0.1641 0.1546 0.1689 0.9590 
Pept9GPG 9.9494 0.1516 0.1720 0.1462 0.1632 0.1550 0.1704 0.9584 
Pept8 2G-3G 9.9498 0.1513 0.1694 0.1481 0.1627 0.1550 0.1714 0.9579 
Pept8 3G-2G 9.9496 0.1493 0.1665 0.1486 0.1648 0.1544 0.1749 0.9586 
Pept7 (hexa) 9.9498 0.1626 0.1659 0.1418 0.1628 0.1550 0.1700 0.9581 
Pept7 (penta) 9.9459 0.1744 0.2036 0.0005 0.2228 0.1875 0.1881 0.9769 
Pept6G-2G 9.9475 0.1714 0.1999 0.0006 0.2290 0.1989 0.1798 0.9796 
Pept62G-G 9.9466 0.1924 0.1876 0.0005 0.2220 0.1734 0.2029 0.9789 
Pept5 9.9474 0.1973 0.1823 0.0006 0.2283 0.1666 0.2011 0.9761 
Al-DFP3  0.1540 0.1657 0.1522 0.1665 0.1531 0.1665 0.9580 
 
Table 4.3. Electron localization index (L.I.) for the aluminum atom and electron delocalization indices (D. I.) 
for the aluminum-Mimosine oxygen bonds (a. u.). All structures were optimized in solution and refined at the 
B3LYP-D3(BJ)/6-311++G(3df,2p) - IEFPCMlevel of theory (see Methodology). 
 
4.3.4 Relative stability of the Al-Pept complexes 
As pointed out in the Methodology section, the Pept93G peptide was taken as reference to estimate the 
relative binding energies (ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
) of the eight peptides, which were computed from the QM/MM 
MD simulations of the apoform and holoforms of free peptides. The results are presented in Table 
4.2. 
The ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 values indicate that there is a direct relationship between the length of the peptide, the 
stability of their Al(III)-Peptide complexes, and the coordination mode of Al(III): the complexes 
formed by the four longest peptides show similar energies and in all of them Al(III) is octahedral. 
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The Al-Pept93G complex is the most stable one, followed by Pept
8
3G-2G (ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 = +1.7 kcal/mol), 
Pept9GPG (ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦  = +1.8 kcal/mol) and Pept82G-3G (ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦  = +2.5 kcal/mol).  
The remaining four complexes are significantly less stable. Among them, Al-Pept7 is the most stable 
one, with ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦  = +11.4 kcal/mol. It must be pointed out that this is the relative energy computed 
with consideration of all snapshots extracted from the MD simulation. As described above, in the Al-
Pept7 complex Al(III) can be either hexacoordinated (ca 72% of the structures) or pentacoordinated 
(ca 28%). When the relative energies are analysed separately, for each of the coordination modes, the 
ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 value of hexacoordinated structures reduces to +9.4 kcal/mol, whereas the ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 value 
of Al(III) pentacoordinated complex increases to +17.3 kcal/mol. 
 
 
  
A) Pept93G (purple) vs Pept
9
GPG (green) B) Pept
9
3G (purple) vs Pept
7
hexa (white) 
  
  
C) Pept7hexa (white) vs Pept
7
penta (orange) D) Pept
7
hexa (white) vs Pept
6
G-2G (green) 
 
Fig. 4.5. Superposition between representative structures of QM/MM MD simulations of Al(III)-peptide 
complexes determined by cluster analysis. 
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The complexes formed by the two Pept6 peptides present similar energies, with ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 values of 
+12.9 (Al-Pept6G-2G) and +13.9 (Al-Pept
6
2G-G) kcal/mol. The Al-Pept
5 is the less stable complex, with 
a ΔΔ𝐻𝑏𝑖𝑛𝑑
𝑥−𝑦
 value of 20.0 kcal/mol. 
 
4.3.5 Comparison with defriprone 
The three pyrodine rings present in the Al-DFP3 complex have no restraint to adopt an optimum 
orientation and maximize their interactions with Al(III). Consequently, the Al-DFP3 complex is a 
good reference of the best interaction with aluminum that can be expected with the combination of 
three pyrodine rings. The comparison of the features of the Al-O bonds in Al-DFP3 with those in the 
eight Al(III)-Peptide complexes can shed light on whether the geometrical constraints of the peptide 
backbone exerts a restraint to adopt the optimum coordination to maximize aluminum-pyrodine rings 
interactions. With this aim, we compare three different structures (shown in Appendix B): i) 
experimental structure of the Al-DFP3 complex crystallized in water,
35 ii) the Al-DFP3 complex 
optimized by a  DFT high level quantum method, and iii) a DFT-optimized representative structure 
of the Al-Pep93G complex. The distances and angles computed on these structures are shown in 
Appendix B.  
Regarding the Al-DFP3 complex, the six Al-O distances computed on the DFT optimized structures 
are systematically 0.02 Å longer than in the X-ray structure, and in both of them the Al-OC distances 
are 0.03 Å longer than the Al-OOH bonds. The computed angles are also very similar, with differences 
less than 1 degree between the experimental and theoretical Al-DFP3 structures. On the other hand, 
the distances computed on the Al-DFP3 and Al-Pept
9
3G structures optimized with DFT, are in general 
equivalent, with differences of ca 0.01 Å, except the Al-OC
5 distance, which is 0.05 Å longer at the 
Al-Pept93G complex. Nevertheless, the average Al-O distance and angle values computed along the 
QM/MM MD simulation of the Al.Pept93G complex are in very good agreement with the Al-DFP3 
DFT-based structure, what may reinforce the importance of sampling different conformations of the 
peptide, with many possible conformations. This issue is not so problematic with the Al-DFP3 
complex due to the fewer number of degrees of freedom. Moreover, the delocalization indices 
computed on the Al-DFP3 complex are also very similar to the ones computed on the complexes 
formed by the four longest peptides. All in all, all these evidences support the fact that the interactions 
between Al(III) and the four longest Mimosine-containing peptides are analogous to the interactions 
between Al(III) and three DFP molecules. 
In order assess whether the Mimosine-containing peptides can chelate Al(III) as efficiently as DFP, 
we should consider not only their interactions with the cation, but also entropic effects, an issue 
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difficult to quantify. On one hand, it must be taken into account that the formation of the Al-DFP3 
complex may involve a larger entropic penalty due to the complexation of three molecules in three 
reaction steps (see chelate effect), while in the Mimosine-containing peptide the three chelating units 
belong to the same molecule. However, on the other hand, the formation of the Al-Peptide complex 
depends not only on the complex but also on the stability of the free peptide in solution (see Equation 
4.1). The stability of the apoforms of the Mimosine-containing peptides is difficult to quantify 
accurately, because of the hugh amount of degrees of freedom that require an accurate and reliable 
sampling technique. However, we think that it is reasonable to assume that the formation of hydrogen 
bonds may contribute to their stability, and, therefore, the larger the number of hydrogen bonds 
formed by a free peptide in solution, the higher its stability (and the higher the energetic penalty 
required to deform the ligand in a  conformation suitable to bind aluminum).. The list of all individual 
backbone hydrogen bond interactions during the QM/MM MD simulations of the peptides in solution 
and their lifetimes are shown in Appendix B. The data collected reveals the total number of hydrogen 
bonds is low, not surprising for such small peptides, although a clear trend is observed: the longest 
peptides form more intramolecular hydrogen bond interactions than the shorter ones. Among them, 
the number of interactions is larger for Pept9GPG peptide due to the presence of the proline residues. 
In this case, the summation of lifetime of all hydrogen bonds identified is 23% of the QM/MM MD 
simulation (see Appendix B), whereas the summation reduces to 10-15% during the simulation of the 
complexes formed by Pep93G and the two Pept
8 peptides. The accumulated hydrogen bond lifetime 
reduces to ca. 5% on the complexes formed by the four shortest peptides. On the other hand, in none 
of the Al(III)-Peptide complexes intramolecular hydrogen bond interactions were detected. Thus, 
based on this data we can conclude that the number of hydrogen bonds is very small and therefore a 
small entropic penalty needs to be paid for the conformational change between the apoform and the 
metal-bound peptide. 
 
4.4 Conclusions 
 
In the present study we explore the suitability of a new family of high-valent metal chelators based 
on Mimosine-containing polypeptides that can be efficient chelator of Al(III). We analyze the 
structural and energetic stability of the complexes formed by Al(III) with several Mimosine-
containing peptides of different length and sequence, going from the shortest polypeptide of five 
amino acids to the largest ones with nine residues.  
Results reveal that with the longest four peptides, made of 9 and 8 residues, Al(III) shows no 
difficulties to interact in a hexadentate fashion with Mimosine sidechains. A comparative analysis of 
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the geometrical and electronic features characterized for these complexes reveals Al-O interactions 
very similar to the ones find in Al-DFP3. The geometrical analysis indicates that the ligands of the 
cation are placced in a near-optimum octahedral arrangement, very similar to the disposition adopted 
by the aromatic rings in the Al-DFP3 complex. On the other hand, the shortest three peptides, with 
only five or six residues, are too short to place the side chains of the three Mimosine residues in the 
proper arrangement to form six stable interactions with the cation. Consequently, the central 
Mimosine interacts in a mnodentate fashion with Al(III) so that only five Mimosine oxygen atoms 
interact with the ion. Finally, the Pept7 peptide is the borderline case, since during the QM/MM MD 
simulation of the complex both coordination modes are sampled, that is, with Al(III) penta- or 
hexacoordinated. However, during the simulation the octahedral arrangement is clearly predominant, 
with >70% of the snapshots with this coordination mode. 
The stabilities of the eight complexes characterized are directly related with the coordination mode 
of Al(III). Thus, the four complexes with the octahedral binding mode are clearly the most stable 
ones. The relative energies of all these complexes (see Table 4.2) are within the 2.5 kcal/mol range, 
Pept93G being the most stable one. On the other hand, with the remaining peptides, the shorter the 
peptide, the less stable the complex, so that the stability trend is: Pept7>Pept6>Pept5. Among them, 
Pept7 is the most stable one, 11.4 kcal/mol less stable than Pept93G.  
In summary, the computational study presented herein provides a deep description of the interaction 
between Al(III) and Mimosine-containing peptides, and provide significant atomistic details about 
the interaction between the peptide and the cation. The results clearly point to the longest peptides, 
and more in particular to Pept93G as the best potential Mimosine chelating agent suitable for Al(III), 
since this peptide provides an optimum interaction mode with the cation and forms the most stable 
complex. The present results can encourage further experimental characterization of these 
polypeptides which, we predict, potentially have promising properties to chelate not only aluminum, 
but also highly-charged metals such as Fe(III) that show octahedral coordination modes and for which 
Deferiprone is well known for being a good chelator.  
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PART II 
Understanding the potential toxic 
roles of Al(III) in the biological 
environment 
 
 
 
 
“Ain't no angel gonna greet me 
It's just you and I my friend 
And my clothes don't fit me no more 
I walked a thousand miles 
Just to slip this skin” 
(B. Springsteen, Streets of Philadelphia) 
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Aluminum’s preferential binding site in proteins: sidechain of amino 
acids versus backbone interactions 
 
 
5.1. Introduction 
 
During the last century, the massive introduction of aluminum in daily life has dramatically increased 
its bioavailability, altering the natural geochemical cycle that has consistently maintained the most 
abundant metal element in the Earth’s crust absent from biota180. Unfortunately, the burden of 
aluminum we suffer is likely to have deep consequences, still not fully understood at the molecular 
level. Aluminum has been demonstrated to be involved in diseases such as dialysis encephalopaty223, 
and this element is nowadays accepted as a risk factor in neurodegenerative diseases4, such as 
Alzheimer disease (AD).  
Due to its chemical properties, aluminum ion Al(III) has the capability of interacting with many 
biological molecules, which makes the mapping of these interactions difficult. Moreover, the 
complexes formed by aluminum with different biological building blocks are highly dependent on 
factors such as pH, concentration, etc... Therefore, the study of the interaction of biological molecules 
with aluminum (refer to aluminum speciation) is still challenging and presents inherent difficulties 
using experimental techniques alone. In this sense, theoretical methods have become a fundamental 
tool to characterize the structure and thermodynamics of aluminum compounds with biological 
molecules115. 
As a hard Lewis acid, aluminum shows preference towards oxygen donor ligands, such as 
carboxylates, phosphates, nucleotides (NADH, ATP,...) and nucleic acids such as DNA252. Similarly, 
polypeptides and proteins are a clear target of this cation and in fact aluminum has been proven to 
inhibit the activity of several proteins, mainly because of a strong interaction with a phosphate 
cofactor253,254. Aluminum may also contribute in the development of AD by promoting the formation 
and growing of the two most clear hallmarks in the disease5,49,61,255: i) intracellular neurofibrillary 
tangles (NFT) composed of hyperphosphorylated  tau protein and ii) Amyloid-β (Aβ) fibrils, the main 
constituent in senile plaques, which are mainly made of aggregated Aβ peptides.  
More recently, Song et al.31, have suggested a new paradigm in the type of aluminum-protein 
interaction. They have proposed aluminum could directly interact with the backbone of the proteins, 
forming very stable structures with a characteristic 5-member ring, in which aluminum is directly 
coordinated to the carbonyl oxygen and a deprotonated peptide nitrogen, forming strong covalent 
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bonds. This type of binding motif would lead to a dramatic change on the secondary structure of the 
protein, altering its conformation and provoking its denaturation. However, the existence of this type 
of binding motif is difficult to reconcile with previous experimental22,49 and theoretical66,256 studies 
that have unequivocally established the propensity of aluminum to interact with amino acid sidechains 
with Al-O bonds of mainly electrostatic nature.  
In the present paper, we apply different quantum methods to determine the thermodynamics of 
aluminum binding to the backbone of proteins. To do so, we consider a series of model structures 
based on the work of Song et al.31, and we compare their binding energies to model structures in 
which aluminum is interacting with the sidechain of an amino acid. We also compare our results with 
previous calculations of model polypeptides in which the interaction is mediated through a variety of 
sidechains, including phosphorylated serines, known biological low-molecular-mass (LMM) 
chelators such as citrate, and a variety of phosphate molecules. Our results clearly point to a 
preference of aluminum to interact with amino acid sidechains, with backbone structures much less 
favorable and even endothermic for cases in which aluminum interacts with the peptide nitrogen. 
 
 
 
Fig. 5.1: Schematic representation of the structures characterized. 
 
5.2. Methodology 
 
Al(III) can form a large variety of different hydrated species257. Herein three hydrated Al(III) 
structures were considered (see Figure 1): i) Al(III) interacting with a hydroxide and four water 
molecules ([Al(OH)(H2O)4]
2+), ii) Al(III) interacting with a hydroxide and five water molecules 
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([Al(OH)(H2O)5]
2+) and iii) Al(III) interacting with six water molecules ([Al(H2O)6]
3+). Moreover, 
two Al(III)-peptide structures were optimized (see Figure 1): i)  Al(III) interacts with the peptide 
bond carbonyl oxygen (referred to as State I) and ii) Al(III) interacts with the peptide bond carbonyl 
oxygen and the deprotonated N atom (referred to as State II). For these two structures, the 
coordination shell of Al(III) was fulfilled based on the three coordination shells considered for the 
hydrated Al(III), that is: i) pentacoordinated with one hydroxide in the coordination shell (as in ref, 
no subscript added) ii) pentacoordinated and shell completed with water molecules (the “1,5” 
subscript added) and iii) hexacoordinated  and shell completed with water molecules (the “0,6” 
subscript added). All the structures are represented in Fig. 5.1 and the optimized geometries illustrated 
in Fig. 5.2. 
All geometrical optimizations were carried out in aqueous phase using the Gaussian 09 program258, 
B3LYP functional132,259 and 6-31++G(d,p) basis set. To confirm that optimized structures were real 
minima on the potential energy surfaces, frequency calculations were carried out at the same level of 
theory. All structures showed positive force constants for all normal modes of vibration. The 
frequencies were then used to evaluate the zero-point vibrational energy (ZPVE) and thermal (T=298 
K) vibrational corrections to the Gibbs free energies within the harmonic oscillator approximation. 
To calculate the entropy, the different contributions to the partition function were evaluated using the 
standard statistical mechanics expressions in the canonical ensemble and the harmonic oscillator and 
rigid rotor approximation. The solvent effect was introduced using the self-consistent reaction field 
(SCRF) method with the polarized continuum model (PCM), using the integral equation formalism 
variant (IEFPCM)177. 
The electronic energies were refined by single-point energy calculations at the B3LYP/6- 
311++G(3df,2p) level of theory, both in gas-phase and in solution, and then used to estimate energies 
in gas-phase (Egas) and in solution (Eaq). On the other hand, the free energy contributions computed 
by the frequency calculations were added to Eaq to determine the free energy in solution (Gaq). 
Moreover, single-point calculations at the MP2/6-311++G(3df,2p) level of theory were carried out 
both in the gas-phase and in aqueous environment in order to assess the accuracy of the results. In 
spite of some deviations between the relative energies computed with the B3LYP functional and 
MP2, in all cases the trends observed with the DFT functional are corroborated by the MP2 method, 
and for the sake of simplicity only the DFT results will be discuss in the body text. 
 
5.3. Results 
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5.3.1 Interaction with the backbone of proteins 
As a first approach, we follow the proposal of Song et al.31, who employed a small model to analyze 
the interaction between Al(III) and the backbone of a peptide (an alanine capped by H atoms, shown 
in Fig. 5.1), with the reference structure for Al(III) in solution taken as a pentacoordinate 
[Al(OH)(H2O)4] 
2+. Based on this model, they characterized two Al(III)-peptide structures 
(illustrated in Fig. 5.1 and 2 and referred to as State I and II in their paper and hereafter). In State I, 
Al(III) interacts with the peptide bond carbonyl oxygen, while in State II, both the carbonyl oxygen 
and the deprotonated peptide nitrogen interact with Al(III), forming a five-member ring. They 
evaluated the binding energies (Δ𝐸) of State I and II according to the following reactions: 
 
 
𝐒𝐭𝐚𝐭𝐞 𝐈: [Al(OH)(H2O)4]
2+ + C4N2O2H8
⟶ [Al(OH)(H2O)3(C4N2O2H8)]
2+ + H2O 
 (5.1) 
 
 
𝐒𝐭𝐚𝐭𝐞 𝐈𝐈: [Al(OH)(H2O)4]
2+ + C4N2O2H8
⟶ [Al(OH)(H2O)2(C4N2O2H7)]
1+ + H2O + H3O
+ 
 (5.2) 
 
Their results pointed to a high stabilization of both States I and State II with Δ𝐸 values of -27.05 
kcal/mol and -50.71 kcal/mol at the MP2 level of theory. Due to the high stability of State II, the 
authors concluded that Al(III) can indeed form five-member rings with the backbone of proteins. 
Furthermore, based on the analysis of orbitals and Mulliken charges the authors suggested a 
significant reduction of aluminum in State II, with a significant covalent nature of the bond between 
aluminum and the carbonyl oxygen and peptide nitrogen. This capacity of aluminum to form chemical 
bonds with the backbone of proteins would lead naturally to the formation of highly stable five-
member ring structures with their backbone, provoking their denaturalization, and being an important 
molecular mechanism to understand aluminum toxicity. 
However, these results were obtained based on binding energies computed in the gas-phase, and 
therefore a proper treatment of bulk solvent effects is needed to account for the possibility of the 
formation of these structures in a biological aqueous environment.  On the other hand, the authors 
took as a reference in aqueous environment a pentacoordinated [Al(OH)(H2O)4]
2+  species31. 
However, both experiments260,261 and computational257 studies indicate that Al(III) shows preference 
towards being octahedral in aqueous solution, either coordinated to six water molecules, i.e. 
[Al(H2O)6]
3+, or with a combination of one hydroxide and five water molecules,  [Al(OH)(H2O)5]
2+. 
Therefore, we decided to calculate the binding/formation energies for State I and II introducing  i) 
bulk solvent effects through the use of a continuum model in the context of DFT level of theory, ii) 
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entropic effects by evaluating binding free energies (Δ𝐺) and iii) using additionally, more reliable 
hydrated aluminum structures as reference so that three coordination shells are chosen: 
[Al(OH)(H2O)4]
2+ (used in ref.31), [Al(OH)(H2O)5]
2+, and Al(H2O)6]
3+ . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2: State I corresponds to the binding of aluminum to the peptide bond carbonyl oxygen, whereas State 
II corresponds to the formation of an Al-N bond from State I. Both structures characterized considering three 
different coordination shells for Al(III) (nomenclature defined in Methodology section). Atoms represented 
as: O (red), H (white), C (grey) and N (blue). 
 
In addition, we would like to note that dealing with a small charged molecule such as a hydronium 
ion involves some technical difficulties, mainly an accurate estimation of its solvation energy. In 
order to alleviate this shortcoming, the microsolvated hydronium model [H3O(H2O)3] and its neutral 
counterparts were used to calculate the energy of State II: 
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State II: [Al(OH)(H2O)4]
2+ + C4N2O2H8 + H2O(H2O)2
⟶ [Al(OH)(H2O)2(C4N2O2H7)]
1+ + H2O + [H3O(H2O)3]
+ 
 (5.3) 
 
Results are summarized in Table 5.1 and all geometries characterized illustrated in Fig. 5.2. 
 
 MP2 DFT 
 Δ𝐸𝑔𝑎𝑠
(𝑎)
 Δ𝐸𝑔𝑎𝑠
(𝑏)
 Δ𝐸𝑎𝑞
(𝑐)
 Δ𝐸𝑔𝑎𝑠
(𝑑)
 Δ𝐸𝑎𝑞
(𝑒)
 Δ𝐺𝑎𝑞
(𝑒)
 
[Al(OH)(H2O)4]
2+ 
State I(1) -27.1 -40.2 -13.0 -38.9 -11.1 -7.6 
State II(2) -50.7 -44.9 17.2 -41.9 20.7 13.2 
State II(3) - -112.6 -14.4 -110.5 -11.8 -8.0 
 [Al(OH)(H2O)5]
2+ 
State I(1) - -41.6 -13.6 -39.5 -10.7 -2.9 
State II(2) - -33.1 26.3 -29.0 30.7 25.0 
State II(3) - -100.9 -5.4 -97.7 -1.8 3.7 
 [Al(H2O)6]
3+ 
State I(1) - -70.7 -17.1 -69.4 -14.7 -11.1 
State II(2) - -130.9 20.4 -127.9 24.0 20.7 
State II(3) - -198.7 -11.3 -196.6 -8.6 -0.6 
 
Table 5.1: Thermodynamics of Formation of State I and II. Reaction energies and free energies computed 
at different level of theories: a) MP2, taken from ref; b) MP2/6-311++G(3df,2p) in the gas-phase; c) MP2/6-
311++G(3df,2p) in aqueous environment using the IEFPCM continuum model; d) B3LYP/6-311++G(3df,2p) 
in the gas-phase; e) B3LYP/6-311++G(3df,2p) in aqueous environment using the IEFPCM continuum model.  
Three different structure of hydrated aluminum are taken as reference for these two reactions: 
[Al(OH)(H2O)4]2+, [Al(OH)(H2O)5]2+ or [Al(H2O)6]3+. For each state, the superscript corresponds to the 
label of the reaction used to calculate the energy of the corresponding compound.  
 
We start comparing the results of State I and II according to reactions (1) and (2), that is, using the 
bare hydronium to evaluate the energies of State II. For gas phase calculations and taking the 
[Al(OH)(H2O)4]
2+ species as reference, we obtain similar gas phase energies as ref.31 for State I and 
II, -38.9 kcal/mol and -41.9 kcal/mol, respectively. However, the introduction of solvent effects has 
a profound effect on the thermodynamics of these charged systems, and now although formation of 
Aluminum’s preferential binding site in proteins: side chains of aminoacids versus backbone interactions 
 
146 
 
State I is still exothermic, -11.1 kcal/mol, State II is highly endothermic, 20.7 kcal/mol, and therefore 
unlikely to be formed in aqueous solution. The change of hydrated aluminum reference structure to 
[Al(OH)(H2O)5]
2+  or [Al(H2O)6]
3+ has a sizeable effect on the gas phase energetic and especially 
for the case  of [Al(H2O)6]
3+, with a significant increase in the gas-phase exothermic behavior for 
the formation of States I and II. However, again the introduction of solvent effects yields an increase 
in the Δ𝐸𝑎𝑞 values, with the result that only the formation of State I is moderately exothermic, while 
formation of State II is highly endothermic in all cases. Similarly, the computed Δ𝐺𝑎𝑞 values confirm 
this trend, with values of State II between 13.2 to 25 kcal/mol depending on the hydrated aluminum 
structure taken as reference. Note that this is somehow expected, since State II requires the 
deprotonation of a peptide bond nitrogen, and this is a very unfavorable process in solution according 
to the high values of the pKa of amides.  
Interestingly, the relative energies of State II decreases in ca. 20 kcal/mol (see Table 5.1)  when its 
binding energies are evaluated using the microsolvated H3O(H2O)3 model (reaction 3) instead of the 
bare hydronium ion, and consequently the difference between the energies of State I and State II 
shrinks. In spite of this modification, State II remains clearly less stable than State I when Al(III) 
presents any of the two octahedral arrangements, and only with Al(III) pentacoordinated the stability 
of the two compounds are similar. However, as pointed out above, this coordination mode is the most 
unlikely one for Al(III). More importantly, all these results confirm on one hand that special cautions 
should be taken evaluating binding energies and choosing the reference molecule, and on the other 
hand that the interaction of Al(III) with the backbone of a peptide bond (either State I or II) can not 
compete with the interaction of the cation with a negatively charged side chain (see below).   
Song et al.31 claimed that the energy required to deprotonate the peptide bond N atom could be 
somehow compensated by a strong binding of the carbonyl oxygen and peptide nitrogen to aluminum, 
with a significant degree of covalent character, and significant reduction of the aluminum oxidation 
state. Their analysis was based on the investigation of orbitals shapes and Mulliken charges, which 
shows inherent limitations262. We decided to analyze the bonding features of State I and II generated 
by the [Al(OH)(H2O)4]
2+ structure using the more accurate Quantum Theory of Atoms in Molecules 
(QTAIM)208. Briefly, the theory makes use of an unambiguous partition of electron density in atom 
basins based on Bader’s definition of an atom in a molecule (zero-flux condition). In this context, the 
bonding between two atoms is characterized by the so-called bond critical point (BCP). Various 
properties at the BCPs characterize the type of bonding, in particular the value of the density 
(𝜌(𝑟𝐵𝐶𝑃)), the Laplacian of the density (∇
2𝜌(𝑟𝐵𝐶𝑃)), and the energy density (𝐻(𝑟𝐵𝐶𝑃)) are commonly 
used to classify the type of bonding (covalent versus ionic) between a pair of atoms. In Table 5.2, we 
summarize the values obtained for all the Al-O and Al-N bonds found in State I and State II. Typical 
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covalent bonds show negative values of both the Laplacian and the energy density at the BCP. This 
indicates that the accumulation of the electronic charge at BCP leads to stabilization of the bonding 
interaction. On the contrary, ionic bonds show typically positive values of the Laplacian and the 
energy density214. As one can see in Table 5.2, all Al-O bonds of State I fall into the latter category. 
The formation of State II does not change the qualitative picture for Al-O bonds, whereas in the case 
of Al-N bonds, we find also a positive value of the Laplacian, and only a very small negative value 
of the energy density at the bond critical point. This can be related to very minor dative interactions 
from the nitrogen lone pair into the empty valence shell of aluminum, but not to a strong chemical 
bond due to the reduction of the aluminum oxidation state. In fact, the Bader atomic charges show 
only a very slight reduction of the charge of aluminum, from 2.578 to 2.546 a.u., when passing from 
State I to State II, another evidence of the mainly electrostatic nature of the bonding interactions 
between the peptide atoms and aluminum. Analogous results were obtained for the State I and II 
structures with Al(III) hexacoordinated. 
 
 𝜌(𝑟𝐵𝐶𝑃) ∇
2𝜌(𝑟𝐵𝐶𝑃) 𝐻(𝑟𝐵𝐶𝑃)  𝜌(𝑟𝐵𝐶𝑃) ∇
2𝜌(𝑟𝐵𝐶𝑃) 𝐻(𝑟𝐵𝐶𝑃) 
State I1,5 (QAl = +2.578 a.u.) State II1,5 (QAl = +2.546 a.u.) 
Al-Ocarb 0.073 0.573 0.010 Al-N 0.076 0.449 -0.005 
Al-OOH 0.097 0.832 0.008 Al-Ocarb 0.060 0.392 0.004 
Al-OW1 0.050 0.331 0.005 Al-OOH 0.093 0.787 0.008 
Al-OW2 0.059 0.427 0.009 Al-OW1 0.052 0.359 0.007 
Al-OW3 0.049 0.320 0.005 Al-OW2 0.045 0.281 0.004 
State I0,6 (QAl = +2.604 a.u.) State II0,6 (QAl = +2.572 a.u.) 
Al-Ocarb 0.066 0.498 0.008 Al-N 0.075 0.426 -0.006 
Al-OW1 0.062 0.439 0.007 Al-Ocarb 0.067 0.459 0.004 
Al-OW2 0.051 0.333 0.005 Al-OW1 0.051 0.328 0.005 
Al-OW3 0.054 0.358 0.005 Al-OW2 0.048 0.300 0.004 
Al-OW4 0.055 0.381 0.006 Al-OW3 0.047 0.295 0.004 
Al-OW5 0.053 0.352 0.005 Al-OW4 0.052 0.347 0.005 
 
Table 5.2: QTAIM analysis of Al-O and Al-N bonding. Values of the electron density (𝜌(𝑟𝐵𝐶𝑃)), Laplacian 
of electron density (∇2𝜌(𝑟𝐵𝐶𝑃)) and energy density (𝐻(𝑟𝐵𝐶𝑃)) at the bond critical point for all Al-X (X=O,N) 
bonds in States I and II structures characterized considering the [1,5] and [0,6] coordination shells (defined in 
the Methodology section). All quantities in atomic units. 
Aluminum’s preferential binding site in proteins: side chains of aminoacids versus backbone interactions 
 
148 
 
5.3.2 Interaction with amino acid sidechains  
In summary, the calculations carried out in the model employed in ref.31 do not support the idea of a 
strong interaction of Al(III) with the peptide backbone through the formation of 5-member rings 
(State II) in aqueous solution, although the interaction with the carbonyl oxygen (State I) could still 
be favorable thermodynamically. However, taking into account that the bond between aluminum and 
the carbonyl oxygen or nitrogen is mainly of electrostatic character, one could think that it could not 
compete with the interaction with other functional groups commonly present in residues, such as 
negatively charged carboxylic groups (Asp/Glu sidechains or C-terminals in proteins). In fact, it is 
well known that Al(III) has large affinity  towards negatively charged carboxylic or phosphates 
groups263. To analyze this point, we evaluate the binding interaction energy of aluminum to a 
carboxylic sidechain in Ala-Ala-Asp-Ala-Ala (AADAA) pentapeptide (See Fig. 5.1 and 5.3). Results 
(shown in Table 5.3) clearly show a much larger exothermic character for the resultant structure with 
∆𝐺𝑎𝑞 values of -48.7 kcal/mol.  
In addition, we also provide in Table 5.3, the thermodynamics of relevant structures found in our 
previous works, with similar quantum methods. For instance, in the case of the experimentally and 
theoretically studied GEGEGSGG octapeptide, we obtain different ∆𝐺 values depending on the 
coordination of aluminum66. We have chosen three paradigmatic cases: i)   N1-GEGEGSGG where 
aluminum interacts with only one aspartate sidechain, -33.7 kcal/mol, N6-GEGEGSGG which shows 
one aspartate sidechain in the first coordination shell and a second carboxylate group in the second 
coordination sphere, -67.9 kcal/mol, and finally, P1-GEGEGSGG with a phosphorylated serine 
coordinating aluminum, -78.2 kcal/mol. All cases show a more favorable interaction than with the 
models in which aluminum is directly interacting with the peptide backbone. It is remarkable the 
enhancement of affinity obtained upon phosphorylation of the serine sidechain that increases the 
negative charge associated to the corresponding residue. Notice as well, the tendency of aluminum to 
favor structures in which several functional groups coordinate aluminum, (either in the first 
coordination sphere or in the second one). In this sense, the most favorable interaction is obtained for 
Aβ peptide256, where three carboxylic groups (Glu3, Asp7 and Glu11) bind to aluminum in the first 
coordination shell. Thus, the simultaneous interaction with various negatively charged groups present 
in the Aβ peptide sequence makes this polypeptide to be highly favorable for aluminum binding68. 
The conclusion of our data is clear: in the aqueous phase, it is thermodynamically more favorable for 
Al(III) to interact with negative charged amino acid sidechains rather than with the backbone of 
proteins. Even with just one negatively charged amino acid sidechain, there is a substantial 
strengthening of the binding to aluminum with respect to only backbone interactions.  
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Are these sidechain interactions of sufficient strength as to be relevant in biological systems? To 
answer this question we need to compare our data with that obtained with similar methods for known 
low molecular mass biochelators of aluminum. In Table 5.3, we displays the thermodynamics of 
aluminum chelation by citrate, the main LMM chelator in blood serum, and by relevant biophosphates 
such as 2,3-DPG, glucose-6-phosphate (G6P), NADH, and ATP-like triphosphates (TriP). The order 
in binding energies is the following one: citrate (−124.9) >  2,3-DPG (−123.5)  ≃ G6P (-117.2) > 
TriP (−108.7)  ≫ NADH (−54.0 kcal/mol). It is clear that based on these results and among the Al-
peptide interactions shown in this work, only the Al-Aβ complex could be considered as a competitive 
strong chelator in biological systems. 
 
Ligand Ref. 
Ligand 
Charge 
Binding 
Mode 
∆𝐻𝑎𝑞  ∆𝐺𝑎𝑞  
 Interaction with the backbone 
State I0,6 This work 0 Backbone O(C) -14.7 -11.1 
State II0,6 This work -1 Backbone N&O 
N&O(C) 
24.0/-8.6 20.7/-0.6 
 Interaction with the sidechain of aminoacids  
AADAA This work -1 Asp - -48.7 
GEGEGSGG Ref66. -2 
N1 -36.5 -33.7 
N6 -69.7 -67.9 
GEGEGS(P)GG Ref66. -4 P1 -81.0 -78.2 
Aβ1-16 peptide Ref256. -2 Glu3,Asp7,Glu11 -172.9(a) - 
 Interaction with LMM Ligands 
Citrate Ref39,40. -4 2 COO¯,O¯ -133.0 -124.9 
2,3-DPG Ref40. -5 Multiple -118.9 -123.5 
NADH Ref42. -1 Multiple - -54.0 
Glucose-6-Phosphate Ref41. -3 Multiple -116.5 -117.2 
ATP-like, Triphosphate Ref45. -4 α,β-Phosphate -109.2 -108.7 
(a) ∆𝐸𝑎𝑞 value. 
 
 
Table 5.3: Thermodynamics of the binding to Al(III) of i) peptide through its backbone (State I and II 
compounds) and ii) other relevant biological molecules. Reaction energies calculated according to equations 
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(5.1) and (5.2) (taking [Al(H2O)6]3+ as reference state), computed at B3LYP/6-311++G(3df,2p) with IEFPCM 
continuum model to include solvent effects. 
 
Therefore, a high density of negative charged amino acid sidechains in a reduced sequence region 
seems to be a prerequisite for a polypeptide to have a high affinity for aluminum. 
 
 
 
Figure 5.3: Structures of different polypeptide structures considered in Table 5.3. Note that for clarity 
hydrogen atoms are not displayed. 
 
5.4 Conclusions  
 
In this paper, we have revised the possibility of aluminum to interact with the backbone of proteins, 
using density functional theory in conjunction with continuum solvation models to treat bulk solvent 
effects. To do so, we have compared the thermodynamics of formation of Al(III)-backbone structures 
previously proposed in the literature, with those structures in which aluminum interacts with amino 
acid sidechains, and with known aluminum low molecular mass chelators in biological systems. We 
have found that in an aqueous environment aluminum shows a clear preference to interact with 
Aluminum’s preferential binding site in proteins: side chains of aminoacids versus backbone interactions 
 
\151 
 
negatively charged amino acid sidechains, with aluminum-backbone structures being endothermic or 
much less exothermic than aluminum-sidechain structures. The comparison with known biochelators 
of aluminum, like citrate or biophosphates, clearly indicates that only in cases in which there is a high 
density of negatively charged amino acid sidechains in proteins, such as in Aβ peptide,  could a 
biomolecule be a competitive aluminum chelator in biological environment. 
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Aluminum and Fenton reaction: how can the reaction be modulated 
by speciation? A computational study using citrate as a test case 
 
 
6.1 Introduction 
 
Aluminum is the third most abundant element in Earth’s crust, but complex geochemical cycles 
prevent its solubilization from lithosphere1,180,264, maintaining this abundant metal out from essential 
biological cycles. Nevertheless, in the last century, aluminum has massively been extracted from soil 
due to its favorable properties (easy to manipulate, cheap and good physico-chemical properties) and 
myriad of applications (food additives, pharmaceuticals, Al-containers, etc.). As a consequence, 
aluminum is nowadays present in the biosphere, and humans are highly exposed to this metal2,265. 
Unfortunately, this is not without consequences, and this exposition to aluminum has been linked to 
various diseases6,59,61,266, starting from early evidences of dialysis encephalopathy or osteodistrophy 
in patients with renal failure under dialysis treatment223,267, to more recent evidences linking 
aluminum to several neurodegenerative diseases59,61. The high charge and small volume of aluminum 
make this metal a strong Lewis acid, with high affinity towards oxygen-containing and negatively-
charged functional groups, such as phosphates or carboxylic groups. Therefore, aluminum has the 
potential ability to form strong interactions with important biomolecules such as proteins, 
phospholipids, ATP, NADH, RNA, DNA, etc...115. 
The pro-oxidant ability of aluminum is one of the main deleterious effects of aluminum, observed 
both in-vitro and in-vivo experiments43,72. This is a feature not expected for an element without a 
redox capability52,268. It was early hypothesized43,52 that this pro-oxidant activity was due to the 
formation of a strong aluminum-superoxide complex, which leads to an increase of the lifetime of the 
superoxide radical species. In fact, Fukuzumi et al. reported a linear relationship between the strength 
of the metal-superoxide interaction, and the oxidant activity of the metal269-271. Based on this 
hypothesis, we demonstrated51 the possibility of the formation of an aluminum-superoxide complex 
in solution, departing from various aluminum hydrolytic species. Further calculations confirmed that 
these aluminum-superoxide complexes may increase oxidative stress in biological environments by 
acting as promoting agents of the Fenton reaction56 (see Fig. 6.1). 
However, most of the aluminum present in the human organism is not free in solution, but forms 
stable complexes with low and high molecular mass biomolecules, and this could have a deep effect 
on the pro-oxidant activity of aluminum. Many attempts have been made to identify the molecules 
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interacting with aluminum in biological systems34,36,272,273. However, due to the complex chemistry 
of aluminum, its low total concentration, and the high risk of sample-contamination, the study of the 
speciation of aluminum is a complex task36. 
 
 
 
Fig. 6.1: Above, a possible route for the pro-oxidant activity of aluminum by the promotion of the Fenton 
reaction. Below, the molecular structure of citrate. 
 
Nowadays it is accepted that the 90% of aluminum found in the blood serum is bound to serum 
transferrin protein, while citrate is the main low molecular weight chelator83. Alternatively, citrate is 
identified as the main chelator of aluminum in brain extracellular fluid61. This behavior is not 
surprising as the molecular composition of citrate with three carboxylic groups and an alcohol group 
(shown in Fig. 6.1) provides high affinity towards Al(III). Interestingly, in previous works, it was 
demonstrated that the formation of ternary complexes with citrate can show a protective role with 
respect to some of the deleterious effects of aluminum40,186. 
In the present study, our goal is to analyze how the interaction with citrate could alter i) the possibility 
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of formation of an aluminum-superoxide complexes and ii) the possibility of reducing Fe(III) to 
Fe(II), promoting the Fenton reaction. To do so, we evaluate the binding energies of Al(III) to 
superoxide and citrate, and the reaction free energy of iron reduction from Fe(III) to Fe(II) in the 
presence of aluminum-superoxide radical binary species and aluminum-citrate-superoxide ternary 
species. To be consistent, we also consider the changes in the corresponding energies when citrate is 
bound to iron. The study describes a complex scenario that ultimately depends on the relative 
concentrations of each species. However, the results point in general to a protective role of citrate 
with respect to the pro-oxidant ability of aluminum, specially in high-citrate concentration regimes. 
 
6.2 Methodology 
 
All geometries were optimized in solution at two level of theories using the 6-31++g(d,p) basis set: 
B3LYP/6-31++g(d,p) and B3LYP-D3(BJ)/6-31++g(d,p). In the latter level of theory D3 version of 
Grimme’s dispersion153 with Becke-Johnson damping274 is included. To confirm that the optimized 
structures were real minima on the potential energy surfaces, frequency calculations were carried out 
at the same level of theory. All structures showed positive force constants for all the normal modes 
of vibration. The frequencies were then used to evaluate the zero-point vibrational energy (ZPVE) 
and the thermal (T = 298 K) vibrational corrections to the enthalpies and Gibbs free energies within 
the harmonic oscillator approximation. To calculate the entropy, the different contributions to the 
partition function were evaluated using the standard statistical mechanics expressions in the canonical 
ensemble and the harmonic oscillator and rigid rotor approximation. The solvent effect was 
introduced by using the self-consistent reaction field (SCRF) method with the polarized continuum 
model (PCM), using the integral equation formalism variant (IEFPCM)177. 
Once the geometries were optimized at the two level of theories stated above, the electronic energies 
were refined using the larger basis set 6-311++g(3df,2p) by two distinct single-point energy 
calculations: a) using the same functional as in the geometry optimization, or b) using the ωB97XD 
hybrid functional275 with dispersion correction included in the functional form.  Thus, for each 
reaction a set of four different energies are presented (energy evaluation//geometry optimization): i) 
B3LYP/TZ//B3LYP/DZ (Δ𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃), ii) ωB97XD/TZ//B3LYP/DZ (Δ𝐺𝑎𝑞
𝐵3,𝑤𝐵97
), iii) B3LYP-
D3/TZ//B3LYP-D3/DZ (Δ𝐺𝑎𝑞
𝐵3−𝐷3), iv) ωB97XD/TZ//B3LYP-D3/DZ (Δ𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
), where TZ=6-
311++g(3df,2p) and DZ=6-31++g(d,p). All these calculations were carried out using the Gaussian 09 
and 16 packages276. 
As in our previous study51, we considered different hydrated models for the Al-Citr complex, where 
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different number of waters and hydroxide molecules were included. Departing from each of these 
models, the substitution reaction of a water molecule (Equation 6.1) or a hydroxide (Equation 6. 2) 
by the superoxide to form a Al-Citr-O2
· complex was studied: 
 
 
[Al. Citr(H2O)n(OH)m]aq
(1−m) + [O2(H2O)2]aq
− ⟶ 
[Al. Citr(H2O)n−1(OH)mO2]aq
(2−m) + [H2O(H2O)2]aq 
 (6.1) 
 
 
[Al. Citr(H2O)n(OH)m]aq
(1−m) + [O2(H2O)2]aq
− ⟶ 
[Al. Citr(H2O)n(OH)m−1O2]aq
(1−m) + [OH(H2O)2]aq
−  
 (6.2) 
 
were n and m are the number of water and hydroxide molecules, respectively. Note that in 
concordance with some test calculations carried out previously51, the small ligands (superoxide, water 
molecule and hydroxide) were micro-solvated with two explicit water molecules to improve their 
solvation energy. Moreover, citrate was considered completely deprotonated with a net charge of -4 
(see below). 
The free energies in solution corresponding to these two reactions are calculated as: 
 
 
𝛥𝐺𝑎𝑞 =  𝐺𝑎𝑞(𝐴𝑙. 𝐶𝑖𝑡𝑟(𝐻2𝑂)𝑛−1(𝑂𝐻)𝑚𝑂2) + 𝐺𝑎𝑞(𝐻2𝑂(𝐻2𝑂)2)
− 𝐺𝑎𝑞(𝐴𝑙. 𝐶𝑖𝑡𝑟(𝐻2𝑂)𝑛(𝑂𝐻)𝑚) − 𝐺𝑎𝑞(𝑂2(𝐻2𝑂)2) 
 (6.3) 
 
Or 
 
 
𝛥𝐺𝑎𝑞 =  𝐺𝑎𝑞(𝐴𝑙. 𝐶𝑖𝑡𝑟(𝐻2𝑂)𝑛(𝑂𝐻)𝑚−1𝑂2) + 𝐺𝑎𝑞(𝑂𝐻(𝐻2𝑂)2)
− 𝐺𝑎𝑞(𝐴𝑙. 𝐶𝑖𝑡𝑟(𝐻2𝑂)𝑛(𝑂𝐻)𝑚) − 𝐺𝑎𝑞(𝑂2(𝐻2𝑂)2) 
 (6.4) 
 
The Δ𝐺𝑎𝑞 values were computed at the four level of theories described above. All these values are 
presented in Table 6.1, 6.2 and 6.3, but since the overall trends are maintained, only the Δ𝐺𝑎𝑞
𝐵3−𝐷3 
values are discussed throughout the body text. 
For all aluminum containing structures we also calculated delocalization Indices (D.I.). These are a 
measure of the covariance between the population of two atoms  and  and, consequently, a measure 
of the number of electrons simultaneously fluctuating between these atoms248,249, 
 
 𝛿(𝐴, 𝐵) = ∫ ∫ 𝑑
𝐵𝐴
1𝑑2𝜌𝑥𝑐(1,2) = 𝑐𝑜𝑣(𝑁𝐴, 𝑁𝐵)  (6.5) 
 
where ρxc(1,2) is the exchange-correlation density277. It can be taken as the number of electron pairs 
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shared between atoms  and , i.e., the bond order278. The AIMAll v11.08.23 program250 was used to 
carry out the QTAIM analysis (what includes the characterization of D.I.) on the previously optimized 
structures. Wavefunctions for QTAIM analysis were obtained at the B3LYP/6-311++g(3df,2p) level 
of theory using the IEFPCM solvation model. 
 
6.3 Results and discussion 
 
6.3.1 Incorporation of the O2· superoxide radical  
In our previous work, we investigated the incorporation of O2
- to first coordination shell of aluminum 
hydrolytic species51. In particular the displacement of either a water molecule or an hydroxide from 
the first coordination shell was analyzed by evaluating the ΔGaq of one of the next reactions: 
 
 [Al(H2O)n(OH)m]aq
3−m + [O2]aq
− ⟶ [Al(H2O)n−1(OH)mO2]aq
(2−m)
+ [H2O]aq  (6.6) 
 
 [Al(H2O)n(OH)m]aq
3−m + [O2]aq
− ⟶ [Al(H2O)n(OH)m−1O2]aq
(3−m) + [OH]aq
−   (6.7) 
 
where Equation 6.6 implies the substitution of a water molecule by the superoxide anion, and 
Equation 6.7 the substitution of an hydroxide. The subscripts n and m refer to the number of water 
molecules and hydroxides present in the complexes. Note that these reactions are analogous to 
reactions 6.1 and 6.2, but without the presence of citrate.  
 
 Δ𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃 Δ𝐺𝑎𝑞
𝐵3,𝑤𝐵97
 Δ𝐺𝑎𝑞
𝐵3−𝐷3 Δ𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
 
 [Al(H2O)6]
3+ + [O2]
− ⟶ 
[Al(O2)(H2O)5]
2+ + H2O 
-24.7 -25.9 -19.5 -19.9 
[Al(OH)(H2O)5]
2+ + [O2]
− ⟶ 
[Al(O2)(OH)(H2O)4]
+ + H2O 
-24.6 -24.1 -17.9 -18.3 
[Al(OH)2(H2O)4]
+ + [O2]
− ⟶ 
[Al(O2)(OH)2(H2O)3] + H2O 
-18.7 -18.6 -17.6 -17.4 
[Al(OH)3(H2O)3] + [O2]
− ⟶ 
[Al(O2)(OH)3(H2O)2]
− + H2O 
-16.4 -17.4 -8.5 -8.6 
[Al(OH)4]
− + [O2]
− ⟶ 
[Al(O2)(OH + OH
− 
31.1 30.5 21.5 22.1 
 
Table 6.1. Reaction free energies in solution (in kcal/mol) evaluated for the substitution of a water molecule 
(Equation 6.6) or hydroxide (Equation 6.7) located in the aluminum first coordination shell of aluminum 
hydrolytic species by the O2* superoxide radical computed at the four level of theories described in 
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Methodology: B3LYP/TZ//B3LYP/DZ (ΔGaq
B3LYP), wB97XD/TZ//B3LYP/DZ (ΔGaq
B3,wB97
), B3LYP-
D3/TZ//B3LYP-D3/DZ (ΔGaq
B3−D3) and wB97XD/TZ/B3LYP-D3/DZ (ΔGaq
B3−D3,wB97
). 
 
The results clearly indicated that the substitution of a water molecule by the superoxide radical anion 
was energetically favorable (data shown in Table 6.1), whereas the substitution of an hydroxide was 
unfavorable in all cases. Besides, we concluded that the charge of the complex is a contributing factor, 
as the larger the number of negatively charged hydroxides in the first coordination shell, the less 
negative the Δ𝐺𝑎𝑞 value for the displacement of water molecules by the superoxide radical. 
Now, we will analyze whether aluminum can form a stable complex with the superoxide radical anion 
in the presence of citrate, a ligand composed by three carboxylic groups and an alcohol group (see 
Fig. 6.1). Previously, pKa values of -14.5, -8.0, 0.6 and 3.6 were computed for the four titratable 
groups of an aluminum-bound citrate molecule39, which are in concordance with the two known 
experimental values, the two highest ones: 2.3 and 3.634. Therefore, we assume that, at physiological 
conditions, the Al(III)-bound citrate is fully deprotonated. Note that the pKa values of free citrate in 
solution (2.9, 4.3, 5.6 and 11.6/14.4) suggest a different protonation state, with the alcohol group 
protonated39. Different coordination modes between citrate and Al(III) were also compared39, 
concluding that citrate interacts tridentately with aluminum. 
 
 Δ𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃 Δ𝐺𝑎𝑞
𝐵3,𝑤𝐵97
 Δ𝐺𝑎𝑞
𝐵3−𝐷3 Δ𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
 
[Al. Citr(H2O)3(H2O)10]
− + [O2]
− ⟶ 
[Al. Citr(H2O)2(O2)(H2O)10]
2− + H2O 
-7.2 -5.5 -4.0 -5.2 
[Al. Citr(H2O)2(OH)(H2O)10]
2− + [O2]
− ⟶ 
[Al. Citr(H2O)(OH)(O2)(H2O)10]
3− + H2O 
-4.4 -4.2 -3.9 -4.5 
[Al. Citr(H2O)(OH)2(H2O)10]
3− + [O2]
− ⟶ 
[Al. Citr(OH)2(O2)(H2O)10]
4− + H2O 
4.1 7.4 6.2 6.6 
 
[Al. Citr(H2O)2(OH)(H2O)10]
2− + [O2]
− ⟶ 
[Al. Citr(H2O)2(O2)(H2O)10]
2− + [OH]− 
15.5 16.3 16.5 17.5 
[Al. Citr(H2O)(OH)2(H2O)10]
3− + [O2]
− ⟶ 
[Al. Citr(H2O)(OH)(O2)(H2O)10]
3− + [OH]− 
16.6 16.1 14.0 14.8 
[Al. Citr(OH)3(H2O)10]
− + [O2]
4− ⟶ 
[Al. Citr(OH)2(O2)(H2O)10]
4− + [OH]− 
3.2 5.2 4.1 5.2 
 
Table 6.2. Reaction free energies in solution (in kcal/mol) evaluated for the substitution of a water molecule 
(Equation 6.1) or a hydroxide ion (Equation 6.2) located in the aluminum first coordination shell of Al-Citr 
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complexes by the O2* superoxide radical (structures shown in Fig. 6.2). 𝛥𝐺𝑎𝑞 values computed at the level of 
theories described in Methodology: B3LYP/TZ//B3LYP/DZ (𝛥𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃), wB97XD/TZ//B3LYP/DZ 
(𝛥𝐺𝑎𝑞
𝐵3,𝑤𝐵97
), B3LYP-D3/TZ//B3LYP-D3/DZ (𝛥𝐺𝑎𝑞
𝐵3−𝐷3) and wB97XD/TZ/B3LYP-D3/DZ (𝛥𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
). 
 
 
Fig. 6.2. Density Functional Theory structures optimized at B3LYP/6-31++g(d,p) level of theory. On the left, 
initial Al-Citr complexes with different number of H2O/OH- molecules (according to Equations 6.1 and 6.2). 
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On the right, Al-Citr-O2- complexes formed by the substitution of either a H2O or a OH- molecule by O2-. . 
 
Different solvation models were considered for the aluminum-citrate complexes, varying in the 
number of water/hydroxide molecules. In all of them, aluminum presents an octahedral  arrangement, 
with three of the six first coordination shell positions occupied by citrate, and three of them available 
for water or hydroxide molecules. All possible combinations were taken into account, giving rise to 
a total of four structures (see Fig. 6.2). In addition, our previous calculations demonstrated the 
importance of including the second solvation sphere explicitly in order to obtain reliable solvation 
energies247; therefore, ten water molecules were placed in the second coordination shell, mainly 
around the water/hydroxide molecules. All these structures are shown in Fig. 6.2. 
We found that the substitution of a water molecule by the superoxide radical anion is 
thermodynamically favorable in solution, when at least two water molecules are found in the first 
coordination shell. Thus, the formation of [Al.Citr(H2O)2(O
.
2)(H2O)10]
−2 and 
[Al.Citr(H2O)(OH)(O
.
2)(H2O)10]
−3 shows Δ𝐺𝑎𝑞 values of -4.0 and -3.9 kcal/mol, respectively. In 
contrast, the Δ𝐺𝑎𝑞 for the formation of [Al.Citr(OH)2(O
.
2)(H2O)10]
−4 is positive, 6.2 kcal/mol. Thus, 
the amount of negatively charged groups in the first coordination shell influences the final stability 
of the aluminum-citrate-superoxide ternary complexes. 
On the other hand, none of the substitution of an hydroxide anion by the superoxide radical is 
thermodynamically favorable. The formation of [Al.Citr(H2O)2(O
.
2)(H2O)10]
− and 
[Al.Citr(H2O)(OH)(O
.
2)(H2O)10]
−3 species show values of 16.5 and 14.0 kcal/mol, respectively. 
However, departing from the [Al.Citr(OH)3(H2O)10]
−4 species, the formation of the 
[Al.Citr(OH)2(O
.
2)(H2O)10]
−4 complex is less endoergic, with a Δ𝐺𝑎𝑞 value of 4.1 kcal/mol. 
In summary, as in the case of the absence of citrate, the interaction of superoxide with aluminum can 
lead to thermodynamically favorable species, with negative formation energies, only in the case of 
substitution of water molecules in the first-coordination shell around aluminum, whereas the 
substitution of hydroxides is highly unfavorable. As expected, the presence of other negatively-
charged groups in the first-coordination shell of aluminum leads to less favorable formation of an 
aluminum-superoxide complex, both in binary and ternary compounds. In this sense, the presence of 
citrate, with a total charge of -4, has a sizable effect on the substitution reactions. The addition of 
more negative charge by the incorporation of a superoxide radical is energetically less favorable than 
in the absence of citrate. For instance, in the absence of citrate, the exchange of a water molecule with 
the superoxide shows a Δ𝐺𝑎𝑞 value of -19.5 kcal/mol, while the same reaction in the presence of 
citrate shows a value of -4.0 kcal/mol. However, although the binding of aluminum to citrate makes 
less favorable the interaction of the metal with the superoxide, the formation of a ternary aluminum-
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citrate-superoxide complex is still thermodynamically favorable, and therefore a ternary complex of 
this kind could also take part in the promotion of the Fenton reaction. In the next section, we evaluate 
how the inclusion of citrate influences the thermodynamics of the resultant redox reaction. 
 
6.3.2 Fenton reaction 
 Δ𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃 Δ𝐺𝑎𝑞
𝐵3,𝑤𝐵97
 Δ𝐺𝑎𝑞
𝐵3−𝐷3 Δ𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
 
Absence of Citrate and Aluminum 
[FeW6]
3+ + [O2
∗ ]− ⟶ [FeW6]
2+ + O2  -54.7 -57.8 -50.0 -55.7 
Absence of Citrate(a) 
[FeW6]
3+ + [AlW5(O2
∗ )]2+ ⟶ 
[FeW6]
2+ + [AlW5(O2)]
3+ -19.6 -16.7 -9.2 -12.7 
[FeW6]
3+ + [AlW5(O2
∗ )]2+ + H2O ⟶ 
[FeW6]
2+ + [AlW6]
3+ + O2 
-30.0 -31.9 -30.5 -35.8 
[FeW6]
3+ + [Al(OH)W4(O2
∗ )]+ + H2O ⟶ 
[FeW6]
2+ + [Al(OH)W5]
2+ + O2 
-30.1 -33.7 -32.1 -37.4 
[FeW6]
3+ + [Al(OH)2W3(O2
∗ )] + H2O ⟶ 
[FeW6]
2+ + [Al(OH)2W4]
+ + O2 
-1.6 -3.9 -32.4 -38.4 
Citrate interacting only with Aluminum 
[FeW6]
3+ + [Al. CitrW2(O2
∗ )]−2 ⟶ 
[FeW6]
2+ + [Al. CitrW2(O2)]
− -10.2 -4.8 -4.9 -2.6 
[FeW6]
3+ + [Al. CitrW2(O2
∗ )]2+ + H2O ⟶ 
[FeW6]
2+ + [Al. CitrW3]
− + O2 
-37.9 -30.6 -36.1 -41.2 
[FeW6]
3+ + [Al. Citr(OH)W(O2
∗ )]3− + H2O ⟶ 
[FeW6]
2+ + [Al. Citr(OH)W2]
2− + O2 
-40.6 -31.8 -36.5 -42.1 
Citrate interacting only with Iron 
[Fe. CitrW3]
− + [AlW5(O2
∗ )]2+ ⟶ 
[Fe. CitrW3]
2− + [AlW5(O2)]
3+ 
28.2 28.7 34.0 30.2 
[Fe. CitrW3]
− + [AlW5(O2
∗ )]2+ + H2O ⟶ 
[Fe. CitrW3]
2− + [AlW6]
3+ + O2 
17.8 26.0 12.7 7.0 
[Fe. CitrW3]
− + [Al(OH)W4(O2
∗ )]+ + H2O ⟶ 
[Fe. CitrW3]
2− + [Al(OH)W5]
2+ + O2 
17.7 24.2 11.1 5.5 
Citrate interacting with both Aluminum and Iron 
[Fe. CitrW3]
− + [Al. CitrW2(O2
∗ )]2− ⟶ 
[Fe. CitrW3]
2− + [Al. CitrW2(O2)]
− 
37.7 40.7 38.3 40.3 
[Fe. CitrW3]
− + [Al. CitrW2(O2
∗ )]2− + H2O ⟶ 
[Fe. CitrW3]
2− + [Al. CitrW3]
− + O2 
10.0 14.9 7.0 1.7 
[Fe. CitrW3]
− + [Al. Citr(OH)W(O2
∗ )]3− + H2O ⟶ 
[Fe. CitrW3]
2− + [Al. Citr(OH)W2]
2− + O2 
7.3 13.7 6.6 0.7 
(a) Data taken from ref.51. 
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Table 6.3. Reaction free energies in solution (in kcal/mol) evaluated for the reduction of Fe(III) in presence of 
different forms of the Al-O2* or Al-Citr-O2* complex. As reference, the Fenton reaction in absence of Al(III) 
is also included. 𝛥𝐺𝑎𝑞 values computed at the level of theories described in Methodology: 
B3LYP/TZ//B3LYP/DZ (𝛥𝐺𝑎𝑞
𝐵3𝐿𝑌𝑃), wB97XD/TZ//B3LYP/DZ (𝛥𝐺𝑎𝑞
𝐵3,𝑤𝐵97
), B3LYP-D3/TZ//B3LYP-D3/DZ 
(𝛥𝐺𝑎𝑞
𝐵3−𝐷3) and wB97XD/TZ/B3LYP-D3/DZ (𝛥𝐺𝑎𝑞
𝐵3−𝐷3,𝑤𝐵97
). 
 
Previously56, it was shown that an aluminum-superoxide complex could promote thermodynamically 
the Fenton reaction by reducing Fe(III) (sextuplet spin state) to Fe(II) (pentuplet spin state) through 
the following redox reaction: 
 
 [Fe3+ + [Al(O2
∗ )]2+ ⟶ Fe2+ + Al3+ + O2  (6.8) 
 
As shown in Table 6.3, this reaction is thermodynamically favorable with a Δ𝐺𝑎𝑞 value of -30.5 
kcal/mol when the superoxide is forming the [Al(O2
*)]2+ complex, and the reaction is even more 
favorable with the [Al(OH)(O2
*)]+ and [Al(OH)2(O2
*)] species, -32.1 and -32.4 kcal/mol, 
respectively. Note that the reaction is significantly less exothermic than when O2
* does not interact 
with Al(III) (-50.0 kcal/mol, see Table 6.3). Nevertheless, the formation of a stable Al(III)-O2
* 
complex may increase the lifetime of O2
52, a very reactive species, what ultimately favors the Fenton 
reaction51. Now, we analyze the effect in the thermodynamics of the redox reaction caused by the 
coordination of citrate to aluminum (Table 6.3). 
Taking into account the most stable aluminum-citrate-superoxide ternary complex 
(Al.Citr(H2O)2(O2
*)(H2O)10]
2-)  as reference, the Δ𝐺𝑎𝑞 value of reaction in Equation 8 is -36.1 
kcal/mol, thus, 6 kcal/mol more stable than in the absence of citrate. A very similar  exothermicity is 
found (Δ𝐺𝑎𝑞 value of -36.5 kcal/mol) when the [Al.Citr(H2O)(OH)(O2
*)(H2O)10]
3- complex is taken 
as reference. Thus, the formation of a ternary aluminum-citrate-superoxide complex favors the redox 
reaction that reduces Fe(III) to Fe(II). In this sense, the presence of citrate would enhance the ability 
of aluminum to promote the Fenton reaction. The reason for that behavior is that the presence of a 
highly-negative charged citrate in the coordination shell of aluminum makes the loss of an electron 
in superoxide, and therefore reduction of its negative charge, more likely. 
However, citrate is not only a good chelator for aluminum in biological systems, but also a good 
chelator of Fe(III). In fact, the binding free energy of the citrate-Fe(III) complex is -133 kcal/mol, 10 
kcal/mol more stable than those of the citrate-Al(III) complex. Therefore, we also investigated the 
possibility of iron reduction with complexes in which iron is also chelated to citrate. We consider two 
possibilities: i) reduction of Fe(III)-Citrate to Fe(II)-Citrate by an aluminum-superoxide binary 
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species and ii) the reduction of Fe(III)-Citrate to Fe(II)-Citrate by an aluminum-citrate-superoxide 
ternary complex. In both cases and for all the complexes considered, the redox reaction is 
thermodynamically unfavorable. For instance in the case that both iron and aluminum are chelated 
by citrate, the Δ𝐺𝑎𝑞 value of the redox reaction 7 is 7.0 kcal/mol when the 
[Al.Citr(H2O)2(O2
*)(H2O)10]
2- complex is taken as reference, and 6.6 kcal/mol with 
[Al.Citr(H2O)(OH)(O2
*)(H2O)10]
3-. Therefore, the high stabilization of Fe(III) by citrate is a dominant 
factor with respect to the loss of an electron by the superoxide and stabilization of the aluminum-
citrate complex. Thus, the chelation of iron by citrate has a protective effect with respect to the 
generation of Fe(II), and the promotion of Fenton reaction. 
Overall from our calculations a complex picture emerges on the role of citrate in the thermodynamic 
promotion/inhibition of aluminum pro-oxidant activity, which is summarized in the scheme of Fig. 
6.3. Aluminum hydrolytic species can form stable complexes with superoxide, leading to stable 
binary aluminum-superoxide and ternary aluminum-citrate-superoxide complexes. Both type of 
complexes have the ability to reduce Fe(III) to Fe(II) from a thermodynamic point of view. Moreover, 
the presence of citrate in ternary complexes promotes the loss of an electron from the superoxide, 
thus, increasing the iron-reduction ability of the aluminum ternary complexes with respect to binary 
ones. However, if iron is also chelated to citrate, the possibility of iron reduction is compromised, 
leading in all cases to endothermic redox reactions.  
 
 
 
Fig. 6.3. Schematic representation of how citrate modulates the promotion of Fenton reaction by Al(III). 
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Finally, we should also take into account that in excess of citrate and formation of the [Al-Citr2] 
complex, in which all coordination positions of aluminum are occupied by citrate, there would be no 
possibility of stabilization of superoxide by aluminum, and therefore, no possibility to reduce iron 
from the thermodynamic point of view. 
Therefore, an overall sophisticated scenario is drawn from these calculations, where, depending on 
the type of complexes formed (binary/ternary), and the relative concentrations of 
citrate/aluminum/iron, one could observe a promotion or an inhibition of the pro-oxidant activity of 
aluminum. In addition, the reactions of oligonuclear and/or mixed hydroxo complexes of Al(III) can 
be extremely slow, resulting in long-lived non-equilibrium states of Al(III)-ligand complexes20,83, 
which in the current context could imply that aluminum could exert its pro-oxidant activity from the 
ternary species characterized in this work, even at conditions in which there is an excess of citrate. 
 
6.3.3 Delocalization Indices and ligand affinity 
The effects of different functional groups considered herein (i.e. H2O, OH
-, O2
*, and the alkoxide and 
carboxylate groups of citrate) on the Al-O interactions are analyzed by calculating the delocalization 
indices (D.I.) for all the Al-O bonds in 17 structures: five aluminum hydrolytic species, five binary 
aluminum-superoxide complexes, four binary aluminum-citrate complexes and three ternary 
aluminum-superoxide-citrate complexes. Within each family of compounds, the complexes differ by 
the number of H2O/OH
- ligands in the first solvation shell of aluminum. Most of the structures 
correspond to hexacoordinated species, but there are also examples of structures penta- 
([Al(H2O)2(OH)3]) and tetra-coordinated ([Al(OH)4]
−). In all cases, the structures consider a double 
layer of explicit waters around aluminum, embedded in an implicit solvation model. The results are 
summarized in Fig. 6.4 and in Table 6.4. 
Delocalization indices (D.I.) are a measure of the degree of electron sharing between two atoms (see 
Methodology section). Although Al-O bonds are mainly electrostatic in nature, there are also 
important dative interactions20 from the lone pair of the oxygen donors to the formally vacant  3s and 
3p  orbitals of Al(III). For functional groups/ligands of similar charge, like in the case of hydroxide, 
alkoxide, carboxylate and superoxide, the analysis of D.I. can help in the rationalization of the specific 
aluminum-binding affinities of the different oxygen donors. Among the 17 structures analyzed, we 
find a consistent pattern with the D.I. decreasing in the following order: Al-OH− > Al-CO− > Al-
COO− > Al-O·2
− > Al-H2O. There are several aspects to highlight in the following trends, which allow 
for a clear rationalization of the ligand affinities described in the previous sections.  
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Aluminum Hydrolytic Species 
 [Al(H2O)6]
3+ 
0.1614 
(W) 
0.1536 
(W) 
0.1383 
(W) 
0.1560 
(W) 
0.1507 
(W) 
0.1545 
(W) 
  
[Al(H2O)5(OH)]
2+ 
0.1476 
(W) 
0.1386 
(W) 
0.1454 
(W) 
0.1385 
(W) 
0.1378 
(W) 
0.2160 
(OH) 
  
[Al(H2O)4(OH)2]
+ 
0.1269 
(W) 
0.1240 
(W) 
0.1130 
(W) 
0.1238 
(W) 
0.2075 
(OH) 
0.2428 
(OH) 
  
[Al(H2O)2(OH)3]  
0.1094 
(W) 
0.1081 
(W) 
0.2707 
(OH) 
0.2395 
(OH) 
0.2709 
(OH) 
   
[Al(OH)4]
− 
0.2693 
(OH) 
0.2694 
(OH) 
0.2393 
(OH) 
0.2583 
(OH) 
    
Aluminum-Superoxide Complexes ρ𝑂2
∗ ρ𝑂2
∗𝐴𝑙 
[Al(H2O)5O2
∗ ]2+ 
0.1561 
(W) 
0.1533 
(W) 
0.1459 
(W) 
0.1453 
(W) 
0.1515 
(W) 
0.1715 
(SO) 
0.6723 0.3164 
[Al(H2O)4(OH)O2
∗ ]+ 
0.1326 
(W) 
0.1344 
(W) 
0.1478 
(W) 
0.1444 
(W) 
0.2265 
(OH) 
0.1500 
(SO) 
0.6577 0.3251 
[Al(H2O)3(OH)2O2
∗ ]  
0.1217 
(W) 
0.1161 
(W) 
0.1320 
(W) 
0.2197 
(OH) 
0.2123 
(OH) 
0.1384 
(SO) 
0.6103 0.3828 
[Al(H2O)(OH)3O2
∗ ]− 
0.1148 
(W) 
0.2589 
(OH) 
0.2539 
(OH) 
0.2336 
(OH) 
 
0.1344 
(SO) 
0.6024 0.3880 
[Al(OH)3O2
∗ ]2− 
0.2869 
(OH) 
0.2771 
(OH) 
0.2860 
(OH) 
  
0.1774 
(SO) 
0.6322 0.3599 
Aluminum-Citrate Complexes 
[Al. Citr(H2O)3]
− 
0.2232 
(CA) 
0.1645 
(CCC) 
0.1596 
(CCT) 
0.1240 
(W) 
0.1480 
(W) 
0.1333 
(W) 
  
[Al. Citr(H2O)2(OH)]
2− 
0.2134 
(CA) 
0.1410 
(CCC) 
0.1417 
(CCT) 
0.1072 
(W) 
0.1097 
(W) 
0.2428 
(OH) 
  
[Al. Citr(H2O)(OH)2]
3− 
0.1947 
(CA) 
0.1266 
(CCC) 
0.1305 
(CCT) 
0.0936 
(W) 
0.1894 
(OH) 
0.2197 
(OH 
  
Al. Citr(OH)3]
4− 
0.1845 
(CA) 
0.1125 
(CCC) 
0.1059 
(CCT) 
0.1930 
(OH) 
0.1996 
(OH) 
0.1593 
(OH) 
  
Aluminum-Superoxide-Citrate Complexes ρ𝑂2
∗ ρ𝑂2
∗𝐴𝑙 
[Al. Citr(H2O)2O2
∗ ]2− 
0.2159 
(CA) 
0.1610 
(CCC) 
0.1574 
(CCT) 
0.1244 
(W) 
0.1348 
(W) 
0.1613 
(SO) 
0.5814 0.4012 
[Al. Citr(H2O)(OH)O2
∗ ]3− 
0.1985 
(CA) 
0.1455 
(CCC) 
0.1455 
(CCT) 
0.1111 
(W) 
0.2211 
(OH) 
0.1326 
(SO) 
0.5496 0.4310 
[Al. Citr(OH)2O2
∗ ]4− 
0.1872 
(CA) 
0.1318 
(CCC) 
0.1263 
(CCT) 
0.2199 
(OH) 
0.1827 
(OH) 
0.1102 
(SO) 
0.5306 0.4484 
 
Table 6.4. Delocalization Indices (in a.u.) obtained at the B3LYP/6-311++G(3df,2p) level of theory using the 
IEFPCM solvation model calculated for the Al-O interactions on aluminum complexes. The molecule of each 
oxygen atom is specified in parenthesis as: W: water (OH 2O); OH: hydroxide (OOH); SO: superoxide (OO2*); 
Aluminum and Fenton reaction: how can the reaction be modulated by speciation? A computational study 
using citrate as a test case 
 
\167 
 
CA: citrate alkoxide (OCO); CCC: citrate central carboxylate (OCOOc); citrate terminal carboxylate (CTC) 
(OCOOt). The Mulliken spin densities computed at the same level of theory for the two oxygen atoms of O2* are 
also reported (𝜌𝑂2
∗), 𝜌𝑂2
∗𝐴𝑙 referring to the O atom interacting with Al(III). 
 
 
 
 
Fig. 6.4.: The delocalization indices for the Al-O bonds of various aluminum hydrolytic species, aluminum-
superoxide and aluminum-citrate binary complexes and ternary aluminum-superoxide-citrate complexes with 
different number of H2O/OH filling the first-coordination shell of aluminum. The D.I. are classified according 
to the different functional groups: hydroxide (Al-OH−), alkoxide (Al-CO−), acetate (Al-CO2− ), superoxide (Al-
O2*) and water (Al-OH2). In the case that for a given structure several Al-O bonds with the same functional 
groups are present, the average value is provided in the figure. 
 
The D.I. for  Al−O·2− bonds are the lowest among charged ligands/groups, but higher than that for 
water. This is in agreement with the favorable substitution of a water molecule by superoxide, and 
the unfavorable substitution of a charged ligand like hydroxide characterized in our previous work51 
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and showed in Table 6.1. 
On the other hand, the highest Al-O delocalization indices correspond to the interaction of aluminum 
with hydroxides, with alkoxide having similar but smaller values. This is in agreement with the fact 
that hydrogen being less electronegative than carbon, makes OH- to be a better Lewis base than 
alkoxide. 
However, the D.I. for carboxylate groups are substantially lower, due to the resonance of the COO- 
moiety, which leads to a less dative oxygen. Finally, considering superoxide, the higher 
electronegativity of oxygen compared to carbon and hydrogen makes O2
- the poorest Lewis base 
among the charged functional groups/ligands of the present work. 
We should also remark that the strong Al-OH− interaction characterized in our structures is in 
agreement with the inherent stability of hydroxides at the first solvation layer around aluminum279. 
Moreover, the presence of hydroxides has a sizable effect on the strength of the rest of Al-O bonds 
with other ligands and functional groups, leading to a weakening of the rest of Al-O bonds, and 
therefore, a lowering of their D.I.. This is also in agreement with the known fact that the presence of 
hydroxides leads to a depleting of the toxicity of aluminum, by hindering the direct interaction of 
aluminum with bioligands. This leads to a low toxicity of aluminum at neutral pH at the limit of 
chemical equilibrium, i.e., when all aluminum is in the [Al(OH)4]
− form. However, as Exley et al.83 
has established, one should always bear in mind that non-equilibrium aluminum species could be 
highly relevant in the biological effects of this metal. 
Finally, when we compare similar structures in the presence or in the absence of citrate, we encounter 
that the presence of citrate leads consistently to lower D.I. for aluminum-superoxide bonds, in 
agreement with the lower affinity for superoxide displayed by aluminum-citrate complexes with 
respect to aluminum hydrolytic species. However, the D.I. of superoxide are still higher than the ones 
of water, and therefore the displacement of a water molecule by a O2
* remains favorable. This 
decrease in aluminum-superoxide interaction with the presence of citrate also explains the fact that 
the aluminum-citrate-superoxide ternary complex is a better reductant than an aluminum-superoxide 
binary complex, since the loss of an electron and therefore the loss of an aluminum-superoxide 
interaction is energetically less unfavorable for the former than for the latter. 
Similar conclusions can be reached based on the analysis of the Mulliken spin densities (ρ) at the two 
oxygen atoms of the O2
* molecule. It should be pointed out that the spin densities computed based on 
the Mulliken atom partition are physically unsound, but they can be useful to determine qualitatively 
where the radical character is located and to describe trends in similar structures. The spin densities 
at the two oxygen atoms of O2
* are shown in Table 6.4. For instance, the ρ values at the two oxygen 
atoms of O2
* in the [Al(H2O)5(O2
*)]2+ structure are 0.6723 and  0.3164. So, the sum of these two 
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values is approximately 1, but the spin density is mainly located at the O atom not interacting with 
Al(III). In other words, the molecule is highly polarized by the cation. However, the ρ values 
computed on other structures show that: 1) the inclusion of OH− radicals on the Al(III) first 
coordination shell leads to a small but consistent decrease of the polarization, and b) this effect is 
more effective when Al(III) interacts with citrate. 
 
6.4 Conclusions 
 
We have presented a thorough computational study on the influence of citrate, the main low-
molecular-mass chelator of aluminum, on the pro-oxidant activity of this metal. We have found that 
from the thermodynamic point of view stable ternary aluminum-citrate-superoxide complexes can be 
formed in aqueous solution, which can in turn promote the Fenton reaction by reducing Fe(III) to 
Fe(II). The presence of citrate has a two-fold effect: it reduces the affinity of aluminum towards 
superoxide, although it is still thermodynamically favorable to form aluminum-citrate-superoxide 
compounds, and thermodynamically, it favors the redox reaction in which iron is reduced from Fe(III) 
to Fe(II). However, we also found that citrate has a protective role in two ways: if iron is linked to 
citrate, the Fe(III) oxidation state is highly stabilized, and the reduction of iron is not longer 
thermodynamically favorable, irrespective of whether we depart from an aluminum-superoxide 
binary complex or an aluminum-superoxide-citrate ternary one. In addition, in excess of citrate the 
formation of very stable 1:2 aluminum-citrate compounds is predicted to outcompete 
thermodynamically the formation of aluminum-superoxide-citrate complexes. In conclusion, we 
would like to remark that the use of delocalization indices, and in general of the QTAIM theory, is a 
powerful tool for the clear and full rationalization of the observed trends in complex stability, 
allowing us to establish an order of affinity of aluminum towards the different functional 
groups/ligands analyzed in the present work: Al-OH− > Al-CO− > Al-COO− > Al-O2
− > Al−H2O. 
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potential risk factor for neurodegenerative diseases? 
 
 
7.1 Introduction 
 
The possible toxicity of aluminum is a highly controversial issue3. Although scientific literature on 
the adverse health effects of aluminum is extensive5,14,49, the exact molecular mechanisms of 
aluminum toxicity are not sufficiently understood59,61. Among the possible detrimental effects of 
aluminum, we can mention the promotion of oxidative stress51,52,56, the inhibition of the normal 
function of several enzymes (such as hexokinase184, glutamate dehydrogenase185-187, etc), the 
interference with several key cell metabolism cycles188-190, as well as alteration of the structure and 
chemistry of important metabolites115,186 and cofactors42. Moreover, since it has been pointed out that 
aluminum can cross the blood-brain barrier and accumulate in cerebral tissues63, special concerns 
have been raised on the possibility of local toxic effects caused by the presence of the aluminum ion. 
In fact, aluminum is widely recognized as a potential neurotoxic element191. Early studies supported 
this hypothesis, linking aluminum to the formation of neurofibrillary tangles (NFT)192, and more 
recent experimental and theoretical studies have underlined the ability of aluminum to bind to 
phosphorylated peptides66,193 and to promote hyperphosphorylation of normal neurofilaments194. In 
addition, the ability of aluminum to contribute to Aβ-amyloid aggregation has been recently 
demonstrated48,49,256, and growing evidence is linking aluminum as  a decisive contributing factor in 
Alzheimers disease4,5. 
Another proposed route for aluminum neurotoxicity is the alteration of signaling processes in which 
neurotransmitters are somehow affected by the presence of this exogenous metal. Due to the 
possibility of aluminum to bind catechols, that bear two of the hardest Lewis base oxygen donors to 
Al(III)20, an obvious target would be catecholamine-based neurotransmitters7,22,195-197. As a matter of 
fact, it has been shown that aluminum affects the signaling process mediated by these 
neurotransmitters198, altering their content in animal models195, and interfering with enzymatic 
activities in which these neurotransmitters are involved76. 
Catechol-aluminum interactions have been extensively studied in the framework of aluminum 
chelation therapy6,16,20,21,94, because of their strong binding affinity towards high valence metals and 
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their low molecular mass. Although several experimental efforts have been made in this sense, the 
clear and complete understanding of the properties and behavior of these metal-ligand complexes is 
still a challenging task. Accordingly, computational chemistry has raised as a very powerful tool to 
complement the available experimental data and help towards their rationalization and clear 
understanding. The use of state-of-the-art theoretical approaches can provide fundamental knowledge 
and valuable insights on the properties of these systems, unattainable by other means. In this sense, 
we have recently proposed and applied a validated computational protocol21 to account for the binding 
affinity of a wide set of catechols and salicylates towards Al(III), finding a good qualitative agreement 
with respect to experimental stability constants. Moreover, the use of the Bader’s Quantum Theory 
of Atoms in Molecules (QTAIM) and the Energy Decomposition Analysis (EDA) approach allowed 
us to characterize the physico-chemical features of the Al-O bonds and rationalize the effects of 
different substituents towards the modulation of the binding affinities. In this sense, we have stressed 
how electron withdrawing/donating effects can modulate the strength of the Al-O bonds by means of 
their efficient transmission through the aromatic rings of these compounds21. 
In the present work, we apply a similar methodology to investigate the stability of complexes formed 
by aluminum and catecholamine-based neurotransmitters (Fig. 7.1). Four catecholamines are 
considered in different metal-ligand stoichiometries: L-DOPA, dopamine, noradrenaline 
(norepinephrine) and adrenaline (epinephrine). Furthermore, and more importantly, we carefully 
analyze the proton/aluminum ion competition for the binding to these neurotransmitters, comparing 
our results with those previously published for catechol and 4-nitrocatechol21, as well as other known 
low-molecular-mass (LMM) Al(III) chelators such as citrate, deferiprone (1,2-dimetil-3-hydroxy-
4(1H)-piridinone) and ethylenediaminetetraacetic acid (EDTA) (Fig. 7.1). In particular, citrate was 
chosen as a reference compound of endogenous aluminum chelators because of its well established 
high affinity for Al(III) in human serum36,39,280; deferiprone was chosen as reference of exogenous 
Al(III) chelators since it is the most efficient LMM drug currently employed in aluminum and iron 
chelation therapy6,28. Finally, the choice of EDTA as reference compound is due to its high affinity 
for trivalent and divalent metal ions, which is also the reason of its controversial role in chelation 
therapy112,114. It is important to note that these polydentate ligands span different binding modes 
(tridentate for citrate, bidentate for deferiprone and hexadentate for EDTA, Fig. 7.1), leading to 
different stoiochimetric complexes with different entropic contributions, therefore are very suitable 
choices to compare the thermodynamics of formation of catecholamines. 
Our results show that, although the formation of different Al-catecholamines complexes show 
favourable complexation energies compared to catechol, due to the electron withdrawing (EW) effect 
of the positively charged amino group, the overall stability is not competitive with the formation of 
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other species in solution. Indeed, Al-catecholamine complexes can only barely compete, from a 
thermodynamic point of view, with the formation of [Al(OH)4
−] species in solution, in agreement with 
the available experimental data. Al-hydroxide is widely recognized as the most stable Al(III) 
hydrolitic species at physiological pH7,22. Moreover, in an open biological environment, the formation 
of Al-catecholamine complexes is not as stable as the formation of other metal-ligand complexes such 
as Al-citrate, Al-Defriprone and Al-EDTA. 
In summary, we rule out the possibility that the interaction of aluminum with these neurotransmitters 
in an open biological environment could explain the experimentally assessed toxic effects of Al(III) 
with neuronal processes involving catechol-based neurotransmitters. Other possibilities are examined 
and discussed in light of an up-to-date view of the catecholamines biosynthesis pathway. 
 
 
 
Fig. 7.1. Structures of the compounds considered in the present work: L-DOPA, dopamine, noradrenaline 
(norepinephrine), adrenaline (epinephrine), catechol, 4-nitro catechol, deferiprone (Ferriprox®), citric acid, 
ethylenediaminetetraacetic acid (EDTA). In red, atoms that form the aluminum coordination site. 
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7.2. Methodology 
 
7.2.1 Cluster-continuum approach 
In order to investigate the thermodynamics of these Al-catecholamine complexes, a cluster-
continuum approach is employed115,204,205. The first coordination shell of aluminum is surrounded by 
explicit water molecules in an octahedral fashion; the effect of the remaining solvent is treated using 
the self-consistent reaction field (SCRF) method with the polarized continuum model (PCM), using 
the integral equation formalism variant (IEFPCM)177. All geometrical optimizations were carried out 
in aqueous phase using the Gaussian 16 Rev.A03 suite of programs276, the B3LYP functional132,259 
and 6-31++G(d,p) basis set. Additionally, we added Grimme’s D3 dispersion correction153, along 
with the Becke-Johnson (BJ) damping function274, that was shown to further increase 
accuracy155,156,281. 
To confirm that the optimized structures were real minima on the potential energy surfaces, frequency 
calculations were carried out at the same level of theory. All structures showed positive force 
constants for all the normal modes of vibration. The frequencies were then used to evaluate the zero-
point vibrational energy (ZPVE) and the thermal ( T = 298 K) vibrational corrections to the enthalpies 
and Gibbs free energies within the harmonic oscillator approximation. To calculate the entropy, the 
different contributions to the partition function were evaluated using the standard statistical 
mechanics expressions in the canonical ensemble and the harmonic oscillator and rigid rotor 
approximation. 
The electronic energies were refined by single-point energy calculations at the B3LYP-D3(BJ)/6- 
311++G(3df,2p) level of theory. Single point calculations with other dispersion corrected DFT 
functionals, as well as MP2, were also performed to validate the methodology, with similar results 
(Appendix C). 
 
7.2.2 Definition of binding affinities 
We characterized Al(III)-Lig complexes with 1:1, 1:2 and the 1:3 stoichiometry. The formation 
stability of these complexes was studied following the ligand substitution reaction shown in (eq. 7.1): 
 
 Al(H2O)6](aq.,1M)
3+ + Lr(aq.1M)
−q
⇄ Al(H2O)6−mLr](aq,1M)
3−q
+ mH2O(aq,1M)     (7.1) 
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where q is the net charge of the ligand L, 𝑟 is the number of ligands and m depends on the 
stoichiometry of the complex, such as m=2, m=4 and m=6 for 1:1, 1:2 and 1:3 complexes, 
respectively. Notice that we consider the ligand’s coordinating groups in their unprotonated form, 
which is the state considered when evaluating experimental logβ. 
The enthalpy in solution corresponding to the binding of the ligand to Al(III) is therefore calculated 
as: 
 
 Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝 = 𝐻𝑎𝑞𝐴𝑙(𝐻2𝑂)6−𝑚𝐿𝑟 + 𝑚𝐻𝑎𝑞(𝐻2𝑂) − 𝐻𝑎𝑞[𝐴𝑙(𝐻2𝑂)6] − 𝐻𝑎𝑞(𝐿)𝑟
+ Δ𝑛𝑅𝑇𝑙𝑛(24.46) 
    
(7.2) 
 
Since the enthalpies are determined using an ideal gas at 1 atm as the standard state, the last term in 
eq. (7.2) corresponds to the volume change due to the transformation from 1 atm to 1 M in solution, 
where Δ𝑛 refers to the change in the number of species in the reaction207. In a similar way, the free 
energy of the complexes is determined as: 
 
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝 = 𝐺𝑎𝑞𝐴𝑙(𝐻2𝑂)6−𝑚𝐿𝑟 + 𝑚𝐺𝑎𝑞(𝐻2𝑂) − 𝐺𝑎𝑞[𝐴𝑙(𝐻2𝑂)6] − 𝐺𝑎𝑞(𝐿)𝑟
+ Δ𝑛𝑅𝑇𝑙𝑛(24.46) + 𝑚𝑅𝑇𝑙𝑛(55.34) 
    
(7.3) 
 
where the last term is the entropic factor that accounts for the concentration of 55.34 M of water in 
liquid water207. 
In order to take into account the influence of the protonation constants at the coordination site, we 
also define a free energy at physiological pH values that takes into account the energy penalty 
associated to the deprotonation of the two phenoxide groups of these catechol-based ligands at 
physiological pH (7.4), defined as: 
 
 Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠 = Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝 + Δ𝐺𝑎𝑞
𝑑𝑒𝑝𝑟𝑜𝑡
     (7.4) 
 
The last term in Eq. 4 corresponds to the free energy of deprotonation of a given ligand at 
physiological pH (7.4). This is calculated according to the experimental values for the titratable 
groups (phenolate) of the ligands. 𝑝𝐾𝑎 values for catechol and 4-nitro catechol were taken from ref.
94; 
for L-DOPA, dopamine, noradrenaline and adrenaline were taken from ref.196. 
 
 Δ𝐺𝑑𝑒𝑝𝑟𝑜𝑡 = 2.303𝑅𝑇 ∑(
𝑖
𝑝𝐾𝑎
𝑖 − 𝑝𝐻)     (7.5) 
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where 𝑝𝐾𝑎
𝑖  is the experimental pKa and pH is taken as 7.4. 
 
7.2.3 Al-ligand formation energies 
A strategy to take into account the aluminum ion/proton competition for the ligand’s binding site is 
presented. Formation energies for aluminum-ligand complexes of different stoichiometries were 
considered according to the general equilibria: 
 
 Al(H2O)6
3+ + LnH
0 → AlL(H2O)6−m
+ + nH3O
+ + (m − n)H2O     (7.6) 
 
Where 𝑛 is the number of protons in the coordination site of a given ligand at physiological pH; 𝑚 
depends on the stoichiometry and the binding mode (bidentate, tridentate, hexadentate) of the ligand 
considered (Table 7.2). 
As pointed out by Jensen30, the calculation of binding energies in solution is a challenging task from 
a computational point of view. This is mainly due to the inaccurate prediction of solvation energies 
of small charged ions with continuum solvation models such as IEFPCM. In order to alleviate this 
problem, the Gibbs free energies of the hydronium and hydroxide ions were calculated as: 
 
 𝐺𝑎𝑞(𝐻3𝑂)
+ = 𝐺𝑔𝑎𝑠(𝐻3𝑂)
+ + Δ𝐺𝑠𝑜𝑙𝑣(𝐻3𝑂)
+     (7.7) 
 
 𝐺𝑎𝑞(𝑂𝐻)
− = 𝐺𝑔𝑎𝑠(𝑂𝐻)
− + Δ𝐺𝑠𝑜𝑙𝑣(𝑂𝐻)
−     (7.8) 
 
Where 𝐺𝑔𝑎𝑠 is calculated at the DFT level; Δ𝐺𝑠𝑜𝑙𝑣 are the experimental solvation energies of the 
hydronium and hydroxide ions (-103.45 and -106.40 kcal/mol, respectively) taken from ref.282. 
Moreover, a correction term in the free energies is introduced to account for the pH as: 
 
 𝐺𝑝𝐻 = 𝑚(−𝑝𝐻)𝑅𝑇𝐿𝑛(10)     (7.9) 
 
where physiological pH is 7.4 and 𝑚 is the number of hydroniums. 
In the case of the calculation of the formation free energy of [Al(OH)4
−] hydrolytic species a similar 
correction term was introduced to account for pOH: 
 
 𝐺𝑝𝑂𝐻 = 𝑚(−𝑝𝑂𝐻)𝑅𝑇𝐿𝑛(10)     (7.10) 
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7.2.4 pAl calculation 
Experimental pAl values of L-DOPA, dopamine, noradrenaline and adrenaline were calculated by 
means of the Hyperquad simulation and speciation (HySS) program283 using speciation data from 
ref.196. 
 
7.2.5 QTAIM and Delocalization Indices (D.I.) 
The Quantum Theory of Atoms in Molecules (QTAIM)208 was used to perform a topological analysis 
of the electron density, providing the critical points of the electron density and the atomic boundaries 
that define the atomic partition of the molecular space. The so-called bond critical points (BCP) are 
saddle points of the electron density that usually occur between two bonded atoms and provide 
important information about the nature of the bonding. Closed-shell interactions (such as van der 
Waals, ionic and hydrogen bonds) and metal-metal interactions are characterized by small values of 
the density, charge depletion and positive energy densities (i.e., small 𝜌(𝑟𝐵𝐶𝑃), ∇
2𝜌(𝑟𝐵𝐶𝑃) > 0 and 
𝐻(𝑟𝐵𝐶𝑃) > 0). Conversely, covalent interactions are characterized by large electron density values, 
charge concentration and negative energy densities (i.e., large 𝜌(𝑟𝐵𝐶𝑃), ∇
2𝜌(𝑟𝐵𝐶𝑃) < 0 and 
𝐻(𝑟𝐵𝐶𝑃) < 0)
208,214,216. However, it has been pointed out that for some interactions which may be 
classified as covalent bonds, the Laplacian is positive and the total energy density at the BCP 
(𝐻(𝑟𝐵𝐶𝑃)) is negative. Such a situation is often observed for strong AH⋯B hydrogen bonds classified 
as partly covalent in nature (𝐻(𝑟𝐵𝐶𝑃) < 0)
284. 
Delocalization Indices (D.I.) are a measure of the covariance between the population of two atoms A 
and B and, consequently, a measure of the number of electrons simultaneously fluctuating between 
these atoms248,249, 
 
 
𝛿(𝐴, 𝐵) = ∫ ∫ 𝑑
𝐵𝐴
1𝑑2𝜌𝑥𝑐(1,2) = 𝑐𝑜𝑣(𝑁𝐴, 𝑁𝐵) 
    
(7.11) 
 
where 𝜌𝑥𝑐(1,2) is the exchange-correlation density
277. It can be taken as the number of electron pairs 
shared between atoms 𝐴 and 𝐵, i.e., the bond order278. 
The AIMAll v11.08.23 program250 was used to carry out the QTAIM analysis on the previously 
optimized structures at the B3LYP-D3(BJ)/6-311++G(3df,2p) level of theory. 
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7.2.6 Energy Decomposition Analysis (EDA) 
The energy decomposition analysis (EDA) is a state-of-the-art tool for a quantitative interpretation of 
chemical bonds285. The EDA scheme based on the theory developed by Ziegler and Rauk210 and by 
Morokuma209 was carried out using the ADF2017 suite of programs. In order to perform the EDA 
analysis, all 1:1 Al-ligand complexes previously optimized at the B3LYP-D3(BJ)/6-31++G(d,p) 
IEFPCM level with Gaussian16 were split in two fragments: the aluminum ion surrounded by four 
water molecules and the unprotonated ligand. Single-point energies for the EDA analysis were 
calculated using the B3LYP-D3(BJ) functional and the very robust full electron even-tempered 
quadruple-𝜁 basis set176,286 (ET-QZ3P-1DIFFUSE) provided by ADF2017287-289. All EDA 
calculations were performed in gas phase. 
The EDA decomposes the instantaneous interaction energy Δ𝐸𝑖𝑛𝑡 between two fragments A and B in 
a molecule AB into three well defined terms that can be interpreted in chemical meaningful ways: 
 
 Δ𝐸𝑖𝑛𝑡= Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 + Δ𝐸𝑃𝑎𝑢𝑙𝑖 + Δ𝐸𝑜𝑖     (7.12) 
 
These terms are (1) the quasi-classical electrostatic interaction energy between the charge densities 
of the fragments, Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 (2) the exchange/repulsion between the fragments due to Pauli’s principle, 
Δ𝐸𝑃𝑎𝑢𝑙𝑖, and (3) the energy gain due to orbital mixing of the fragments, Δ𝐸𝑜𝑖. 
Considering that EDA calculations are usually carried out in the framework of density functional 
theory, if an explicit correction term for dispersion interaction is employed (such as Grimme’s D3 
method), then EDA numerical results remain unchanged but the dispersion correction appears as an 
extra term: 
 
 Δ𝐸𝑖𝑛𝑡= Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 + Δ𝐸𝑃𝑎𝑢𝑙𝑖 + Δ𝐸𝑜𝑖 + Δ𝐸𝑑𝑖𝑠𝑝     (7.13) 
 
7.3 Results and discussion 
 
7.3.1 Binding affinities of 1:1, 1:2 and 1:3 Al-catecholamines with respect to reference catechol 
In Fig. 7.2, we depict the structures characterized in the present work for 1:1, 1:2 and 1:3 aluminum-
catecholamines complexes along with our previously determined structures for catechol and 4-nitro 
catechol ligands21. Very similar structures are obtained with respect to catechol, indicating that the 
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different amine substituents have a little effect on the coordination mode of aluminum to the catechol 
moiety. 
In Table 7.1, we can find the binding energies of catecholamines compared to catechol and 4-nitro 
catechol chosen as reference structures of our previous work21. Two states have been considered for 
the amino group: protonated and unprotonated. Although the estimation of Kiss et al.196 is that at 
physiological pH these amines will be protonated, we have decided to consider both possibilities in 
order to gain more insights into the thermodynamics of binding energies and the role played by the 
positively charged amino group. It is worth to emphasize that the theoretical methodology employed 
in this work has been recently thoroughly validated for a wide dataset of catechols and salicylates 
using different density functionals, the MP2 method and experimental data21. In Fig. 7.3, we compare 
the binding free energies, Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
, of the catecholamines along with the previously obtained values 
for catechol and 4-nitro catechol with respect to experimental stability constants (logβ) finding a 
remarkable good correlation coefficient of 0.9909, which confirms the validity of our approach. It is 
important to mention, at this stage, that experimental logβ values were taken from two different 
sources: those of catecholamines from an old paper by Kiss et al.196 and those of catechol and 4-nitro 
catechol from a more recent paper by Nurchi et al.94. Binding energies with different functionals 
(M06-2X290 and 𝜔B97X-D275) as well as the MP2 method291,292 can be found in Appendix C giving 
very similar correlation coefficients when compared with experimental stability constants. 
We first discuss results for N-protonated catecholamines, as this is the most likely situation at 
physiological pH. In general, catecholamines show lower Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 (in absolute values) than catechol, 
in agreement with the lower experimental stability constants (Table 7.1). However, these binding 
affinities are higher than the one of 4-nitro catechol; this compound was chosen as reference system 
to evaluate the electron withdrawing (EW) effect of substituents in the catechol ring. Accordingly, 
the introduction of a positively charged amino tail in catecholamines has an EW effect, which is 
smaller than the one provoked by the 4-nitro substituent. This can be explained considering that, as 
assessed in our previous work21, the strong EW effect of the NO2 group added to a catecholate ring 
is mediated through both resonance and inductive mechanisms of action. On the other hand, the EW 
effect of the protonated amino group of catecholamines is mediated only by the electron attracting 
behavior of the positive charge. Among catecholamines, L-DOPA and dopamine show, in general, 
higher Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 than adrenaline and noradrenaline. In this sense, we should bear in mind that 
protonated L-DOPA has a higher total negative charge (-2) than the rest of catecholamines (-1) due 
to the presence of the carboxylate group (Fig. 7.1); therefore, its interaction with the trivalent  
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Fig.7.2. Optimized geometries in aqueous solution of 1:1, 1:2 and 1:3 complexes of aluminum with L-DOPA, 
dopamine, noradrenaline (norepinephrine), adrenaline (epinephrine), catechol and 4-nitro catechol. 
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  Theoretical Experimental(a) 
  ΔHaq
comp
 ΔGaq
comp
 ΔGaq
Phys
 ΔHaq
comp
 ΔGaq
comp
 ΔGaq
Phys
 logβ logβCond. pAl 
Ligands  Protonated Amine Unprotonated Amine    
L-DOPA 
1:1 -88.3 -92.8 -82.7 -91.8 -95.2 -81.9 16.0 8.1 
10.8 1:2 -160.0 -166.6 -146.4 -160.3 -165.6 -138.8 29.2 13.3 
1:3 -182.8 -193.5 -163.3 -187.7 -195.7 -155.5 38.4 14.5 
Dopamine 
1:1 -85.7 -88.6 -78.8 -89.5 -92.8 -78.9 15.6 8.0 
10.8 1:2 -148.4 -154.7 -135.1 -153.6 -161.6 -133.8 28.6 13.4 
1:3 -181.8 -190.0 -160.6 -186.2 -195.2 -153.5 37.6 14.7 
Noradrenaline 
1:1 -83.1 -87.2 -77.8 -88.3 -91.8 -79.8 15.6 8.3 
11.4 1:2 -143.0 -150.7 -131.8 -148.5 -157.0 -133.0 28.6 14.0 
1:3 -177.5 -186.1 -157.7 -179.2 -189.8 -153.8 37.9 16.0 
Epinephrine 
1:1 -83.0 -87.2 -78.1 -88.2 -91.5 -78.7 15.6 8.2 
11.3 1:2 -143.0 -150.7 -132.5 -146.4 -154.6 -129.3 28.6 13.9 
1:3 -176.4 -187.2 -159.2 -178.4 -186.3 -148.0 37.9 15.8 
Catechol 
1:1 -88.4 -91.4 -79.6 -   16.3 8.2 
10.1 1:2 -151.8 -157.7 -134.1 -   31.7 13.2 
1:3 -183.1 -191.7 -156.6 -   41.1 13.5 
4-nitro 
Catechol 
1:1 -71.6 -75.8 -71.2 -   13.3  
14.2 1:2 -124.0 -130.8 -121.7 -   24.8  
1:3 -183.1 -164.6 -150.8 -   33.7  
 
Table 7.1. DFT binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
), binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) and physiological binding energies 
(Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
) with available experimental stability constant (logβ, logβCond) and pAl data for the whole dataset of 
catechol-based ligands. Notice that cumulative stability constants (logβ ) are comparable with Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
, while 
conditional stability constants (logβCond) are comparable with Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
, since the last two quantities take into 
account the influence of protonation constants. (a)Experimental pKa and parameters values for L-DOPA, 
dopamine, noradrenaline and adrenaline are taken and calculated (pAl) using data from ref.196; for catechol 
and 4-nitro catechol are taken from ref.94. All energies in kcal/mol are calculated at the B3LYP-D3(BJ)/6-
311++G(3df,2p) - IEFPCM level of theory. 
 
aluminum ion is expected to be stronger. Besides, the higher Al(III) affinity of dopamine compared 
to noradrenaline and adrenaline can be explained considering that the latter two compounds contain  
a hydroxyl group in the alkyl chain, which has an EW effect. These aspects will be discussed in detail 
in the next section through chemical bond analysis. 
In order to check the effect of the positive charge of the amine towards binding affinities, we re-
evaluated Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 values considering the unprotonated amino groups. In all cases, there is an increase 
of absolute Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 values (Table 7.1), which is due to the higher total negative charge of N-
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unprotonated catecholamines. Interestingly, now L-DOPA and dopamine show larger binding 
energies than catechol. Again, L-DOPA bears a higher total negative charge (-3) than catechol (-2) 
and the other catecholamines (-2), that explains its stronger aluminum affinity. However, in the case 
of dopamine, the presence of the alkyl tail acts as an electron donating group (ED) by induction, 
although such an effect is weakened by the presence of the EW effect (by induction) of NH2. 
Moreover, when a second EW group is added to the alkyl chain, namely, −OH in noradrenaline and 
adrenaline, the overall EW effect prevails over the ED one, lowering the binding ability of these two 
catecholamines with respect to catechol (Table 7.1). 
In summary, the positive charge at the amino group plays a major role in the modulation of the binding 
affinities in these aluminum-ligand complexes, although the presence of other substituents also 
influence the overall stability. 
In order to confirm these speculations and to get a more physically sound picture of the substituent 
effects, as well as to investigate the bonding nature of these complexes, we decided to perform a 
detailed chemical bond analysis based on both QTAIM and EDA analysis which is presented in the 
next section. 
 
 
 
Fig. 7.3. B3LYP-D3(BJ) binding energies (ΔGaq
comp
) versus experimental stability constants (logβ)94,196. A 
correlation coefficient of 0.9909 is obtained. All amino groups are considered in their protonated state. 
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7.3.2 Analysis of Al-O bonds 
The Bader’s Quantum Theory of Atoms in Molecules (QTAIM, Appendix C) allows us to get more 
insight into the physico-chemical properties of these Al-ligand interactions. For simplicity, we will 
focus our discussion on 1:1 complexes, considering both N-protonated and N-unprotonated 
catecholamines. Similarly as reported in our previous work on the interaction of aluminum with 
substituted catechols and salicylic acids21, we find positive values of the Laplacian of the electron 
density, ∇2𝜌(𝑟𝐵𝐶𝑃), and small but negative values of the energy density, 𝐻(𝑟𝐵𝐶𝑃), consistently for all 
Al-O bond critical points. According to the Bader’s criteria, positive values of ∇2𝜌(𝑟𝐵𝐶𝑃) and 
𝐻(𝑟𝐵𝐶𝑃) are indicative of closed-shell interactions (i.e. ionic or electrostatic bonds), while negative 
values for both quantities indicate the presence of shared (covalent) interactions. The mixed situation 
present in our results, previously reported for bonds involving metals214, suggests that, although Al-
O bonds are mainly of ionic nature, they also contain a small degree of covalency, due to their dative 
nature. To provide a more accurate analysis of these aluminum-ligand interactions, Al-O 
delocalization indices (D. I.Al−O) were also calculated. Delocalization indices are a measure of the 
average number of electron pairs shared between two atoms, therefore they have been related to the 
measure of the covalent character of a given bond278. 
As previously hypothesized, the results seem to confirm the electron withdrawing effect mediated by 
the positively charged amino group (Appendix C) that decreases the electron density from the two 
Al-O bonds; a more detailed albeit speculative analysis of the D. I.Al−O values is presented and 
thorougly discussed in Appendix C. 
In summary, the Bader’s analysis confirmed the hybrid nature of the Al-O interactions, and has been 
proven to be a powerful tool to rationalize the effects that the different chemical environments of 
these catechol-based compounds have on their binding affinity trend. 
The EDA approach was also used to characterize the degree of the ionic/covalent character of the Al-
O bonds (Appendix C) by splitting the total interaction energy (Δ𝐸𝐼𝑛𝑡) into the electrostatic (Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡), 
orbital interaction (Δ𝐸𝑜𝑖) and Pauli repulsion (Δ𝐸𝑃𝑎𝑢𝑙𝑖) terms. EDA results confirm the previous 
QTAIM analysis, pointing to a mainly ionic bond with a smaller but significant covalent character. 
As expected, there are pronounced differences in the electrostatic contributions to the bond depending 
on the total charge of the ligand. In this sense, unprotonated catecholamines show higher Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 
values than protonated ones (Appendix C). Moreover, N-protonated L-DOPA, catechol and 4-nitro 
catechol show larger electrostatic energies than protonated dopamine, noradrenaline and adrenaline, 
in agreement with their higher negative charge. One has to take into account that a lower Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 
will be compensated with a lower de-solvation energy when forming the complex, and therefore the 
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big differences in Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 and Δ𝐸𝑖𝑛𝑡 shown in Table S5 of Appendix C are not reflected in the actual 
Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 trend (Table 7.1), due to the lack of solvation effects in EDA analysis. Also, this puts a word 
of caution in the use of EDA with no-solvation effects when comparing ligands of different total 
charge. 
In general, protonated catecholamines show lower orbital interaction energies (Δ𝐸𝑜𝑖) than the 
protonated counterparts, in agreement with the previous Delocalization Indices analysis (Appendix 
C), indicating a lower covalent contribution. However, among different compounds a clear trend in 
orbital and interaction energies with respect to binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) could not be established. 
Therefore, we remark again that EDA results should be taken only with caution, since no solvation is 
introduced in this energy decomposition scheme; we already reported the paramount importance of 
considering solvation effects when dealing with charged complexes in solution24. 
 
7.3.3 Aluminum ion/proton competition for ligand binding 
Unlike logβ, conditional (apparent) stability constants (logβCond) are weighted by taking into account 
the influence of the protonation constants of a given ligand78. That is, their calculation considers the 
ligand in all of its possible forms in solution78; accordingly, logβCond takes into account the 
proton/aluminum ion competition for ligand’s coordination site. This is due to the fact that both 
Al(III) and H+are hard Lewis acids and, therefore, compete for the binding of hard Lewis bases, 
coherently with the Pearson’s Hard and Soft Acids and Bases (HSAB) principle17. 
A comparison between the experimental values of logβ and logβCond points to a change in chelation 
performance between catechol and catecholamines (Table 7.1). Thus, whereas in general higher 
values of logβ are found for catechol with respect to catecholamines, the opposite is true when 
considering conditional stability constants, indicating that when proton competition is taken into 
account catecholamines are better aluminum chelators than catechol. The reason relies on the lower 
pKa values of the two hydroxyl groups of the catechol ring of catecholamines
196 compared with those 
of catechol94. In Table 7.1, we report the values of physiological binding energies (Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
), 
calculated by taking into account the energetic penalty that Al(III) has to pay in order to deprotonate 
the ligands, based on their experimental pKa values (see Methodology section). In agreement with the 
experimental logβCond data, we also observe a change in the trend between Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
 and Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
, with 
catecholamines showing slightly higher Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
values than catechol but smaller Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
(Table 7.1). 
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The estimation of Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
 is a first approach to understand the chelation performance towards Al(III). 
However, the fact that both theoretical and experimental information are combined in the evaluation 
of Δ𝐺𝑎𝑞
𝑃ℎ𝑦𝑠
partially jeopardize the usefulness of this approach; both contributions to the final binding 
  
Ligands Reaction equilibria Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑃ℎ𝑦𝑠
 ΔΔ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑃ℎ𝑦𝑠
 pAl 
Hydroxide Al(H2O)6
3+ + 4OH− → Al(OH)4
− + 6H2O -59.0 0.0 12.1
(a) 
L-DOPA 
Al(H2O)6
3+ + L2H
0 → AlL(H2O)4
+ + 2H3O
+ -40.1 18.9 
10.8(b) Al(H2O)6
3+ + 2L2H
0 → AlL2(H2O)2
− + 4H3O
+ -61.1 -2.1 
Al(H2O)6
3+ + 3L2H
0 → AlL3
3− + 6H3O
+ -31.9 27.1 
Dopamine 
Al(H2O)6
3+ + L2H
+ → AlL(H2O)4
2+ + 2H3O
+ -39.0 20.0 
10.8(b) Al(H2O)6
3+ + 2L2H
+ → AlL2(H2O)2
+ + 4H3O
+ -55.5 3.4 
Al(H2O)6
3+ + 3L2H→
+ → AlL3
0 + 6H3O
+ -41.3 17.7 
Adrenaline 
Al(H2O)6
3+ + L2H
+ → AlL(H2O)4
2+ + 2H3O
+ -41.3 17.7 
11.3(b) Al(H2O)6
3+ + 2L2H
+ → AlL2(H2O)2
+ + 4H3O
+ -59.0 0.0 
Al(H2O)6
3+ + 3L2H
+ → AlL3
0 + 6H3O
+ -48.5 10.5 
Noradrenaline 
Al(H2O)6
3+ + L2H
+ → AlL(H2O)4
2+ + 2H3O
+ -42.1 16.9 
11.4(b) Al(H2O)6
3+ + 2L2H
+ → AlL2(H2O)2
+ + 4H3O
+ -60.6 -1.6 
Al(H2O)6
3+ + 3L2H
+ → AlL3
0 + 6H3O
+ -52.1 6.9 
Catechol 
Al(H2O)6
3+ + L2H
0 → AlL(H2O)4
+ + 2H3O
+ -39.6 19.4 
10.1(c) Al(H2O)6
3+ + 2L2H
0 → AlL2(H2O)2
− + 4H3O
+ -54.0 5.0 
Al(H2O)6
3+ + 3L2H
0 → AlL3
3− + 6H3O
+ -36.2 22.8 
4-nitro 
Catechol 
Al(H2O)6
3+ + L2H
0 → AlL(H2O)4
+ + 2H3O
+ -45.2 13.8 
14.2(c) Al(H2O)6
3+ + 2L2H
0 → AlL2(H2O)2
− + 4H3O
+ -70.4 -11.4 
Al(H2O)6
3+ + 3L2H
0 → AlL3
3− + 6H3O
+ -74.6 -15.6 
Deferiprone 
Al(H2O)6
3+ + LH → 
AlL(H2O)4
2+ + H2O + H3O
+ 
-43.4 15.6 
15.4(d) Al(H2O)6
3+ + 2LH → 
AlL2(H2O)2
+ + 2H2O + 2H3O
+ 
-71.2 -12.2 
Al(H2O)6
3+ + 3LH → AlL3
0 + 3H2O + 3H3O
+ -84.0 -25.0 
Citrate 
Al(H2O)6
3+ + LH
3− → 
AlL(H2O)4
− + 2H2O + H3O
+ 
-80.0 -21.0 
14.4(a) 
Al(H2O)6
3+ + 2LH
3− → 
AlL(H2O)4
5− + 3H2O + 3H3O
+ 
-91.8 -32.8 
EDTA Al(H2O)6
3+ + LH
3− → AlL + 5H2O + H3O
+ -121.9 -62.9 16.4(a) 
 
Table 7.2. DFT and experimental (pAl) proton/aluminum ion competition for ligand binding, compared to 
hydroxide formation used as reference. Ligands are considered in their physiological protonation state. (a) Data 
taken from ref.7. (b) Calculated with the HySS program using data from ref.196. (c) Data taken from ref.94. (d) 
Calculated with the HySS program using data from ref.111. All energies in kcal/mol are obtained at the B3LYP-
D3(BJ)/6-311++(3df,2p)-IEFPCM level of theory. 
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energy are not evaluated at the same level and the procedure depends on the availability of 
experimental pKa values for the ligands. In order to overcome these limitations, we decided to 
calculate binding energies of Al-ligand complexes departing from protonated ligands. In this way, 
the proton/aluminum ion competition for ligand binding is intrinsically considered in the definition 
of the corresponding reaction equilibria (see Methodology section). We will refer to these free 
energies as Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑃ℎ𝑦𝑠
, where the subscript 𝐿𝑛𝐻 stands for the protonation state of a given ligand L at 
physiological pH. Results can be found in Table 7.2; we have considered that both hydroxyl groups 
of the catechol moiety in all compounds are protonated and that the amino groups of catecholamines 
are also in their protonated state. We have observed that, irrespective of the stoichiometry and of the 
catecholamine, we obtain in all cases substantial negative Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑝ℎ𝑦𝑠
 values. This suggests that, in all 
cases, aluminum is able to displace the protons from the catechol moieties and form stable Al-ligand 
complexes. 
In summary, both experimental and theoretical results point to the importance of considering properly 
the effect of ligand’s deprotonation in order to evaluate the overall performance of a given ligand 
towards aluminum binding. In fact, the order in relative binding affinity can be altered when 
deprotonation energies of the ligands are taken into account. Nevertheless, the interaction between 
aluminum and catechol/catecholamines is strong enough to displace the protons from the ligand, 
leading to potentially stable complexes. 
 
7.3.4 Comparison between different ligands towards aluminum binding and aluminum 
hydroxide formation in solution 
In an open biological environment, in order to bind to a given ligand, the aluminum ion has to compete 
not only with protons, but also with other endogenous (and eventually exogenous) chelators. 
Moreover, the speciation of the Al(III) ion in solution is a complex task7; indeed, at physiological pH, 
there exist several Al(III)-hydroxide species, with [Al(OH)4 ]
− being the most stable one7. 
Accordingly, we also need to consider the possibility of the hydroxide binding competition, in order 
to evaluate the chelation performance of a given ligand. 
In this sense, the main shortcoming in the use of logβCond as a criterion to evaluate chelation properties 
is the fact that conditional stability constants depend on the stoichiometries of the corresponding 
metal-ligand complexes28,78. For this reason, stability constant values of ligands displaying diffferent 
denticities (e.g. bidentate, tridentate, hexadentate etc.) cannot be directly compared because of 
different entropic contributions of their chelate effect28. 
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In order to overcome such limitations, the pM parameter has been introduced as a general criterion to 
compare the chelation performance between different ligands109. This is defined as −log[MF] usually 
taken at [MT] = 1 × 10
−6 M and [LT] = 1 × 10
−5 M at pH 7.4, where [MF] is the concentration of 
free metal in solution (in this case aluminum), and [MT] and [LT] are the total concentration of the 
metal and the ligand, respectively78. Such experimental parameter is very useful to asses the potential 
competitiveness of different ligands towards Al(III) in an open biological environment, and it will be 
used in this section for the discussion of the Al(III) binding efficiency of different ligands (see Table 
7.2 and Fig. 7.5). 
 
 
 
Fig. 7.4. Optimized geometries in aqueous solution of aluminum bound to different reference ligands: 
deferiprone (Ferriprox®), citrate and ethylenediaminetetraacetic acid (EDTA). Notice that deferiprone, citrate 
and EDTA are, respectively, bidentate, tridentate and hexadentate aluminum chelators. 
 
In Table 7.2, and Fig. 7.5, we compare the formation energies of the catechol-based ligands with 
those of some reference compounds displaying different denticities, namely: citrate, the main 
biochelator of aluminum in blood serum36,39,280; deferiprone, one of the main drugs used in Al(III) 
chelation therapy6,28,86; EDTA, one of the most powerful Al(III) chelating agents112,114 (Fig. 7.1 and 
7.4). As in the previous section, all ligands are considered at their most likely protonation states at 
physiological pH (Table 7.2): citrate with hydroxyl group protonated and the three carboxylates 
unprotonated; deferiprone with the hydroxyl group protonated, and EDTA with one amine protonated 
The interaction of aluminum with catecholamine-based neurotransmitters: can the formation of these species 
be considered a potential risk factor for neurodegenerative diseases? 
 
\189 
 
and the four carboxylates unprotonated. In addition, relative formation energies (ΔΔ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑝ℎ𝑦𝑠
) for each 
ligand are calculated with respect to the formation energy of [Al(OH)4 ]
− hydrolytic species, which 
represents the competition of hydroxide for aluminum binding in solution (Table 7.2). We depict both 
theoretical and experimental pAl data in Fig. 7.5. Notice that the vertical line at pAl=12.1 indicates 
the threshold for an efficient competition with aluminum hydroxide formation; the same is true for 
the horizontal line at Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑝ℎ𝑦𝑠
= -59.0 kcal/mol, which marks the theoretical limit for a given ligand 
to be able to compete with hydroxide formation at physiological pH (Table 7.2). 
 
 
 
Fig. 7.5. Proton versus aluminum ion competition for different ligands at different stoichiometries. On the x-
axis, experimental pAl values. On the y-axis, DFT formation energies. Aluminum hydroxide [Al(OH)4]- 
formation is used as threshold for positive/negative Al-ligand competition. All Al-ligand reaction equilibria 
are presented in Table 7.2. 
 
Looking at Fig. 7.5 we see that, although all catecholamines and catechol compounds show negative 
formation energies, only 4-nitro catechol at 1:2 and 1:3 stoichiometries is able to outcompete in an 
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effective way hydroxide at physiological pH (Fig. 7.5). This is coherent with an experimental pAl 
value of 14.2 for 4-nitro catechol, similar to the 14.4 value of citrate. Likewise, citrate, deferiprone 
and EDTA lie in the top-right region of Fig. 7.5, the region where they can form more stable 
complexes than [Al(OH)4 ]
− according to both theoretical and experimental data. The Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑝ℎ𝑦𝑠
 
values of catechol, irrespective of the stoichiometry, are lower (in absolute values) than -59.0 
kcal/mol, the calculated formation free energy of [Al(OH)4 ]
− hydrolytic species (Table 7.2). This is 
in agreement with the lower pAl value of Al-catechol, 10.2, than those of Al-hydroxide, 12.1. 
Catecholamines lie in an intermediate situation between that of catechol and 4-nitro catechol, but both 
theoretical and experimental results restrain them in an area of low competitiveness with respect to 
hydroxide formation (Fig. 7.5). Indeed, only 1:2 Al-L-DOPA and Al-noradrenaline seem to be barely 
competitive with Al-hydroxide, showing Δ𝐺𝑎𝑞,𝐿𝑛𝐻
𝑃ℎ𝑦𝑠
 values of -61.1 and -60.6 kcal/mol, respectively 
(Table 7.2). Interestingly, among bidentate compounds, all Al-catecholamines complexes, as well as 
all Al-catechol ones (but not Al-4-nitrocatechol nor Al-deferiprone) show a preference towards the 
formation of the 1:2 metal-ligand complex (Fig. 7.5). This is in agreement with the speciation diagram 
for Al-adrenaline depicted by Kiss et al.196, where they found that the 1:2 Al-adrenaline complex is 
the prevalent one in the 5-8 pH range. 
The overall low competitive situation of all catecholamines is reflected by their pAl values around 
10-11, that we calculated using the speciation data of Kiss et al.196. They are close but lower than thE 
pAl value of Al-hydroxide, 12.1 (Table 7.2), although Martin7 has reported a generic and single pAl 
value for all catecholamines of 12.8, which seems to be only barely competitive compared with Al-
hydroxide formation. 
In summary, despite catecholamines display in principle favorable proton/aluminum ion competition 
with an enhanced affinity with respect to catechol, this is not sufficient to transform them into 
potential strong aluminum binders in aqueous solution at physiological pH; they can only barely 
compete with aluminum-hydroxide formation. Moreover, as demonstrated by our calculations and by 
the available experimental data, other well known aluminum chelators such as citrate, deferiprone 
and EDTA, are much more prompt to bind to Al(III) than catecholamines in an open biological 
environment. Accordingly, we can classify these neurotransmitters as overall poor aluminum binders; 
the impact of these findings in light of the catecholamine biosynthesis pathway will be discussed in 
the next section. 
 
7.4 Biological implications of the results 
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The catechol moiety is the building block of catecholamines, a class of neurotransmitters and 
hormones of fundamental importance for the correct homeostasis and function of both the central 
(CNS) and peripheral (PNS) nervous systems, where they exert a wide range of tasks293-295. Within 
the CNS, these neurotransmitters, are involved in many cognitive, motor, emotional, neuronal 
plasticity and memory-related functions. In the PNS, as hormones they find their way in the correct 
behavior of both the sympathetic and parasympathetic systems, where they play an important role in 
the fight-or-flight response and, in general, in the body’s response to stress296. L-DOPA, dopamine, 
noradrenaline (norepinephrine) and adrenaline (epinephrine) are synthesized from the amino acid L-
tyrosine (Fig. 7.6); the resulting catecholamines biosynthesis pathway involves several enzymes, 
substrates, cofactors, metal ions and regulatory mechanisms that are highly intertwined with other 
metabolic pathways, leading to a complex and finely controlled network294. Hence, the perturbation, 
interference or impairment of such an intricate network is associated to the development of severe 
clinical phenotypes and neurometabolic disorders294. 
 
 
 
Fig. 7.6. Schematic representation of the catecholamine biosynthesis pathway with sites of aluminum 
interference according to the literature. Cofactors involved in each specific enzymatic reaction are highlighted 
in blue, while functional groups that are added/removed in red. THB=Tetrahydrobiopterin; P5P=Pyridoxal 
phosphate; SAM=S-Adenosyl methionine; vitamin C=ascorbic acid; Dβ H=Dopamine β -Hydroxylase. 
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As introduced in the beginning, Al(III) is believed to play a role in the insurgence of 
neurodegenerative diseases (in particular the Alzheimer’s Disease4) as well as in the impairment of 
several key neuronal processes5. Indeed, it has been shown that this exogenous metal affects the 
signaling process mediated by catecholamines198, it alters their content in animal models195, and 
interferes with enzymatic activities that involve these neurotransmitters64,76,297,298. Moreover, it has 
been demonstrated that the ingestion of aluminum affects catecholamine levels in different brain 
tissues299,300. 
Therefore, a relationship between the presence of aluminum in the brain and interferences with the 
metabolic routes involving catecholamines has been established. Does the interaction of aluminum 
with catecholamines, and the resulting metal-neurotransmitter complexes, play a direct and crucial 
role that could be considered a potential risk factor for neurodegenerative phenotypes? Our 
calculations clearly support the formation of stable complexes between aluminum and 
catecholamines, with favorable complexation energies even when proton displacement is taken into 
account. However, in solution the resultant complexes are only barely competitive with the formation 
of [Al(OH)4 ]
− hydrolytic species at physiological pH. Additionally, both theoretical and available 
experimental data point to a very low competitiveness of all Al-neurotransmitter complexes with 
respect to other endogenous biochelators such as citrate, or with respect to other ligands like 
deferiprone and EDTA. 
As a consequence, the direct interaction of a free aluminum in solution with catecholamines does not 
seem to be a likely factor that could interfere with these metabolic pathways. Based on our 
thermodynamic data, the formation of strong aluminum-catecholamine complexes must fulfill two 
conditions: i) a solvent-free environment that protects from hydroxide attack or prevents hydroxide 
formation, and ii) the absence of other efficient aluminum chelators. Some authors have already 
suggested that the formation of aluminum-catecholamine complexes requires a citrate-free 
environment7,196, although they did not discuss carefully the effect of hydroxide molecules. 
In light of these considerations, what is the experimentally assessed detrimental role of aluminum 
within the catecholamines route? 
To answer this question, in the rest of the section we will collect and discuss (to the best of our 
knowledge) the literature regarding Al(III) and catecholamines, and evaluate some other possible 
mechanisms of Al(III) interference that could be assessed in future. For that purpose, an up-to-date 
representation of the catecholamine biosynthesis pathway with sites of aluminum influence 
(according to the literature) is proposed in Fig. 7.6. 
There are three enzymes whose activity has been reported to be inhibited by the presence of 
aluminum: tyrosine hydroxylase (TH)297,298, dopamine 𝛽-hydroxylase (DBH)64,76 and catechol-O-
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methyltransferase (COMT)301,302. Tyrosine hydroxylase is responsible for the synthesis of L-DOPA 
using the amino acid L-tyrosine as substrate and Fe(II) and tetrahydrobiopterin (THB) as cofactors. 
Dopamine 𝛽-hydroxylase, an enzyme that contains Cu(II) metal ions in its active site, converts 
dopamine to noradrenaline using vitamin C as cofactor. Finally, catechol-O-methyltransferase is 
involved in the regulation (inactivation) of catecholamine levels by methylation of their hydroxyl 
groups, using Mg(II) and S-adenosil methionine (SAM) as cofactors (Fig. 7.6). 
Interestingly, all of these three enzymes make use of divalent metal ions (iron, copper and 
magnesium) in order to perform the redox reactions required by their active sites. Al(III) is well 
known for being a non-redox metal51,52,56, therefore can have a direct and strong influence on the 
reaction mechanisms catalyzed by these enzymes. Aluminum has been shown to be able to bind to 
Fe(III)-loaded transferrin46,47,181,303. Accordingly, aluminum might be able to displace the copper ion 
from the active site of DBH and, due to its different ionic radius, impair the activity of that enzyme 
from a conformational point of view. Alternatively, another possibility is that the non-redox behavior 
of Al(III) alters the reaction mechanism of DBH leading to its inactivation. 
Similarly, Al(III) might compete with Fe(II) and Mg(II) being utilized as cofactor by TH and COMT, 
respectively, thus affecting their normal behavior. 
Quite interestingly, Al(III) inhibits O-methylation (COMT) but no N-methylation (phenylalanine N-
methyltransferase, PNMT) of catecholamines301,302. PNMT is the enzyme in charge of the synthesis 
of adrenaline through N-methylation of noradrenaline (Fig. 7.6). These findings were interpreted in 
terms of the formation of strong and stable Al-catecholamine complexes, in which the methylation at 
the oxygen atoms of the catecholate would be affected by the binding of the metal, whereas the 
methylation at the terminal amino group of noradrenaline would be unaffected since this group is not 
directly bound to aluminum301,302. In line with this interpretation, authors showed that the use of a 
potent chelating agent such as deferoxamine (DFO) is able to reverse the Al(III)-induced inhibition 
of COMT302, in agreement with the much higher Al(III) affinity of EDTA and deferiprone 
characterized in this work. They also reported that an excess of DFO inhibits again COMT, because 
of the removal of magnesium ions that are required as cofactors302. 
Our results would further support this hypothesis, since in COMT, contrary to PNMT, there is a well-
defined Mg(II) binding site that can protect aluminum from hydroxide formation, due to the lack of 
solvent molecules. Therefore, such an environment could favor the formation of a strong aluminum-
catecholamine complex that, ultimately, impair the normal functioning of COMT. In this sense, 
Sparta and Alexandrova investigated the effects of various divalent and trivalent metal ions towards 
the enzymatic activity of COMT by means of QM/MM simulations304. They found that trivalent metal 
ions such as Fe(III) impair the reaction mechanism by increasing the activation energy needed for the 
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methyl transfer reaction; this is due to the higher electrophilic nature of Fe(III) that reduces the 
basicity of the oxygen donors of the catechol-based substrate, rather than to an iron-induced 
conformational change of the enzyme304. Aluminum could certainly play a similar role since it also 
shows a strong electrophilic nature according to its high charge and small size. 
Regarding the non-inhibition of PNMT, it is important to note that while COMT requires metal ions 
as cofactors, PNMT does not rely on metal ions305. The unfavorable competition of Al-adrenaline 
complexes with respect to Al-hydroxide formation in absence of a protective metal ion binding site 
might explain its non-sensitivity to the presence of Al(III) reported in literature302. 
The catecholamine pathway contains two main enzymatic regulators that ensure the correct 
homeostasis of the levels of these neurotransmitters: one is the previously discussed catechol-O-
methyltransferase, and the second one is monoamine oxydase (MAO, Fig. 7.6). MAO enzymes 
catalyze the oxidative deamination of biological monoamines using flavin adenine dinucleotide 
(FAD) as cofactors, thus leading to their inactivation. Different mechanisms of action (at least four) 
have been proposed for MAO catalytic activity, although the exact one is still not well understood306. 
Interestingly, while Al(III) inhibits COMT, some authors reported, by means of kinetic studies in rat 
brain, that this metal is instead able to increase the activity of MAO, in particular the B isotype307,308. 
Hyperactivation of monoamine oxidase enzymatic activity is one of the hallmarks of both 
Alzheimer’s309 and Parkinson’s310 diseases. However, it is hard to hypothesize what could be the role 
of aluminum in the overactivation of MAO, considering the lack of a clear reaction mechanism. 
So far we have discussed the role that aluminum might have with respect to the enzymatic machineries 
acting on the catecholamines pathway. However, there are many low-molecular-mass organic 
cofactors that are pivotal for the correct behavior of these enzymes and therefore could be important 
targets of this metal (Fig. 7.6). 
In this sense, there is evidence that aluminum affects the metabolism of tetrahydrobiopterin 
(THB84,311,312). THB is an essential cofactor employed by many enzymes, including tyrosine 
hydroxylase. Impaired THB metabolism by aluminum has been related in particular with dialysis 
dementia84. One hypothesis that has been made, is that Al(III) might interfere with the activity of 
dihydrobiopterin reductase312, an enzyme that employs the nicotinamide adenine dinucleotide 
phosphate (NADPH) cofactor to catalyze the production of tetrahydrobiopterin from 
dihydrobiopterin. However, such a hypothesis was not further investigated. Quite interestingly, 
computational studies proved the ability of Al(III) to alter the conformation of NADH42, a cofactor 
closely related to NADPH. Although still unclear, Al(III) interference with THB metabolism might 
be another possibility to explain the metal-induced inhibition of TH. 
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Vitamin C, also known as ascorbic acid, is an essential vitamin required as cofactor by DBH for the 
conversion of dopamine into noradrenaline (Fig. 7.6). Perturbation of Vitamin C metabolism in the 
brain has been related to the occurrence of severe neurodegenerative diseases313. Moreover, several 
studies highlight the chelation properties of vitamin C and its interaction with aluminum has been 
investigated314-317. In this sense, the structure and binding mode of the Al-ascorbate complexes in 
solution have been unveiled and clarified by means of both experimental and DFT computations317. 
Therefore, vitamin C might be a potential Al(III) target, and the resulting complex might be involved 
in the impairment of DHB activity (Fig. 7.6). 
 
7.5 Conclusions 
 
We have investigated the possibility of the formation of complexes between aluminum and an 
important class of catecholamine-based neurotransmitters: L-DOPA, dopamine, noradrenaline 
(norephinephrine) and adrenaline (ephinephrine). Chemical bond analyses confirmed the main ionic 
nature of the Al-O interaction, but a singnificant degree of covalent character. Then, we have 
determined that aluminum can clearly displace the protons of the hydroxyl groups of the catechol 
moiety forming stable aluminum-catecholamine complexes. However, in solution the estimated 
binding affinities are lower than the formation energies of aluminum-hydroxide, and much lower than 
the Al(III) affinities of other ligands such as citrate, deferiprone and EDTA. According to these 
results, we can rule out that the formation of aluminum-cathecolamine complexes in an open 
biological environment, considering the competition with other endogenous/exogenous ligands, 
might be behind the toxic role attributed to this metal ion within the catecholamine biosynthesis 
pathway. 
Other possible mechanisms are discussed; aluminum could interfere/compete with the homeostasis 
of other metal ions required as cofactors of the enzymes involved in the catecholamines route. It could 
bind within the active site of metal-dependent enzymes, where the presence of a protective metal-ion 
binding site, like in the case of COMT, would provide the necessary conditions for the formation of 
strong aluminum-catecholamine complexes. It could bind to other organic cofactors such as vitamin 
C and it could interfere with the upstream metabolic routes of other cofactors. Again, it is worth to 
emphasize that little-to-nothing is known about the molecular basis of aluminum’s behavior in these 
neurotransmitter pathways; therefore, much more basic knowledge in this sense must be gained in 
future. The present paper certainly helps in this regard, and also encourages further theoretical and 
experimental works. 
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8.1 Training schools and international courses 
 
1. Doctorate Core Course (Autonomous University of Madrid) – 28/09/2015 – 09/09/2015, 
Madrid, Spain. 
 
2. School on Parallel Computing (University of Barcelona and Barcelona Supercomputing 
Center) – 25/01/2016 – 31/01/2016, Barcelona, Spain. 
 
3. Tutorial on ADF (University of Groningen and Software for Chemistry & Materials) – 
26/04/2016 – 02/05/2016, Amsterdam, Netherlands. 
 
4. Short Course “The chemical bond” by Prof. Gernot Frenking (University of Marburg) – 
0502/2016 – 28/03/2016, Donostia, Spain. 
 
5. Short Course “New tools for chemical bond analysis” by Dr. Eduard Matito (Donostia 
International Physics Center -DIPC) – 02/06/2016 – 28/06/2016, Donostia, Spain. 
 
6. Dynapeutics International Summer School – 26/09/2016 – 30/09/2016, Donostia, Spain. 
            Poster contribution: A theoretical approach to aluminum chelation therapy: insights from            
            computational chemistry. 
 
7. Tutorial on SHARC (University of Vienna) – 03/10/2016 – 07/10/2016, Vienna, Austria. 
 
8. School on Scientific Visualization (Cineca) – 16/01/2017 – 20/01/2017, Rome, Italy. 
 
9. School on Open Cloud Science (University of Perugia) – 01/06/2017 – 07/06/2017, Perugia, 
Italy. 
 
10. Course on Project Management (KU Leuven) – 19/07/2017 – 21/07/2017, Leuven, Belgium. 
 
11. Theoretical Methods in Quantum Chemistry (Zaragoza Scientific Center for Advanced 
Modelling and University of Tolouse) – 02/10/2017 – 05/10/2017, Zaragoza, Spain. 
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12. Manuel Yanez’s workshop (Donostia International Physics Center) – 26/10/2017 – 
27/10/2017, Donostia, Spain. 
 
8.2 International conferences and workshops contributions 
 
1. 1st ITN Annual Workshop (University Pierre et Marie Curie Paris VI) 18/07/2016 – 
21/07/2016, Paris, France.. 
a. Oral communication: Computational approach to Al(III) chelation therapy: insights 
from computational chemistry. 
b. Poster contribution: Computational approach to Al(III) chelation therapy: insights 
from computational chemistry. 
 
2. ITN Mid-Term Meeting – 16/12/2016, Madrid, Spain. 
a. Oral communication: Aluminum biochemistry. 
b. Poster contribution: Theoretical approach to aluminum biochemistry: a 
computational approach. 
 
3. 12th Keele’s Meeting on Aluminum – 04/03/2017 – 08/03/2017, Vancouver, Canada. 
a. Poster contribution: Characterization of Substituent Effects and Binding Features of 
different Al(III)-Chelator Complexes. (Metallomics Poster Prize) 
 
4. Workshop on Computational Studies applied in Biological Sciences (University of Cagliari) 
– 02/04/2017, Cagliari, Italy. 
a. Oral communication: Theoretical approach to aluminum chelation therapy: 
characterization of the Al(III)-Ligand binding features. 
 
5. 8th Theoretical Biophysics International Symposium – 26/06/2017 – 30/06/2017, Donostia, 
Spain. 
a. Oral communication: Computational approach to Aluminum biochemistry. 
b. Poster contribution: Aluminum, a walk on part in the war or a lead role in a cage ? 
 
6. 2nd ITN Annual Workshop (KU Leuven) – 16/07/2017 – 19/07/2017, Leuven, Belgium. 
a. Oral communication: Computational approach to Aluminum biochemistry. 
b. Poster contribution: Aluminum, a walk on part in the war or a lead role in a cage ? 
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7. 11th European Conference on Theoretical and Computational Chemistry (EUCO) – 
04/09/2017 – 07/09/2017, Barcelona, Spain. 
a. Poster contribution: The Dark Side of aluminium chelation therapy: characterization 
of Al(III)-ligand binding features. 
 
8. 16th International Congress of Quantum Chemistry (ICQC) – 18/06/2018 – 23/06/2018, 
Menton, France. 
a. Poster contribution: Towards new and reliable Al(III) chelating agents. 
 
9. 3rd ITN Annual Workshop (University of Pisa) – 23/07/2018 – 25/07/2018, Pisa, Italy. 
a. Oral communication: Computational approach to Aluminum biochemistry and 
development of new chelation strategies. 
b. Poster contribution: Aluminum: a mysterious metal ion. 
 
10. 14th European Biological Inorganic Chemistry Conference – 26/08/2018 – 30/08/2018, 
Birmingham, U.K. 
a. Poster contribution: Computational Approach to Al(III) Chelation Therapy. 
 
8.3 Outreach activities 
 
1. “Meet the Prof” event with Nobel Laureates Prof. Dudley R. Herschbach, Passion for 
Knowledge Festival – 26/09/2016 – 01/10/2016, Donostia, Spain. 
(http://p4k.dipc.org/en/home) 
 
2. 7th Encuentro “Vidas Cientifica” (Eureka! Science Museum) 23/10/2017, Donostia, Spain. 
(Career meeting for high school students). 
a. Oral communication: Computational chemistry: beyond the dark side of science. 
b. Poster contribution: Computational chemistry: beyond the dark side of science. 
 
3. Co-supervisor of a Bachelor thesis project focused on aluminium biochemistry, degree in 
Chemistry, University of the Basque Country (Spain). 
a. Defense: 22/07/2016.  
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b. Title of the dissertation: Estudio Teórico de la Interacción del Aluminio con 
Moléculas de Interés Biológico. 
 
4. Publication of a dissemination article for general audience, about the controversy of 
aluminium biochemistry, in the Mapping the Ignorance blog 
(https://mappingignorance.org/2016/10/28/dark-side-aliii-chelation-therapy-new-
computational-hope/). 
a. Article title: The Dark Side of Al(III) chelation therapy: A new computational hope. 
 
8.4 Publications 
 
1. Gabriele Dalla Torre, Jon I. Mujika, Elena Formoso, Eduard Matito, Maria J. Ramos and 
Xabier Lopez. Tuning the affinity of catechols and salicylic acids toward Al(III): 
characterization of Al-chelator interactions.  
Dalton Trans., 2018, 47, 9592-9607. (Front cover article) 
 
2. Jon I. Mujika, Gabriele Dalla Torre, Joanna I. Lachowicz and Xabier Lopez. Design of new 
efficient chelators of aluminum based on Mimosine-containing peptides.  
Phys. Chem. Chem. Phys., submitted. 
 
3. Jon I. Mujika, Gabriele Dalla Torre, Elena Formoso, Rafael Grande-Atzazi, Slowmir J. 
Grabowski, Christopher Exley and Xabier Lopez. Aluminum’s preferential binding site in 
proteins: side chains of aminoacids versus backbone interactions.  
J. Inorg. Biochem., 2018, 181, 111. 
 
4. Jon I. Mujika, Gabriele Dalla Torre, and Xabier Lopez. Aluminum and Fenton reaction: How 
can the reaction be modulated by speciation ? A computational study using citrate as test 
case.  
Phys. Chem. Chem. Phys., 2018, 20, 16256. 
 
5. Gabriele Dalla Torre, Jon I. Mujika, Joanna I. Lachowicz, Maria J. Ramos and Xabier Lopez. 
The interaction of aluminum with catecholamine-based neurotransmitters: Can the 
formation of these species be considered a potential risk factor for neurodegenerative 
diseases?  
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Dalton Trans., accepted. 
 
6. Gabriele Dalla Torre, Xabier Lopez and Maria J. Ramos. Benchmarking approximate 
exchange-correlation functionals and sempiempirical methods towards binding energies and 
geometries of different Al-ligand complexes in solution.  
In preparation. 
 
8.5 Awards 
 
1. Metallomics Poster Award. The 12TH Keele’s Meeting on aluminum: living the aluminum 
age. Vancouver, Canada.  
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“They declared me unfit to live said into that great void my soul'd be hurled  
They wanted to know why I did what I did  
Well sir I guess there's just a meanness in this world.” 
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9.1 Concluding remarks 
 
The present PhD dissertation aimed to shed light on the properties and the behaviour of Al(III), an 
exogenous and non-essential metal ion, that  became an important part of our daily lives in the so-
called Aluminum Age.  
In particular, three different but tightly connected areas were covered, that are summarized below 
with the main findings previously discussed in the results chapters. 
 
9.1.1 Chelation therapy and development of new chelation strategies 
In the first paper, we have investigated how different substituents (electron donating/withdrawing 
groups) with different mechanisms of actions (induction and/or resonance) can tune and modulate the 
properties of a given chelating agent towards Al(III). For that purpose, we have used two well known 
families of chelators for which different sources of experimental data are available, so that to calibrate 
our computational protocol and to be able to investigate all their features. 
Our results showed that, depending on the properties of the chelator (e.g. aromaticity, presence of 
substituents) and the aluminum/protons competition for binding the coordination site, these 
substituents can alter the chelation performance in different extents. When aluminum has to compete 
with only one proton for biding the ligand, then electron donating groups (methyl, methoxy) are able 
to increase the binding affinity of the chelator; conversely, when aluminum has to compete with two 
protons, then the addition of electron withdrawing groups (e.g. nitro and trifluoromethyl) provide the 
better chelation performance. Moreover, the aromatic nature of the chelating agent is also pivotal; in 
the case of aromatic chelators, those substituents that work through resonance or both 
induction/resonance mechanisms of action are able to provide a higher effect in terms of chelation 
performance of the ligand. Therefore, we propose that, when the aromatic nature of the ligand is low 
(for instance, pyridine-based ligands), then those substituents that work through induction should be 
more suitable to tune the binding properties of a given ligand. 
Interestingly, the modulation of these binding properties is mediated by the minor covalent character 
of the Al(III)-ligand interactions, rather than their prevalent electrostatic nature. Indeed, such an effect 
is exerted through the modulation of the electron density at the coordination site of the ligand, as 
revealed by the QTAIM and EDA analyses. 
Overall, we developed a computational approach suitable to investigate and predict the properties of 
low-molecular-mass Al(III) chelators, that we beliece it wll be a useful tool to design improved 
compounds to be used in aluminum chelation therapy. 
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In our second paper (chapter 4), we developed a new family of peptide-based chelating agents whose 
chelation unit is composed of Mimosine amino acids. The reason of such a choice relies on the 
similarity between Mimosine and deferiprone, a well-known and performant Al(III) chelating agent. 
We designed eight peptidic sequence that differ by the number (from five to nine) and the nature 
(glycine and proline) of he amino acids of the linker sequences. 
QM/MM simulations showed that those peptide sequences that are too short (five, six and seven 
amino acids) fail to bind aluminum in a octahedral fashion. Conversely, sequences composed of eight 
and nine amino acid are able to properly coordinate Al(III) filling all the six coordination sites. 
The comparison with the x-ray structure of the 1:3 aluminum-deferiprone complex allowed us to 
speculate that the nine peptide long sequences coordinate in a very similar fashion the former 
complex, leading to an optimum complexation with the trivalent metal, as highlighted by the 
calculated binding enthalpies. 
These results would encourage further experimental synthesis and characterization of our newly 
developed family of aluminum chelating agents. 
 
9.1.2 The potential toxic role of aluminum in the biological environment 
The second part of this thesis project was focused on the understanding the molecular basis of the 
(potential) detrimental role of Al(III) within the cellular life of the human organism. 
The first paper (chapter 5) investigated a recent paradigm that has been proposed regarding the 
interaction of aluminum with proteins: backbone versus sidechains. 
Indeed, in a recent paper, some authors proposed that aluminum is able to bind strongly, through 
covalent interactions, the backbone of proteins, thus leading to their denaturation. 
However, our calculations (in agreement with the vast majority of the literature in that respect) 
showed that, from a thermodynamic point of view, Al(III) interaction with protein side chains is much 
more favoured than the interaction with the backbone. The latter situation is therefore way less 
competitive and aluminum prefers to bind the negatively charged side chains of amino acids, in 
agreement with the Pearson’s Hard and Soft Acids and Basis (HSAB) principle. The reason relies on 
the fact that the aluminum-ligand interactions are mainly of electrostatic nature, although the minor 
covalent character can be important in some situations, as discussed in chapter 3. 
In chapter 6, we investigated the role of citrate, the main low-molecular-mass aluminum chelator in 
blood serum, in the context of the Fenton reaction. Although Al(III) is a non-redox metal, it has been 
assessed that it is nevertheless able to promote the Fenton reaction, by stabilizing the superoxide 
radical. The inclusion of the Al-citrate complex in the thermodynamic cycle of the Fenton reaction 
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leads to a complex scenario, where depending on the relative concentrations of aluminum, citrate and 
iron, citrate can have both a promotion and protective role with respect to aluminum. 
Moving to the role of Al(III) in the brain (chapter 7), since it has been linked to several 
neurodegenerative disorders, we assessed whether its binding to catecholamines (e.g. L-DOPA, 
dopamine, adrenaline and noradrenaline) can lead to the formation of strong complexes that can 
potentially contribute to the severe phenotypes associated to the interference of Al(III) within the 
catecholamine biosynthesis pathway. 
Our results highlighted that, differently than what it has been proposed in previous papers, the Al(III)-
catecholamine complex is not competitive in solution when compared to Al-hydroxide formation (the 
most stable aluminum species at physiological pH) and with other endogenous and exogenous 
chelators such as citrate, deferiprone and EDTA. 
Accordingly, we discussed other hypotheses that could be behind the detrimental role of aluminum 
in the catecholamines route, such as the impairment of enzymatic reactions in the catalytic pocket of 
key enzymes, and would encourage further experimental and computational works in the near future. 
 
9.1.3 Improvement and calibration of the theoretical methods 
The major developments in this area are spread through all the previous chapters, as we have updated 
and improved our “standard” computational protocol (see Fig. 3.2) in order to adapt it to the different 
systems under investigation and to calibrate it according to the fitting with the available experimental 
data. 
As a result, we have been able to understand and well reproduce both the main experimental criteria 
that evaluate the chelation performance in solution (e.g. stability constants and pAl, see section 1.2.3). 
This is of pivotal importance in order to produce reliable results and to compare them with what it 
has been proposed in literature, as well as to propose new potentially therapeutic compounds. 
Moreover, since the huge developments of the last years in the fields of DFT and semiempirical 
methods allowed to introduce some important corrections and upgrades, we are currently working on 
an accurate benchmark of the performance of DFT and semiempirical methods towards the evaluation 
of binding energies of Al-chelator complexes in solution, according to eq. 3.4.  
The purpose is to evaluate the accuracy of DFT exchange/correlation functionals (spanning the whole 
DFT Jacob’s ladder) in light of the two most important developments in this area: dispersion 
corrections and range separation (see section 2.2.2 and 2.2.3), with respect to aluminum-containing 
systems. 
We have chosen seven different 1:1 aluminum-ligand systems (catechol, deferiprone, kojic acid, four 
hydroxypyridincarboxylic acids (HPCs) bearing different protonation states and substituents, see Fig. 
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1.11) because they span different donors to aluminum (e.g. carboxyl, hydroxyl, carboxylate) and 
different chemical environments (e.g. phenyl, pyridine, pyrone) as well as for the presence of the 
electron donating methyl group. In this way, a significant modulation of the chelation properties is 
expected, allowing for a good diversification of the dataset and a more reliable calibration of different 
methods. 
The reference energies are calculated at the CCSD(T)/CBS//MP2/aug-cc-pVTZ  level of theory using 
the popular extrapolation schemes developed by Helgaker and Halkier for the correlated and 
uncorrelated energies, respectively.  
Although still work in prograss, some preliminary results with selected methods are presented in table 
9.1 that allows for some important observations. 
 
 
Method MUE 
CCSD(T)/CBS  
MP2=FULL 1.60 
MP2 2.03 
B3LYP 1.61 
B3LYP-D3 1.44 
B3LYP-D3(BJ) 0.78 
CAM-B3LYP-D3(BJ) 0.55 
M06-2X 1.41 
M06-2X-D3 1.12 
TPSS 1.30 
TPSS-D3(BJ) 0.60 
PBE 3.44 
PBE-D3(BJ) 2.96 
LC-wHPBE-D3/BJ) 0.76 
ωB97XD 1.02 
AM1 12.91 
PM3 33.14 
PM6 12.28 
PM7 12.91 
PM7R8 12.84 
  
Table 9.1. Mean unsigned errors (MUEs) in kcal/mol for the physiological binding energies calculated for the 
seven different 1:1 aluminum-ligand complexes discussed above. DFT and MP2 single point energies are 
calculated with the 6-311++G(3df,2p) basis set. All geometry optimizations were carried out at the MP2/aug-
cc-pVTZ level of theory. 
CONCLUSIONS 
 
212 
 
 
 
1) The inclusion of dispersion clearly leads to more accurate results; the D3(BJ) scheme is more 
accurate than the D3 one (see section 2.2.3). Moreover, the inclusion of range-separation 
corrections in addition to dispersion (see section 2.2.2) such as the CAM-B3LYP-D3(BJ) and 
LC-wHPBE-D3(BJ) methods further increases the accuracy. 
 
2) The B3LYP-D3(BJ) functional is one of the best performers among the methods displayed in 
table 9.1 (that were chosen herein since they represent the most accurate ones among all the  
tested functonals that are not reported for simplicity). Likewise, the PM6 method is the most 
accurate among all semiempirical Hamiltonians tested. 
This confirms the suitability of the choice of these two methods that were extensively used in 
the present PhD project. 
 
3) Regarding semiempirical methods, it is reasonable to hypothesize that the addition of 
dispersion corrections, when available in the specific package, would lead to a significant 
improvement of the performance of the method, leading to more accurate results. The same 
speculations might be extended to the newly developed hydrogen bond corrections (see 
section 2.2.3). 
 
4) The MP2 ab initio method is clearly a worse performer when compared to most of DFT 
functionals, even when the full electron basis set is used.  
This situation may be due to the bad estimation of dispersion energy by the MP2 method, 
which is a well known issue. However, these results highlight that this method is not suitable 
for the investigation of the thermodynamics of aluminum-containing systems, and put a word 
of caution on its use in that regard (see chapter 5). 
 
 
9.2 Future perspectives 
 
Overall, the results presented in the present dissertation provide a significant contribution in the 
computational approach to aluminum biochemistry. The overall accuracy of the protocol has been 
increased, and the various aspects that determine an increment of the failure of that accuracy were 
identified.  
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Clearly, this means that in future higher accuracy can be reached, and an even closer fitting with 
experimental criteria is a goal that must the pursued, also trying to investigate other variables that 
influence the accuracy of the computational protocol (e.g. solvation models, pKa prediction, free ions 
in solution). 
Besides, novel knowledge has been provided with respect to the development of novel chelating 
agents to be used in aluminum-based chelation therapy. A novel family of potentially well performing 
peptide-based chelator has been proposed. Moreover, following the findings of chapter 3, we expect 
to further increase the performance of these chelators by tuning the chemical environment with the 
proper electron donating/withdrawing substituents. 
The role of citrate and aluminum in the case of the Fenton reaction has been elucidated, refining 
previous results found in our group. 
Finally the interaction of aluminum with catecholamine-based neurotransmitters was assessed, and 
new hypotheses on the role of Al(III) within the catecholamine biosynthesis pathway were 
formulated, providing new substrate for near-future computational works. 
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“I love to see the cottonwood blossom  
In the early spring  
I love to see the message of love  
That the bluebird brings  
But when I see you walkin' with him  
Down along the strand  
I wish I were blind  
When I see you with your man” 
(B. Springsteen, I Wish I Were Blind) 
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Appendix A 
 
Tuning the Affinity of Catechols and Salicylic Acids towards Al(III): Characterization of Al-
Chelator Interactions 
 
 Table S1: Binding enthalpies and free energies of 1:1,1:2,1:3 complexes with the 𝜔B97XD 
functional. 
 
 Table S2: Binding enthalpies and free energies of 1:1,1:2,1:3 complexes with MP2. 
 
 Table S3: Binding enthalpies and free energies of 1:1,1:2,1:3 complexes with the M06-2X 
functional. 
 
 Table S4: Binding enthalpies and free energies of 1:1,1:2,1:3 complexes with PBE0-D3(BJ) 
functional. 
 
 Table S5: Binding enthalpies and free energies of 1:1,1:2,1:3 complexes with TPSS-D3(BJ) 
functional. 
 
 Figure S1: comparison of all DFT functionals as well as the MP2 method with respect to 
B3LYP-D3(BJ) binding energies. 
 
 Figure S2: comparison of all DFT functionals as well as the MP2 method with respect to 
experimental stability constants. 
 
 Table S6: characteristics of all Al-O Bond Critical Points (BCPs) for the whole dataset of 27 
compounds. 
 
 Figure S3: comparison of binding energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with respect to the sum of the electron 
density for all Al-O BCPs. 
 
 Figure S4: comparison of binding energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with respect to the sum of the Laplacian 
of the electron density for all Al-O BCPs. 
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 Figure S5: comparison of binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with respect to the sum of the total 
energy density for all Al-O BCPs. 
 
 Table S7: values for all Al-O Delocalization Indices (D.I.) as well as the charge of the two 
oxygens directly interacting with aluminum for all the dataset of 27 compounds. 
 
 Table S8: Values of the electrostatic term (Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡), the orbital interaction term (Δ𝐸𝑜𝑖), the 
Pauli repulsion term (Δ𝐸𝑃𝑎𝑢𝑙𝑖) the dispersion term (Δ𝐸𝑑𝑖𝑠𝑝) and the total interaction energy 
(Δ𝐸𝑖𝑛𝑡), for all the 27 compunds, calculated in gas phase. 
 
 Table S9: Aromaticity indices according to the Iring and MCI aromatic descriptors computed 
on the free ligand (Lig) and aluminum-ligand complexes (Al-Lig). 
 
 Figure S6: Electrostatic Potential maps (ESP) summarizing the effects of EDGs and EWGs 
toward the modulation of the covalent character of the bond. 
 
 
Specific computational details 
 
Density Functional Theory calculations 
All geometrical optimizations were carried out in aqueous phase using the B3LYP functional and 6-
31++G(d,p) basis set. Additionally, we added Grimme’s D3 dispersion correction, since dispersion 
may play an important role in describing intra-/inter-ligand interactions in the aromatic compounds. 
Moreover, we included the Becke-Johnson (BJ) damping function that was shown to further increase 
accuracy by allowing the correct treatment of short-, medium- and long-range dispersion energies. In 
general, the addition of methods that properly take into account dispersion energies in DFT has been 
proven to improve the precision of computed non-covalent interactions and 𝜋 − 𝜋 stacking systems. 
Unless otherwise specified, D3 refers to the D3(BJ) scheme. Other dispersion corrected DFT 
functionals, as well as the MP2 method were also employed to validate the methodology, with similar 
results (see Supplementary tables S1 to S5 and Figures S1 and S2). 
To confirm that the optimized structures were real minima on the potential energy surfaces, frequency 
calculations were carried out at the same level of theory. All structures showed positive force 
constants for all the normal modes of vibration. The frequencies were then used to evaluate the zero-
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point vibrational energy (ZPVE) and the thermal (T = 298 K) vibrational corrections to the enthalpies 
and Gibbs free energies within the harmonic oscillator approximation. To calculate the entropy, the 
different contributions to the partition function were evaluated using the standard statistical 
mechanics expressions in the canonical ensemble and the harmonic oscillator and rigid rotor 
approximation. The solvent effect was introduced using the self-consistent reaction field (SCRF) 
method with the polarized continuum model (PCM), using the integral equation formalism variant 
(IEFPCM). The electronic energies were refined by single-point energy calculations at the B3LYP-
D3/6- 311++G(3df,2p) level of theory. Single point calculations with different methods (M06-2X, 
PBE0 and TPSS with the D3(BJ) dispersion correction scheme, 𝜔B97XD and MP2) were carried out 
with the same triple-𝜁 basis set and IEFPCM solvation model at the B3LYP-D3/6-31++G(d,p) 
optimized geometries. 
 
The NBO 3.1 program included in the Gaussian 09 package was used to carry out full Natural Orbital 
Theory population analysis of the orbitals involved in the metal-chelator interaction. Population 
analysis was performed on the SCF density at the B3LYP-D3/6-311++G(3df,2p) level. 
 
QTAIM and Delocalization Indices 
The Quantum Theory of Atoms in Molecules (QTAIM) was used to perform a topological analysis 
of the electron density, providing the critical points of the electron density and the atomic boundaries 
that define the atomic partition of the molecular space. The so-called bond critical points (BCP) are 
saddle points of the electron density that usually occur between two bonded atoms and provide 
important information about the nature of the bonding. Closed-shell interactions (such as van der 
Waals, ionic and hydrogen bonds) are characterized by small values of the density, charge depletion 
and positive energy densities (i.e., small 𝜌(𝑟𝐵𝐶𝑃), ∇
2𝜌(𝑟𝐵𝐶𝑃) > 0 and 𝐻(𝑟𝐵𝐶𝑃) > 0). Conversely, 
covalent interactions are characterized by large electron density values, charge concentration and 
negative energy densities (i.e., large 𝜌(𝑟𝐵𝐶𝑃), ∇
2𝜌(𝑟𝐵𝐶𝑃) < 0 and 𝐻(𝑟𝐵𝐶𝑃) < 0). However, it has 
been pointed out that for some interactions which may be classified as covalent bonds, the Laplacian 
is positive and the total energy density at the BCP (𝐻(𝑟𝐵𝐶𝑃)) is negative. Such a situation is often 
observed for strong AH⋯B hydrogen bonds classified as partly covalent in nature (𝐻(𝑟𝐵𝐶𝑃) < 0). 
Delocalization Indices (D.I.) are a measure of the covariance between the population of two atoms A 
and B and, consequently, a measure of the number of electrons simultaneously fluctuating between 
these atoms, 
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 𝛿(𝐴, 𝐵) = ∫ ∫ 𝑑
𝐵𝐴
1𝑑2𝜌𝑥𝑐(1,2) = 𝑐𝑜𝑣(𝑁𝐴, 𝑁𝐵)  (1) 
 
where 𝜌𝑥𝑐(1,2) is the exchane-correlation density. It can be taken as the number of electron pairs 
shared between atoms 𝐴 and 𝐵, i.e., the bond order. 
The AIMAll v11.08.23 program was used to carry out the QTAIM analysis on the previously 
optimized structures at the B3LYP-D3/6-311++G(3df,2p) level of theory. The ESI was employed to 
perform the calculation of the D.I.. 
 
Aromaticity Indices 
Aromaticity indices provide a computational tool to assess the effect of the aromaticity in ring 
structures, molecules and large conjugated circuits. Among the different aromaticity indices available 
in the literature, the multicenter indices are among the most reliable ones for organic and inorganic 
systems. In particular, for a ring structure 𝐴 composed of 𝑛 atoms, 𝐴 = {𝐴1, … , 𝐴𝑛}, we have chosen 
Iring, 
 
 𝐼𝑟𝑖𝑛𝑔(𝐴) = 2
𝑛−1 ∑ 𝑆𝑖1𝑖2
𝑖1𝑖2…𝑖𝑛
(𝐴1) ⋯ 𝑆𝑖𝑛𝑖1(𝐴𝑛)  (2) 
 
and MCI 
 
 𝑀𝐶𝐼(𝐴) =
1
2𝑛
∑ 𝐼𝑟𝑖𝑛𝑔
𝑃(𝐴)
(𝐴)  (3) 
 
where 𝑆𝑖𝑗(𝐴1) is the atomic overlap matrix (AOMs) of atom 𝐴1, 
 
 
𝑆𝑖𝑗(𝐴1) = ∫ 𝑑
𝐴1
𝑟𝜙𝑖 (𝑟)𝜙𝑗(𝑟)  (4) 
 
𝜙𝑖(𝑟) is a molecular orbital. Iring depends on the order of the atoms in the string for 𝑛 > 3. The MCI 
is related to the 𝑛-center electron sharing index (𝑛c-ESI), which is the 𝑛-center generalization of the 
covariance (eq. 1). These indices provide an electronic-based description of aromaticy, which is the 
most suitable one to investigate the effect of different substituents (EDGs and EWGs) in terms of 
electron density analysis, which is consistent with the D.I. and the topological analysis provided by 
the QTAIM. 
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All the aromaticity calculations were performed using the ESI-3D program and the AOMs obtained 
from AIMall. 
 
Energy decomposition analysis (EDA) 
The energy decomposition analysis (EDA) is a powerful tool for a quantitative interpretation of 
chemical bonds. The EDA scheme based on the energy decomposition analysis developed by Ziegler 
and Rauk and by Morokuma was carried out using the ADF2016 suite of programs. In order to 
perform the EDA analysis, all 1:1 Al-chelator complexes previously optimized at the B3LYP-
D3(BJ)/6-31++G(d,p) IEFPCM level with Gaussian 09 were splitted in two fragments: aluminum 
surrounded by four water molecules and the unprotonated chelator. Single-point energies for the EDA 
analysis were calculated using the B3LYP-D3(BJ) functional and the very robust full electron (no 
frozen core) even-tempered quadruple-𝜁 basis set (ET-QZ3P-1-DIFFUSE) provided by ADF2016. 
All EDA calculations were performed both in gas phase and with the COSMO solvation model using 
the dielectric constant of water. However, it should be noted that a proper description of the solvent 
effect within the EDA scheme is not yet implemented in the ADF Modelling suite, and we have 
decided for an EDA analysis without solvent but at the solvent-including geometry. 
The EDA decomposes the instantaneous interaction energy Δ𝐸𝑖𝑛𝑡 between two fragments A and B in 
a molecule AB into three well defined terms that can be interpreted in chemical meaningful ways: 
 
 Δ𝐸𝑖𝑛𝑡 = Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 + Δ𝐸𝑃𝑎𝑢𝑙𝑖 + Δ𝐸𝑜𝑖  (5) 
 
These terms are (1) the quasiclassical electrostatic interaction energy between the charge densities of 
the fragments, Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 (2) the exchange/repulsion between the fragments due to Pauli’s principle, 
Δ𝐸𝑃𝑎𝑢𝑙𝑖, and (3) the energy gain due to orbital mixing of the fragments, Δ𝐸𝑜𝑖. 
Considering that EDA calculations are usually carried out in the framework of density functional 
theory, if an explicit correction term for dispersion interaction is employed (such as Grimme’s D3 
method), then EDA numerical results remain unchanged but the dispersion correction appears as an 
extra term: 
 
 Δ𝐸𝑖𝑛𝑡 = Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 + Δ𝐸𝑃𝑎𝑢𝑙𝑖 + Δ𝐸𝑜𝑖 + Δ𝐸𝑑𝑖𝑠𝑝  (6) 
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Comparison of different Density Functional Theory and Ab initio methods  
All the DFT functionals tested herein account for dispersion energies, though in different extents. As 
we can notice in Fig. S2, all functionals give very similar binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) when compared 
with B3LYP-D3(BJ) energies; the same is true for MP2, with some slight fluctuations. 
If we compare the binding energies for all the methods with respect to the experimental stability 
constants, we can see that the correlation coefficients (r) obtained for all different DFT functionals 
don’t show significant variations, and the same is true if we consider the MP2 method (see Fig. S3). 
In this regard, we should mention that MP2 is well known to overestimate dispersion interactions. 
Indeed, as reported by these authors, MP2 poorly describes aromatic-containing systems and 𝜋 − 𝜋 
stacking interactions, while dispersion corrections improve such non-covalent interactions. 
Accordingly, the small differences between DFT methods and MP2 shown in Fig. S3 may be due to 
the presence of dispersion corrections which are supposed to improve the description of the behavior 
of these aluminum-ligand complexes. 
The following tables show the values of binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) and binding Enthalpy (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) 
for all the methods, namely PBE0 and TPSS with the D3(BJ) dispersion correction scheme, 𝜔B97XD, 
M06-2X, and MP2. 
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Stochiometry  Ligand Theoretical Exp. 
   Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ 
1:1 Complexes Catecholates Cathecolate -88.7 -91.8 16.3 
  4-nitrocatecholate -74.7 -78.8 13.3 
 Salicylates Salicylicate -75.3 -77.3 13.3 
  3-nitrosalicylicate -64.1 -66.6 9.5 
  5-nitrosalicylicate -64.0 -66.1 9.3 
  3,5-dinitrosalicylicate -55.6 -57.8 6.9 
1:2 Complexes Catecholates Cathecolate -152.3 -158.4 31.7 
  4-nitrocatecholate -129.1 -135.9 24.8 
 Salicylates Salicylicate -128.9 -135.0 24.2 
  3-nitrosalicylicate -110.9 -114.9 17.7 
  5-nitrosalicylicate -110.7 -115.8 17.7 
  3,5-dinitrosalicylicate -96.9 -102.5 13.3 
1:3 Complexes Catecholates Cathecolate -184.1 -192.7 41.1 
  4-nitrocatecholate -160.1 -170.0 33.7 
 Salicylates Salicylicate -158.5 -165.4 32.1 
  3-nitrosalicylicate -140.0 -146.0 23.7 
  5-nitrosalicylicate -139.6 -143.5 23.7 
  3,5-dinitrosalicylicate -127.4 -129.5 18.5 
Total Correlation coefficient 0.9698 
 
Table S1: Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed at the ωB97XD 
level of theory for the 1:1, 1:2 and 1:3 complexes, and experimental logβ. 
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Stochiometry  Ligand Theoretical Exp. 
   Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ 
1:1 Complexes Catecholates Cathecolate -88.4 -91.4 16.3 
  4-nitrocatecholate -74.9 -79.1 13.3 
 Salicylates Salicylicate -73.9 -75.9 13.3 
  3-nitrosalicylicate -64.1 -66.6 9.5 
  5-nitrosalicylicate -63.4 -65.5 9.3 
  3,5-dinitrosalicylicate -55.8 -57.9 6.9 
1:2 Complexes Catecholates Cathecolate -152.4 -158.5 31.7 
  4-nitrocatecholate -130.2 -137.0 24.8 
 Salicylates Salicylicate -126.6 -132.7 24.2 
  3-nitrosalicylicate -111.6 -115.6 17.7 
  5-nitrosalicylicate -109.5 -114.5 17.7 
  3,5-dinitrosalicylicate -97.5 -103.1 13.3 
1:3 Complexes Catecholates Cathecolate -186.8 -195.4 41.1 
  4-nitrocatecholate -163.4 -173.3 33.7 
 Salicylates Salicylicate -159.5 -166.5 32.1 
  3-nitrosalicylicate -147.8 -153.9 23.7 
  5-nitrosalicylicate -142.2 -146.1 23.7 
  3,5-dinitrosalicylicate -137.6 -139.7 18.5 
Total Correlation coefficient 0.9579 
 
Table S2: Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed at the MP2 level 
of theory for the 1:1, 1:2 and 1:3 complexes, and experimental logβ. 
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Stochiometry  Ligand Theoretical Exp. 
   Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ 
1:1 Complexes Catecholates Cathecolate -88.0 -91.7 16.3 
  4-nitrocatecholate -73.2 -77.4 13.3 
 Salicylates Salicylicate -75.3 -77.3 13.3 
  3-nitrosalicylicate -63.3 -65.8 9.5 
  5-nitrosalicylicate -63.4 -65.6 9.3 
  3,5-dinitrosalicylicate -54.4 -56.5 6.9 
1:2 Complexes Catecholates Cathecolate -154.7 -157.0 31.7 
  4-nitrocatecholate -130.1 -133.1 24.8 
 Salicylates Salicylicate -132.3 -134.5 24.2 
  3-nitrosalicylicate -109.0 -113.0 17.7 
  5-nitrosalicylicate -113.1 -114.4 17.7 
  3,5-dinitrosalicylicate -97.8 -99.7 13.3 
1:3 Complexes Catecholates Cathecolate -182.7 -191.2 41.1 
  4-nitrocatecholate -155.4 -165.3 33.7 
 Salicylates Salicylicate -158.9 -165.9 32.1 
  3-nitrosalicylicate -138.4 -144.4 23.7 
  5-nitrosalicylicate -138.4 -142.2 23.7 
  3,5-dinitrosalicylicate -125.0 -127.0 18.5 
Total Correlation coefficient 0.9717 
 
Table S3: Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed at the M06-2X 
level of theory for the 1:1, 1:2 and 1:3 complexes, and experimental logβ. 
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Stochiometry  Ligand Theoretical Exp. 
   Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ 
1:1 Complexes Catecholates Cathecolate -89.1 -92.1 16.3 
  4-nitrocatecholate -73.3 -77.5 13.3 
 Salicylates Salicylicate -76.7 -78.7 13.3 
  3-nitrosalicylicate -64.7 -67.1 9.5 
  5-nitrosalicylicate -64.0 -66.1 9.3 
  3,5-dinitrosalicylicate -55.5 -57.7 6.9 
1:2 Complexes Catecholates Cathecolate -152.9 -159.0 31.7 
  4-nitrocatecholate -126.9 -133.7 24.8 
 Salicylates Salicylicate -130.9 -136.9 24.2 
  3-nitrosalicylicate -111.4 -115.4 17.7 
  5-nitrosalicylicate -110.3 -115.4 17.7 
  3,5-dinitrosalicylicate -96.2 -101.8 13.3 
1:3 Complexes Catecholates Cathecolate -185.1 -193.7 41.1 
  4-nitrocatecholate -158.4 -168.2 33.7 
 Salicylates Salicylicate -161.0 -168.0 32.1 
  3-nitrosalicylicate -140.9 -147.0 23.7 
  5-nitrosalicylicate -143.3 -139.4 23.7 
  3,5-dinitrosalicylicate -126.7 -128.8 18.5 
Total Correlation coefficient 0.9718 
 
Table S4: Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed at the PBE0-
D3(BJ) level of theory for the 1:1, 1:2 and 1:3 complexes, and experimental logβ. 
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Stochiometry  Ligand Theoretical Exp. 
   Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 logβ 
1:1 Complexes Catecholates Cathecolate -89.0 -92.1 16.3 
  4-nitrocatecholate -71.6 -75.8 13.3 
 Salicylates Salicylicate -77.1 -79.1 13.3 
  3-nitrosalicylicate -64.1 -66.6 9.5 
  5-nitrosalicylicate -63.0 -65.1 9.3 
  3,5-dinitrosalicylicate -54.4 -56.5 6.9 
1:2 Complexes Catecholates Cathecolate -152.7 -158.8 31.7 
  4-nitrocatecholate -124.2 -131.0 24.8 
 Salicylates Salicylicate -131.3 -137.3 24.2 
  3-nitrosalicylicate -110.1 -114.1 17.7 
  5-nitrosalicylicate -108.4 -113.5 17.7 
  3,5-dinitrosalicylicate -94.0 -99.6 13.3 
1:3 Complexes Catecholates Cathecolate -184.6 -193.2 41.1 
  4-nitrocatecholate -155.7 -165.6 33.7 
 Salicylates Salicylicate -161.5 -168.4 32.1 
  3-nitrosalicylicate -140.0 -146.0 23.7 
  5-nitrosalicylicate -137.6 -141.4 23.7 
  3,5-dinitrosalicylicate -124.8 -126.9 18.5 
Total Correlation coefficient 0.9726 
 
Table S5: Binding enthalpies (𝛥𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and free energies (𝛥𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) in kcal/mol computed at the TPSS-D3(BJ) 
level of theory for the 1:1, 1:2 and 1:3 complexes, and experimental logβ. 
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Figure S1: B3LYP-D3(BJ) Free binding energies (∆Gaqcomp) compared with other dispersion corrected 
functionals:PBE0-D3(BJ), TPSS-D3(BJ), M06-2X, ωB97XD and the MP2 method. All single point 
calculations were performed with the 6-311++G(3df,2p) basis set on the B3LYP-D3(BJ)/6-31++G(d,p) 
optimized geometries using the self-consistent reaction field (SCRF) method with the polarized continuum 
model (PCM) with the integral equation formalism variant (IEFPCM). All energies are in kcal/mol. 
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Figure S2: Different DFT and ab initio methods (B3LYP-D3(BJ), PBE0-D3(BJ), TPSS-D3(BJ), M06-
2X,ωB97XD and MP2) compared with experimental stability constants. All single point calculations were 
performed with the 6-311++G(3df,2p) basis set on the B3LYP-D3(BJ)/6-31++G(d,p) optimized geometries 
using the self-consistent reaction field (SCRF) method with the polarized continuum model (PCM) with the 
integral equation formalism variant (IEFPCM).All energies are in kcal/mol. 
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 Al − O 1 Al − O 2 
Ligand 𝜌(𝑟𝐵𝐶𝑃) ∇
2𝜌(𝑟𝐵𝐶𝑃) 𝐻(𝑟𝐵𝐶𝑃) 𝜌(𝑟𝐵𝐶𝑃) ∇
2𝜌(𝑟𝐵𝐶𝑃) 𝐻(𝑟𝐵𝐶𝑃) 
Catecholates 
Catecholate 0.0858 0.5271 -0.0078 0.0847 0.5193 -0.0074 
Electron Withdrawing Groups 
4-nitrocatecholate 0.0846 0.5189 -0.0073 0.0802 0.4838 -0.0062 
4,6-dinitrocatecholate 0.0842 0.5196 -0.0070 0.0764 0.4581 -0.0050 
4,5,6-trinitrocatecholate 0.0752 0.4488 -0.0047 0.0815 0.4966 -0.0064 
4-trifluoromethylcatecholate 0.0848 0.5207 -0.0074 0.0830 0.5059 -0.0069 
4,6-trifluoromethilcatecholate 0.0841 0.5151 -0.0072 0.0806 0.4899 -0.0061 
4,5,6-trifluoromethylcatecholate 0.0827 0.5057 -0.0067 0.0803 0.4887 -0.0059 
Electron Donating Groups 
4-methylcatecholate 0.0857 0.5263 -0.0078 0.0853 0.52436 -0.0076 
4,6-dimethylcatecholate 0.0860 0.5283 -0.0079 0.0858 0.5279 -0.0078 
3,4,5,6-tetramethylcatecholate 0.0877 0.5444 -0.0082 0.867 0.5377 -0.0078 
4-methoxycatecholate 0.0851 0.5214 -0.0076 0.0858 0.5273 -0.0078 
Salicylates 
Salicylic acid 0.0842 0.5515 -0.0042 0.0887 0.5822 -0.0060 
Electron Withdrawing Groups 
3-nitrosalicylicate 0.0840 0.5513 -0.0041 0.0850 0.5613 -0.0042 
5-nitrosalicylicate 0.0834 0.5465 -0.0039 0.0844 0.5491 -0.0046 
3,5-dinitrosalicylicate 0.0832 0.5458 -0.0038 0.0814 0.5334 -0.0031 
3,4,5-trinitrosalicylicate 0.0790 0.5128 -0.0026 0.0823 0.5399 -0.0035 
5-trifluoromethylsalicylicate 0.0866 0.5659 -0.0053 0.0836 0.5477 -0.0040 
3,5-trifluoromethylsalicylicate 0.0835 0.5475 -0.0039 0.0847 0.5550 -0.0044 
3,4,5-trifluoromethylsalicylicate 0.0834 0.5480 -0.0038 0.0827 0.5418 -0.0037 
Electron Donating Groups 
3-methylsalicylicate 0.0847 0.5546 -0.0045 0.0884 0.5826 -0.0057 
4-methylsalicylicate 0.0847 0.5542 -0.0045 0.0879 0.5764 -0.0057 
5-methylsalicylicate 0.0846 0.5540 -0.0044 0.0884 0.5807 -0.0059 
6-methylsalicylicate 0.0853 0.5623 -0.0045 0.0885 0.5823 -0.0059 
3,5-dimethylsalicylicate 0.0848 0.5552 -0.0045 0.0890 0.5873 -0.0059 
4,6-dimethylsalicylicate 0.0860 0.5694 -0.0046 0.0891 0.5886 -0.0059 
3,4,5-trimethylsalicilicate 0.0851 0.5571 -0.0046 0.0893 0.5915 -0.0059 
3,5-dimethoxysalicylicate 0.0842 0.5511 -0.0043 0.0892 0.5899 -0.0059 
 
Table S6 (previous page): Characteristics of the Al-O Bond Critical Points (in a.u.) for the aluminum-chelator 
interactions: the electron density at the BCP (ρ(rBCP)), the Laplacian of electron density (∇2ρ(rBCP)), and the 
total energy density at the BCP (H(rBCP)). All structures were optimized and refined at the B3LYP-D3(BJ)/6-
311++G(3df,2p) level of theory as reported in the methods section. All calculations take into account implicit 
solvent effects according to the IEFPCM formalism. 
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Figure S3: Free binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) versus the sum of the electron density for all Al-O bond critical 
points 𝜌(𝑟𝐵𝐶𝑃). 
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Figure S4: Free binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) versus the sum of the Laplacian of the electron density for all Al-
O bond critical points  ∇2𝜌(𝑟𝐵𝐶𝑃). 
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Figure S5: Free binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) versus the sum of the total energy density for all Al-O bond critical 
points 𝐻(𝑟𝐵𝐶𝑃).  
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L.I. 
(a.u.) 
D.I.(a.u.) q(Bader, a.u.) 
Structure Al Al-O1 Al-O2 qAl qO1 qO2 
Catecholates 
Catecholate 9.9433 0.2228 0.2208 2.5623 -1.3469 -1.3440 
Electron Withdrawing Groups 
4-nitrocatecholate 9.9427 0.2183 0.2065 2.5658 -1.3239 -1.3337 
4,6-dinitrocatecholate 9.9419 0.2151 0.1926 2.5686 -1.3250 -1.2877 
4,5,6-trinitrocatecholate 9.409 0.2080 0.1900 2.5698 -1.3133 -1.2895 
4-trifluoromethylcatecholate 9.9429 0.2193 0.2154 2.5644 -1.3378 -1.3385 
4,6-trifluoromethilcatecholate 9.9426 0.2171 0.2064 2.5661 -1.3314 -1.3197 
4,5,6-trifluoromethylcatecholate 9.9422 0.2119 0.2041 2.5670 -1.3237 -1.3099 
Electron Donating Groups 
4-methylcatecholate 9.9433 0.2226 0.2226 2.5628 -1.3446 -1.3489 
4,6-dimethylcatecholate 9.9433 0.2231 0.2230 2.5623 -1.3463 -1.3478 
3,4,5,6-tetramethylcatecholate 9.9429 0.2262 0.2248 2.5616 -1.3465 -1.3499 
4-methoxycatecholate 9.9433 0.2209 0.2246 2.5624 -1.3423 -1.3491 
Salicylates 
Salicylic acid 9.9395 0.2065 0.2187 2.5743 -1.3593 -1.3600 
Electron Withdrawing Groups 
3-nitrosalicylicate 9.9387 0.2047 0.2038 2.5768 -1.3551 -1.3338 
5-nitrosalicylicate 9.9394 0.2041 0.2067 2.5763 -1.3551 -1.3407 
3,5-dinitrosalicylicate 9.9386 0.2019 0.1943 2.5788 -1.3514 -1.3190 
3,4,5-trinitrosalicylicate 9.9388 0.1901 0.1998 2.5780 -1.3122 -1.3491 
5-trifluoromethylsalicylicate 9.9395 0.2130 0.2054 2.5751 -1.3517 -1.3569 
3,5-trifluoromethylsalicylicate 9.9390 0.2055 0.2038 2.5768 -1.3350 -1.3546 
3,4,5-trifluoromethylsalicylicate 9.9390 0.2019 0.2019 2.5770 -1.3284 -1.3514 
Electron Donating Groups 
3-methylsalicylicate 9.9392 0.2086 0.2183 2.5758 -1.3593 -1.3590 
4-methylsalicylicate 9.9395 0.2093 0.2187 2.5746 -1.3596 -1.3614 
5-methylsalicylicate 9.9395 0.2090 0.2200 2.5746 -1.3594 -1.3624 
6-methylsalicylicate 9.9389 0.2090 0.2182 2.5751 -1.3592 -1.3614 
3,5-dimethylsalicylicate 9.9392 0.2091 0.2199 2.5755 -1.3598 -1.3608 
4,6-dimethylsalicylicate 9.9389 0.2110 0.2192 2.5746 -1.3618 -1.3626 
3,4,5-trimethylsalicilicate 9.9393 0.2102 0.2214 2.5742 -1.3606 -1.3642 
3,5-dimethoxysalicylicate 9.9393 0.2079 0.2211 2.5745 -1.3581 -1.3538 
 
Table S7: Localization and Delocalization Indices (D.I.), in a.u., for the aluminum-oxygen bonds in the 
Al.chelator complex dataset. Localization Index (L.I.), in a.u., for the aluminum atom. Bader's atomic charges, 
in a.u., are also provided. All structures were optimized and refined at the B3LYP-D3(BJ)/6-311++G(3df,2p) 
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level of theory as reported in the methods section. All calculations take into account implicit solvent effects 
according to the IEFPCM formalism  
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Structure Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 (%) Δ𝐸𝑜𝑖 (%) Δ𝐸𝑃𝑎𝑢𝑙𝑖 Δ𝐸𝑑𝑖𝑠𝑝 𝚫𝑬𝒊𝒏𝒕 
Al-Catecholates  
Catecholate -610.4 (64.9) -329.7 (35.1) 149.9 -6.5 -796.7 
Electron Withdrawing Groups  
4-nitrocatecholate -647.1 (72.4) -247.1 (27.6) 147.2 -6.5 -753.5 
4,6-dinitrocatecholate -610.0 (71.7) -240.9 (28.3) 139.0 -6.7 -718.6 
4,5,6-trinitrocatecholate -583.4 (70.9) -239.4 (29.1) 133.6 -6.7 -695.9 
4-trifluoromethylcatecholate -571.2 (63.1) -333.8 (36.9) 144.4 -6.5 -767.2 
4,6-trifluoromethilcatecholate -578.0 (65.4) -306.4 (34.6) 141.3 -6.7 -749.8 
4,5,6-trifluoromethylcatecholate -589.1 (67.5) -283.3 (32.5) 144.9 -6.8 -734.3 
Electron Donating Groups  
4-methylcatecholate -601.0 (64.0) -337.6 (36.0) 149.6 -6.4 -795.4 
4,6-dimethylcatecholate -601.1 (63.9) -339.3 (36.1) 151.1 -6.7 -796.0 
3,4,5,6-tetramethylcatecholate -593.5 (62.9) -350.8 (37.1) 153.1 -6.9 -798.0 
4-methoxycatecholate -590.1 (63.2) -343.8 (36.2) 148.8 -6.5 -791.6 
Al-Salicylates  
Salicylic acid -659.8 (70.6) -274.7 (29.4) 153.6 -7.7 -788.7 
Electron Withdrawing Groups  
3-nitrosalicylicate -654.8 (73.0) -241.9 (27.0) 148.0 -8.2 -757.0 
5-nitrosalicylicate -634.8 (72.0) -246.6 (27.0) 146.8 -7.8 -742.4 
3,5-dinitrosalicylicate -610.2 (71.6) -241.9 (28.4) 141.4 -8.3 -718.9 
3,4,5-trinitrosalicylicate -588.8 (71.2) -238.3 (28.8) 136.6 -8.2 -698.8 
5-trifluoromethylsalicylicate -615.7 (68.2) -287.5 (31.8) 148.5 -7.8 -762.4 
3,5-trifluoromethylsalicylicate -620.1 (70.1) -263.9 (29.9) 145.3 -8.3 -746.9 
3,4,5-trifluoromethylsalicylicate -629.3 (72.6) -238.1 (27.4) 143.7 -8.4 -732.1 
Electron Donating Groups  
3-methylsalicylicate -651.5 (70.2) -276.8 (29.8) 153.5 -8.1 -782.9 
4-methylsalicylicate -639.5 (68.8) -289.7 (31.2) 152.8 -7.7 -784.1 
5-methylsalicylicate -642.0 (69.0) -288.4 (31.0) 153.1 -7.7 -785.0 
6-methylsalicylate -652.3 (70.7) -279.1 (29.3) 153.5 -7.9 -758.8 
3,5-dimethylsalicylicate -642.2 (69.1) -287.8 (30.9) 153.8 -8.1 -784.3 
4,6-dimethylsalicylicate -638.3 (68.4) -295.0 (31.4) 154.2 -7.9 -786.9 
3,4,5-trimethylsalicilicate -637.4 (68.4) -295.0 (31.6) 154.4 -8.2 -786.1 
3,5-dimethoxysalicylicate -626.4 (67.1) -306.8 (32.9) 152.1 -7.9 -789.0 
 
Table S8: Energy Decomposition Analysis, values obtained at the full electron (no frozen core) B3LYP-
D3(BJ)/ET-QZ3P-1DIFFUSE level of theory in gas phase, using the ADF2016 modelling suite of programs. 
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  Iring MCI 
Structure Al-Lig Lig (ΔArom.) Al-Lig Lig (ΔArom.) 
Benzene  0.0472   0.0705  
Ciclohexane  0.0003   0.0003  
 Al-Catecholates 
Catechol  0.0374   0.0551  
Catecholate 0.0345 0.0235 (0.0110) 0.0503 0.0322 (0.0181) 
 Electron Withdrawing Groups 
4-nitrocatecholate 0.0258 0.0128 (0.0130) 0.0353 0.0150 (0.0203) 
4,6-dinitrocatecholate 0.0211 0.0096 (0.0115) 0.0283 0.0116 (0.0167) 
4,5,6-trinitrocatecholate 0.0207 0.0074 (0.0133) 0.0280 0.0086 (0.0194) 
4-trifluoromethylcatecholate 0.0308 0.0193 (0.0115) 0.0440 0.0257 (0.0183) 
4,6-trifluoromethilcatecholate 0.0279 0.0159 (0.0120) 0.0396 0.0212 (0.0184) 
4,5,6-trifluoromethylcatecholate 0.0258 0.0136 (0.0122) 0.0363 0.0181 (0.0182) 
 Electron Donating Groups 
4-methylcatecholate 0.0331 0.0227 (0.0104) 0.0480 0.0310 (0.0170) 
4,6-dimethylcatecholate 0.0320 0.0224 (0.0096) 0.0463 0.0307 (0.0156) 
3,4,5,6-tetramethylcatecholate 0.0302 0.0216 (0.0086) 0.0436 0.0297 (0.0139) 
4-methoxycatecholate 0.0308 0.0218 (0.0090) 0.0447 0.0297 (0.0150) 
 Al-Salicylates 
Salicylic acid  0.0353   0.0510  
Salycilicate 0.0351 0.0306 (0.0045) 0.0510 0.0436 (0.0074) 
 Electron Withdrawing Groups 
3-nitrosalicylicate 0.0295 0.0187 (0.0108) 0.0419 0.0248 (0.0171) 
5-nitrosalicylicate 0.0284 0.0185 (0.0099) 0.0395 0.0232 (0.0163) 
3,5-dinitrosalicylicate 0.0255 0.0154 (0.0101) 0.0353 0.0196 (0.0157) 
3,4,5-trinitrosalicylicate 0.0249 0.0156 (0.0093) 0.0345 0.0199 (0.0146) 
5-trifluoromethylsalicylicate 0.0323 0.0259 (0.0064) 0.0462 0.0355 (0.0107) 
3,5-trifluoromethylsalicylicate 0.0305 0.0229 (0.0076) 0.0437 0.0311 (0.0126) 
3,4,5-trifluoromethylsalicylicate 0.0294 0.0214 (0.0080) 0.0421 0.0291 (0.0130) 
 Electron Donating Groups 
3-methylsalicylate 0.0332 0.0295 (0.0037) 0.0478 0.0419 (0.0059) 
4-methylsalicylicate 0.0327 0.0294 (0.0033) 0.0469 0.0416 (0.0053) 
5-methylsalicylicate 0.0334 0.0301 (0.0033) 0.0482 0.0428 (0.0054) 
6-methylsalicylicate 0.0333 0.0296 (0.0037) 0.0481 0.0419 (0.0062) 
3,5-dimethylsalicylicate 0.0317 0.0291 (0.0026) 0.0454 0.0414 (0.0040) 
4,6-dimethylsalicylate 0.0310 0.0284 (0.0026) 0.0443 0.0401 (0.0035) 
3,4,5-trimethylsalicilicate 0.0305 0.0282 (0.0026) 0.0436 0.0401 (0.0035) 
3,5-dimethoxysalicylicate 0.0271 0.0254 (0.0017) 0.0387 0.0360 (0.0027) 
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Table S9: Aromaticity indices according to the Iring and MCI aromatic descriptors computed on the free ligand 
(Lig) and aluminum-ligand complexes (Al-Lig). Relative aromatic changes from aluminum-bound to unbound 
state (∆arom. ) are also provided. Benzene is used as reference for an aromatic compound, ciclohexane for a non-
aromatic one. All indices are in a.u. 
 
 
 
 
Fig. S10: Electrostatic potential surfaces obtained from the SCF density calculated at the B3LYP-D3(BJ)/ET-
QZ3P-1DIFFUSE level of theory using the ADF2016 suite of programs. Red areas account for negative charge 
distribution (low potential, high electron density), while blue areas account for positive charge distribution 
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(high potential, low electron density). The introduction of a methyl group increases the electron density, while 
the introduction of a nitro group leads to the decrease of the electron density. In general, catecholates show 
higher electron density (covalent character) than salicylates. 
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“I come from down in the valley  
where mister when you're young  
They bring you up to do like your daddy done  
Me and Mary we met in high school  
when she was just seventeen  
We'd ride out of this valley down to where the fields were green” 
(B. Springsteen, The River) 
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Appendix B 
 
 Design of New Efficient Chelators of Aluminum Based on Mimosine Containing Peptides 
 
 
 Figure S1: Crystal structure of Al(III)-DFP3.  
 
 Figure S2: DFT structures of Al.DFP3 and Al.Pept93G.   
 
 Figure S3: RMSD of all Al-Peptide complexes. 
 
 Table S1: geometries on Al-DFP3 and Al.Pept93G structures. 
 
 Table S2: radius of gyrations computed on all QM/MM MD simulations. 
 
 Table S3: Average values of all possible OMim-Al-OMim angles. 
 
 Table S4-S11: all individual hydrogen bonds during the QM/MM MD simulations of the 
apoforms of the eight peptides.  
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Figure S1. Crystal structure of Al(III)-DFP3. Al-O distances (Å). 
 
 
 
 
 
 
 
 
Figure S2. DFT structures of Al(III)-DFP3 (left) and Al-Pept93G (right). 
 
  
APPENDIX B 
 
244 
 
 
  
  
  
  
 
Figure S3. Root mean square deviations (RMSD, in Å) computed on the QM/MM MD simulations. From left 
to right: Pept93G, Pept9GPG, Pept82G-3G and Pept83G-2G, Pept7, Pept6G-2G, Pept62G-G and Pept5. 
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   Al-DFP3 
Al-
Pept93G 
   X-ray DFT DFT 
 Atom1 Atom2    
 Al OC
A 1.924 1.951 1.943 
 Al OH
A 1.894 1.916 1.903 
 Al OC
B 1.923 1.946 1.990 
 Al OH
B 1.893 1.914 1.913 
 Al OC
C 1.923 1.945 1.954 
 Al OH
C 1.893 1.918 1.908 
Atom1 Atom2 Atom3  
Al1 OC
A CC
A 112.22 112.18 109.76 
Al1 OH
A CH
A 111.97 112.85 109.81 
Al1 OC
B CC
B 112.19 111.77 110.20 
Al1 OH
B CH
B 112.22 112.32 111.66 
Al1 OC
C CC
C 111.97 112.02 108.96 
Al1 OH
C CH
C 112.00 112.44 108.87 
OC
A Al CH
A 84,23 83.57 83.90 
OC
A Al CC
B 89,83 90.66 92.73 
OC
A Al CH
B 171,91 172.55 93.53 
OC
A Al CC
C 89,79 94.12 175.22 
OC
A Al OH
C 95.65 90.05 95.10 
OH
A Al OC
B 95.73 94.45 88.59 
OH
A Al OH
B 90,87 91.52 170.87 
OH
A Al OC
C 171,82 91.20 91.631 
OH
A Al OH
C 90,84 171.69 100.96 
OC
B Al OH
B 84,25 84.12 82.77 
OC
B Al OC
C 89,82 172.98 88.85 
OC
B Al OH
C 171,85 90.94 168.22 
OH
B Al OC
C 95,68 91.58 91.15 
OH
B Al OH
C 90,83 95.33 87.98 
OC
C Al OH
C 84,19 83.92 84.05 
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Table S1. Distances (in Å) and angles (in degrees) computed on the crystal structure of Al(III)-DFP3, and the 
DFT structures of Al(III)-DFP3 and Al-Pept93G. 
 
 
 Apoform Al(III)-Peptide 
Pept93G 7.68 (1.14) 6.78 (0.10) 
Pept9GPG 7.04 (0.97) 7.05 (0.11) 
Pept82G-
3G 
7.15 (1.01) 6.56 (0.09) 
Pept83G-
2G 
7.12 (0.92) 6.43 (0.12) 
Pept7 6.49 (0.77) 6.25 (0.11) 
Pept6G-2G 6.36 (0.69) 5.71 (0.15) 
Pept62G-G 6.43 (0.70) 5.89 (0.13) 
Pept5 5.90 (0.50) 5.32 (0.18) 
 
Table S2 Average and standard deviation (in Å) radius of Gyration computed along the QM/MM MD 
simulation trajectories of the apoform of the peptides in solution and Al-Pept complexes. 
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 Pept93G Pept9GPG 
Pept82G-
3G 
Pept83G-
2G 
Pept7 
Pept6G-
2G 
Pept62G-
G 
Pept5 
OCA-Al-
OOHA 
88.1 
(3.6) 
87.8 
(3.7) 
87.6 
(3.7) 
87.2 
(4.0) 
88.3 
(3.6) 
88.8  
(3.5) 
89.0  
(3.6) 
88.2 
(3.7) 
OCA-Al-
OCB 
91.5 
(8.1) 
93.7 
(7.9) 
98.8 
(8.1) 
86.0 
(7.8) 
92.6 
(16.5) 
101.7  
(27.1) 
126.8 
(9.2) 
129.4 
(25.7) 
OCA-Al-
OOHB 
90.6 
(8.6) 
87.5 
(8.3) 
84.8 
(7.6) 
103.6 
(25.5) 
134.9 
(35.0) 
93.1  
(8.4) 
112.3  
(10.6) 
129.5 
(16.8) 
OCA-Al-
OCC 
168.2 
(6.2) 
167.3 
(6.5) 
166.5 
(6.5) 
156.5 
(24.8) 
92.5 
(11.4) 
89.7  
(8.1) 
84.6  
(6.6) 
84.6 
(8.6) 
OCA-Al-
OOHC 
89.1 
(8.5) 
85.9 
(7.8) 
84.9 
(7.7) 
95.0 
(12.7) 
122.8 
(31.9) 
165.4  
(7.7) 
128.9  
(13.6) 
116.2 
(19.4) 
OOHA-
Al-OCB 
85.9 
(7.0) 
82.3 
(6.4) 
80.7 
(6.0) 
114.8 
(37.1) 
107.5 
(32.8) 
121.3  
(11.4) 
120.5  
(7.8) 
111.2 
(11.3) 
OOHA-
Al-
OOHB 
167.3 
(6.3) 
164.3 
(7.2) 
161.9 
(6.9) 
135.4 
(35.4) 
94.3 
(14.7) 
125.5  
(8.9) 
103.7  
(9.0) 
95.3 
(12.1) 
OOHA-
Al-OCC 
90.6 
(8.1) 
94.2 
(8.5) 
96.7 
(8.2) 
84.5 
(7.5) 
144.9 
(30.4) 
117.8  
(10.6) 
158.8  
(11.4) 
155.7 
(24.9) 
OOHA-
Al-
OOHC 
100.7 
(8.4) 
101.1 
(8.9) 
103.5 
(8.5) 
107.3 
(23.9) 
89.6 
(16.5) 
83.4  
(6.8) 
83.5  
(7.2) 
94.1 
(10.2) 
OCB-Al-
OOHB 
87.3 
(3.7) 
86.8 
(4.2) 
86.9 
(3.8) 
84.5 
(7.5) 
72.4 
(25.2) 
29.9  
(11.3) 
26.2 
(9.9) 
28.4 
(18.8) 
OCB-Al-
OCC 
91.8 
(9.4) 
92.7 
(9.0) 
89.1 
(8.5) 
107.1 
(25.8) 
98.6 
(17.3) 
111.7  
(17.2) 
77.2  
(10.7) 
86.5 
(23.8) 
OCB-Al-
OOHC 
167.3 
(6.2) 
168.3 
(6.3) 
168.1 
(6.1) 
127.2 
(42.8) 
135.6 
(36.1) 
87.7  
(25.4) 
98.7  
(9.4) 
103.5 
(12.5) 
OOHB-
Al-OCC 
91.3 
(7.9) 
91.8 
(7.9) 
92.6 
(8.0) 
89.3 (8.9 
) 
108.9 
(32.8) 
115.7  
(9.3) 
95.2  
(9.7) 
98.7 
(14.9) 
OOHB-
Al-
OOHC 
86.5 
(7.0) 
90.1 
(8.1) 
89.6 
(7.5) 
110.3 
(35.0) 
94.6 
(13.1) 
96.7  
(7.9) 
117.6  
(8.9) 
112.6 
(10.6) 
OCC-Al-
OOHC 
87.9 
(3.7) 
88.0 
(3.8) 
87.3 
(3.8) 
88.3 
(3.6) 
88.0 
(3.8) 
89.5  
(3.6) 
88.9  
(3.6) 
85.2 
(16.5) 
 
Table S3. Average values (and their standard deviations) of all possible OMim-Al-OMim angles computed along 
the standard MD simulation trajectories of the Al-Pept complexes. Since the indices of the three Mimosine 
residues differ on the systems, they are referred to as A, B and C for the first, central and last Mimosine in the 
corresponding sequence shown in Fig. 4.1.  
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
GLY_3@O GLY_5@H GLY_5@N 215 0.0108 2.8785 146.3374 
GLY_7@O GLY_9@H GLY_9@N 212 0.0107 2.8822 146.6055 
MIH_2@O GLY_4@H GLY_4@N 115 0.0058 2.9048 144.1116 
GLY_3@O GLY_7@H GLY_7@N 108 0.0054 2.8808 155.7838 
MIH_6@O GLY_8@H GLY_8@N 108 0.0054 2.9069 145.295 
GLY_4@O GLY_8@H GLY_8@N 105 0.0053 2.8992 148.6666 
GLY_7@O NME_11@H NME_11@N 103 0.0052 2.9102 158.7487 
GLY_5@O GLY_8@H GLY_8@N 88 0.0044 2.9053 151.2934 
MIH_6@O GLY_9@H GLY_9@N 83 0.0042 2.9332 149.4445 
MIH_2@O GLY_5@H GLY_5@N 79 0.004 2.9273 150.6268 
GLY_8@O GLY_5@H GLY_5@N 76 0.0038 2.8772 152.9991 
GLY_8@O MIH_10@H MIH_10@N 74 0.0037 2.8827 143.9258 
GLY_3@O MIH_6@H MIH_6@N 70 0.0035 2.9301 153.4352 
GLY_4@O MIH_6@H MIH_6@N 67 0.0034 2.8916 143.8881 
GLY_7@O MIH_10@H MIH_10@N 65 0.0033 2.9414 155.0316 
ACE_1@O GLY_4@H GLY_4@N 61 0.0031 2.9071 151.0677 
GLY_3@O GLY_8@H GLY_8@N 57 0.0029 2.8701 147.764 
GLY_4@O GLY_9@H GLY_9@N 47 0.0024 2.8802 150.0839 
GLY_9@O NME_11@H NME_11@N 40 0.002 2.9071 142.9866 
GLY_5@O GLY_7@H GLY_7@N 38 0.0019 2.9128 143.2313 
GLY_5@O GLY_9@H GLY_9@N 36 0.0018 2.8748 154.2794 
ACE_1@O GLY_8@H GLY_8@N 35 0.0018 2.8871 155.9333 
GLY_9@O GLY_4@H GLY_4@N 33 0.0017 2.8694 154.1742 
ACE_1@O GLY_3@H GLY_3@N 32 0.0016 2.9065 145.3006 
GLY_3@O GLY_9@H GLY_9@N 30 0.0015 2.885 148.2627 
GLY_3@O NME_11@H NME_11@N 25 0.0013 2.9134 159.6403 
GLY_9@O GLY_5@H GLY_5@N 23 0.0012 2.8768 153.1714 
GLY_4@O GLY_7@H GLY_7@N 19 0.001 2.9105 151.6243 
GLY_9@O GLY_3@H GLY_3@N 18 0.0009 2.8835 152.2386 
GLY_8@O GLY_4@H GLY_4@N 18 0.0009 2.8916 153.0775 
ACE_1@O GLY_5@H GLY_5@N 18 0.0009 2.8945 153.0308 
MIH_6@O MIH_2@H MIH_2@N 18 0.0009 2.9474 155.769 
ACE_1@O GLY_7@H GLY_7@N 16 0.0008 2.8653 156.489 
GLY_7@O GLY_4@H GLY_4@N 16 0.0008 2.91 160.0729 
GLY_8@O GLY_3@H GLY_3@N 14 0.0007 2.8735 154.0044 
ACE_1@O GLY_9@H GLY_9@N 10 0.0005 2.8745 155.7919 
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ACE_1@O NME_11@H NME_11@N 10 0.0005 2.8876 164.7855 
GLY_8@O NME_11@H NME_11@N 9 0.0005 2.8826 161.073 
GLY_5@O MIH_2@H MIH_2@N 9 0.0005 2.9112 159.5201 
GLY_7@O GLY_3@H GLY_3@N 9 0.0005 2.9287 147.5528 
GLY_9@O MIH_6@H MIH_6@N 9 0.0005 2.9326 161.5631 
GLY_5@O NME_11@H NME_11@N 8 0.0004 2.9105 152.8098 
MIH_6@O MIH_10@H MIH_10@N 8 0.0004 2.9398 149.5473 
MIH_6@O GLY_3@H GLY_3@N 7 0.0004 2.908 156.0943 
MIH_2@O MIH_10@H MIH_10@N 7 0.0004 2.9193 154.3373 
ACE_1@O MIH_10@H MIH_10@N 7 0.0004 2.9381 155.7219 
MIH_10@O GLY_7@H GLY_7@N 7 0.0004 2.9427 153.8193 
MIH_10@O GLY_4@H GLY_4@N 6 0.0003 2.8829 150.1012 
GLY_4@O MIH_10@H MIH_10@N 5 0.0003 2.8669 158.2397 
MIH_10@O MIH_6@H MIH_6@N 4 0.0002 2.8581 154.516 
GLY_4@O NME_11@H NME_11@N 4 0.0002 2.8599 164.25 
GLY_8@O MIH_6@H MIH_6@N 4 0.0002 2.9029 147.6096 
MIH_2@O NME_11@H NME_11@N 4 0.0002 2.9237 146.8696 
MIH_10@O GLY_5@H GLY_5@N 3 0.0002 2.861 147.852 
MIH_2@O GLY_8@H GLY_8@N 3 0.0002 2.8987 143.7901 
ACE_1@O MIH_6@H MIH_6@N 3 0.0002 2.9012 158.9874 
MIH_2@O MIH_6@H MIH_6@N 3 0.0002 2.929 145.2159 
MIH_2@O GLY_7@H GLY_7@N 3 0.0002 2.9306 151.2682 
GLY_7@O GLY_5@H GLY_5@N 3 0.0002 2.9482 164.0803 
GLY_8@O MIH_2@H MIH_2@N 3 0.0002 2.9585 151.8144 
GLY_7@O MIH_2@H MIH_2@N 2 0.0001 2.8744 145.217 
GLY_4@O MIH_2@H MIH_2@N 2 0.0001 2.9244 148.2908 
GLY_3@O MIH_10@H MIH_10@N 2 0.0001 2.9429 170.6483 
MIH_10@O MIH_2@H MIH_2@N 2 0.0001 2.9467 164.2435 
MIH_10@O GLY_3@H GLY_3@N 1 0.0001 2.9103 137.865 
GLY_9@O MIH_2@H MIH_2@N 1 0.0001 2.9395 144.758 
MIH_6@O NME_11@H NME_11@N 1 0.0001 2.9558 173.4173 
   Total 11.79   
 
Table S4. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept93G apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
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degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 11 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
 
Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
GLY_3@O GLY_7@H GLY_7@N 1958 0.1018 2.88 158.3044 
GLY_3@O MIH_6@H MIH_6@N 645 0.0335 2.9143 153.7117 
GLY_7@O NME_11@H NME_11@N 511 0.0266 2.8869 155.9729 
GLY_7@O MIH_10@H MIH_10@N 346 0.018 2.9199 155.4973 
PRO_4@O GLY_9@H GLY_9@N 174 0.009 2.8823 146.9834 
GLY_7@O GLY_9@H GLY_9@N 111 0.0058 2.8501 144.9871 
PRO_4@O MIH_6@H MIH_6@N 87 0.0045 2.8943 144.1337 
PRO_8@O MIH_10@H MIH_10@N 70 0.0036 2.8935 143.1248 
GLY_3@O GLY_5@H GLY_5@N 62 0.0032 2.8747 145.3162 
GLY_3@O NME_11@H NME_11@N 44 0.0023 2.8821 158.9585 
GLY_7@O GLY_3@H GLY_3@N 43 0.0022 2.9058 159.7418 
MIH_10@O GLY_5@H GLY_5@N 33 0.0017 2.9146 154.8955 
MIH_6@O GLY_9@H GLY_9@N 33 0.0017 2.9287 147.7181 
GLY_9@O GLY_3@H GLY_3@N 31 0.0016 2.8865 158.5505 
ACE_1@O GLY_9@H GLY_9@N 27 0.0014 2.868 151.8591 
MIH_2@O GLY_9@H GLY_9@N 27 0.0014 2.9029 153.7497 
PRO_4@O GLY_7@H GLY_7@N 26 0.0014 2.9099 150.8733 
GLY_9@O NME_11@H NME_11@N 25 0.0013 2.9142 142.2446 
ACE_1@O GLY_3@H GLY_3@N 24 0.0012 2.933 143.2126 
MIH_2@O MIH_10@H MIH_10@N 21 0.0011 2.9393 148.7389 
GLY_7@O GLY_5@H GLY_5@N 20 0.001 2.8781 151.2832 
MIH_10@O GLY_7@H GLY_7@N 17 0.0009 2.8736 154.7412 
GLY_9@O GLY_5@H GLY_5@N 15 0.0008 2.895 157.5342 
GLY_7@O MIH_2@H MIH_2@N 15 0.0008 2.8985 157.9786 
PRO_8@O NME_11@H NME_11@N 13 0.0007 2.8961 153.712 
GLY_5@O GLY_7@H GLY_7@N 13 0.0007 2.9011 144.3597 
PRO_4@O NME_11@H NME_11@N 12 0.0006 2.9109 158.0943 
MIH_2@O GLY_5@H GLY_5@N 12 0.0006 2.9299 147.889 
MIH_6@O GLY_3@H GLY_3@N 12 0.0006 2.936 152.2779 
PRO_4@O MIH_10@H MIH_10@N 11 0.0006 2.9064 155.0446 
MIH_10@O GLY_3@H GLY_3@N 11 0.0006 2.907 149.9275 
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GLY_3@O GLY_9@H GLY_9@N 11 0.0006 2.9311 148.8482 
MIH_10@O MIH_2@H MIH_2@N 10 0.0005 2.9149 151.3628 
GLY_3@O MIH_10@H MIH_10@N 8 0.0004 2.9028 151.6664 
MIH_10@O MIH_6@H MIH_6@N 8 0.0004 2.9356 156.3425 
MIH_6@O MIH_2@H MIH_2@N 7 0.0004 2.9368 152.4178 
MIH_2@O NME_11@H NME_11@N 7 0.0004 2.9508 145.2459 
ACE_1@O NME_11@H NME_11@N 6 0.0003 2.9075 159.0805 
GLY_5@O NME_11@H NME_11@N 6 0.0003 2.9109 152.9593 
GLY_9@O MIH_2@H MIH_2@N 4 0.0002 2.9145 150.8553 
PRO_8@O MIH_2@H MIH_2@N 3 0.0002 2.9136 160.2622 
GLY_9@O MIH_6@H MIH_6@N 3 0.0002 2.9233 157.5447 
MIH_2@O MIH_6@H MIH_6@N 3 0.0002 2.95 155.0058 
ACE_1@O GLY_7@H GLY_7@N 1 0.0001 2.7774 145.0489 
ACE_1@O MIH_10@H MIH_10@N 1 0.0001 2.8831 159.7035 
MIH_2@O GLY_7@H GLY_7@N 1 0.0001 2.9581 142.4575 
PRO_4@O MIH_2@H MIH_2@N 1 0.0001 2.9693 136.4532 
GLY_7@O MIH_6@H MIH_6@N 1 0.0001 2.9836 144.6059 
MIH_6@O MIH_10@H MIH_10@N 1 0.0001 2.9965 166.3753 
   Total 23.59   
 
Table S5. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept9GPG apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 11 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
GLY_6@O GLY_8@H GLY_8@N 248 0.0128 2.8873 145.1479 
GLY_6@O NME_10@H NME_10@N 210 0.0108 2.889 159.8586 
GLY_3@O GLY_7@H GLY_7@N 187 0.0096 2.8841 150.9704 
GLY_3@O GLY_8@H GLY_8@N 171 0.0088 2.8873 151.8764 
MIH_2@O GLY_4@H GLY_4@N 107 0.0055 2.9141 144.1075 
GLY_3@O MIH_5@H MIH_5@N 96 0.0049 2.9002 143.7966 
MIH_5@O GLY_8@H GLY_8@N 95 0.0049 2.9182 150.0832 
MIH_5@O GLY_7@H GLY_7@N 93 0.0048 2.8982 144.9737 
GLY_6@O MIH_9@H MIH_9@N 82 0.0042 2.9048 152.6675 
GLY_7@O MIH_9@H MIH_9@N 78 0.004 2.8999 144.4584 
GLY_4@O GLY_7@H GLY_7@N 66 0.0034 2.9005 148.7571 
MIH_2@O MIH_5@H MIH_5@N 66 0.0034 2.9291 154.457 
GLY_3@O GLY_6@H GLY_6@N 53 0.0027 2.9116 148.7328 
ACE_1@O GLY_4@H GLY_4@N 45 0.0023 2.8944 151.9484 
GLY_6@O GLY_3@H GLY_3@N 44 0.0023 2.891 158.822 
MIH_2@O GLY_6@H GLY_6@N 36 0.0019 2.9259 152.5658 
GLY_8@O NME_10@H NME_10@N 30 0.0015 2.9277 143.0043 
GLY_4@O GLY_6@H GLY_6@N 28 0.0014 2.904 145.7611 
ACE_1@O GLY_3@H GLY_3@N 27 0.0014 2.925 144.2819 
ACE_1@O GLY_8@H GLY_8@N 21 0.0011 2.9 157.7117 
GLY_7@O GLY_4@H GLY_4@N 18 0.0009 2.9207 151.1105 
GLY_4@O GLY_8@H GLY_8@N 17 0.0009 2.8906 153.0675 
MIH_2@O GLY_7@H GLY_7@N 16 0.0008 2.898 146.4786 
GLY_7@O GLY_3@H GLY_3@N 14 0.0007 2.8657 155.8258 
GLY_3@O MIH_9@H MIH_9@N 14 0.0007 2.9133 152.3677 
GLY_3@O NME_10@H NME_10@N 14 0.0007 2.9288 162.9838 
GLY_7@O MIH_2@H MIH_2@N 12 0.0006 2.8819 165.9856 
GLY_8@O GLY_3@H GLY_3@N 11 0.0006 2.8759 155.5976 
GLY_8@O GLY_4@H GLY_4@N 11 0.0006 2.8935 156.9359 
MIH_5@O MIH_2@H MIH_2@N 11 0.0006 2.9488 155.4122 
GLY_4@O MIH_9@H MIH_9@N 10 0.0005 2.8999 154.341 
GLY_7@O NME_10@H NME_10@N 10 0.0005 2.9141 147.8452 
MIH_9@O GLY_6@H GLY_6@N 9 0.0005 2.9176 146.6791 
ACE_1@O GLY_6@H GLY_6@N 7 0.0004 2.8864 163.9489 
GLY_4@O NME_10@H NME_10@N 7 0.0004 2.8937 158.9534 
ACE_1@O GLY_7@H GLY_7@N 6 0.0003 2.8577 149.7698 
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MIH_5@O MIH_9@H MIH_9@N 6 0.0003 2.8958 152.0844 
MIH_2@O GLY_8@H GLY_8@N 6 0.0003 2.9162 141.6467 
MIH_9@O GLY_3@H GLY_3@N 5 0.0003 2.9291 145.9894 
MIH_9@O MIH_5@H MIH_5@N 5 0.0003 2.9515 157.0493 
GLY_8@O MIH_2@H MIH_2@N 4 0.0002 2.8319 158.1465 
GLY_8@O MIH_5@H MIH_5@N 4 0.0002 2.8552 156.8847 
ACE_1@O NME_10@H NME_10@N 4 0.0002 2.8561 154.8016 
GLY_8@O GLY_6@H GLY_6@N 4 0.0002 2.9012 159.6242 
MIH_9@O GLY_4@H GLY_4@N 4 0.0002 2.9171 146.3207 
MIH_2@O NME_10@H NME_10@N 4 0.0002 2.9184 143.9855 
MIH_2@O MIH_9@H MIH_9@N 4 0.0002 2.933 160.2773 
ACE_1@O MIH_9@H MIH_9@N 3 0.0002 2.836 153.5137 
MIH_5@O NME_10@H NME_10@N 3 0.0002 2.9165 147.2706 
ACE_1@O MIH_5@H MIH_5@N 3 0.0002 2.9632 140.0127 
MIH_5@O GLY_3@H GLY_3@N 2 0.0001 2.7482 141.7097 
GLY_4@O MIH_2@H MIH_2@N 2 0.0001 2.9692 159.8182 
GLY_6@O GLY_4@H GLY_4@N 1 0.0001 2.9701 137.0208 
MIH_9@O MIH_2@H MIH_2@N 1 0.0001 2.9742 151.3305 
   Total 10.5   
 
Table S6. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept82G-3G apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 10 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
GLY_3@O GLY_7@H GLY_7@N 754 0.0371 2.8779 158.0234 
GLY_3@O GLY_8@H GLY_8@N 373 0.0184 2.8862 152.1049 
GLY_3@O MIH_6@H MIH_6@N 275 0.0135 2.9169 153.2689 
GLY_3@O GLY_5@H GLY_5@N 188 0.0093 2.8767 146.7852 
GLY_4@O GLY_8@H GLY_8@N 132 0.0065 2.8929 148.0462 
MIH_2@O GLY_4@H GLY_4@N 115 0.0057 2.9064 145.7169 
MIH_6@O GLY_8@H GLY_8@N 108 0.0053 2.9102 144.6828 
GLY_5@O GLY_8@H GLY_8@N 89 0.0044 2.8939 152.3736 
MIH_2@O GLY_5@H GLY_5@N 89 0.0044 2.9253 150.4109 
GLY_7@O MIH_9@H MIH_9@N 70 0.0034 2.8882 144.4823 
GLY_4@O MIH_6@H MIH_6@N 66 0.0032 2.8969 143.983 
MIH_6@O MIH_9@H MIH_9@N 63 0.0031 2.9374 153.1904 
GLY_4@O MIH_9@H MIH_9@N 53 0.0026 2.9069 151.0583 
GLY_8@O GLY_5@H GLY_5@N 51 0.0025 2.8768 157.1594 
ACE_1@O GLY_4@H GLY_4@N 40 0.002 2.9045 150.4863 
GLY_5@O GLY_7@H GLY_7@N 39 0.0019 2.9054 142.3242 
GLY_8@O NME_10@H NME_10@N 38 0.0019 2.8974 142.5205 
GLY_4@O NME_10@H NME_10@N 32 0.0016 2.8986 156.9252 
GLY_8@O GLY_4@H GLY_4@N 31 0.0015 2.8739 156.8424 
ACE_1@O GLY_3@H GLY_3@N 30 0.0015 2.9048 141.9304 
GLY_7@O GLY_4@H GLY_4@N 23 0.0011 2.8877 157.1277 
GLY_4@O GLY_7@H GLY_7@N 23 0.0011 2.9003 153.5001 
GLY_3@O NME_10@H NME_10@N 19 0.0009 2.9168 161.7408 
GLY_3@O MIH_9@H MIH_9@N 18 0.0009 2.8883 150.0677 
MIH_2@O MIH_9@H MIH_9@N 15 0.0007 2.9102 152.5233 
ACE_1@O GLY_8@H GLY_8@N 12 0.0006 2.8828 162.1359 
MIH_9@O GLY_4@H GLY_4@N 12 0.0006 2.9078 146.3489 
MIH_6@O NME_10@H NME_10@N 11 0.0005 2.9035 157.8823 
MIH_6@O GLY_3@H GLY_3@N 11 0.0005 2.9111 152.5976 
GLY_8@O GLY_3@H GLY_3@N 10 0.0005 2.8566 156.4978 
ACE_1@O NME_10@H NME_10@N 10 0.0005 2.8869 157.5946 
MIH_9@O MIH_2@H MIH_2@N 10 0.0005 2.93 157.4721 
MIH_2@O NME_10@H NME_10@N 9 0.0004 2.9107 155.7627 
MIH_9@O MIH_6@H MIH_6@N 9 0.0004 2.9145 155.2164 
MIH_9@O GLY_5@H GLY_5@N 8 0.0004 2.8747 149.6254 
GLY_8@O MIH_2@H MIH_2@N 8 0.0004 2.8939 161.4626 
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MIH_2@O MIH_6@H MIH_6@N 7 0.0003 2.9287 151.2034 
ACE_1@O GLY_5@H GLY_5@N 6 0.0003 2.8594 149.8754 
GLY_7@O NME_10@H NME_10@N 6 0.0003 2.9096 154.6404 
GLY_5@O MIH_2@H MIH_2@N 5 0.0002 2.8755 147.8595 
MIH_9@O GLY_3@H GLY_3@N 5 0.0002 2.917 148.1186 
GLY_7@O MIH_2@H MIH_2@N 5 0.0002 2.927 154.0848 
ACE_1@O MIH_9@H MIH_9@N 4 0.0002 2.8645 158.72 
MIH_2@O GLY_8@H GLY_8@N 4 0.0002 2.9498 163.5209 
MIH_2@O GLY_7@H GLY_7@N 3 0.0001 2.9018 143.1263 
ACE_1@O MIH_6@H MIH_6@N 3 0.0001 2.9166 154.1501 
GLY_8@O MIH_6@H MIH_6@N 3 0.0001 2.9461 144.9694 
GLY_7@O GLY_3@H GLY_3@N 2 0.0001 2.8768 148.5593 
MIH_6@O MIH_2@H MIH_2@N 2 0.0001 2.9286 155.9171 
ACE_1@O GLY_7@H GLY_7@N 2 0.0001 2.931 161.2361 
GLY_7@O GLY_5@H GLY_5@N 2 0.0001 2.9482 161.8298 
GLY_5@O MIH_9@H MIH_9@N 1 0 2.9257 163.0251 
GLY_5@O NME_10@H NME_10@N 1 0 2.9809 163.5218 
   Total 14.24   
 
Table S7. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept82G-3G apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 10 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
GLY_3@O GLY_7@H GLY_7@N 170 0.0092 2.8977 148.9097 
MIH_5@O GLY_7@H GLY_7@N 124 0.0067 2.9076 144.4154 
MIH_5@O MIH_8@H MIH_8@N 98 0.0053 2.9312 151.6136 
GLY_3@O MIH_5@H MIH_5@N 81 0.0044 2.899 144.4622 
MIH_2@O GLY_4@H GLY_4@N 81 0.0044 2.9005 145.4876 
GLY_6@O MIH_8@H MIH_8@N 76 0.0041 2.892 143.8784 
MIH_2@O MIH_5@H MIH_5@N 76 0.0041 2.9325 153.2701 
GLY_4@O GLY_7@H GLY_7@N 67 0.0036 2.9203 150.902 
ACE_1@O GLY_4@H GLY_4@N 59 0.0032 2.8874 149.5484 
GLY_3@O MIH_8@H MIH_8@N 57 0.0031 2.9194 151.9448 
MIH_2@O GLY_6@H GLY_6@N 42 0.0023 2.9079 156.0776 
GLY_4@O GLY_6@H GLY_6@N 34 0.0018 2.9045 144.2805 
GLY_3@O GLY_6@H GLY_6@N 32 0.0017 2.9055 148.7617 
GLY_7@O NME_9@H NME_9@N 32 0.0017 2.921 142.9699 
MIH_5@O NME_9@H NME_9@N 28 0.0015 2.9225 156.9073 
ACE_1@O GLY_3@H GLY_3@N 26 0.0014 2.9162 142.4152 
GLY_3@O NME_9@H NME_9@N 23 0.0012 2.9045 160.4789 
MIH_8@O GLY_4@H GLY_4@N 13 0.0007 2.8836 147.0329 
MIH_8@O MIH_2@H MIH_2@N 13 0.0007 2.9253 158.122 
MIH_8@O GLY_3@H GLY_3@N 11 0.0006 2.8877 148.3853 
GLY_6@O NME_9@H NME_9@N 11 0.0006 2.9268 153.3033 
ACE_1@O NME_9@H NME_9@N 10 0.0005 2.9177 160.3734 
ACE_1@O GLY_7@H GLY_7@N 9 0.0005 2.8705 157.9581 
GLY_7@O GLY_3@H GLY_3@N 9 0.0005 2.9412 155.5651 
GLY_4@O MIH_8@H MIH_8@N 8 0.0004 2.8788 153.2212 
MIH_5@O MIH_2@H MIH_2@N 8 0.0004 2.9329 160.2779 
MIH_2@O NME_9@H NME_9@N 7 0.0004 2.9017 153.7408 
MIH_8@O MIH_5@H MIH_5@N 7 0.0004 2.9077 147.7103 
MIH_2@O GLY_7@H GLY_7@N 7 0.0004 2.9253 145.9651 
GLY_4@O NME_9@H NME_9@N 6 0.0003 2.8417 147.9796 
GLY_7@O MIH_2@H MIH_2@N 6 0.0003 2.9405 153.85 
ACE_1@O MIH_8@H MIH_8@N 4 0.0002 2.8922 149.3166 
GLY_6@O GLY_3@H GLY_3@N 4 0.0002 2.9107 157.9424 
GLY_7@O MIH_5@H MIH_5@N 3 0.0002 2.9077 150.4977 
GLY_7@O GLY_4@H GLY_4@N 2 0.0001 2.8335 142.8448 
ACE_1@O MIH_5@H MIH_5@N 1 0.0001 2.7792 139.917 
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GLY_4@O MIH_2@H MIH_2@N 1 0.0001 2.9069 172.5264 
ACE_1@O GLY_6@H GLY_6@N 1 0.0001 2.9183 149.7025 
GLY_6@O GLY_4@H GLY_4@N 1 0.0001 2.9631 157.5588 
   Total 6.75   
 
Table S8. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept7 apoform with 
implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond donor 
hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected (note the 
total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given hydrogen bond 
was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in degrees). Note 
the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue ACE) and 9 
(residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are +1 with respect 
to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
MIH_4@O GLY_6@H GLY_6@N 151 0.0074 2.9008 143.0568 
MIH_2@O MIH_4@H MIH_4@N 131 0.0064 2.9108 142.9848 
GLY_3@O GLY_6@H GLY_6@N 110 0.0054 2.9042 151.6088 
MIH_4@O MIH_7@H MIH_7@N 88 0.0043 2.9415 153.682 
GLY_5@O MIH_7@H MIH_7@N 74 0.0036 2.9013 144.1374 
MIH_4@O NME_8@H NME_8@N 54 0.0027 2.9221 151.3264 
GLY_3@O GLY_5@H GLY_5@N 47 0.0023 2.8913 144.0601 
MIH_7@O MIH_2@H MIH_2@N 33 0.0016 2.9228 153.792 
MIH_2@O GLY_6@H GLY_6@N 32 0.0016 2.9318 145.408 
ACE_1@O GLY_3@H GLY_3@N 28 0.0014 2.8948 144.0492 
GLY_6@O NME_8@H NME_8@N 26 0.0013 2.9062 145.2781 
GLY_6@O MIH_2@H MIH_2@N 24 0.0012 2.9325 159.1319 
MIH_7@O MIH_4@H MIH_4@N 20 0.001 2.9205 157.7276 
GLY_5@O MIH_2@H MIH_2@N 16 0.0008 2.9169 155.0697 
ACE_1@O GLY_5@H GLY_5@N 13 0.0006 2.8988 153.3561 
GLY_6@O GLY_3@H GLY_3@N 11 0.0005 2.9025 153.1315 
GLY_3@O MIH_7@H MIH_7@N 10 0.0005 2.9396 152.6466 
MIH_7@O GLY_3@H GLY_3@N 8 0.0004 2.8474 152.7994 
GLY_6@O MIH_4@H MIH_4@N 8 0.0004 2.9232 155.8506 
GLY_5@O NME_8@H NME_8@N 8 0.0004 2.9491 150.2356 
MIH_2@O GLY_5@H GLY_5@N 6 0.0003 2.9148 144.6319 
ACE_1@O MIH_4@H MIH_4@N 6 0.0003 2.9418 155.3531 
MIH_4@O MIH_2@H MIH_2@N 5 0.0002 2.902 160.4888 
MIH_2@O NME_8@H NME_8@N 5 0.0002 2.9102 145.793 
MIH_2@O MIH_7@H MIH_7@N 5 0.0002 2.9584 148.6413 
GLY_3@O NME_8@H NME_8@N 1 0 2.8016 169.7221 
ACE_1@O NME_8@H NME_8@N 1 0 2.9319 141.9541 
MIH_7@O GLY_5@H GLY_5@N 1 0 2.9348 142.3034 
ACE_1@O GLY_6@H GLY_6@N 1 0 2.9541 147.8889 
   Total 4.5   
 
Table S9. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept6G-2G apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
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degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 8 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
MIH_5@O MIH_7@H MIH_7@N 127 0.0063 2.9082 144.9952 
MIH_7@O GLY_4@H GLY_4@N 124 0.0061 2.9123 147.5652 
MIH_2@O GLY_4@H GLY_4@N 121 0.006 2.9068 144.2411 
GLY_3@O MIH_5@H MIH_5@N 82 0.004 2.9095 143.6877 
MIH_2@O GLY_6@H GLY_6@N 82 0.004 2.9252 154.9145 
MIH_2@O MIH_5@H MIH_5@N 62 0.0031 2.9261 154.3665 
ACE_1@O GLY_4@H GLY_4@N 52 0.0026 2.9231 153.6765 
GLY_3@O NME_8@H NME_8@N 49 0.0024 2.8967 157.6187 
GLY_4@O GLY_6@H GLY_6@N 31 0.0015 2.9201 143.0025 
ACE_1@O GLY_3@H GLY_3@N 27 0.0013 2.9142 145.4752 
GLY_3@O MIH_7@H MIH_7@N 24 0.0012 2.9199 151.945 
MIH_7@O GLY_3@H GLY_3@N 21 0.001 2.9201 147.0023 
GLY_4@O MIH_7@H MIH_7@N 19 0.0009 2.9069 150.5797 
GLY_6@O NME_8@H NME_8@N 19 0.0009 2.9244 143.367 
GLY_3@O GLY_6@H GLY_6@N 16 0.0008 2.8923 149.3829 
MIH_5@O MIH_2@H MIH_2@N 13 0.0006 2.8781 152.0273 
MIH_5@O NME_8@H NME_8@N 9 0.0004 2.9257 146.0922 
ACE_1@O GLY_6@H GLY_6@N 9 0.0004 2.9469 152.4124 
ACE_1@O MIH_5@H MIH_5@N 7 0.0003 2.9539 158.3778 
MIH_7@O MIH_5@H MIH_5@N 6 0.0003 2.9163 156.5813 
GLY_4@O NME_8@H NME_8@N 6 0.0003 2.9287 157.2526 
MIH_7@O MIH_2@H MIH_2@N 5 0.0002 2.8991 151.8919 
ACE_1@O NME_8@H NME_8@N 3 0.0001 2.8847 154.2694 
MIH_2@O MIH_7@H MIH_7@N 2 0.0001 2.9162 157.6013 
GLY_4@O MIH_2@H MIH_2@N 2 0.0001 2.934 149.0547 
GLY_6@O GLY_4@H GLY_4@N 1 0 2.9444 137.7786 
   Total 4.49   
 
Table S10. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept62G-G apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 8 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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Acceptor DonorH Donor Frames Frac AvgDist AvgAng 
MIH_6@O MIH_2@H MIH_2@N 158 0.0079 2.9189 156.8119 
MIH_4@O MIH_6@H MIH_6@N 136 0.0068 2.9137 144.2391 
MIH_2@O MIH_4@H MIH_4@N 120 0.006 2.9172 143.5579 
MIH_6@O GLY_3@H GLY_3@N 101 0.0051 2.9067 148.0095 
GLY_5@O NME_7@H NME_7@N 31 0.0016 2.9042 144.3577 
GLY_5@O MIH_2@H MIH_2@N 29 0.0015 2.8944 153.3918 
ACE_1@O GLY_5@H GLY_5@N 25 0.0013 2.891 155.3835 
GLY_3@O GLY_5@H GLY_5@N 23 0.0012 2.9244 143.6728 
ACE_1@O GLY_3@H GLY_3@N 20 0.001 2.9083 145.2975 
ACE_1@O MIH_4@H MIH_4@N 14 0.0007 2.9484 154.6062 
MIH_4@O MIH_2@H MIH_2@N 13 0.0007 2.9373 145.0839 
GLY_3@O MIH_6@H MIH_6@N 8 0.0004 2.9423 161.4659 
MIH_6@O MIH_4@H MIH_4@N 6 0.0003 2.9324 151.7514 
MIH_2@O NME_7@H NME_7@N 5 0.0003 2.9603 138.5456 
MIH_2@O MIH_6@H MIH_6@N 2 0.0001 2.863 142.462 
MIH_2@O GLY_5@H GLY_5@N 2 0.0001 2.9528 164.4862 
GLY_3@O NME_7@H NME_7@N 2 0.0001 2.9804 154.6807 
MIH_4@O NME_7@H NME_7@N 2 0.0001 2.9916 154.4958 
   Total 3.52   
 
Table S11. List of all hydrogen bonds identified during the QM/MM MD simulation of the Pept5 apoform 
with implicit solvent. From left to right, the columns refer to: hydrogen bond acceptor atom, hydrogen bond 
donor hydrogen atom, donor heavy atom, number of frames in which a given hydrogen bond was detected 
(note the total number of frames is approximately 20000), fraction of time (from 0 to 1) in which a given 
hydrogen bond was detected, average donor-acceptor distance (in Å), and average donor-H-acceptor angle (in 
degrees). Note the accumulated lifetime is given at the end of the table. Note as well residue numbers 1 (residue 
ACE) and 7 (residue NME) correspond to the two terminal methyl groups, and therefore the residue IDs are 
+1 with respect to the residue IDs discussed in the main manuscript. 
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“Down in the shadow of the penitentiary 
Out by the gas fires of the refinery 
I'm ten years burning down the road 
Nowhere to run ain't got nowhere to go” 
(B. Springsteen, Born in the U.S.A) 
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Appendix C 
 
The interaction of aluminum with catecholamine-based neurotransmitters: can the formation 
of these species be considered a potential risk factor for neurodegenerative diseases? 
 
 
 Table S1: Binding enthalpies and free energies of 1:1, 1:2 ,1:3 Al-ligand complexes with 
MP2. 
 
 Table S2: Binding enthalpies and free energies of 1:1, 1:2, 1:3 Al-ligand complexes with the 
M06-2X functional. 
 
 Table S3: Binding enthalpies and free energies of 1:1, 1:2, 1:3 Al-ligand complexes with the 
ωB97XD functional. 
 
 Figure S1: Binding free energies of 1:1, 1:2, 1:3 Al-ligand complexes calculated with 
different methods compared with experimental stability constants (logβ). 
 
 Table S4: Characteristics of the Al-O Bond Critical Points (BCPs) and Delocalization Indices 
(D.I.Al − O). 
 
 
 Figure S2: Delocalization Indices compared with binding enthalpies for 1:1 Al-ligand 
complexes. 
 
 Table S5: Energy Decomposition Analysis (EDA) results. 
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  Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 log𝛽 
Ligands Protonated Amine 
L-DOPA 
1:1 -88.1 -92.6 16.0 
1:2 -160.6 -167.2 29.2 
1:3 -187.4 -193.6 38.4 
Dopamine 
1:1 -85.5 -88.4 15.6 
1:2 -148.9 -155.1 28.6 
1:3 -185.1 -193.3 37.6 
Noradrenaline 
1:1 -83.3 -87.4 15.6 
1:2 -144.3 -152.0 28.6 
1:3 -180.8 -191.7 37.9 
Epinephrine 
1:1 -83.3 -87.5 15.6 
1:2 -144.3 -152.0 28.6 
1:3 -181.7 -190.3 37.9 
Catechol 
1:1 -88.4 -91.4 16.3 
1:2 -152.4 -158.5 31.7 
1:3 -186.8 -195.4 41.1 
4-nitro Catechol 
1:1 -74.9 -79.1 13.3 
1:2 -130.2 -137.0 24.8 
1:3 -163.4 -173.3 33.7 
 
Table S1: Binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with available experimental stability 
constant (logβ) obtained with single point energy calculations at the MP2/6-311++G(3df,2p) - IEFPCM level 
of theory. 
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  Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 log𝛽 
Ligand Protonated Amine 
L-DOPA 
1:1 -87.7 -92.2 16.0 
1:2 -157.8 -164.5 29.2 
1:3 -182.7 -189.0 38.4 
Dopamine 
1:1 -85.1 -88.0 15.6 
1:2 -147.2 -153.4 28.6 
1:3 -180.5 -188.7 37.6 
Noradrenaline 
1:1 -83.1 -87.2 15.6 
1:2 -142.8 -150.5 28.6 
1:3 -176.5 -187.3 37.9 
Epinephrine 
1:1 -83.2 -87.3 15.6 
1:2 -142.8 -150.5 28.6 
1:3 -177.4 -186.0 37.9 
Catechol 
1:1 -88.1 -91.2 16.3 
1:2 -151.0 -157.0 31.7 
1:3 -182.7 -191.2 41.1 
4-nitro Catechol 
1:1 -73.2 -77.4 13.3 
1:2 -126.3 -133.1 24.8 
1:3 -155.4 -165.3 33.7 
 
Table S2: Binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with available experimental stability 
constant (logβ) obtained with single point energy calculations at the M06-2X/6-311++G(3df,2p) - IEFPCM 
level of theory. 
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  Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
 Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
 log𝛽 
Ligand Protonated Amine 
L-DOPA 
1:1 -88.7 -93.2 16.0 
1:2 -160.1 -166.7 29.2 
1:3 -185.1 -191.3 38.4 
Dopamine 
1:1 -86.2 -89.1 15.6 
1:2 -149.3 -155.5 28.6 
1:3 -182.9 -191.2 37.6 
Noradrenaline 
1:1 -84.1 -88.2 15.6 
1:2 -144.8 -152.5 28.6 
1:3 -178.6 -189.5 37.9 
Epinephrine 
1:1 -84.1 -88.2 15.6 
1:2 -144.7 -152.3 28.6 
1:3 -179.5 -188.1 37.9 
Catechol 
1:1 -88.7 -91.8 16.3 
1:2 -152.3 -158.4 31.7 
1:3 -184.1 -192.7 41.1 
4-nitro Catechol 
1:1 -74.7 -78.8 13.3 
1:2 -129.1 -135.9 24.8 
1:3 -160.1 -170.0 33.7 
 
Table S3: Binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
) and binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) with available experimental stability 
constant (logβ) obtained with single point energy calculations at the ωB97X-D/6-311++G(3df,2p) - IEFPCM 
level of theory. 
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Figure S1. Binding energies (Δ𝐺𝑎𝑞
𝑐𝑜𝑚𝑝
) calculated with dfferent functionals (B3LYP-D3(BJ, M06-2X, 
B97XD) and with the MP2 method compared with experimental stability constants (logβ). All single point 
calculations are performed using the 6-311++G/3df,2p) basis set on geometries optimized at the B3LYP-
D3(BJ)/6-31++G(d,p) level of theory. All calculations include solvation e#ects through the IEFPCM model. 
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Bader’s Quantum Theory of Aroms in Molecules (QTAIM) 
Delocalization indices are a measure of the average number of electron pairs shared between two 
atoms, therefore they have been related to the measure of the covalent character of a given bond. 
Results are reported in Table S4, while in Fig. S2 we represent the sum of the two D.I.Al-O of each 
bidentate complex versus their binding enthalpies (Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
). 
Delocalization indices of protonated catecholamines are slightly smaller than those of their 
unprotonated counterparts and of catechol, although differences are quite small. As previously 
hypothesized, this confirms the electron withdrawing effect mediated by the positively charged amino 
group (Fig. S2) that decreases the electron density from the two Al-O bonds. This effect, in turn, 
lowers the covalent character of these interactions, leading to lower binding enthalpies (Fig. S2). In 
both N-protonated and N-unprotonated cases, noradrenaline and adrenaline show smaller D.I.Al-O and 
smaller binding affinities than L-DOPA, dopamine and catechol; this is due to the presence of an EW 
hydroxyl group in noradrenaline and adrenaline. Interestingly, N-unprotonated neurotransmitters L-
DOPA and dopamine bear higher D.I.Al-O than catechol. While, as discussed before, L-DOPA bears 
a higher total negative charge (-3) which is the main responsible of the stronger binding affinity to 
aluminum, in the case of dopamine the inductive ED effect of the alkyl chain increases the covalency 
of its Al-O interactions compared to catechol (table S4). Despite the unprotonated dopamine also 
contains an EW group (NH2), the effect of the alkyl chain prevails leading to an overall electron 
donating behavior. The addition of a second EW group such as OH, in addition to NH2, in the alkyl 
chain of noradrenaline and adrenaline shifts the overall behavior to an electron withdrawing one, 
making these two compounds the poorest aluminum binders in both protonated and unprotonated 
forms (Table S4). 
Finally, it is important to mention that 4-nitro catechol shows the lowest D.I.Al-O values as well as the 
lowest binding enthalpy (Table S4 and Fig. S2) in our dataset. As thoroughly discussed in our 
previous work, the EW nitro group added to an aromatic ring works through both inductive and 
resonance mechanisms of action, with resonance that prevails over induction. Therefore, the overall 
electron withdrawing nature of NO2 is much more pronounced than than the inductive ones mediated 
by OH and/or NH2 in catecholamines (Fig. S2). 
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 Al-O1 Al-O2 D.I. (a.u.) 
Ligand 𝜌(𝐵𝐶𝑃) ∇
2𝜌(𝐵𝐶𝑃) 𝐻(𝐵𝐶𝑃) 𝜌(𝐵𝐶𝑃) ∇
2𝜌(𝐵𝐶𝑃) 𝐻(𝐵𝐶𝑃) Al-O1 Al-O2 
Catecholamines with Protonated Amines   
L-DOPA 0.0845 0.5174 -0.0074 0.0856 0.5260 -0.0077 0.2221 0.2199 
Dopamine 0.0854 0.5241 -0.0077 0.0843 0.5160 -0.0073 0.2218 0.2200 
Noradrenaline 0.0841 0.5143 -0.0072 0.0849 0.5205 -0.0075 0.2198 0.2188 
Adrenaline 0.0850 0.5210 -0.0075 0.842 0.5154 -0.0073 0.2204 0.2194 
Catecholamines with Unprotonated Amines   
L-DOPA 0.0849 0.5207 -0.0075 0.0860 0.5283 -0.0079 0.2236 0.2216 
Dopamine 0.0860 0.5287 -0.0078 0.0848 0.5195 -0.0075 0.2239 0.2212 
Noradrenaline 0.0856 0.5255 -0.0077 0.0847 0.5192 -0.0074 0.2220 0.2207 
Adrenaline 0.0856 0.5254 -0.0077 0.0847 0.5189 -0.0074 0.2224 0.2209 
Catecholate 0.0858 0.5271 -0.0078 0.0847 0.5193 -0.0074 0.2228 0.2208 
4-nitro catechol 0.0846 0.5189 -0.0073 0.0802 0.4838 -0.0062 0.2183 0.2065 
 
Table S4. Characteristics of the Al-O Bond Critical Points (in a.u.) for the aluminum-chelator interactions: the 
electron density at the BCP (𝜌(𝐵𝐶𝑃)), the Laplacian of electron density (∇
2𝜌(𝐵𝐶𝑃)), and the total energy density 
at the BCP (𝐻(𝐵𝐶𝑃)). All structures were optimized and refined at the B3LYP-D3(BJ)/6-311++G(3df,2p) level 
of theory as reported in the methods section. All calculations take into account implicit solvent effects 
according to the IEFPCM formalism. 
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Figure S2. Sum of the delocalization indices of the two Al-O bonds in 1:1 Aluminum-Catechol/Catecholamine 
complexes versus their values of Δ𝐻𝑎𝑞
𝑐𝑜𝑚𝑝
. 
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Structure Δ𝐸𝑒𝑙𝑠𝑡𝑎𝑡 (%) Δ𝐸𝑜𝑖 (%) Δ𝐸𝑃𝑎𝑢𝑙𝑖 Δ𝐸𝑑𝑖𝑠𝑝 Δ𝐸𝑖𝑛𝑡 
Catecholamines with Protonated Amines   
L-DOPA -573.5 (62.3) -346.5 (37.7) 146.6 -6.6 -779.8 
Dopamine -434.5 (57.3) -323.7 (42.7) 142.0 -6.5 -622.7 
Noradrenaline -442.4 (58.5) -313.3 (41.5) 141.8 -6.5  -620.4 
Adrenaline -451.6 (58.9) -314.5 (41.1) 143.0 -6.5 -629.7 
Catecholamines with Unprotonated Amines   
L-DOPA -691.3 (64.5) -380.3 (35.5) 150.2 -6.6  -927.9 
Dopamine -587.4 (63.1) -343.4 (36.9) 148.8 -6.5 -788.6 
Noradrenaline -585.1 (63.0) -343.6 (37.0) 147.9 -6.5 -787.2 
Adrenaline -578.7 (62.4) -348.0 (37.6) 147.6 -6.5 -785.7 
Catecholate -610.4 (64.9) -329.7 (35.1) 149.9 -6.5 -796.7 
4-nitro catechol -647.1 (72.4) -247.1 (27.6) 147.2 -6.5 -753.5 
 
 
Table S5. Energy Decomposition Analysis, values obtained at the full electron (no frozen core) B3LYP-
D3(BJ)/ET-QZ3P-1DIFFUSE level of theory in gas phase, using the ADF2017 modeling suite of programs. 
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